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ABSTRACT
Basal cortisol activity is postulated to be elevated in individuals with central obesity yet
this elevation is not mirrored in the basal diurnal cortisol profile. Individuals with
central obesity may demonstrate an enhanced clearance capability evidenced by
elevated urinary cortisol metabolites, hence basal salivary cortisol levels appear normal
or reduced. Those with central obesity have been found to demonstrate an elevated
cortisol response to psychological stress due to dysregulation of the HPA axis.
Cognitive decrement has been observed in individuals with central obesity who show
insulin resistance, high blood pressure and other features of the metabolic syndrome,
however, research to date has failed to address the collective influence of elevated
cortisol and metabolic risk factors on cognitive performance. A study was conducted
(n=83) to explore the basal diurnal cortisol profile in those with central obesity (high
waist-hip ratio) compared to those without (low waist-hip ratio). The findings
demonstrated that profiles exhibited by high waist-hip ratio individuals mirrored those
exhibited by low waist-hip ratio individuals, although mean cortisol was reduced. A
subsequent study (n=70) explored cortisol responses to a psychosocial stressor (The
Trier Social Stress Test-TSST). High waist-hip ratio individuals exhibited greater
cortisol during stress induction (TSST) than low waist-hip ratio individuals. Both the
stress induction procedure and actual stress responses (cortisol and blood pressure)
reduced performance on the Auditory Verbal Learning Task (AVLT). Performance on a
paired associates learning task was impaired in high waist-hip ratio males who
demonstrated a cortisol and/or blood pressure (BP) response to the stressor/no stressor.
Impairment was further evident in high waist-hip ratio males who demonstrated a
cortisol and/or BP response to the stress induction. The findings presented in this thesis
suggest that individuals with central obesity exhibit altered basal and stress induced
cortisol which may contribute along with metabolic factors, to cognitive impairment.
Finally, it was observed that differences in the shape of the diurnal cortisol profiles were
attributable to various psychological and metabolic characteristics. Flattened profiles
(non-classic), which have been associated with non-compliance, were associated with
greater subjective reporting of stress, intensity of daily hassles, poorer sleep quality and
more severe metabolic syndrome symptomology. This highlights the usefulness of the
basal profile in determining individual vulnerability to stress and poorer health. In
conclusion, diurnal cortisol, central obesity and markers of metabolic syndrome may
interact to influence hippocampal memory function.
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Chapter One: Literature Review
CHAPTER ONE
Literature Review
The aim of this thesis is to explore stress responsivity in an older adult sample in
relation to central obesity and the impact of these factors on cognitive performance.
This chapter considers the relevant literature upon which this research question is based.
The review begins with an introduction to the concept of psychosocial stress and the
biological systems involved in producing and regulating a stress response. The review
pays particular attention to the activity of the stress hormone cortisol and its role in the
stress response. The basal activity of cortisol is explored, in addition to associated
variables that interact with cortisol activity. These included; perceived stress, sleeping
behaviour, immunity, gender, and age. The review briefly explores the methods
implemented in stress research and the potential for response habituation. The focus
subsequently turns to the role of cortisol in central obesity and in the expression of the
metabolic syndrome. Finally, the potential for cortisol, central obesity, and metabolic
syndrome symptomology to influence cognitive performance is examined.
1.1 Stress
It is important to explore the fundamental stress response and the systems of regulation
in order to appreciate the role of cortisol.
1.1.1 Psychological Approaches to Stress
Stress arises when individuals perceive that they cannot adequately cope with the
demands being made on them or with threats to their well-being (Lazarus, 1966). A
stressor is a stimulus that can elicit a psychological or physiological response. This
external stimulus can be physical (actual threat or danger) or psychological (job strain,
loss of a loved one etc). The internal representation of this stressor contributes to an
overall perception of the stressor and dictates whether a response will ensue. This can
manifest in the form of mental strain or actual physical harm (depending on the
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interpretation of the stressor for example, using past experience), emotional and
defensive responses, and the initiation of coping strategies where necessary. These
factors collectively determine the reaction of the body to the stressor i.e. the stress
response. The response to a stressor is dependent on the psychological appraisal of the
stimulus for example, is the stressor is perceived as a threat? Dangerous? Harmful? If an
individual copes effectively with stress exposure then little or no physiological stress
response should be observed (Holroyd and Lazarus, 1982; Vogel, 1985). Similarly, if no
stress response is observed then it is presumed that the individual is coping effectively
(Levine, 1978).
Walter Cannon (1928) introduced the concept of 'homeostasis' or the maintenance of a
stable internal environment. This concept views the response to stress as a regulatory
system that allows itself to adapt in order to maintain stability. Cannon (1928) coined
the phrase 'fight or flight' to account for the ability of the body to cope in emergencies
by using one of two options; fight or flight in the response to a stressor. The 'fight or
flight' approach formed the basis for Hans Selye's General Adaptation Model of stress
(GAS) in the 1970's (Selye, 1974; 1979). This theory was the first to explore the
response to stress from a biological and psychological perspective. The GAS model is
based on four fundamental ideas. The first concerns the body's drive for stability of the
internal system (homeostasis). The second concerns the ability of external stressors to
disrupt the internal equilibrium of the body and induce a response. Third, is a period of
resistance or adjustment to the stressor (which could be short or long). Fourth and
finally, the body may reach exhaustion due to depleted energy resources and can no
longer cope with the imposing stressor with potentially fatal consequences. This stage is
not always reached but if energy resources are depleted then the organism may be more
susceptible to illness and disease as energy resources are not replenished. The main
biopsychological systems involved in the response to stress are outlined below.
1.1.2 Biological Systems in the Stress Response
The human nervous system branches primarily into the central nervous system (CNS;
brain and spinal cord) and the peripheral nervous system (PNS). The peripheral nervous
system branches into two sub-components, the autonomic nervous system (ANS) and
the somatic nervous system (SNS).
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The ANS can be sub-divided into the sympathetic nervous system and the
parasympathetic nervous system, both of which are implicated in the response to stress.
The two-system view of the response to stress is based on the interaction between the
HPA axis (hypothalamic-pituitary-adrenal axis) and ANS (Stanford and Salmon, 1993).
The hypothalamus in the brain initiates the response through secretion of corticotrophin
releasing factor as a signal to the anterior pituitary gland. The pituitary responds by
releasing adrenocorticotrophin hormone (ACTH) and beta-endorphin (to mediate mood
with analgesic properties). This change in endocrine status (ACTH) is detected by the
adrenal glands and promotes the synthesis and release of glucocorticoids, corticosterone
in animals and more importantly in humans, cortisol (Figure 1.1). Cortisol acts as the
major chemical messenger in the HPA axis. Secreted in response to stress from the
adrenal glands, cortisol is the key component in the negative feedback loop that
regulates HPA activity. Elevated cortisol detected by the hypothalamus signals for a
reduction in the activity of the response mechanism and thus can signal the end of the
response.
Hypothalamus
Secretes corticotrophin releasing hormone
(CRH)
Anterior Pituitary Gland
Detects CRH and releases ACTH
(adrenocorticotrophin hormone) and beta
endorphin
Adrenal Glands
Stimulate release of
Clucocorticoids
jJ jt
Cortisone Cortisol
(Animals) (Humans)
Figure 1.1:Diagrammaticrepresentationof the HPAAxis
There is evidence for the importance of the hippocampus in the feedback regulation of
the HPA axis (Jacobsen and Sapolsky, 1991) due to the observation of the corticosteroid
receptors; Type 1 (MR) and Type 2 (GR) receptors. Type 1 (MR) have a low affinity for
glucocorticoids (cortisol) and only respond when cortisol is in low concentrations. MR
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receptors are postulated to be important for the efficient regulation of the HPA axis.
Type 2 receptors (GR) have a high affinity for glucocorticoids (cortisol) and respond
when concentrations are high (De Kloet and Reul, 1987; Reul and De Kloet, 1985).
Chronic stress can result in the over-activation of GR receptors which consequently
overrides the effect of MR receptors when controlling the HPA axis.
In addition to the activation of the HPA axis, stressors also activate the sympathetic
nervous system to increase the amount of available norepinephrine and epinephrine
from the adrenal medulla. In times of stress, the body is prepared for action through
stimulation of the mechanisms of priority for efficient coping. This results in an
increase in the activity of the respiratory and cardiovascular systems whilst
simultaneously reducing the activity of the gastrointestinal system and reproductive
system. The hypothalamus secretes corticotrophin releasing factor as an alert to the
adrenal glands to increase the production of the stress hormone epinephrine to allow for
an increase in energy availability increasing stress responsivity.
1.1.3 Allostasis & Allostatic Load
Traditional views of stress and the systems that respond to stress have been more
recently reconceptualised as the concept of allostasis. Allostasis defines the response to
stress as an adaptive process that involves the activation of neuroendocrine and
neuroendocrine-immune mechanisms (McEwen, 1998). In the short term, activating
these mechanisms promotes internal stability and coping in the presence of a stressor.
When these systems are chronically initiated, over a considerable period of time,
damage can occur. This repeated activation results in a state of health which is referred
to as 'allostatic load' (McEwen, 1998). The development of an 'allostatically loaded'
state can occur as a result of one of (or a combination of) three experiences of stress
dysregulation (McEwen and Wingfield, 2003). Type 1 involves frequent exposure to
stress; hence, the manifestation and degree of allostatic load consequently depends on
the frequency and intensity of the episodes of stress. Alternatively, a failure to cease the
action of associated neural and endocrine response mechanisms can produce a state of
allostatic load (Type 2) and finally, Type 3 involves a failure of the system to respond
appropriately resulting in an under-response. These are all instances of failure within
each associated system to adapt and as a result, subsequently increase the probability
that stress related disease and impairments will result. Research highlights that a
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primary factor in this outcome is the secretion of glucocorticoids (cortisol) (McEwen
and Wingfield, 2003).
1.2 The Fundamentals of Cortisol Activity
Cortisol is the primary output from the HPA axis and is the primary marker of stress
responsivity. For this reason, this thesis focuses on the activity of cortisol as a marker of
stress exposure and stress response in the centrally obese. The following sections
explore the fundamentals of cortisol and related behaviours.
1.2.1 What is Cortisol?
Cortisol is a corticosteroid hormone. Corticosteroids can be subdivided into
mineralcorticoids e.g. aldosterone and glucocorticoids e.g. cortisol. Glucocorticoids are
steroid hormones secreted by the adrenal glands, which chiefly promote the conversion
of fats and proteins to glucose and glycogen for energy. Cortisol has a small molecular
weight (362), is made from cholesterol, and is highly lipid soluble and poorly water-
soluble. Research has identified glucocorticoid receptor sites in abundance in almost
every cell ofthe body, enabling cortisol to have widespread effects. Hence, cortisol has
the ability to influence in some way every major organ in the body and is responsible
for normal organic and metabolic functioning (Munck et al., 1984). One of the ways in
which this is achieved is through the hormonal regulation of gluconeogenesis. In times
of stress, elevated cortisol levels potentiate the activity of the sympathetic nervous
system and have a profound effect on glucose metabolism. The release of stored glucose
and fats is increased and proteins are converted to increase energy availability. More
specifically, cortisol signals for the breakdown of muscle protein leading to the release
of amino acids into the bloodstream. Subsequently these amino acids are synthesised by
the liver in order to synthesise glucose for energy in the process of gluconeogenesis
(Miller and Tyrell, 1995). Cortisol is vital to the maintenance of normal functioning but
at extremes (too little or too much) exposure to cortisol can have negative effects.
Extremely elevated cortisol has been associated with blocking the action of insulin in
taking up excess glucose which promotes the storage of energy in the form of fat. This
fat is stored around the abdomen resulting in the development of central obesity which
is accompanied by many problematic health consequences (Bjomtorp, 1997). Elevation
of cortisol naturally results in an increase in gluconeogenesis, an elevated rate of
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glucose production and ultimately the development of glucose intolerance concurrent
with metabolic syndrome symptomology (Levitt et al., 2000) (see Section 1.5.2).
1.3 Basal Circadian Activity of Cortisol
Aside from stimulated activity, cortisol also exhibits a natural stable circadian rhythm
comprising a cortisol awakening response and subsequent diurnal activity. This is
discussed in the next section.
1.3.1 Cortisol Awakening Response (CAR)
The transition from a sleeping state to an awakened state is characterised by a sharp
burst in HPA activity indicated by increased ACTH and by elevations in cortisol
secretion (Born et al., 1999). This response is initiated to prepare the body for the
metabolic demands of the day in the transition from a rested state to an active phase
(PrUssner et al., 1997). Cortisol commonly exhibits a 2-3 fold increase in most
individuals during the first 30 to 45 minutes following waking (Edwards et al., 2001;
Hucklebridge et al., 1998; PrUssner et al., 1997) before declining steadily to exhibit a
stable diurnal profile (Figure 1.2). Cortisol demonstrates an average increase of9nmol/l
within a range of 4-15nmol/l (Clow et al., 2004) during the awakening response.
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Figure 1.2: Example of a typical Basal Cortisol Diurnal Profile (taken from S.Edwards et al. /
Life Sciences 68 (2001) 2093-2103)
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Individuals can be characterised by their daily basal cortisol diurnal profile which can
be associated with a number of factors, for example time of awakening (Edwards et al.,
2001) and may also be predictive of general health (Roberts et al., 2004; Sapse, 1997;
Smyth et al., 1997). Dettenborn et al. (2005) found that those at familial risk of breast
cancer exhibited heritable cortisol responses to waking, whereas diurnal cortisol activity
appeared not to be under genetic control. The cortisol awakening response has also been
shown to be sensitive to factors such as bum out (Prussner et al., 2003; See Section
1.3.2. part vi.), and chronic fatigue (Kudielka and Kirschbaum, 2003). Additional
factors associated with the basal cortisol response to waking are discussed in the next
section.
1.3.2 Factors related to the Cortisol Awakening Response:
The cortisol response to waking may not be exclusively related to HPA activity. This
section explores factors associated with the response and the extent of their influence.
i. Blood Glucose
As the cortisol awakening response is presumed to be a preparation process of the body
for the metabolic demands of the day, it was initially hypothesised that an increase in
awakening cortisol is both concurrent with and results from low fasted blood glucose
(Bamberger et al., 1996). This was supported by the role of cortisol in the process of
gluconeogenesis (Miller and Tyrell, 1995). Thus, it could be hypothesised that lower
glucose levels at waking should result in a greater cortisol awakening response.
However, Hucklebridge et at. (1999) found no association between the cortisol
awakening response and blood glucose levels. It is clear that cortisol is closely
associated with changes in blood glucose. However support for the role of blood
glucose in the cortisol awakening response is not as well established as for the influence
of blood glucose on cortisol responses to stress. A relationship between blood glucose
and cortisol responses to the Trier Social Stress Test, a psychological stress induction
technique (TSST, Kirschbaum et al., 1993: See Chapter Three, Section 3.4) has been
demonstrated. Kirschbaum et at. (1997) found that glucose response positively
correlated with cortisol responses during exposure to the TSST. In addition, elevation of
blood glucose following a glucose load initiates a normal cortisol response to stress.
Further, individuals in the low euglyceamic range (low blood glucose) often fail to
initiate a substantial cortisol response when confronted with a stressor (Kirschbaum et
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al 1997). However this does not concur with the relationship between blood glucose and
the cortisol awakening response. Hucklebridge et al. (1999) found that individuals who
had low blood glucose at waking were still capable of demonstrating a substantial
cortisol response on waking. It appears then, that no correlation exists between cortisol
awakening responses and stress responses (Schmidt-Reinwald et al., 1999) particularly
when changes in blood glucose are considered. It is possible, therefore, that the cortisol
awakening response is governed by a regulatory system that is distinct from that
involved solely in HPA activity.
ii Waking time and Sleep
Based on the hypothesis that the cortisol awakening response may not be solely
governed by the HPA axis, research has suggested alternative systems that may exert
some influence over the cortisol response to waking. One prominent system of interest
is that which governs sleep, mediated largely by the Suprachiasmatic nucleus (SCN) in
the hypothalamus, the same region that regulates the secretory activity of the pituitary
and adrenal glands controlling ACTH and cortisol secretion (Van Cauter and Turek,
1995). This theory proposes that cortisol secretion is linked to the sleep-wake cycle.
Research has highlighted the consistency between the circadian rhythmicity of ACTH
and cortisol with patterns of sleep and waking in that cortisol is low during nocturnal
sleep and the second half of nocturnal sleep is characteristic of increasing HPA activity
(Weitzman et al., 1971). The activity of ACTH is consistent with this (Horrocks et al.,
1990) and it has been suggested that the simultaneous increase in cortisol and ACTH
combined with rapid eye movement sleep (REM) initiates spontaneous waking (Born et
al., 1999; Spath-Schwalbe et al., 1992) followed immediately by the cortisol awakening
response.
Cortisol and sleep are closely associated. Cortisol infusions during sleep can influence
sleep patterns, affecting the amount oftime spent in specific cycles of sleep (Born et al.,
1989; Freiss et al., 2004). Born et al. (1989) observed that cortisol infusions decreased
the amount of REM sleep. This is consistent with previous observations of lowered
cortisol indicative of diminished adrenocortical activity during REM sleep (Follenius et
al., 1992). Prinz et al. (2000) found that higher cortisol was associated with an earlier
awakening time and less REM sleep in healthy older adults. Moreover, cortisol levels
appear to be inhibited by slow wave sleep (Bierwolf et al., 1997; Brandenberger et al.,
9 Chapter One: Literature Review
1996; Scheen et al., 1996; Seifritz et al., 1995; Weitzman et al., 1983) and cortisol
levels are stimulated through sleep disturbance (Vgontzas et al., 1999).
Sleep disturbance can influence cortisol activity on the subsequent day. For example,
Backhaus et al. (2004) found a negative correlation between the cortisol awakening
response and subjective rating of sleep quality. Lower cortisol immediately after waking
correlated with a higher frequency of nightly awakenings and diminished sleep quality.
However, the direct influence of sleep quality on the cortisol awakening response is
under question and many studies have failed to find an effect. Hucklebridge et al. (2000)
explored the effect of nocturnal waking on the subsequent cortisol awakening response
and found no evidence of a direct impact. Similarly, Waye et al. (2004) found no effect
of noise interruption during sleep on the subsequent cortisol awakening response. Some
studies indicate that it is the remaining diurnal profile of cortisol that is most open to
influence from such disturbances. For example, Leproult et al. (1997) found that partial
sleep loss resulted in more elevated cortisol the following evening and suggested that
sleep loss specifically affects HPA recovery during the circadian rhythm.
In addition to sleep quality, there is also evidence that the time of waking can influence
subsequent cortisol activity in addition to (and often related to) sleep duration. There is
evidence to suggest that individuals active in the morning hours demonstrate a greater
elevation in salivary cortisol during the cortisol awakening response when compared to
those active in the evening (Bailey and Heitkemper, 1991). Edwards et al. (2001)
observed that early awakeners also exhibit more elevated cortisol levels throughout the
remainder of the diurnal cycle despite showing a steeper decline when compared to late
awakeners. Data concerning the duration of sleep was however, not collected in this
study and whether those waking earlier experienced shorter sleep duration could not be
ascertained. Some individuals can exhibit a more elevated cortisol awakening response
from a shorter period of sleep (Spath-Schwalbe et al., 1992; WUst et al., 2000b).
However, PrUssner et al. (1997) failed to find any association between sleep duration
and subsequent cortisol awakening responses.
It is clear that a close relationship exists between cortisol and patterns of sleep and
waking. This relationship appears to be mediated via the Suprachiasmatic nucleus
(SCN) in the hypothalamus. There is direct evidence that specific neural pathways
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connect the SCN with the adrenal cortex (Buijs et aI., 1993; 1997; 1998; 1999; Dijkswa
et aI., 1996; Kalsbeek et aI., 1992; 1996). The SCN-HPA pathway may exert a
regulatory influence over the cortisol awakening response in relation to patterns of sleep
and waking. This is supported by the observed dissociation between cortisol and ACTH
during the morning cortisol peak which implies that it is not simply the HPA axis that is
involved (Born et aI., 1999; Fehm et aI., 1984; Spath-Schwalbe et aI., 1991; Thorn et al.,
2004). These findings contribute to the growing body of evidence which suggests that
the cortisol awakening response and subsequent diurnal cortisol activity are independent
(see Chapter Five, Section 5.5.3.4).
iii. Immune activity
The cortisol awakening response has additionally been postulated to modulate the
balance between cellular and humoral immunity. Cellular or Type I immunity involves
'cytotoxic' or cell destroying cells for intracellular organisms for example, viruses.
Humoral or Type 2 immunity involves antibody secretion for extracellular organisms.
(Petrovsky et al., 1997; Visser et aI., 1998). Elevations in cortisol could mediate the
change of night time Type 1 activity to daytime Type 2 activity (Edwards et aI., 2003).
Abnormal cortisol profiles have been associated with certain pathologies including
cancer and AIDS (Sapse, 1997). Flattened profiles (a blunted cortisol awakening
response coupled with normal or elevated diurnal cortisol) have been found to be
predictive of earlier mortality particularly in breast cancer patients (Sephton et al.,
2000). These associations are presumed to occur as a result of suppressed anti-tumour
cell activity of immune natural killer (NK) cells. However, Smyth et al. (1997)
concluded that flattened profiles may be predictive of fewer pathological conditions.
Thus, profiles of cortisol activity may reflect an individual's vulnerability and
susceptibility rather than indicate their current health condition.
iv. Age
Age is an important factor in shaping the cortisol awakening response and diurnal
secretion profiles. Profiles become more flattened as a result of age (Wolf et aI., 2002)
and older adults tend to show more elevated overall cortisol secretion than younger
adults (Nicolson et al., 1997). Profiles have been shown to become more inconsistent
with age, with increased variation in the diurnal cycle. In many cases, the cortisol
awakening response remains comparable to that in those of a younger age (Raff et al.,
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1999) with the biggest changes observed in subsequent diurnal secretion. Otte et al.
(2005) concluded from a meta-analysis that cortisol responses to challenge (for
example, psychological stressors) increase with age and are more pronounced in
females compared with males. However, this age related change is not always observed
(Lupien et aI., 1996). Research examining these proposed diurnal alterations is limited
and therefore, this is in need of further assessment.
v. Gender
The evidence for gender differences in terms of basal circadian cortisol activity is
conflicting. Some studies fail to observe a gender difference particularly in the cortisol
awakening response (e.g. Kudielka and Kirschbaum, 2003). Some studies report a
greater cortisol awakening response in middle-aged females compared to middle aged
males (Scholtz et aI., 2004; Schulz et al., 1998; Wright and Steptoe, 2005; WUst et al.,
2000). Others observe greater cortisol responses to waking (PrUssner et al., 1997) but
only after thirty minutes with no difference in responses upon waking. Some studies
report increased responsivity in males compared to females particularly in relation to
stress exposure (Kirschbaum et al., 1992; Prinz et al., 2000). The main problem in
exploring gender differences is that many studies are conducted in single gender
samples which preclude such comparisons.
vi. Perceived Chronic Stress & Burn Out
The perception of stress correlates with changes in cortisol (Bernet et al., 1998;
Lightman, 1995) but there is little evidence for perceived stress to be associated with
changes in the cortisol response to waking. Goldman et al. (2005) found that older
adults demonstrated a greater physiological response to perceived stress in terms of
cortisol and certain biomarkers including IL-6, triglycerides, and fasted blood glucose.
There was further evidence to suggest that these effects were more pronounced in older
females compared with older males. However, the specific influence of this on the
cortisol awakening response was not assessed.
Chronic exposure to stress can result in a state of 'bum out', a syndrome characterised
by emotional exhaustion, physical fatigue, and mental weariness (Melamed et al., 1992;
1999; Shirom, 1989; 1997). Burnout has been associated with an altered cortisol
awakening response but the literature conflicts in terms of how burnout specifically
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alters cortisol secretion. In states of chronic burnout, cortisol profiles are flattened
(Hellhammer, 1990; Melamed et al., 1999; Morgan et al., 2002; PrUssner et al., 1999).
Yet, other studies have highlighted an elevated cortisol response to waking for example,
Grossi et al. (2005) demonstrated elevated morning cortisol in females with high levels
of bum-out compared with moderate and lower levels of bum-out identified by the
Shirom-Melamed Bum-Out Questionnaire (SMBQ). This distinction was not so clear in
males. Similarly, in an assessment of clinically diagnosed burnout patients, De Vente et
al. (2003) demonstrated elevated morning cortisol responses. More recently,
Mommersteeg et al. (2006) found no evidence of cortisol dysregulation in those with
clinical burnout. Further research is clearly required. The observed differences in
response patterns may be attributed to differences in the diagnosis of burnout and the
severity of symptoms.
1.4 Evaluating Stress Induction Techniques
A number of different tools, techniques, and approaches have been implemented to
induce a stress response so that stress related states can be assessed. Some stress
induction tools have been more successful than others. The variance in response from
such tools refutes the idea that stress responses are non-specific and all stressors,
physical or psychological will elicit the same stress response (Selye, 1956). Some stress
induction tools have failed to induce any change in cortisol (Manuck et al., 1991).
In a review of various stress induction tools, Dickerson and Kemeny (2004) identified a
number of factors that are important in determining the effectiveness of stress induction.
These are the specific contexts of the situation and include novelty (Rose, 1980),
unpredictability (Mason, 1968), uncontrollability (Henry and Grim, 1990) and threat
(Blascovich and Tomaka, 1996; Dienstbier, 1989). The differing stress induction tools
were categorised in terms of their main characteristics in a meta-analysis (Dickerson
and Kemeny, 2004). These classifications included: i) cognitive tasks, ii) public
speaking/verbal interaction, iii) public speaking/cognitive combination, iv) noise
exposure, v) emotional induction. In all, 208 techniques for stress induction were
considered. The analysis revealed that tasks that included some form of social-
evaluative threat in which others negatively judged performance and in which the
outcome was uncontrollable proved the most reliable in inducing a significant stress
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response. The inclusion of social-evaluative threat and uncontrollability affected
response magnitude and rate of recovery. Public speaking tasks significantly elevated
cortisol levels where noise exposure and emotional stress induction techniques failed to
induce a significant cortisol response. The most effective stress induction tools were
those that combined public speaking with a cognitive task counterpart. With this tool,
the effect size was almost twice as large as for the remaining stress induction tools.
Dickerson and Kemeny (2004) suggested that this particular tool was the most effective
due to the combination of a form of social evaluative threat and uncontrollability. A
good example of this type of task is the Trier Social Stress Test (TSST) (Kirschbaum et
al., 1993), which combines a public speaking interview task with a mental arithmetic
task in front of a panel of judges. Application of the TSST has been found to
successfully elevate ACTH, cortisol (both serum and saliva), growth hormone,
prolactin, and heart rate post administration (Kirschbaum et al., 1993). More
specifically, a 2- to 4- fold increase in cortisol above baseline has been observed in just
under 80% of subjects (Schommer et al., 2003) and a 2.5mmolll increase in cortisol
observed as a result of exposure (Kirschbaum et al., 1993). The TSST is a reliable tool
for stress induction and is an important application in the study of stress responses.
Therefore, it appears that stress responses can be effectively and reliably induced in the
laboratory using the right tools. Response to such challenges occur in most cases but
can still be open to individual differences in terms of gender and age, both of which
may significantly affect the process of habituation. It is those individuals, therefore,
who respond most to such tools and who fail to habituate who are most at risk from
developing stress related illness and disease.
1.4.1 Stress Responsivity
Studies of the biological response to stress are informative when determining an
individual's vulnerability to the negative effects of stress. Individuals who show
elevated stress responses to laboratory stressors are more at risk of developing a range
of metabolic and cardiovascular related illness and disease including cardiovascular
disease (Kirschbaum et al., 1995). There exists significant heterogeneity in the literature
in terms of individual difference in the response to stress, in particular, the ability of one
individual to habituate to a repeated stressor when another does not and what these
differences can be attributed to. It has been suggested that these observed individual
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differences in response are of paramount importance and essentially reflect the current
state of the hypothalamic-pituitary-adrenal axis and its regulation (Keller-Wood and
Dallman, 1984).
i. The Influence of Cognitive Appraisal on the Response to Stress
As discussed in Section 1.1.1, it was traditionally supposed that if an individual can
cope effectively with stress exposure then little or no physiological stress response will
be observed (Holroyd and Lazarus, 1982; Vogel, 1985). Similarly, if no stress
responses/cortisol elevations are observed then it is presumed that the individual is
coping effectively (Levine, 1978). Lazarus and Folkman (1984) suggested that
cognitive appraisal was important to the likelihood that a stress response will occur. If
an individual perceives a threat (primary appraisal) and further that the individual is
unable to remove the threat (secondary appraisal) then the individual will experience a
stress response. Indeed, cognitive appraisal of the Trier Social Stress Test has been
shown to correlate with subsequent cortisol responses (Gaab et aI., 2005) and that this
has been shown to explain 35% of the variance in the cortisol response (Rohrmann et
aI., 1999). Based on this theory, research has explored in detail the use of effective
coping strategies in determining the magnitude of a stress response in the experience of
daily stressors. Bohnen et al. (1991) examined a variety of coping strategies that could
be employed in response to a daily stressor and found that use of coping strategies was,
in part, effective in maintaining minimal response initiation. The study found that by
employing 'comforting cognitions' (from the Utrecht Coping List), considering the
problem in a relative way, using self encouragement and reframing the problem in a
positive way, served as powerful predictors of subsequent physiological response to a
stressor. This has further been shown, to modulate the cortisol response to
pharmacological activation of the HPA axis using pentagastrin (Abelson et al., 2006).
ii. Age Differences in Stress Responsivity
The literature provides conflicting evidence for changes in stress responsivity (both
cortisol and ACTH) with advancing age. Gotthardt et a1. (1995) found greater stress
responsivity in older adults compared with younger adults participating in the same
study. Lindheim et a1. (1992) found greater responsivity in pre-menopausal females
compared to post-menopausal females. Similarly, Kudielka et a1. (2004) found that the
ACTH response to a psychological stressor in young males decreased with advancing
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age which suggests that adrenal sensitivity is greater in young males and decreases with
age. However, Kudielka et al. (1999 and 2000) previously failed to identify any age
related changes in either males or females. It would seem plausible that stress responses
increase with age due to a higher basal level of glucocorticoids (e.g. Lupien et aI.,
1995). This is consistent with the findings reported by Gotthardt et al. (1995).
Alternatively, the literature which explores glucocorticoid secretions with advancing
age suggests that it would be plausible to expect a diminished response to stress due to
down-regulation of glucocorticoid receptors from chronic life stress (see Lupien et al.,
1994). The issue of age effects clearly merits further research.
iii. Gender Differences in Stress Responsivity
Most research fails to report gender differences in response to stress (e.g. Kudielka et
aI., 2004) Others report only differences in younger populations (Collins and
Frankenhauser, 1978; Forsman and Lundberg, 1982; Frankenhauser et aI., 1978;
Kirschbaum et aI., 1992; 1995; Lundberg, 1983). Seeman et al. (1995) reported greater
stress responsivity in elderly females compared to males. However, Wolf et al. (2001)
found the opposite in a study designed to assess possible gender differences. They
found that males demonstrated a more pronounced response to a stress induction task
compared to females in their study which explored the effect of stress induced
glucocorticoids on cognitive function. Kirschbaum et al. (1999) argue that the effect of
gender is not evident in plasma cortisol levels but is evident in changes in ACTH levels
and total free salivary cortisol (ACTH release is the stimulus for cortisol release from
the adrenal glands). It appears that ACTH tends to be elevated in males compared to
females regardless of menstrual cycle phase and/or oral contraceptive use. The
observation that when gender differences are observed, males tend to be more
responsive suggests that females are in someway protected from over-responding. Wolf
et al. (2001) propose that this is due to the activity of sex hormones, particularly
oestrogen, which may protect against the effect of stress (Galea et al., 1997).
Differences in responsivity due to oestrogen could be linked to the activity of
corticosteroid binding globulin (CBG; bound to the majority of circulating cortisol).
CBG is higher in pre-menopausal females than in males of the same age (Fernandez-
Real et aI., 2003) and is higher during oral contraceptive use (Fujimoto et aI., 1986;
Weigratz et aI., 2003). CBG synthesis is stimulated by oestrogen and so may explain the
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reduced bioavailability of cortisol in females and the lesser response to psychological
stressors (Kajantie and Phillips, 2006).
iv. Other factors
Other factors that have been explored to explain the individual differences that have
been observed include genetic heritability yet there is little evidence to suggest genetic
predisposition to stress responsivity (WUst et al., 2005), however, polymorphisms in the
glucocorticoid receptor gene have been associated with adrenocortical responses to
stress (Wust et al., 2004). Further, exhaustion appears to correlate with a loss of stress
response habituation (Kudielka et al., 2005). Finally, a low birth weight has been
associated with elevated salivary cortisol responses to psychosocial stress (Wust et al.,
2005). These are factors to consider when exploring individual difference in the
response to a psychological stressor.
1.4.2 Stress Habituation
Differences in the ability to habituate to a repeated stressor have also been observed. In
the long term, failure to habituate may predispose an individual to greater risk of stress
related illness and disease. Kirschbaum et al. (1995) observed that some individuals fail
to habituate to a repeated stressor. These 'high responders' demonstrated the same
magnitude of cortisol elevation at each presentation of the stressor compared to 'low
responders' who demonstrated an initial rise on the first exposure but failed to show an
equivalent response on subsequent exposures. Schommer et al. (2003) found clear
habituation of the HPA axis which did not arise from underlying sympathetic nervous
system responses, evidenced by clear habituation of cortisol responses concurrent with a
lack of change in norepinephrine and epinephrine secretion. Differences in habituation
can be explained in the same way as gender and ageing influences due to a number of
factors including the intensity, number and frequency of stress exposure as well as to
individual experience of stress and coping. All of these factors determine the
development of habituation to some degree (De Souza et al., 1986; Natelson et al.,
1988; Pitman et al., 1988; 1990; Schommer et al., 2003; Terrazzino et al., 1995).
However, separating these factors in terms of importance is difficult.
In summary, it is evident that cortisol is a key component of the stress response.
Cortisol demonstrates a diurnal profile of basal activity and can be clearly measured in
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response to stress using stress induction techniques. What is less well established is if
these patterns of cortisol activity, both basal and in response to psychological stress
differ in relation to the presence of central obesity and the metabolic syndrome. This
will be discussed in the next section.
1.5 Cortisol, Central Obesity & the Metabolic Syndrome
1.5.1 Central Obesity: Definitions & Diagnosis
Obesity is categorised in terms of the distribution and type of fat present. Presence of fat
specifically around the abdomen is termed 'central adiposity' (androgenoid
physiognomy) as distinct from peripheral obesity or 'full body obesity' (gynaecoid
proportions). Central obesity differs from peripheral obesity by the type of fatty tissue
present. Central fat is marked by an increase in adipose tissue in the form of visceral fat.
Visceral fat is more sensitive fatty tissue which has increased blood flow compared to
other types of fatty tissue (for example, subcutaneous peripheral fat) and contains an
increased number of glucocorticoid receptors. As a direct result of this, visceral fat is
more sensitive to the presence and action of glucocorticoids such as cortisol and the
action of triglycerides (Pedersen et al., 1994). Further, adipose tissue is a known target
organ for glucocorticoids (Feldman, 1978). Research has shown that the maturation of
human adipocyte precursor cells into mature fat cells is triggered by the presence of
cortisol and insulin (Hauner et al., 1987). Therefore, exposure to elevated
glucocorticoids, the presence of insulin and elevated blood lipids causes the tissue to
respond by further accumulating fatty tissue and consequently increasing its size.
Research has shown that there are more cells per unit mass in visceral fat compared to
peripheral subcutaneous fat (Bjomtorp, 1995). Changes in the amount of visceral fatty
tissue accumulated have been found to facilitate the release of free fatty acids into the
blood stream and contribute to cholesterol synthesis, increasing the risk of developing
insulin resistance (Bjorntorp, 1997).
The World Health Organisation (WHO, 2000) defines central obesity as a waist-hip
ratio (WHR) of greater than 0.85 in females and 0.90 in males, a calculation based on
accurate measurement of waist circumference compared to hip circumference. The
presence of central obesity can also be identified by single measurement of waist
circumference such that a measurement greater than thirty-five inches in females and
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forty inches in males indicates central obesity (NCEP, 2001). Measurement of
abdominal fat can also be determined from assessment of skin fold thickness using
callipers (Durnin and Rahaman, 1967) or by use of bio-impedance (Kushner, 1992;
Kotler et aI., 1996). More recent research has utilised computerised tomography
(Rockall et aI., 2003) to determine the volume of visceral tissue exhibited for an
individual in relation to their overall obesity status (e.g. body mass index, BMI). Some
techniques have been found to be more accurate than others but each technique has
contributed to the modern understanding of the diagnosis of central obesity and its
implications.
The use of calculated waist-hip ratio as a tool has helped to develop understanding of
the link between obesity status and health status (see Chapter Three, Section 3.2). Hartz
et al. (1984) reported that individuals with a high waist-hip ratio also had a higher
prevalence of diabetes and hypertension compared to those with a low waist-hip ratio.
The risk of developing such disorders in those with central obesity rises from 3% to
10% regardless of the degree of obesity. Similar results were obtained using skin fold
thickness as a diagnostic tool for central adiposity (Blair et aI., 1984). Kalkhoff et al.
(1983) identified a correlation between increase in central obesity and increases in blood
pressure, insulin and reduction in carbohydrate tolerance. Indeed, waist-hip ratio and the
diagnosis of central obesity appear more useful in identifying risk for insulin resistance
and diabetes than weight alone (Rivera and Svec, 1989).
1.5.2 The Metabolic Syndrome: Definitions & Diagnosis
The acknowledgment that central obesity is associated with a number of negative health
consequences prompted the suggestion that central obesity is an important component
of the metabolic syndrome. The metabolic syndrome is a cluster of metabolic and
cardiovascular risk factors (Isomaa, 2003). These symptoms include; impaired glucose
tolerance and/or insulin resistance, obesity (specifically, central obesity), dyslipidemia,
and hypertension (WHO, 1999). The metabolic syndrome was first formally identified
by Reaven in 1988 who suggested that insulin resistance and compensatory
hyperinsulinemia were central to a cluster of symptoms that make up the metabolic
syndrome. The degree of insulin resistance has since been identified as the key
component of the syndrome and has been shown to be the important link between the
syndromes main features (De Fronzo and Ferannini, 1991). The metabolic syndrome
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occurs in approximately 15% of males and 10% females without prior impaired glucose
tolerance and prevalence increases when there is pre-existing insulin resistance and
diabetes mellitus to 84% of males and 78% of females (lsomaa et al., 2001). A number
of theories have been proposed to explain the development of metabolic syndrome.
These include individual lifestyle theories, for example, the amount of physical activity
and exercise (Whaley et al., 1999), early prenatal experience, particularly low birth
weight and reduced fetal growth (Jaquet et al., 2000) and also genetic theories based on
the heritability of individual characteristics of the syndrome which comprise, obesity
(Maes et al., 1997), type 2 diabetes (e.g. Groop et al., 1996), hypertension (e.g. Levy et
al., 2000), elevated triglycerides and HDL cholesterol (Snieder et al., 1999) and cortisol
(Bjomtorp and Rosmond, 2000) (See Section 1.5.4).
1.5.3 Cortisol & Central Obesity
The presumed role of cortisol in the expression of obesity, specifically, central obesity
and the metabolic syndrome is complex. Initial suggestions that a glucocorticoid excess
was in some way related to visceral adiposity resulted from observations of patients
with Cushing's syndrome (Bjomtorp and Rosmond, 2000). Cushing's syndrome is a
condition of cortisol excess with many obvious characteristics, one of which is central
obesity. It has been reported that patients with Cushing's syndrome demonstrate the
same risk and tendency to develop insulin resistance, diabetes, dyslipidemia,
hypertension, and risk of cardiovascular disease as those with a high waist-hip ratio
(Bjomtorp and Rosmond, 2000). Researchers have attempted to ascertain whether
cortisol plays a central role in the expression of central obesity and if it is in some way
related to a dysfunctioning HPA axis. In addition, if cortisol is identified as a key factor
in central obesity, the direction of the relationship could be that cortisol excess precedes
the obese state or that the cortisol excess and associated negative health aspects are the
result of pre-existing obesity. It is difficult to separate cause from effect because
glucocorticoids have not been measured prior to the onset of central obesity in
longitudinal studies (for a review see Bjomtorp and Rosmond, 2000). The vast majority
of research in this area examines whether glucocorticoid excess is present in individuals
whose central obesity is pre-established in comparison to those who do not exhibit
visceral fat accumulation (peripheral) or lean individuals. Hence, these correlational
studies do not clarify the direction of the relationship or the nature of cause and effect.
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Obesity is a heterogeneous condition and the task of separating cause from consequence
is a complex one.
1.5.3.1 Glucocorticoid Level in Central Obesity
Historically, clinical studies have revealed that cortisol production in the obese is
elevated (Simkin et al., 1961; Szenas and Pattee, 1959). However, the distribution of fat
and type of fat exhibited was not considered by research until recently and early
findings need to be treated with caution. It is also important to consider the possibility
that the larger body of an obese individual could show more cortisol activity simply
because of its mass (Rivera and Svec, 1989). Indeed, many researchers have highlighted
the difficulty in comparing obese and non-obese individuals (Migeon et al., 1963;
Streeten et al., 1969). In pregnancy, cortisol is also found to be elevated (Nolten et al.,
1980; Weerth and Buitlaar, 2005) with blood pressure, fat deposition and impaired
glucose tolerance (lGT) also elevated during gestation. Smokers often exhibit a higher
degree of central obesity and elevated cortisol (Szostak-Wegierek et al., 1996). In
individuals with depressive illness, cortisol activity is known to be elevated (Mortola et
al., 1967). It is also frequently observed that depressive states are often accompanied by
increased visceral adiposity (Weber-Hamann et al., 2002).
Animal models of obesity further support a theory of glucocorticoid excess. A number
of studies have highlighted hypercortisolaemia in the Zucker rat (Cunningham et al.,
1986) and a diminished response to corticotrophin-releasing factor (CRF) which can be
reversed by an adrenalectomy (Freedman et al., 1986). Similar observations have been
noted in the OBIOB mouse (Dubuc et al., 1986). Such studies provide useful support for
the suggestion that glucocorticoid activity is associated with central obesity. These
observations also suggest that the effects of glucocorticoids may be transient and that
their consequences will only occur for the length of the abnormality (Rivera and Svec,
1989).
Further, support for the postulation that there is an apparent glucocorticoid excess
derives from the observation that individuals with central obesity show less
glucocorticoid suppression following administration of the synthetic glucocorticoid
dexamethasone (DEX). This has been demonstrated in both obese women (Pasquali et
al., 2002) and in high waist-hip ratio men (Ljung et al., 1996). When stimulated with
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synthetic glucocorticoids, the normal physiological response of the HPA axis would be
negative feedback to suppress further cortisol secretion. Reduced suppression of cortisol
following DEX administration indicates a poorly regulated HPA axis. Another test to
explore HPA responsiveness is to administer corticotrophin-releasing factor (CRF),
which in normal individuals should prompt the HPA axis to respond by secreting
cortisol. In individuals with central obesity, this response is diminished in both men and
women (Katz et al., 2000; Vincennati and Pasquali, 2000).
Research has provided some support for the observed glucocorticoid excess hypothesis
but there is also a wealth of research that runs contrary to this hypothesis. For example,
experimental findings which show that levels of circulating plasma and salivary cortisol
are not elevated in those exhibiting central obesity and are often lower than in those
individuals with a peripherally obese or lean body shape. For example, Glass et al.
(1981) demonstrated that circulating glucocorticoids (both basal and following DEX
suppression) are normal in individuals with central obesity. Glucocorticoid
hypersecretion is still a viable explanation for this. However, these alterations are not
observed in baseline circulating plasma or salivary cortisol measurements. Hence, it has
recently been suggested that individuals with central obesity display increased cortisol
clearance capability (Lottenberg et al., 1998). In an examination of the
pharmacokinetics of cortisol in central obesity, Lottenberg et al. (1998) found that high
waist-hip ratio individuals displayed a greater ability to remove cortisol during
glucocorticoid hypersecretion which resulted in lower measured plasma cortisol.
Lottenberg et al. (1998) noted an increased level of cortisol metabolites excreted in the
urine of high waist-hip ratio participants who also showed lower basal cortisol. Several
studies have supported this observation. Lower morning cortisol levels (as part of the
diurnal cortisol profile) have been found in both general obesity (Strain et al., 1980) and
in central obesity (Ljung et aI., 1996; Marin et al., 1992). It has therefore been
suggested that in central obesity, cortisol turnover is much greater than normal (Strain et
al., 1980) and occasionally, though not always, results in a net increase of cortisol,
marked by an increase in excreted urinary metabolites. Further, Duclos et al. (1999)
observed lower salivary cortisol concentrations across the diurnal period in comparison
to lean or peripherally obese individuals, in addition to elevated urinary cortisol
excretion.
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Research has explored the suggestion that cortisol clearance is in some way enhanced in
the centrally obese via the action of 5a and 5p reductase enzymes. These enzymes are
the primary catalysts for the breakdown of cortisol in the liver. Animal studies have
shown that activity of these enzymes is elevated in the liver of obese rodents
(Livingstone et al., 2000). In centrally obese humans, increased excretion of 5a and 5p
reductase metabolites has been observed (Andrew et al., 1998; Fraser et al., 1999;
Reynolds et al., 200 1). The increased inactivation of cortisol by these enzymes may
explain why observed basal cortisol is normal or low in central obesity when compared
to peripheral or non-obese individuals (Ljung et al., 1996; Walker et al., 2000). It is
therefore, possible that the HPA axis over-secretes as a compensatory mechanism and
this results in the accumulation of visceral fat in central obesity (Bjomtorp, 1991).
However, the proposed mechanism of action of these catalysing enzymes is still not
clear. Westerbacka et al. (2003) found that 5p reductase was associated with an increase
in body fat but not specifically, central fat accumulation.
If it is the case that glucocorticoid hypersecretion occurs in the centrally obese but that
the rate of removal is elevated to such a degree that it is difficult to detect in basal
secretion, to what degree would individuals need to be exposed to glucocorticoid excess
in order for negative health effects to become apparent? On a basal level
cortisol/glucocorticoid secretion rates appear normal but in response to a stressor,
cortisol responses are significantly elevated in the centrally obese compared to
peripherally obese or lean individuals. Whether frequent stress exposure is sufficient for
the manifestation of poor health remains to be determined but it seems plausible on the
basis of the suggestive evidence outlined above.
The suggestion that elevated cortisol occurs as a result of chronic exposure to stress
(particularly psychological stress), which increases vulnerability to stress induced
cortisol secretion and results in fat deposition (Bjomtorp, 1991; Rebuffe-Scrive, 1991)
is well documented and will be discussed further in Section 1.5.3.3.
1.5.3.2 The Cortisol Awakening Response & Cortisol Profile in the Centrally
Obese
Although it is reasonably well accepted that basal cortisol in the centrally obese is
frequently normal or slightly lowered, compared to controls, the 24-hour circadian
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rhythm of cortisol and the cortisol awakening response in the centrally obese has yet to
be examined. It is interesting to note that some earlier studies examined basal cortisol in
the obese during the early morning and found cortisol to be lowered compared to non-
obese individuals (e.g. Simkin et al., 1961; Szenas and Pattee, 1959). However, this
research was conducted prior to the identification of the cortisol awakening response.
The dexamethasone (DEX) suppression test as previously discussed in Section 1.5.3.1,
has offered some insight into the basal activity of cortisol in the centrally obese.
Females with central obesity demonstrate poor cortisol suppression post DEX
administration (Pasquali et al., 2002) and as do males with high waist-hip ratios (Ljung
et al., 1996). In terms of cortisol profiling, those who demonstrate a clear cortisol
response to waking and low evening cortisol showed effective DEX suppression (for
example lean individuals). Those with flattened or blunted cortisol awakening response
profiles showed elevated cortisol post DEX administration. The combination of a
flattened cortisol profile and poor DEX suppression are arguably characteristic of
repeated or chronic challenges to the HPA axis (Dallman, 1993; Chrousos and Gold,
1992) and are interestingly common in individuals with central obesity (Ljung et al.,
1996; Marin et al., 1992).
It has been presumed that basal cortisol is altered as a consequence of chronic over-
activation of glucocorticoid receptors as discussed in Section 1.1.2. The circadian
profile demonstrates periods of very low cortisol activity and very high activity
requiring effective HPA regulation at both ends of the scale to maintain a stable basal
diurnal profile. Studies in rats (Spencer et al., 1993) have demonstrated a circadian
trough in corticosterone (cortisol in humans) activity, which is reflected in the human
circadian profile. Low levels of cortisone/cortisol secretion activate only MR receptors
and fail to activate GR receptors (Spencer et al., 1993). When cortisone/cortisol level is
raised from a trough, the HPA axis compensates by lowering peak levels at waking
(Akana et al., 1992) such that the net cortisol secretion during the 24-hour period does
not change. In humans, elevated nocturnal cortisol is characteristic of chronic stress as
well as depression, mania, ageing and fasting (Cella et al., 1995; Linkowski et al., 1985;
Linkowski et al., 1987; Van Cauter et al., 1996). Nocturnal cortisol elevation results in a
compensatory normalisation or reduction in morning cortisol activity (peak levels)
which can lead to subtle but insignificant rise in daily mean cortisol output (Van Cauter
et al., 1996). This rise in night time activation is sufficient to induce GR receptor
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activity and increase vulnerability to the negative effects of stress exposure and central
obesity.
Some studies have demonstrated a negative relationship between waist-hip ratio and
morning cortisol level (measured between 0800 and 0900 hours) (Andrew et al., 1998;
Ljung et al., 2000; Phillips et al., 2000) while others have found no effect of central
obesity on the cortisol awakening response (Phillips et al., 1998; Rask et al., 2002;
Ward et al., 2003). Wallerius et al. (2004) reported a positive correlation between waist-
hip ratio and the cortisol awakening response which suggests central adiposity and
chronic stress exposure influence basal morning cortisol activity. The cortisol response
to waking was also found to be positively correlated with BMI and fasting plasma
glucose, insulin and triglyceride levels. Steptoe et al. (2004) explored the cortisol
response to waking in a larger study of 89 males and 83 females. The findings
confirmed previous observations from Wallerius et al. (2004) in that cortisol responses
were positively associated with central adiposity in males (using waist-hip ratio).
However, in both studies, only one day was sampled to determine cortisol activity and
this may not reflect typical individual cortisol activity.
1.5.3.3 Stress Exposure & Cortisol Activity in the Centrally Obese
Stress exposure is a major contributor to the relationship between cortisol and obesity.
Research suggests that chronic exposure to stress disrupts HPA axis regulation resulting
in an over-secretion of glucocorticoids. This suggests that the response to stress could
be elevated in individuals with central obesity when compared to peripherally obese or
lean individuals. Previous research appears to support this. For example, Marin et al.
(1992) found an elevated serum cortisol response in a group of centrally obese post-
menopausal women compared with lean or peripherally obese individuals in response to
a series of stressor tasks including the cold pressor test, colour-word (stroop), and
mathematical tests. Marin et al. (1992) concluded that an increased sensitivity of the
HPA axis in centrally obese females actively fuelled abdominal fat deposition. Similar
results were found by Moyer et al. (1994) in a sample of centrally obese females.
However, both studies failed to exclude participants with confounding characteristics
for example, smokers. Smoking is known to affect both cortisol activity and the
incidence of central obesity (Szostak-Wegierek et al., 1996).
25 Chapter One: Literature Review
Epel et al. (2000) compared both lean and overweight females on the basis of their
peripheral and central fat. This comparison avoided confusing central obesity with
whole body obesity, an error frequently made in previous research and a possible
explanation for the lack of glucocorticoid excess observed in previous studies. Epel et
al. (2000) observed a more pronounced cortisol response to a series of stressors in those
individuals with central obesity. Furthermore, these results showed that high waist-hip
ratio lean females (who exhibited central obesity but with a normal BMI) failed to
habituate to a repeated stressor. An elevated cortisol response was observed on the first
exposure to stress and also on subsequent occasions despite increased familiarity and
predictability of the stress exposure. Individuals with a high waist-hip ratio, in addition
to being overweight (though not centrally obese), did demonstrate habituation. Cortisol
responses were elevated following the first exposure to the stressor but were followed
by adaptation to the stressors on subsequent exposure. These findings concur with the
research described above but can be viewed with greater confidence due to better
controls. Nevertheless, the criteria used by Epel et al. (2000) for the diagnosis of central
obesity (WHR calculation) differed from previous studies and from the WHO definition
(WHO, 2000). Epel considered a ratio of 0.79 or greater to be high, which was
considerably lower than the WHO criteria (0.85 or greater). How this affected the
outcome of the study is unclear. Another limitation of the study is that only female
volunteers were included and a strict set of exclusion criteria were applied. The use of
very stringent exclusion criteria has been highlighted as potentially responsible for the
exclusion of a key population. Obesity is associated with poorer health, insulin
resistance, diabetes, hypertension, particularly in central obesity. Research tends to
exclude on the basis of these conditions and symptoms. Rivera and Svec (1989) argue
that as a consequence this key population is likely to be excluded and that this permits
skew in data towards 'lower body proportions' or peripheral obesity, individuals who
will be marked by an absence of glucocorticoid excess and fewer health problems.
High waist-hip ratio individuals may be more likely to succumb to illness more often,
experience ulcers, stomach bleeding and health complaints which could be related to
stress and coping strategies (Bjorntorp, 1995). It has been suggested that glucocorticoid
excess arises out of chronic exposure to stress with a consequent accumulation of
visceral fat. Exposure to high levels of stress results in repeated activation of the HPA
axis which leads to excessive secretion of cortisol. Studies suggest an association
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between high waist-hip ratio, poor coping, high stress and antidepressant use
(Bjorntorp, 1995; Lapidus et al., 1989; Larsson et al., 1989). High waist-hip ratio
individuals also tend to use more stimulants, smoke and consume more alcohol. This
could promote the continued stimulation of the HPA axis contributing to the
development of central obesity (Lapidus et al., 1989; Larsson et al., 1989). Indeed,
chronic exposure to stress is a plausible explanation for the suggested glucocorticoid
excess in central obesity. In Cannon's (1928) 'fight or flight' hypothesis of a classic
stress response, one of the peripheral actions of the HPA axis is the suppression of sex
hormones and inhibition of growth hormone from the pituitary. Previous research has
suggested that sex hormones (oestrogen) are protective against the development of
obesity (Vamvakopoulos and Chrousos, 1993). Chronic stress thus leads to chronic
over-stimulation of the HPA axis and constant inhibition of sex and growth hormones
(Laatikainen, 1991). These effects also account for the increase in obesity with age,
when sex hormones and growth hormone diminish whereas cortisol and insulin, which
also promotes lipid accumulation, do not (Bjorntorp, 1995). Studies have shown that
administering testosterone to males with low endogenous levels and high visceral fat
produces a reduction in adiposity. Similarly, administration of growth hormone to
patients with growth hormone deficiency reduced visceral adiposity by 30% (Bengtsson
et al., 1993). Furthermore, elevated cortisol combined with reduced sex hormone levels
is often associated with an increased risk of insulin resistance (Bjorntorp, 1995).
Exposure to chronic stress provides a route to cortisol hypersecretion through HPA
dysregulation. Both over- and under- feeding can result in cortisol hypersecretion (Abell
et al., 1987; Galvao-Teles et al., 1976; O'Connell et al., 1973). Regulation of weight
about a set point is important, and is an allostatic process driven by HPA axis activity
(McEwen, 1998). However, patients with anorexia nervosa despite apparent cortisol
hypersecretion do not exhibit central obesity. This may suggests that the relationship
between cortisol activity and central obesity may be open to other mediating factors and
is not solely based on glucocorticoid activity from overexposure to chronic stress. This
suggests that other metabolic factors may be involved (Invitti et al., 1999).
In addition to the role of allostasis in feeding and weight regulation, McEwen (1998)
suggests that allostatic load has a role in the basic regulation of the HPA axis.
Dysregulation may be the result of neuronal damage in the suprahypothalamic region of
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the brain, which is responsible for regulating the negative feedback process. This can
occur as a result of early life stress or chronic exposure to stress in later life and is a
plausible explanation for apparent HPA dysregulation in those with central obesity
and/or metabolic syndrome symptomology. Following this suggestion, it could be
hypothesised that HPA dysregulation precedes central obesity and central obesity in
tum is a consequence of stress exposure.
1.5.4 Stress & the Metabolic Syndrome
The connection of the metabolic syndrome to stress has led to the implication of cortisol
in the expression of the syndrome. One of the main symptoms of metabolic syndrome is
central obesity, and as described in Section 1.5.3, central obesity has been clearly linked
to altered cortisol secretion. The most important symptom of metabolic syndrome,
insulin resistance, is also linked to cortisol activity. Cortisol, via its role in
gluconeogenesis is involved in the expression of impaired glucose tolerance and insulin
resistance in the centrally' obese (See Section 1.2.1). Stress is also implicated in
inflammatory responses. Stress activates an acute phase response (APR) which is an
innate immune response resulting in the release of acute phase proteins and this process
is associated with the onset of metabolic diseases (Black, 2003).
The proposed role of stress in the manifestation of the metabolic syndrome led to the
suggestion that cortisol directly underlies the expression of syndrome and that metabolic
syndrome is a neuroendocrine disorder (Bjorntorp and Rosmond, 2001). Rosmond et al.
(1998; 1999b) assessed salivary cortisol over one working day in relation to central
obesity. They observed that pathological cortisol secretion occurred in a small number
of males who also demonstrated symptoms of the metabolic syndrome. Rosmond et al.
(1998; 1999b) argue that altered cortisol secretion and HPA dysregulation are important
contributors to the manifestation of related metabolic syndrome symptomology.
Cross-cultural studies have also shown that increased glucocorticoid action may explain
ethnic differences in the prevalence of metabolic syndrome and more interestingly from
the point of view of the research conducted in this thesis, in those women with a higher
body mass index (Ward et al., 2003). Research has also considered the possibility that
abnormal HPA regulation may be the result of genetic alterations at the glucocorticoid
receptor gene locus that predispose to the development of central obesity (Rosmond et
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al., 2000). Further support for the association between cortisol and metabolic syndrome
comes from the observation that altered cortisol secretion has often been associated with
insulin resistance and abnormalities in lipid metabolism including elevations in blood
pressure and hypertension (Rosmond and Bjomtorp, 2001).
Taken together, the evidence suggests that altered cortisol secretion is an important
factor in the development of metabolic and cardiovascular risk factors and ultimately,
the development of a metabolic syndrome. The metabolic syndrome is currently viewed
as a neuroendocrine disorder with research increasingly exploring glucocorticoid
activity in relation to observed metabolic symptomology (Bjomtorp and Rosmond,
2000; Gale et al., 2002; Khani and Tayek, 2001; Rosmond and Bjomtorp, 2001).
However, it is important to note that research conducted since Bjomtorp and Rosmond,
(2000) initial proposal, segregates in terms of those who find cortisol alterations in
association with metabolic syndrome symptoms and those who do not. For example,
Ward et a1. (2004) assessed basal salivary cortisol responses in a group of older adult
males and found no association between level of cortisol output and metabolic
syndrome symptomology. Further to this, Kajantie et al. (2004) explored the
relationship between cortisol and birth weight and failed to find any associations
between cortisol and metabolic syndrome and between cortisol and birth weight.
1.5.5 Additional Factors Influencing Cortisol in the Centrally Obese
i, IIp-Hydroxysteroid Dehydrogenase (llP-HSD)
A number of metabolic factors have been considered in an attempt to explain the
apparent glucocorticoid excess in central obesity. One important factor is the activity of
the enzyme l lji-Hydroxysteroid Dehydrogenase (11~-HSD). 11~-HSD is an enzyme
that acts on cortisol to assist the conversion of inactive cortisone to active cortisol. 11~-
HSD has been shown to regulate corticosteroid action at the pre-receptor level and
exists in two isoforms (Albiston et al., 1994; Tannin et al., 1991). Low affinity ll~-
HSDI controls the conversion of cortisol to cortisone and vice versa and is
predominantly expressed in hepatic, gonadal and central nervous system tissues where
it is known to modulate glucocorticoid action (Jamieson et al., 1995; Whorwood et al.,
1995). 11~-HSD2 is the high affinity isoform that has been shown to protect from
cortisol excess, inactivating active cortisol to cortisone (Stewart, 1996). Previous
research has observed that only the type 1 isoform was found in the adipose tissue of the
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omentum (the collection of fat around the stomach and colon covering most of the
intestine which serves to connect the viscera and support blood vessels) which could
lead to the continuous generation of active cortisol from inactive cortisone (Bujalska et
al., 1997). The expression of this enzyme was also increased following exposure of the
omental adipose stromal cells to cortisol and insulin. This suggests continuous exposure
to glucocorticoids (from repeated stress and other factors) or adipose tissue could
contribute to the development of central obesity and increase the risk of developing
associated health problems such as insulin resistance, glucose intolerance, and
hypertension. The 11~-HSD2 isoform has not yet been detected in the same tissue.
Further exposure to cortisol and insulin has been found to produce greater expression of
11~-HSDI suggesting a possible 'fast-forward' mechanism of action (Bujalska et al.,
1997). It is possible that even though cortisol levels remain normal, cortisol has the
ability to act as a potent mineralcorticoid which would have negative health
consequences (Bujalska et a., 1997). A similar pattern of activity was noted in relation
to the effect of the type 2 isoform in the kidney on the production of a hypertensive state
(Edwards et al., 1985). Bujalska et al. (1997) comment on the possibility that the same
may occur in adipose tissue, attributable to the 11P-HSD1 isoform and leading to the
development of insulin resistance, hypertension, and dyslipidemia. However,
Westerbacka et al. (2003) failed to establish a link between the activity of I IP-HSDI
and central obesity, but was able to link the type 1 isoform and whole body obesity.
Westerbacka et al. (2003) argue that the mechanisms underlying these associations
remain to be fully elucidated and in light of previous research suggest that waist-hip
ratio may not be an accurate enough measure for the diagnosis of central obesity.
ii. Catecholamines
HPA dysregulation has been linked to the presence of abdominal catecholamines
(Pasquali and Vincennati, 2000). Catecholamines modulate the activity of
corticotrophin releasing factor (CRF) and adrenocorticotrophin (ACTH) secretion
during acute and chronic exposure to stress. These effects are mediated by a 1 and a2
adrenoreceptor subtypes. The a2 receptor subtype is known to inhibit ACTH activation
and in essence is presumed to be a contributing factor to the negative feedback
mechanism of the HPA axis to prevent cortisol/glucocorticoid hypersecretion. Obese
women are known to show an increased ACTH response to stress (Pasquali et al., 2000)
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indicating the possibility that centrally obese women may lack normal control of the (12
adrenoreceptor.
iii. Food consumption
Food consumption has been shown to influence cortisol secretion (Abell et al., 1987;
Galvao-Teles et al., 1976; O'Connell et al., 1973). Conversely, glucocorticoids have
been found to directly stimulate food intake through stimulation of neuropeptide Y (a
peptide neurotransmitter). NPY stimulates feeding, insulin and interacts with
glucocorticoids. NPY also reduces the breakdown of triglycerides and lowers body
temperature). NPY also stimulates food intake through inhibition of corticotrophin
releasing hormone (Henrichs et al., 1993; Tataranni et al., 1996; Tempel and Leibovitz,
1994). Glucocorticoids bind to glucocorticoid type 1 receptors (mineralocorticoid
receptors) in the hypothalamus, which are sensitive to low concentrations of
glucocorticoids and also bind to type 2 receptors when in higher concentrations
(glucocorticoid receptors). It has been shown that glucocorticoid binding to these
receptors is followed by increased food consumption with preferential selection of fatty
foods (type 1 receptor) and carbohydrates (type 2 receptors) (Levine and Billington,
1997). It is possible that chronic stress exposure could contribute to the development of
obesity by enhancing food intake via activation of glucocorticoid receptors.
In summary, the basal cortisol diurnal profile may be different in those with central
obesity reflecting a dysregulated HPA axis. Further, cortisol responses to a
psychological stressor are elevated compared with lean or peripherally obese
individuals. Finally, cortisol activity may be related to the biological parameters that are
associated with the metabolic syndrome.
1.6 Cortisol & Cognitive Performance
The literature exploring the impact of glucocorticoids on cognitive performance is
extensive, dating back to the 1950's when health professionals used corticosteroids as a
form of treatment for rheumatoid arthritis and asthma. It was discovered that
corticosteroid treatment had significant side effects on mood and cognition labelled as
'steroid psychosis' (Clark et al., 1952). Subsequent research has examined many aspects
of glucocorticoid activity in relation to cognition and is discussed below.
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1.6.1 Mechanisms of Action - MR & GR Receptors & the Hippocampus
The hippocampus is an important area of the brain for learning and memory with a key
role in declarative memory, spatial memory and the processing of emotional stimuli (De
Kloet et aI., 1998; McEwen et aI., 1995; McEwen, 1997). The hippocampus contains a
large number of MR and GR receptors reflecting a high level of glucocorticoid activity
(McEwen et aI., 1986) as discussed in Section 1.1.2. The dynamics of the activation of
these receptors modulates the effect of cortisol on cognitive performance. The combined
activation of the receptors produces a dual effect on cognition reminiscent of the
Yerkes-Dodson inverted 'U' hypothesis (Figure 1.3) for the effect of arousal on
performance (Luine et aI., 1993).
Optimal performence (moderate cortisol)
••
••·
Performance
Facilitation Inhibition
Cortisol
Figure 1.3: Adaptation of the Inverted 'U' Hypothesis of Stress-Induced Cognitive Impairment
High occupation of the MR receptors in conjunction with high occupation of the GR
receptors would produce deficits in cognitive performance. Similarly, at the lower end
of the spectrum, too little activation of the MR and GR receptors should also result in
cognitive deficit. An MRlGR receptor balance is required to ensure optimum cognitive
performance. Over-activation of MR and GR receptors in the hippocampus leads to
stress induced memory impairments specifically in declarative memory. Increased
activity of the receptors within the hippocampus due to chronic stress, ageing, or
glucocorticoid exposure causes a down regulation of the glucocorticoid receptors. This
is known as the 'glucocorticoid cascade hypothesis' (Sapolskyet aI., 1986) in which the
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role of the hippocampus in the human physiological stress response is emphasised.
Down-regulation of MRlGR receptors in the hippocampus can interfere with the
negative feedback system of the HPA axis. This causes secretion of excess levels of
glucocorticoids and leads to a down-regulation of the receptors in the hippocampus.
This can lead to neuro-degeneration and hippocampal atrophy (Starkman et al., 1992).
In addition to a direct impact of glucocorticoids on the hippocampus, neuronal loss can
also occur from a disruption of neuronal energy metabolism. Glucocorticoids have been
shown to prevent glucose transport into the brain in humans (De Leon et al., 1997), in
cultured hippocampal neurons and glia (Homer et al., 1990; Virgin et al., 1991). A
reduction in glucose availability as a result of this inhibition could explain observed
cognitive impairment since glucose is the main source of energy for the brain and
cognitive performance can be enhanced by increasing glucose availability (Benton et
al., 1994; Dye and Blundell, 2002). Gold et al. (1987) demonstrated that glucose
supplementation in the elderly (who are more likely to demonstrate high basal
glucocorticoids) improved memory performance. Natural glucose inhibition is
insufficient to reduce the amount of available adenosine triphosphate (ATP), a molecule
primarily involved in cellular energy metabolism. It is only when levels of
glucocorticoids are raised through chronic stress or ageing and there is a high demand
for energy, that inhibition becomes disruptive (Lawrence and Sapolsky, 1994;
Tombaugh and Sapolsky, 1992).
When available energy is reduced in the brain, the process of Long Term Potentiation
(LTP) is affected. Long-term potentiation facilitates the consolidation and storage of
new memories a process that has been shown to rely on NMDA receptors in the cornu
ammonis region one (CAl) of the hippocampus (for a review see Alderson and Novak,
2002). Selective activation of the glucocorticoid receptors in the hippocampus has been
shown to increase the rate of LTP (Pavlides et al., 1994; Pavlides et al., 1995) but high
levels of glucocorticoids suppress LTP (Pavlides et al., 1993; Pavlides et al., 1995) and
have even been shown to encourage Long Term Depotentiation (LTD) (Pavlides et al.,
1995). Similarly, glucocorticoids have demonstrated an effect on the excitability of
hippocampal neurons interfering with the electrophysiology of the hippocampus.
Exposure to elevated glucocorticoids results in reduced excitability (Joels and De Kloet,
1992; Zeise et al., 1992). This action is again biphasic and corresponds to an inverted
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'U' hypothesis (Luine et al., 1993) and altered LTP (Pavlides et al., 1994; Pavlides et
al., 1995). In conjunction with proposed glucose inhibition, these findings could account
for a collective modulatory effect of glucocorticoids on cognitive performance.
1.6.2 Effects of Endogenous Cortisol on Memory
The hippocampus is an important component of the relationship between glucocorticoid
activity and cognition as previously discussed. It is the region of the brain frequently
associated with memory, its encoding, consolidation and retrieval particularly in
declarative and spatial memory (De Kloet et al., 1998; McEwen et al., 1995; 1997). In
general, glucocorticoids have been shown to enhance memory consolidation but to
impair retrieval and aspects of working memory as will be discussed. The impact of
glucocorticoids on performance can be explored in relation to acute changes in
glucocorticoid, for example, due to external stressors in both young and older adult
populations and will be discussed in the next section.
The most common method of studying the impact of acute stress induced
glucocorticoids on cognitive performance is by first exposing the individual to some
form of external stressor and measuring subsequent performance. Many studies follow
this procedure; the majority have found that acute exposure to stress is sufficient to
produce cognitive impairment. Lupien et al. (1997) exposed a sample of healthy elderly
subjects to a public speaking stressor task (a variation on the TSST) and discovered that
subsequent declarative memory performance was impaired in those who demonstrated a
cortisol response to the stressor. No effects were reported for non-declarative memory.
Further, the results demonstrated that those who responded to the stressor also
demonstrated an anticipatory rise in cortisol 60 minutes prior to stress exposure. This in
conjunction with actual stress responses as a result of stress exposure could have
influenced performance and was sufficient to produce impairment (Lupien et al., 1997).
However, it is possible that this anticipatory rise may have been due to pre-experimental
baseline cognitive testing administered prior to stress exposure, which could itself have
been a stressor. For example, Bohnen et al. (1990) used a cognitive test battery as a
stress induction tool, in a sample of middle-aged subjects. However, the results showed
that those who exhibited the greatest cortisol rise (responders) were impaired in
attentional processing. Domes et al. (2002) exposed a sample of healthy post-
menopausal females to the Trier Social Stress Test and found no impairment in memory
34 Chapter One: Literature Review
performance. Post hoc analysis of the data revealed that those exhibiting an elevated
cortisol response to the stressor demonstrated better performance than those who did not
respond. It is possible, however, that the stress induction was insufficient to raise
cortisol levels to a point of impairment. Further, de Quervain et al. (2000) proposed that
it is not possible to determine which aspect of memory is impaired since exposure to the
stressor occurred prior to learning. Should exposure occur after learning and during
retrieval, then impairment will be observed (de Quervain et al., 2000). This further
supports the theory that an MRlGR receptor balance is vital for optimum performance,
from the observation impairment was observed in those demonstrated a cortisol
elevation post stressor, hence shifting the receptor balance.
Wright et al. (2005) failed to find an association between basal cortisol activity and
subsequent memory performance but did find that cortisol responsivity was inversely
related to cognitive performance. The findings demonstrated that a better recovery of
heart rate (in both males and females) and blood pressure (in males) post stress
exposure was associated with superior memory performance.
These findings suggest that acute stress exposure can be sufficient to cause cognitive
impairment. Discrepancies in the findings are often due to the implementation of
different types of stressors and also the use of different methods of cognitive testing.
These may account for the observed differences in performance and should be
considered when evaluating research findings.
1.6.3 Effects of Exogenous Cortisol on Memory
An alternative method of assessing the influence of glucocorticoids on cognition is by
exogenous pharmacological intervention. This may be more likely to produce a cortisol
elevation whereas some stress induction tools may be ineffective. This method also
allows for easy control of timing and dosage. A dose-response study was conducted by
Beckwith et al. (1986) administering hydrocortisone. Doses of 5, 10, 20 and 40mg were
administered and short and long-term memory assessed 60 minutes post administration.
Glucocorticoid administration at all dosage levels facilitated recall during the first few
presentations but only the higher doses continued to enhance recall when task load
(number of words to recall) was increased. The hydrocortisone, however, was
administered in a glucose drink. Glucose alone is known to enhance memory
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performance (e.g. Benton et aI., 1994) and so the resultant impact on memory is
unlikely to be solely related to glucocorticoid administration. In terms of cognitive
impairment, Kirschbaum et al. (1996) found that administering 10mg of hydrocortisone
significantly reduced performance specifically in delayed recall (declarative memory)
60 minutes post administration. Similarly using prednisone, Wolkowitz et al. (1990;
1993), found that high doses (80mg) were sufficient to disrupt long term recall (over
one week). The number of errors made increased in comparison to a daily low dose of
DEX (1mg daily) which suppresses glucocorticoid activity and which failed to have an
effect on memory. However. Newcomer et al. (1994) did find impairment in declarative
memory (acquisition and recall) from suppressed glucocorticoid activity after four days
of exogenous DEX administration (doses of 0.5. 1. 1. and lmg per day). No
impairments were noted for non-declarative memory or attentional processing. The
findings previously discussed (Newcomer et al., 1994; Wolkowitz et al., 1990; 1993)
were attributed to the inverted 'U' hypothesis for the modulatory effects of
glucocorticoids on cognitive performance with each study highlighting impairment from
too little or too much glucocorticoid exposure.
In a double-blind study. Schmidt et al. (1999) found that high doses of prednisone in
young males impaired object recall up to four days post administration. Similarly.
Young et al. (1999) found impaired paired associates learning performance (a test of
declarative memory) following hydrocortisone administration over a ten-day period
(20mg twice daily). Impairments in both spatial and working memory tasks were also
observed to confirm earlier observations in endogenously administered glucocorticoids
(e.g. Lupien et al., 1999b). Indeed. Young et al. (1999) observed deficits in spatial and
working memory and suggested that glucocorticoids could also mediate a frontal lobe
dysfunction in addition to hippocampal-related processing. It would be of importance to
make a global assessment of cognitive performance to determine in which cognitive
domain these deficits occur.
- Influence of Time of Day
The time of day when exogenous administration occurs is of importance. Endogenous
glucocorticoids follow a circadian rhythm as previously described (Section 1.3);
therefore there will be a differential activation of the MRlGR receptors at in the AM
phase than in the PM phase (DeKloet et al., 1999). Consequently. the relationship
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between glucocorticoids and memory may be a function of time of day (Lupien et al.,
2002a; Maheu et al., 2005). Fehm-Wolfsdorf et al. (1993) administered 50mg oral
hydrocortisone to a group of young healthy subjects in the AM phase followed by a free
recall task. Elevating cortisol further during the morning period, when cortisol is
naturally highest, disrupted performance. The same level of administration had no effect
in the evening. These findings are consistent with studies of the influence of
endogenous glucocorticoid on cognition as discussed previously.
- Influence of Dosage Timing
Pharmacological studies add further support to the emerging view that the time of
glucocorticoid elevation is important in terms of determining specific effects on
cognitive performance. Lupien et al. (1995) compared fixed doses of hydrocortisone
(40f.lg/kg, 300f.lg/kg, and 600f.lg/kg) with comparable doses of saline. The results
showed a dramatic decrease in memory performance in those who had shown the
greatest increase in cortisol post drug administration and when learning had occurred
during the infusion period. The same pattern of results was not evident for those who
undertook learning after the infusion or those who had not demonstrated a significant
response to hydrocortisone administration (Lupien et al., 1995). de Quervain et al.
(2000) suggested that the timing of the glucocorticoid elevation is important, with
glucocorticoids administered during learning subsequently weakening memory
consolidation. This was further confirmed by Lupien et al. (1995). de Quervain et at.
(2000) observed that glucocorticoid elevations (exogenously produced) one hour prior
to learning failed to affect memory retrieval. de Quervain et al. (2000) permits that
glucocorticoids will only affect recall of information when the cortisol elevation occurs
during the actual retrieval process itself. This suggests that glucocorticoid elevations
differentially affect encoding, storage and retrieval (de Quervain et al., 1998).
- Influence of Age
Consistent with studies of endogenous administration of glucocorticoids, differential
effects are noted between younger adults and older adults/elderly populations.
Newcomer et al. (1995) found that administration of higher DEX treatment (1, 2, 3 and
4mg per day) resulted in better immediate and delayed declarative memory performance
in a younger population but showed no effects in an elderly population. Lupien et al.
(1994) argued that as an elderly population exhibit generally higher basal levels of
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glucocorticoids, administration of DEX could be beneficial if it reduces glucocorticoid
activation and this would explain the absence of change in memory performance. Porter
et al. (2002) administered hydrocortisone to an elderly population and failed to find any
effect on memory performance despite cortisol levels at testing being ten fold compared
to a placebo condition. It is possible that the elderly individuals in this study exhibited
high basal cortisol and lacked sensitivity to changes in glucocorticoid concentration due
to disruption in the MRiOR balance resulting from chronic glucocorticoid exposure.
This supports Sapolsky et al.' s (1986) glucocorticoid cascade hypothesis in that it
reflects down-regulation of glucocorticoid receptors (Sapolsky et aI., 1986).
In a double blind study, Lupien at al. (1995) lowered basal glucocorticoid levels through
administration of metyrapone (a glucocorticoid synthesis inhibitor) before restoring
glucocorticoid levels by administration of hydrocortisone. In those with high basal
cortisol, a chemical lowering of glucocorticoids had no effect on memory performance.
Restoring glucocorticoids to baseline using hydrocortisone resulted in significantly
impaired memory. In contrast, those with moderate basal cortisol demonstrated a
significant impairment of memory when glucocorticoid reduction was taking place.
Administration of hydrocortisone restored glucocorticoid levels and hence restored
performance. Lupien et al. (2002a) suggested that the observed impairment in those
with high basal cortisol was the result of diminished numbers of MR receptors and
consequent heightened sensitivity to OR receptors. The lowering of glucocorticoid
levels had no effect due to the lower number of MR's available for binding and greater
binding to the OR receptor. The glucocorticoid replacement produced impairment due
to faster saturation of the OR receptors because of the reduced number ofMR receptors.
For example, in a longitudinal study, Wetzel et al. (1995) demonstrated a reduced
number of MR's as result of excessive glucocorticoid exposure in aged subjects who
showed consistently increasing basal cortisol levels over time with current high basal
levels. Further, Lupien et al. (2002) demonstrated that chemically lowering
glucocorticoids (using metyrapone) impairs performance in younger adults who exhibit
lower basal cortisol levels. Administration of hydrocortisone restored glucocorticoid
levels and as a result, restored performance. Hence, lowering cortisol in individuals who
already exhibit low basal glucocorticoid levels, results in poorer cognitive performance.
This contributes to the growing body of evidence that supports the changing MRlGR
balance across the lifespan. However, De Kloet et al. (1999) argue that exogenous
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glucocorticoid administration studies may be less reliable than endogenous studies
because context is important in determining steroid mediated effects. Moreover,
synthetically administering glucocorticoids does not allow for differential receptor
activation and are not administered in what could be described as a natural order of
environmental input during information processing (De Kloet et al., 1999). The deficits
observed are not natural responses but rather 'opportune' responses to an 'out of
context' steroid simulation. Nevertheless, studies using exogenous glucocorticoid
administration mirror the results studies which used stress induction tools and studies of
endogenously raised glucocorticoids.
1.6.4 Influence of Emotion
Research has suggested that the influence of stress induced glucocorticoids (cortisol) on
memory depends on emotional state (Abercrombie et al., 2006; Elzinga and Roelofs,
2005). This is postulated to be linked to the influence of the limbic system on the HPA
axis, in particular the basolateral nucleus of the amygdala, crucial for the processing of
emotional material (Anderson and Phelps, 2001). The effect of cortisol on noradrenergic
processing within the amygdala is necessary for its effects of memory (reviewed by
Roozendaal, 2000; Van Stegeren et al., 2004). Glucocorticoids have shown no effect on
memory for emotional material when there is no activation of the basolateral nucleus of
the amygdala (Roozendaal and McGaugh, 1997; Roozendaal et al., 1999). Elevations in
glucocorticoids have been shown to enhance the consolidation of emotional material.
For example, Buchanan and Lovallo (2001) observed a facilitation of memory for
emotional material following an exogenous cortisol administration (20mg). Further,
Elzinga et al. (2005) found a stronger recall for emotional material compared to neutral
material. Kuhlmann et al. (2005) observed specific impairment in the retrieval of
negative words compared with neutral words in a 5hour delayed recall task. This
confirms the negative effect of glucocorticoids on memory retrieval but support the
hypothesis that emotional material is more sensitive to the modulatory effects of
glucocorticoids on memory.
1.6.5 Gender Differences in the Cortisol- Cognition Relationship
A number of studies have highlighted that some of the effects of glucocorticoid levels
on cognitive performance are gender specific. Kalmijin et al. (1998) reported a non-
significant trend for males to experience longitudinal increases in free cortisol compared
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to females yet Lupien et al. (1995) failed to find any gender differences in a study of a
similar duration. Animal studies have reported differential effects in male and female
rats with stress enhancing classical conditioning in males more than in females in whom
it is impaired (Woods and Shors, 1998). Similarly in humans, stress has been shown to
impair declarative memory in females compared to males (Seeman et al., 1997; Wolf et
al., 1999) affecting declarative memory performance. Females who showed impaired
declarative memory had higher basal glucocorticoids.
The prevalence of some psychiatric conditions such as depression which may involve a
dysregulated HPA axis is 2x greater in females (Breslau et al., 1997; Desai and Jann,
2000). However, confounding variables that are often difficult to control for may be
more common in women. Many studies fail to consider menstrual phase, menopausal
status, or oral contraceptive use (for example in de Quervain et al. 2000 and Newcomer
et al., 1999). These may have had an effect on cognitive performance, leading to
observed heightened responsivity and poorer performance in females that was inflated.
Wolf et al. (2001) explored potential gender differences and found that males
demonstrated a more pronounced association between stress-induced glucocorticoids
and performance on a verbal recall task than did females. The observation that females
were seemingly protected from the effect of the stressor was attributed to the protective
effects of oestrogen against stress (Galea et al., 1997) and the possibility that estradiol
modulates the relationship between cortisol and memory (Carlson and Sherwin, 1999).
1.6.6 Dehydroepiandrosterone (DHEA), Cortisol & Cognition
The role of cortisol in cognition is associated with another major secretory product of
the adrenal glands, Dehydroepiandrosterone (DHEA) and its sulphate ester DHEAS.
DHEA shows a significant decrease with age whereas it is presumed that cortisol levels
can remain stable or may show an increase (Laughlin and Barrett-Connor, 2000).
Research has indicated that DHEA may prevent stress-induced suppression of the
immune system (Kalimi et al., 1994) but the literature which examines such
associations is limited. Due to a small number of positive outcomes DHEA(S) has been
labelled as a functional anti-glucocorticoid (Kalimi et al., 1994; Wright et al., 1992).
However, research which substantiates these claims is minimal. Of relevance to the
research presented in this thesis, DHEA has been linked to cognitive performance via its
relationship with cortisol. Cortisol and DHEA are linked as a ratio of action. A low
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DHEAS: high Cortisol ratio is associated with cognitive impairment, particularly in the
elderly based on epidemiology studies (Kalmijin et aI., 1998). DHEA demonstrates a
circadian rhythm with a similar profile to cortisol that has been shown to diminish with
age and appears unaffected by cortisol circadian activity (Ceresini et aI., 2000). As
DHEA activity exists as a ratio with cortisol, a number of studies have explored the
treatment potential of DHEA in Cushing's syndrome as DHEA levels are lowered in
this condition. Laureti et al. (2000) find it to be mildly successful in the short term in
reducing cortisol activity. Similarly, basal DHEA levels have been found to be
chronically suppressed in diabetic patients (Yamaguchi et aI., 1998). Hucklebridge et al.
(2005) found the mean level of DHEA over a two-day period to be positively correlated
with the mean of cortisol but with greater stability when compared with daily variances
in cortisol activity.
While obesity tends to increase as a result of ageing, DHEA levels decrease. In non-
obese pre-menopausal women, De Pergola et al. (1991) found that DHEA and body
mass index were inversely related. Yet the same was not true for obese individuals,
where the relationship was less clear (De Pergola et al., 1996). Other studies have failed
to find an association between obesity and DHEA (Williams et al., 1993).
- DHEA & Cognition
DHEA supplementation is postulated to improve cognitive performance and mood, but
the mechanism of action is yet to be fully established. Van Niekerk et al. (2001) found
no significant effects of DHEA on mood or cognitive performance following a three
month DHEA treatment program in older adult males and thus little evidence for the
benefits of DHEA supplementation. It is possible that DHEA has an anti-glucocorticoid
effect, rather than directly enhancing cognitive performance. Wolf et al. (1997) found
that following a single administration of DHEA to a younger adult population, cortisol
levels immediately reduced but there was no effect on cognitive performance. Similarly,
Wolf et al. (1998) found no effect of DHEA supplementation after exposure to stress in
an elderly population. No effect of DHEA was noted on declarative memory however
attention improved. Again, these mixed findings do not offer support for the role of
DHEA as an anti-glucocorticoid nor do they provide strong evidence that it is actively
involved in the modulation of cognitive processes.
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1.6.7 Cognitive Performance in the Centrally Obese
Few studies have examined the direct impact that central obesity may have on cognitive
performance. Jagust et al. (2006) found that greater waist-hip ratio was negatively
associated with hippocampal volume. More specifically a one standard deviation
increase in waist-hip ratio was associated with a 0.2 standard deviation decrease in
hippocampal volume in addition to a 27% increase in white matter hyperintensities.
Reduced hippocampal volumes and white matter hyperintensities have both been shown
to significantly contribute to the development of dementia (Wu et al., 2002). The results
of this study indicate that central obesity may contribute to neurodegenerative deficit.
II~-HSD (see Section 1.5.5i) is postulated to be a key factor in cortisol related obesity.
The interaction of 11~-HSD and obesity on cognition is little researched but it has been
observed that II~-HSDI knockout mice show improvements in cognitive performance
suggesting a collective influence of metabolic factors on cognition. Further,
administration of the 11~-HSD1 inhibitor carbonoxelone has been shown to improve
memory performance in diabetics (Sandeep et al., 2004). Kilander et al. (1997) and
Sorensen et al. (1982) have linked obesity with poorer cognitive performance yet
neither study included females, nor was the influence of obesity on cognition the
primary endpoint. It is possible that obesity is not viewed as being a direct pathway to
cognitive impairment, but exacerbates pre-existing vulnerability in those with a
tendency for impaired glucose regulation (Elias et al., 2005).
Cognitive decrement has been associated with impaired glucose tolerance (Hiltunen et
al., 200 I; Vanhanen et al., 1998) and type 2 diabetes (Bent et al., 2000; Goldstein et al.,
2001; Strachan et al., 1997). A recent review by Messier et al. (2005) concluded that
subtle impairments in glucoregulation can result in cognitive impairment (Convit, 2005;
Craft, 2005; Ryan, 2005). Poorer glucoregulation has been associated with worse
performance on tests of working memory, executive function and declarative memory
(Messier et al., 2003). The observation that obesity is a cofactor in the incidence of
impaired glucose tolerance, diabetes and the metabolic syndrome suggests that obesity
could be linked to cognitive impairment. Elias et al. (2005) found a direct association
between obesity and cognition in males but not females when other cardiovascular risk
factors were controlled for with cumulative effects. Further, an association between the
presence of diabetes and cognition was observed but that diabetes did not interact with
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obesity. The findings may suggest that the mechanisms that link obesity and cognition
are different to those which link diabetes and cognition even though key metabolic
parameters are implicated in each (Elias et al., 2005; Ryan, 2003). Waldstein and Katzel
(2006) assessed cognitive performance and found that individuals with a greater waist
circumference were impaired on tasks of manual dexterity, motor speed, and executive
function. These findings were only of significance when blood pressure was also
elevated. Neither of the two aforementioned studies examined cortisol levels, nor was
any observed elevation in blood pressure due to stress exposure, indicating scope for the
studies presented in thesis to build on these findings.
1.7 Summary
This literature review has explored the characteristics of salivary basal cortisol and
cortisol in response to stress. It has also identified and explored factors which may
affect cortisol response and has examined in detail the proposed relationship between
cortisol and central obesity. This review highlights that the current understanding of the
relationship between cortisol, central obesity and cognitive function is limited. It
appears that cortisol responses are altered in central obesity and that this has
implications for future health. In relative terms, research into central obesity based on
waist-hip ratio is a novel area. Our understanding of the role of cortisol in the
development of central obesity and in response to psychological stress is also relatively
under-developed. The literature reviewed has highlighted the importance of basal
cortisol, the diurnal profile and the cortisol awakening response. The factors which may
affect cortisol response have been examined and are important to consider in the
research presented in this thesis. Cortisol activity is associated with changes in cognitive
performance in young and older adult/elderly samples. Research to date has failed to
examine cortisol, central obesity and cognition concurrently. Future research to explore
the link between cortisol responsivity, central obesity and cognitive function has clear
implications in a society where obesity is reaching epidemic proportions. This coupled
with the large body of knowledge about the health effects of obesity and metabolic
syndrome, makes the research outlined in this thesis, a novel and timely avenue for
investigation.
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CHAPTER TWO
Aims and Objectives
2.1 General Aims
The main aim of this thesis was to explore salivary cortisol secretions, both basal and in
response to stress, in individuals who exhibit central obesity compared with those who
do not. Elevated responses to psychological stress in individuals with central obesity in
conjunction with obesity related metabolic parameters may influence cognitive
performance.
This thesis presents a detailed exploration of stress responsivity in the centrally obese
(high waist-hip ratio) compared with lean or peripherally obese individuals (low waist-
hip ratio). An assessment of baseline salivary cortisol using waking synchronised saliva
samples was conducted to compare the diurnal profiles of those who exhibit central
obesity and those who do not. The cortisol response to stress using the psychological
laboratory stressor, the Trier Social Stress Test was assessed. A novel component of this
thesis explored the proposed vulnerability of the centrally obese to a cortisol mediated
cognitive deficit using a validated cognitive test battery (CANTAB) to administer
neuropsychological tests sensitive to hippocampal processing (declarative memory and
spatial memory). The main hypothesis was that those who exhibit central obesity will
show greater stress responsivity marked by an exaggerated cortisol response and poorer
cognitive performance.
2.2 Basal Cortisol in HighlLow Waist-Hip Ratio (WHR) Individuals
2.2.1 Reproducibility & Consistency of Cortisol Diurnal Profiles
Previous studies of basal diurnal cortisol have relied on volunteer sampling protocols in
a free-living environment. This is often confounded by the issue of participant
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compliance. There have been discrepancies in the number of days sampled in order to
identify an individual's typical diurnal profile and the number of samples required to
correctly display a basal diurnal cortisol profile.
A pilot study (Chapter Four) was conducted to explore the practicalities and feasibility
of studying differences in basal cortisol activity using saliva sampling methods. Using a
small sample of volunteers, cortisol samples were collected over a three day period at
set time points synchronised to waking. The objectives of this study were to assess (i)
the ability to reproduce the cortisol diurnal profile based on salivary cortisol samples (ii)
the consistency of the cortisol diurnal profile across the three day period and (iii) to
explore participant compliance with a strict salivary cortisol sampling protocol under
free-living conditions. The study aimed to establish the reproducibility and consistency
of the cortisol awakening response and diurnal profile over a three day monitoring
period in a general sample, not based on waist-hip ratio or psychological profile.
2.2.2 Patterns of Basal Diurnal Cortisol in HighlLow WHR individuals in relation
to Psychological & Metabolic Parameters
Following on from the demonstration that it was indeed feasible to repeatedly sample
cortisol in a free-living environment and that basal diurnal cortisol profiles are
reproducible, one of the main aims of this thesis was addressed. Study One (Chapter
Five) presents a detailed assessment of the potential differences in basal salivary cortisol
activity between those who exhibit central obesity and those who do not. Salivary
cortisol was assessed at set time points synchronised to waking over three consecutive
week days. Additional factors that could potentially influence basal cortisol were
assessed. These included sleep quality (using the LSEQ), daily hassles (using the Daily
Hassles Scale), and perceived stress (using the PSS). Further, an assessment of a range
of biological markers associated with obesity and the metabolic syndrome was made.
These biomarkers included fasting plasma glucose, insulin (insulin resistance using the
Homeostatic Model AssessmentIHOMA technique), total cholesterol, triglycerides, high
and low density lipoproteins, interleukin-6 (lL-6), C-reactive protein (CRP) and
adiponectin.
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2.3 Cortisol Responses to Stress in HighlLow WHR Individuals
Study Two developed the hypothesis that cortisol responses to stress are elevated in
high waist-hip ratio individuals and investigated the cortisol response to stress using the
Trier Social Stress Test (Kirschbaum et al., 1993). Differences in the cortisol response
of high and low waist-hip ratio individuals were explored. Epel et al. (2000) assessed
stress responsivity in a sample of females and found that increasing responsiveness was
associated with central obesity. The study presented in Chapter Six, explored responses
in both males and females. The hypothesis was that those who exhibit central obesity
will show an elevated salivary cortisol response to a psychological stressor compared
with lean or peripherally obese individuals.
2.4 The effect of Psychological Stress on Cognitive Performance in HighlLow
WHR Individuals
The literature explored in Chapter One suggested that there may be links between
cortisol, central obesity and cognition. Previous studies exploring the stress response in
high waist-hip ratio individuals did not consider the impact this could have on cognitive
performance. Further, central obesity has been identified as a risk factor for cognitive
impairment in conjunction with other metabolic factors such as hypertension (Elias et
al., 2005; Waldstein and Katzel, 2005). To date, the interaction of central obesity and
cortisol on cognition has not been explored. The study presented in Chapter Six was an
assessment of cognitive performance in high and low waist-hip ratio individuals and
their cortisol response to stress following exposure to a psychological stressor. Chronic
elevated cortisol has been shown to impact on cognitive performance, particularly
declarative memory (Lupien et al., 2005). If those who exhibit central obesity also
exhibit elevated cortisol in response to a psychological stressor, then one might predict
poorer cognitive performance.
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CHAPTER THREE
General Methodology
3.1 Introduction
There is large variation between studies in terms of the methods employed to assess
stress responsivity. Similarly, there is a large range of tests of cognitive function, each
measuring change in one or more specific domains. While one might suppose that the
classification of obesity has been agreed, this is not the case and there is an ongoing
debate as to whether central obesity is better reflected in waist-hip ratio or waist
circumference. Body mass index (BMI) is also subject to debate.
This chapter describes and discusses the methodology used to determine obesity in
particular central obesity, the determination of cortisol and the resultant indices which
can be calculated from the diurnal profile, as well as the stress induction technique
(TSST) adopted in the studies presented in this thesis. Further, the use of the CANTAB
neuropsychological assessment battery is explored. Additional measures employed in
the three studies are described in their respective chapters.
3.2 Measurement of Obesity
3.2.1 Body Mass Index (BMI)
Body mass index (BMI) is a calculation based on height and weight, which provides an
estimate of body mass. BMI is related to the risk of disease (Segal et al., 1986). A BMI
within the 18-25kg m-" is considered normal. A BMI greater than 26 and less than 30kg
m-" classifies an individual as being overweight and a BMI greater than 30kg m-?
indicates obesity (NHLBI and NIDDKD, 1998) with a BMI of greater than 35 kg m-"
indicating morbid obesity. A BMI greater than 30kg m-" is also indicative of risk of
incidence metabolic syndrome (WHO, 2000). The relevance of body mass index as a
marker of body composition is debated (Prentice and Jebb, 2001). BMI has been shown
to provide misleading information about the presence of obesity in a range of
..
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conditions, including ageing (Cohn, 1987), racial differences (Deurenberg et al., 1991;
Rush et al., 1997) and athletes (Katch and Katch, 1984) leading to an incorrect
diagnosis of obesity (Frankenfield et aI., 2001).
3.2.2 Body Composition
Due to the questionable reliability of body mass index alone, a measure of body
composition using bioelectric impedance was made. The use of bioelectric impedance
has been championed in the last decade in light of the failings of body mass index
calculations (Houtkooper et aI., 1996). Body composition (specifically fat mass) was
hence determined via bioelectrical impedance analysis (BIA) using the 'Biospace In
Body 3.0' body composition analyser. This gave an indication of the amount of fatty
tissue, muscle and water that contributed to the overall weight of the person tested. This
was conducted whilst the volunteer was in a fasted state.
3.2.3 Waist-Hip Ratio (WHR)
As discussed in Chapter One, the measurement of central obesity can be conducted
using more than one method, the most common being the measurement of waist to hip
ratio. The World Health Organisation (WHO, 2000) defines central obesity as a waist-
hip ratio of greater than 0.85 in females and 0.90 in males, a calculation based on
accurate measurement of waist circumference compared to hip circumference. Several
studies have demonstrated the effectiveness of measuring waist-hip ratio and its value in
predicting negative health states (Hartz et aI., 1984; Kalkhoff et aI., 1983; Rivera and
Svec, 1989). A single measurement of waist circumference has been used to predict
morbidity, with a circumference greater than thirty-five inches in females or forty
inches in males is indicative of central obesity (NCEP, 2001). However, Welborn et al.
(2003) found that waist to hip ratio to be a more dominant risk factor for cardiovascular
death than waist circumference alone.
When diagnosing central obesity, the distribution of fat is of paramount importance.
Methods that consider whole body obesity may not be sensitive enough to determine
central obesity from peripheral obesity. For example, body mass index (BMI) is a global
measure of obesity, but is inaccurate in the diagnosis of central obesity. Kontogianni et
al. (2005) found that BMI did not accurately reflect obesity status in a sample of
perimenopausal women and found inconclusive evidence for the use of BMI in
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determining vulnerability to obesity related disease. Skin fold thickness improves on
BMI despite being an assessment of whole body obesity (using callipers). Blair et al.
(1984) found similar results to waist-hip ratio measurements when using skin folds as a
diagnostic tool for central adiposity when predicting later morbidity.
Other techniques for measuring fat distribution are available. Waist to stature ratio
(WSR) proposes that waist circumference should not exceed half of the stature of the
body. Ho et al. (2003) in exploring predictors for cardiovascular disease found this
method to correlate more significantly than other measures (waist to hip ratio and waist
circumference) with cardiovascular risk factors. However, WSR is a relatively new
approach and as a result lacks reliability.
Other tools include the use of hip girth (Raja et al., 2004), 3D body scanning (Lin et al.,
2004) and computerised tomography (e.g. Borkan et al., 1982 and Yoshizumi et al.,
1999). Computerised tomography appears by far the most accurate method of
measuring body fat and determining body fat distribution. Such an approach has been
regularly applied to the diagnosis of Cushing's syndrome (Rockall et al., 2003),
confirming the observation that patients with Cushing's syndrome accumulate visceral
fat about the abdomen. However, computerised tomography despite its accuracy is
impractical for research conducted outside of a clinical setting.
In this thesis, it was decided that waist-hip ratio was the most reliable measurement of
central obesity when measured accurately. To ensure accurate measurement the
following guidelines were adhered to in the studies presented in this thesis. Separate
measurements of waist and hip circumference (in centimetres) were taken to determine
body shape in terms of waist-to-hip ratio. Waist circumference was measured at the
level midway between the lower rib margin and the iliac crest with volunteers in the
standing position without heavy outer garments and with emptied pockets, breathing out
gently. Hip circumference was recorded as the maximum circumference over the
buttocks. Waist-hip ratio was subsequently calculated as the ratio of waist
circumference over the hip circumference (Visscher et al., 2001; Molarius et al., 1999).
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3.2.3.1 Obesity Related Biomarkers
The incidence of central obesity is commonly associated with an incidence of elevated
blood biomarkers that are associated with poor health (Hartz et al., 1984; Kalkhoff et
aI., 1983). In particular central obesity concurs with the incidence of the metabolic
syndrome (Bjomtorp, 1997). To assess the association between central obesity and
poorer health a range of blood biomarkers were assessed that collectively form key
metabolic syndrome symptomology. These are outlined below.
i,Glucose & Insulin (with calculated Insulin Resistance)
Blood plasma and serum were collected from a fasted blood sample to assess presence
of diabetes / insulin resistance since these are key factors in metabolic syndrome
symptomology in relation to the role of cortisol in the metabolic syndrome (See Chapter
One, Section 1.5.2). The estimated degree of insulin resistance was inferred from the
fasting blood glucose sample obtained via application of the Homeostasis Model
Assessment (HOMA) technique. Concentrations of 11-12.2mJ.II'Lor 6.1 -7.0 mmol are
indicative of impaired glucose tolerance (IGT). Increases in concentration of over
126mg/dl or 7.0 mmollL indicate an increased risk of diabetes (Diabetes Mellitus
Expert Committee on the Diagnosis and Classification of Diabetes, 1997). It is
suggested that those with central obesity are at risk of impaired glucose tolerance and
diabetes (Bjomtorp, 1997).
Fasting glucose and insulin measures were used to calculate the degree to which
individuals may present insulin resistance. This was calculated using the homeostatic
model assessment technique (HOMA) (Matthews et al., 1985). This provides an
estimate of steady beta cell function and insulin sensitivity as a percentage of a normal
reference population. The calculation is as follows:
Insulin resistance (lR) = fasting plasma insulin x fasting plasma glucose
22.5
An assay for the detection of insulin was performed using a Perkin Elmer time resolved
fluoroimmunoassay kit developed for use on AutoDelfia. The principle is based on the
direct sandwich technique in which two monoclonal antibodies are directed against
separate antigenic determinants on the insulin molecule. Standards, controls and
50 Chapter Three: General Methodology
volunteer samples containing insulin are reacted simultaneously with immobilised
monoclonal antibodies directed against the insulin molecule and with europium-labelled
monoclonal antibodies directed against different specific antigenic sites on insulin. This
is carried out in one incubation step. Enhancement solution dissolves the europium ions
from the labelled antibody, which produces fluorescence. This is measured in each well
and the fluorescence from each sample is directly proportional to the concentration of
insulin in the sample (Soini & Kojola 1983; Hemmila et al., 1984; Lovgren et al., 1985)
The analysis of volunteer samples to determine glucose concentration was conducted
courtesy of Charing Cross Hospital, London using Hexokinase method on an Olympus
AU640 analyser (reagents and analyser from Olympus Diagnostics, UK).
ii,Adiponectin
Adiponectin has been found to be reduced in cases of obesity and type II diabetes. The
level of adiponectin in serum has been found to be between 5 and 10 ug/ml in human
serum (Berg et al., 2001). This was measured in serum collected from a fasted blood
sample to assess relationship between Adiponectin levels and the presence of insulin
resistance.
An 'in-house' AutoDelfia assay at Colworth (Unilever Research and Development) was
implemented to detect the level of adiponectin in human serum. The following protocol
was adhered to. MABI0651 (antibody) was absorbed to the surface of each well of
Nunc Maxisorb fluoronunc microtitre plates (100J.lI of 2J.lg/ml antibody in 50nM
Bicarbonate buffer pH 9.8, overnight at 4°C). Sensitised plates were washed three times
using PBST and 100J.lIserum samples or standard were added to the wells in duplicate
(diluted 1/1000 in Perkin Elmer DELFIA assay buffer). Plates were incubated at room
temperature for 1 hour on a microtitre plate shaker). The plates were washed as before
and 100J.lIof the biotinylated detection antibody BAM 1065 was added to each well
(2ug/mI in DELFIA assay buffer). The plates were again incubated for 1 hour on a
shaker. The plates were washed as before and 100J.llof streptavidin Eu conjugate was
added to each well (diluted 1/1000 in DELFIA assay buffer and filtered through a
0.22J.lIDfilter). The plates were again incubated for 1 hour on a shaker. The plates were
given a final six washes and 200J.lIof enhancement solution was added to each well.
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The plates were incubated for a minimum of five minutes on a shaker before reading via
a Victor- multi-analyte detection system set up for the detection of free Eu.
iii. Total Cholesterol
In addition to measured level of glucose and insulin, the measured level of total
cholesterol has also been shown to be higher in those with central obesity. Elevated
levels of total cholesterol (greater than 5.2mMIL) are indicative of high blood total
cholesterol and risk of metabolic syndrome. Hence in the subsequent studies presented
in this thesis, this was measured in serum collected from a fasted blood sample.
The analysis of volunteer samples to determine cholesterol concentration was conducted
courtesy of Charing Cross Hospital, London. The assay employed; (i) The Cholesterol
Oxidase method on an Olympus AU640 analyser (reagents and analyser from Olympus
Diagnostics, UK) for cholesterol assessment. (ii) Enzymatic method on an Olympus
AU640 analyser (reagents and analyser from Olympus Diagnostics, UK) for
Triglyceride assessment. (iii) Immunoinhibition method on an Olympus AU640
analyser (reagents and analyser from Olympus Diagnostics, UK) for HDL cholesterol
assessment and (iv) calculated from Total Cholesterol, HDL Cholesterol and
Triglyceride using the Friedewald Equation {LDL = TC - (HDL + TG/2.2)}for LDL
cholesterol assessment.
iv. High Density Lipoprotein (HDL) / Low Density Lipoprotein (LDL) Cholesterol
In conjunction with total cholesterol, elevated LDL and reduced HDL are characteristic
of central obesity and are additional symptoms of metabolic syndrome. Increased
quantities of LDL (>3.5 mmol/L) indicate the possible presence of
hypertriglyceridemia, in addition to low quantities of HDL «l.lmMIL). Hence, this
was measured in serum collected from a fasted blood sample to measure degree of
hyperlipidemia as a potential marker for metabolic syndrome.
The analysis of volunteer samples to determine HDL and LDL concentration was
conducted courtesy of Charing Cross Hospital, London using the same procedure as
employed in the assessment oftotal cholesterol.
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v. Triglycerides
Elevated levels of triglycerides (> 2.3mMIL; WHO, 2002) are a risk factor for
cardiovascular disease and diabetes and are markers for the metabolic syndrome. This
was measured in serum collected from a fasted blood sample.
The analysis of volunteer samples to determine triglyceride concentration was
conducted courtesy of Charing Cross Hospital, London using the same procedure as
employed in the assessment of total cholesterol.
vi. InterLeukin-6 (IL-6)
Elevated levels of IL-6 are associated with the presence of metabolic syndrome. Levels
of <1.Opg/ml are considered normal. This was measured in serum collected from a
fasted blood sample to assess the concentration of circulatory inflammatory cytokines
from blood samples to infer immune status.
The assay employed to determine IL- concentration employed the quantitative sandwich
enzyme immunoassay technique. A monoclonal antibody specific for IL-6 was pre-
coated onto a micro plate. Standards and samples were pipetted into the wells and any
IL-6 present was bound by the immobilized antibody. After washing away any unbound
substances, an enzyme-linked polyclonal antibody specific for IL-6 was added to the
wells. Following a wash to remove any unbound antibody-enzyme reagent, a substrate
solution was added. After an incubation period, an amplifier solution was added and
colour developed in proportion to the amount of IL-6 bound in the initial step. The
colour development was stopped and the intensity of the colour measured.
vii. C- Reactive Protein (CRP)
In addition to an elevation of IL-6 in the metabolic syndrome, an additional
inflammatory marker, CRP has also been shown to be elevated in a centrally obese state
concurrent with metabolic syndrome. The normal range of CRP is between 0.18 to
5.05mg/L (Tchemof et al., 2002).This was measured in serum collected from a fasted
blood sample to assess immune function.
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The analysis to determine CRP concentration was conducted courtesy of Charing Cross
Hospital, London using Immunoturbidimetry on an Olympus AU640 analyser (reagents
and analyser from Olympus Diagnostics, UK).
3.3 Measurement of Cortisol
Research has used various psychological or biological indices of stress and stress
responsivity ranging from subjective reports on psychological questionnaires to
physiological biomarkers such as cortisol, the focus of the studies in this thesis.
3.3.1 Cortisol
i. Detecting Cortisol
Cortisol can be detected in human plasma, saliva and urine. Each method of detection
has certain practical implications. For example, measuring urinary cortisol although
useful for exploring cortisol excretion rate over the nocturnal period, is not appropriate
for tracking rapid changes in cortisol activity (including the diurnal period) (Gozansky
et aI., 2005) as it takes a significant amount of time to excrete cortisol metabolites in
urine. Plasma cortisol can track rapid changes in cortisol activity. However, the
venepuncture procedure artificially elevates cortisol activity (Meeran et aI., 1993) as it
can be a stressful procedure. Further, serial blood collections for the assessment of
cortisol are impractical, uncomfortable and inconvenient for the volunteer. The use of
saliva sampling overcomes these practical issues. Samples are quick and easy to collect
using specialised collection devices (salivettes). Cortisol in saliva is able to track rapid
changes in activity. Further, salivary cortisol reliably and accurately correlates with
plasma cortisol when analysed using a radioimmunoassay (RI) procedure (Vining et al.,
1983). This applies to the assessment of basal cortisol, cortisol responses to an external
stressor and responses to exogenous glucocorticoid administration (Umeda et aI., 1981;
Kahn et al., 1988; Port, 1991; O'Connor and Corrigan, 1987; Vining et al., 1983;
Contreras et al., 2004 and Turin et aI., 1992). Gozanksy et al. (2005) contributed
additional support for the use of salivary cortisol using a commercial enzyme
immunoassay (ElA) to confirm that salivary cortisol analysis represents the bioactive
fraction of cortisol (not the cortisol that is bound to cortisol binding globulin (CBG) or
other proteins) compared to serum cortisol. This accurately reflects the activity of the
hypothalamic-pituitary-adrenal (HPA) axis. Hence, Gozansky et al. (2005) argued that
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the use of saliva for cortisol analysis is physiologically more relevant in stress research.
Further, Putignano et al. (2002) demonstrated the effectiveness of salivary cortisol
assessment in exploring differences in cortisol activity in those demonstrating central
obesity.
In this thesis, the collection of saliva for cortisol assessment was deemed to be an
acceptable method for exploring differences in cortisol activity between individuals
with central obesity and lean or peripherally obese individuals, for both the diurnal
profile and stimulated cortisol responses to stress.
ii. Sampling Methods
The number and frequency of saliva samples collected for the assessment of basal
cortisol varies largely in research studies. Early research formed conclusions about
cortisol awakening activity based on one saliva sample obtained during the early
morning (Simkin et al., 1961; Szenas and Pattee, 1959). This was later deemed
insufficient to accurately assess the dynamic activity of cortisol during the period of the
cortisol awakening response (Hucklebridge et al., 1998; Pruessner et al., 1997).
Consequently, it is now accepted that a series of samples are required. For example, a
number of studies have obtained samples immediately upon waking, 30minutes, forty-
five minutes and sixty minutes post waking (Federenko et aI., 2004; Wust et aI., 2000).
Other studies have conducted a more detailed sample collection procedure and obtained
samples at waking, 15minutes, 30minutes, 45minutes post waking and every three hours
post waking until 12hour post waking in an attempt to capture more sensitive changes in
the cortisol awakening response and subsequent diurnal response (Edwards et aI.,
2001 ;2001; Hucklebridge et aI., 2002; 2005). Some studies have obtained fewer
samples, collecting samples upon waking and subsequently at thirty and sixty minutes
(Williams et aI., 2005) or at waking and 30minutes post waking (Kunz-Ebrecht et aI.,
2004) hence there is some variation in terms of capturing the cortisol awakening
response. In this thesis, a more detailed profile of cortisol activity over the diurnal
period was required. Hence, the sample times adopted by Edwards et al. (2001) and
Hucklebridge et al. (2002; 2005) were used as a guide, that is to say that samples were
collected immediately upon waking (Ominutes), 15,30 and 45 minutes post waking and
subsequently at 3, 6, 9 and 12 hours post waking.
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It is also important to consider the period of saliva sampling. For example, Steptoe et al.
(2004) obtained saliva samples over the course of one day only. Other studies have
monitored cortisol activity over two days (for example, Edwards et al., 2001; Federenko
et al., 2004) and one study assessed cortisol activity over a six day period exploring
differences between responses on week days to weekends (Schlotz et al., 2004). Cortisol
responses appear to differ between weekdays and weekends (Kunz-Ebrecht et al., 2004;
Thorn et al., 2006) with attenuated cortisol awakening responses at the weekend
compared to weekday. In the current study it was decided to monitor the activity over
cortisol over a three day weekday period in order to obtain an aggregate profile of
cortisol activity to improve accuracy of the cortisol responses collected and gain a more
detailed view of the consistency of cortisol activity within each volunteer over a three
day period. To prevent extraneous factors altering measured cortisol awakening
responses, sampling over a weekend was not permitted.
The nature of waking can also influence subsequent changes in cortisol output. Some
studies adhere to a pre-decided 'clock-time waking' rather than natural biological
waking time (Ice et al., 2004; Smyth et al., 1997) with actual time points synchronised
to this time of waking (e.g. 8am). Other studies have explored the collection of saliva
samples that are synchronised to natural waking followed by set time points based on
time of waking (Abercrombie et al., 2004). Both approaches have observed
methodological issues. A forced waking time may not be truly representative of the
natural cortisol response to waking leading to an alteration of the cortisol awakening
response (Spath-Schwalbe et al., 1991). Natural waking, with waking time synchronised
sampling, is heavily reliant on the compliance of the volunteer and may result in a lack
of synchronicity and inaccurate data being obtained. However, while it is possible to
screen data for non-compliance once obtained, it would be difficult to ascertain whether
the cortisol awakening response was altered due to forced waking. For this reason,
responses to natural waking with set time points after this were selected as the method
used in this thesis.
In this thesis, eight Sarstedt salivettes were provided for each volunteer per day
sampled; each was labelled clearly with the sample day and time. These samples were
taken immediately upon waking, 15mins, 30mins and 45mins post waking, and
subsequently at 3, 6, 9 and 12 hours post waking. The volunteers were provided with
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both oral and written instructions on how to use the salivettes correctly. It was
imperative that the cotton wool insert be kept in the mouth for an absolute minimum of
thirty seconds and ideally retained in the mouth for one minute to allow to complete
saturation of the cotton wool with saliva. The volunteers were asked to refrain from
eating and drinking or from brushing teeth until the samples for the assessment of the
cortisol awakening response had been collected. This is due to the observation that
vascular leakage and micro-abrasion can alter the saliva in the sample (Vining and
McGinley, 1987). Once returned to the laboratory, the salivettes were frozen at -20°C by
the researcher to precipitate mucins until transported for analysis. The data was used to
construct a cortisol diurnal profile for each day incorporating the cortisol awakening
response to assess consistency over the sampling period with a view to forming an
aggregate profile to compare between groups
iii.Biochemical Assay of Saliva for Cortisol
A number of assay techniques exist that may be employed to determine the
concentration of cortisol in saliva. The majority of previous studies employ a
radioimmunoassay (RIA) technique (e.g. Cook et al., 1997; Morineau et al., 1997).
Another common technique is the use of the widely available Salimetrics enzyme
immunoassay (EIA) kit (Salimetrics, LLC) specifically developed for use with saliva.
Cortisol was determined in the studies presented in this thesis by a DELFIA validated
'in-house' assay developed at Unilever Research and Development. Colworth, that was
more cost effective in comparison to the Salimetrics EIA and equally as sensitive and
reliable. The amount of cortisol present in the saliva samples was determined using a
competitive inhibition immunoassay using fluorescence on AutoDelfia at Colworth
(Unilever Research and Development). This was an in-house technique developed from
previous use of the widely used Salimetrics Kit (Salimetrics LLC). The process uses
pre-coated and quality controlled Goat anti-Rabbit plates (rabbit cortisol antibodies
linked to goat peroxidase). Cortisol in the unknown samples competes with the cortisol
contained on the plate for the antibody binding sites during an incubation period.
Unbound components are washed away and the plate is treated with europium treated
cortisol (Cortisol Eu3+) as a fluorescence to illuminate the degree of binding and
determine to concentration of cortisol present in the sample (by 'counts'). The count of
cortisol europium binding is inversely proportional to the concentration of cortisol
present.
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3.3.2 Dehydroepiandrosterone (DHEA)
DHEA is related to cortisol and can be readily measured in human saliva (using passive
drool samples). DHEA demonstrates a circadian rhythm in a similar profile to cortisol
that has been shown to diminish with age and appears unaffected by cortisol circadian
activity (Ceresini et aI., 2000). More importantly, DHEA has often been linked to
cognitive performance via its relationship with cortisol. Cortisol and DHEA are linked
as a ratio of action. Research suggests that a low DHEAS: high Cortisol ratio leads to
cognitive impairment particularly in elderly people (Kalmijin et aI., 1998). An
assessment of dehydroepiandrosterone (DHEA) was made via collection of passive
drool samples using a small pre-labelled collection pots. One awakening sample was
obtained was collected per day of assessment in Chapter Five and Chapter Six. Samples
were obtained immediately upon waking in conjunction (but not following) the first
cortisol sample. Salivary DHEA correlates well with plasma DHEA (r = 0.9; Goodyer et
aI., 1996) and shows stability over a two day sampling period (Hucklebridge et aI.,
2005).
The assay procedure for determining Dehydroepiandrosterone concentration present is
similar to the procedure for cortisol analysis in that it is based on the original
Salimetrics Kit technique and uses horseradish peroxidase coated plates, again with
rabbit antibodies. Following incubation, the unbound components are washed away, the
degree of bound DHEA peroxidase is determined by the reaction of the peroxidase
enzyme on the added substrate tetramethylbenzidine (TMB). This reaction produces a
blue colour. The reaction is stopped by addition of sulphuric acid changing the colour
from blue to yellow. The optical density is subsequently read on a plate reader. The
amount of DHEA peroxidase present is inversely proportional to the concentration of
DHEA present in the sample.
3.3.3 Assessing Cortisol Diurnal Profiles (Computational Indices)
There are a number of techniques that can be applied in the statistical assessment of the
basal diurnal cortisol profile. As previously, discussed, salivary samples for cortisol
assessment are usually collected over a period of 1-3 days. Past research has formed an
aggregated profile in determining average cortisol activity over a brief period (1-3 days)
and on occasion assessed the consistency of the profiles obtained (e.g. Edwards et al.,
2001). Assessing profile consistency has been found to be particularly useful in
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exploring HPA regulation (Ice et al., 2004; Smyth et al., 1997). An inconsistent profile
may reflect poor HPA regulation. Another approach to the data is the use of calculated
indices of cortisol activity. These indices reflect changes in the rate and level of cortisol
secretion at certain time points across the diurnal period including change in cortisol
during the cortisol awakening response (CAR). These indices are outlined below:
i. Area under the curve with respect to zero (AVC) (Edwards et al., 2001)
The AUC is an assessment of the amount of cortisol secreted during the awakening
response from 0 (Sample A), 15 (Sample B), 30 (Sample C) and 45minutes (Sample D)
post waking. This is calculated as follows:
Sample A + Sample B + Sample C + «Sample D - Sample A) / 2)
H.Area under the curve with reference to the first sample (AVRC) (Edwards et al.,
2001).
The AURC is an assessment of the amount of cortisol secreted during the awakening
response from 0 - 45minutes post waking. This was calculated as follows:
Sample B + Sample C - (2 * Sample A) + «Sample 0 - Sample B) / 2)
iii. Mean Increase in cortisol from waking to 45 minutes post waking (MnIne)
(Edwards et al., 2001)
The MnInc is an assessment of the rate of increase in cortisol activity from 0 - 45
minutes post waking. This was calculated as follows:
(Sample B + Sample C + Sample D) / 3 - Sample A
iv. Change between waking (Sample A) & 30minutes (Change 0-30) (Steptoe et al.,
2004).
Change 0-30 is an assessment of the change in cortisol activity from 0 - 30minutes post
waking to examine the cortisol response to waking. This analysis has been used recently
in research that specifically explores associations between cortisol and central obesity.
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v. Difference between the awakening cortisol level & the final sample (Day-
Difference, Edwards et al., 2001)
Day-Difference is an assessment of the change in cortisol level between waking and the
12-hours post waking. This is reflects the rate of cortisol activity over the course of the
diurnal profile.
vi. Difference between the 3h sample & 12hr sample (day Difference 3-12;
Edwards et al., 2001)
The Day-Difference index can also be applied to assess cortisol activity over the diurnal
period excluding the cortisol awakening response as a change between 3 hours post
waking and 12 hours post waking.
vii. Final Sample (Sample H) (Edwards et al., 2001)
Assessment of the Final Sample has often been used as an indicator of continuing
cortisol activity into the evening/nocturnal period after the 12-hour assessment has
completed. It is postulated that an elevated final sample indicative of the possibility of
elevated cortisol secretion throughout the evening and nocturnal period and can be a
predictor of subsequent health problems (Dallman et al., 1993).
viii. Day Mean (Edwards et al., 2001)
Day Mean, using equal interval sample times (0, 3, 6, 9, 12) can be calculated to assess
the mean level of cortisol activity across the diurnal profile.
ix. Diurnal Mean
A Diurnal Mean in addition to a Day Mean (previous) can be calculated using the
diurnal sample time points E, F, G and H (3hour - 12hours post waking) as an
indication of the mean level of cortisol activity post awakening response.
3.4 Biopsychological Stress Induction & Measurement
3.4.1 Stress Induction: The Trier Social Stress Test
The Trier Social Stress Test (TSST) (Kirschbaum et al., 1993) combines a public
speaking (interview) with a mental arithmetic task in front of a panel of judges.
Application of the TSST as a stress induction tool successfully elevates ACTH, growth
60 Chapter Three: General Methodology
hormone, prolactin, and heart rate post administration (Kirschbaum et al., 1993). A 2- to
4- fold increase in cortisol (both serum and saliva) from baseline has been observed in
80% of subjects who undergo the TSST (Schommer et al., 2003) with subjects
displaying at least a 2.5mmol/l increase in cortisol as a result of exposure (Kirschbaum
et al., 1993). The TSST has applications in a wide range of research but with particular
relevance in the investigation of stress induced memory impairment (Domes et al.,
2002; Hoffman and AI'Absi, 2004; Lupien et al., 1997; Maheu et al., 2005; Takahashi
et al., 2004) where the impact of stress-induced cortisol elevations on cognitive
performance was assessed.
The procedure adopted for the TSST is consistent among previous applications. The
success of the TSST is hinged upon the inclusion of a socio-evaluative threat
component with an element of uncontrollability (reviewed by Dickerson and Kemeny,
2004). This combination is most effectively represented in a public speaking task. The
TSST adopts the following procedure. The volunteer is taken into a room (a) where they
are introduced to the task they were about to complete. In a separate room, (b), two
people are sat behind a desk (interview panel) with a video camera and microphone
installed. The volunteer is taken into room (b) and asked to sit in front of the panel (the
panel always comprises both male and females). The volunteer is asked to assume the
role of a job applicant who has been invited for a personal interview with the company
staff managers (the selection committee). These managers are introduced as being
especially trained in the assessment of non-verbal behaviour. The volunteer is informed
that following a brief preparation period, they will be asked to introduce themselves to
the panel and perform a 5 minutes speech detailing why they feel they are the best
person to fill the vacancy. Further, the volunteer is informed that a voice frequency
analysis of their performance is to be conducted. Following these instructions, the
volunteer is returned to room (a) where they are allowed 10 mins preparation for their
speech. Pen and paper notes are permitted whilst in preparation but are not allowed in
the interview room.
After ten minutes of preparation, the volunteer is taken back into room (b), whilst the
investigator waits outside. The manager invites the volunteer to begin the speech and
the volunteer stands before the committee. If the volunteer has finished his speech prior
to the allotted five minutes, the managers respond using a standardised script. First, the
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volunteer is told, "You still have some time, please continue!" If the volunteer stalls
again before the end of the five minutes, the mangers remain silent for 20 seconds
before using a set of prepared questions.
Fifteen minutes into the TSST, the volunteer is instructed to serially subtract the number
13 from 1022 as fast and accurately as possible. On every failure, the volunteer is asked
to restart, by the command "stop 1022" (this is a timed five-minute task; however, the
volunteer is unaware of the time allotted). Twenty minutes into the TSST, the task is
complete and the volunteer is taken back into room (a). The volunteer is fully debriefed
at the end of the experiment and is informed that neither voice pattern nor video
analysis was performed.
Saliva samples for cortisol assessment were collected at baseline and throughout the
TSST procedure (six samples in total). Concurrent with cortisol samples, blood pressure
was also measured using an ambulatory blood pressure device (Star Labs®). To
measure subjective stress, the state trait anxiety inventory (STAI) and state self esteem
scale (SSES) were administered at baseline and subsequently at set time points during
the procedure. At the end of the session, a debrief questionnaire in the form of visual
analogue scales was administered to assess subjective perception of how stressful the
TSST was perceived to be (See Section 3.4.2.3).
3.4.2 Subjective Measures of Stress
3.4.2.1 Perceived Stress Scale (pSS; Cohen, 1994).
The PSS is a widely used, reliable tool, which is a measure of the perception of stress
and the degree to which situations in an individual's life are appraised as being stressful
(See Appendix 10). The questions contained are easy to understand, easy to respond to
and are free from context specific effects to any subpopulation. The short form of the
perceived stress scale (used in this thesis), also allows for quick administration.
Responses are made on a five point Likert Scale (0-4) from "never" to "very often" with
a higher score suggesting greater perceived stress. Scoring is based on norms for
defined categories including gender, age, and race. Scores above 12.1 in males and 13.7
in females are considered above average indicating greater subjective stress.
Assessment is usually made from thoughts over the past month but can be adjusted for
weekly or daily assessment and so is flexible in its administration. In this thesis, a
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monthly assessment was made for a more general perception of stress. Assessment of
the reliability of the Perceived Stress Scale yields satisfactory internal consistency with
Cronbach alpha's ranging from 0.84 to 0.86 (Cohen et aI., 1983). Similarly, no ceiling
or floor effects have been observed (Froelicher et aI., 2004). This measure was
administered prior to the start of the study to assess how stressful each volunteer
perceived their current situation to be. This was of particular relevance when exploring
basal cortisol diurnal profiles. A non-classic diurnal profile may be attributed to greater
subjective perceived stress.
3.4.2.2 Daily Hassles Scale (Kanner et al., 1981)
As an additional measure of daily stress, the Daily Hassles Scale was administered in
conjunction with the PSS. The subjective reporting of daily hassles could impact
heavily on the expression of basal diurnal cortisol profiles. The Daily Hassles Scale
consists of 117 items that cover aspects of health, family, friends and the environment,
practical considerations and chance occurrences (See Appendix 15). These items
measure the frequency and severity of transactions with the environment that are
considered by the person to be stressful. Volunteers rate each item on a scale of 0 (did
not occur), 1,2 or 3 (somewhat, moderately or extremely). Scores include an indication
of the severity of the hassle and its persistence (yielding essentially the same
information r = 0.95; Kanner et aI., 1981). A frequency score is obtained by counting
the number of hassles checked. An intensity score is calculated by taking the mean of
the severity rating. In this thesis, the scale was amended to include a self-report section
for the volunteer to detail particular events experienced during sampling that were
perceived as being particularly stressful. Test re-test assessment based on monthly
administration demonstrates consistency of scores. Correlations are higher for frequency
(average r = 0.79) than intensity of hassles (average r = 0.48) (Kanner et aI., 1981).
Themes have been identified according to age for the most frequently checked hassles.
For example, middle-aged volunteers tend to select hassles related to property, finance,
taxes etc.
3.4.2.3 Visual Analogue Scales (Debrief Questionnaire)
At the end of the test session in Chapter Six, an 'in-house' debrief questionnaire using
visual analogue scales was administered to assess perception of the stress induction
procedure (See Appendix 8). The questions assessed perceived preparation,
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performance and stressfulness of both the TSST and also of the cognitive test battery
(CANTAB). It has been suggested that individual response to a stressor is largely
dependent on the perception of the stressor. If a stimulus is not perceived as being
stressful then little or no response will be observed (Holroyd and Lazarus, 1982; Levine,
1978; Vogel, 1985).
3.4.3 Additional Physiological Measures of Stress
3.4.3.1 Blood Pressure
This was measured at the screening stage of the study using an ambulatory blood
pressure device (Omron ®) to assess potential hypertension as a component of the
metabolic syndrome. A measured blood pressure of over 160 mmHg I 90 mmHg
indicates the risk of hypertension (WHO, 2000) and was measured prior to experimental
completion. Blood pressure exceeding 140/90mmHg is indicative of risk of incidence of
Metabolic Syndrome (WHO, 2000). The pressure cuff is placed on the preferred arm
(usually the left). An initial reading is taken to demonstrate the procedure to the
volunteer (this reading is later discarded). The volunteer is asked to undergo seated rest
for 5-minutes whilst wearing the blood pressure cuff to acclimate to the equipment.
Four readings subsequently taken at I minute intervals whilst the volunteer remains
seated (Bardwell et al., 2000; Everson et al., 2001) and an average of these readings was
taken.
During the test session a continuous measurement of blood pressure was taken using an
ambulatory device (Star Labs ®). This was taken to assess the physiological response to
stress in conjunction with measures of cortisol and psychological appraisal using the
STAI and SSES. Blood pressure responses to stress have been found to correlate with
stress -induced changes in cortisol (Cacioppo et al., 1995).
3.S Measuring Cognitive Performance
A wide range of cognitive testing procedures have been implemented in research
exploring stress-induced cognitive impairment. These range from those testing a wide
range of cognitive performance in the form of a battery (e.g. Hoffinan and AI' Absi,
2004) to specific tests of declarative versus non declarative memory using simple
immediate and delayed word recall lists (e.g. Lupien et al., 1997). In this thesis, it was
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deemed appropriate to administer a range of cognitive tasks due to the observation that
impairment, although more commonly observed for declarative memory (Lupien et aI.,
2005), has also been observed on other tasks, for example spatial memory (Young et aI.,
1999) and attention (Bohnen et aI., 1990). Therefore, the Cambridge Automated
Neuropsychological Test Battery (CANT AB) was supplemented with a specific test of
immediate and delayed verbal declarative memory, the auditory verbal learning task
(AVLT) (Rey, 1964).
3.5.1 Background
Volunteers were assessed on their cognitive performance using the Cambridge
Neuropsychological Test Automated Battery (CANTAB). Originally developed at the
University of Cambridge by Professor Robbins and colleagues in 1986, the battery has
gained considerable popularity in the assessment of functional deficit related cognitive
impairment. The battery is sensitive to a range of brain disorders and has been applied
in the assessment of patients with Parkinson's disease, Alzheimer's disease, unipolar
depression and schizophrenia. CANT AB is language independent with good test re-test
reliability and clinical validity through extensive application in clinical research. For
example in brain lesion studies (e.g. Fowler et al., 1997), degenerative disorders e.g.
Parkinson's disease (Owen et al., 1997) and psychiatric illness (Rahman et al., 1999).
The accuracy and sensitivity of CANT AB has also been confirmed from neuroimaging
tests (PET and tMRI) in patients exhibiting brain dysfunction (Lee et al., 2000).
Sensitivity to cognitive deficit associated with human ageing has also been
demonstrated (De Luca et al., 2003; Rabbitt and Lowe, 2000). The range of level of
difficulty within the 13 subtests prevents floor and ceiling effects and allows for a more
accurate assessment of cognitive performance.
3.5.2 Cognitive Tasks
The battery contains a number of neuropsychological tests of which eight were selected
for the current study and are detailed below. The tests were administered using a touch
screen computer with the researcher present, to guide the volunteer through the correct
procedure. The tests are detailed in the following sections:
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(a) Auditory Verbal Learning Task (AVLT) (Rey, 1964)
The volunteer is verbally presented with a list of 15 words 'List A' and asked to listen
very carefully (See Appendix 16). When the researcher finishes reading the list, the
volunteer is asked to repeat as many of the words back to the researcher from the list as
they can remember. The volunteer is not informed of the number of correct response,
any repeats made or of the number of words yet to recall. Any repeats are noted using
appropriate documentation in addition to any word confusions/associations or
confabulations. This is repeated for five trials, for each trial the volunteer is asked to
predict the number of words they estimated that they would be able to recall. Following
trial five, a new list 'List B' is introduced to the volunteer and the same procedure
repeated for one trial. The volunteer is asked to begin the CANTAB test battery.
Following the paired associates learning task (PAL) the volunteer is asked to recall
verbally as many words as possible from List A (after a delay of approximately
20minutes). All words recalled are recorded in addition to any errors or any intrusions
from List B. Care was taken to ensure that neutral words were included in the word lists
to avoid the influence of emotion on stress-induced verbal recall (See Chapter One,
Section 1.6.4).
(b) CANTAB
i. Motor Screening (MOT)
This task was administered before all other tests as part of a training task to ensure
accurate use of the touch screen and assesses the possibility of any visual or movement
problems. The volunteer is asked to touch a series of crosses that appear on screen
randomly so that they disappear as quickly as possible (Figure 3.1). The researcher first
demonstrates the procedure.
Figure 3.1: Motor Screening Figure 3.2: Delayed Matching to Sample
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ii. Delayed Matching to Sample (DMS)
The volunteer is shown a complex visual pattern (sample) and after a brief delay, four
patterns (Figure 3.2). Each pattern is made up of four sub elements each in a different
colour. One of the four choices is identical to the sample, one is a novel distracter, one
has the shape of the sample but the colours of the distracter and one has the colours of
the sample but the shape of the distracter. To avoid the possibility of a strategy based on
learning single quadrants, all four choices have one quadrant in common with the
sample. The volunteer is required to correctly identify the sample from the four choices
by touching the selected pattern on the screen. If the volunteer makes an incorrect
choice, then a second choice must be made and so on until the correct pattern is
identified. The task begins with three practice trials (aided by the researcher) followed
by 20 counterbalanced trials of simultaneous, 0, 4 or 12 second delay presentation.
iii. Paired Associates Learning (PAL)
The task requires the volunteer to remember patterns associated with different locations
on the screen. Six boxes appear on the screen and are opened randomly revealing a
pattern (Figure 3.3). During the test phase, the volunteer must point to the correct
location as each pattern is presented. The test moves through varying levels of difficulty
from 2 locations through to 8 locations. If an error is made, the patterns are presented
again and the volunteer must repeat the trial. The volunteer can have up to ten repeat
reminder trials within each set of patterns. If the trial is not completed within those ten
repeat trials, the test is automatically terminated. This task tests the ability to form
visuospatial associations within a delay response procedure. In particular two aspects
are assessed; 'list memory' indicating the correct identification of the patterns in their
locations and 'list learning' in reference to the number of times the patterns are repeated
in order to learning to occur, leading to a correct identification.
III •• •I. II
II II
Figure 3.3: Paired Associates Learning Task Figure 3.4: Pattern Recognition Memory
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iv. Pattern Recognition Memory (PRM)
The volunteer is presented with a series of visual patterns (12 in total) in the centre of
the screen (Figure 3.4) and asked to remember them. These patterns are designed so that
they cannot be assigned a verbal description. In the recognition phase, the screen
displays two patterns, one is the test pattern, and one is a distracter. the volunteer is
required to select the pattern they believe was part of the list previously viewed by
touching the screen. In this phase, the test patterns are presented in reverse order to the
original order of presentation. This is repeated with 12 new patterns.
v. Spatial Recognition Memory (SRM)
The volunteer is presented with a white box that moves about the screen in a set
sequence to five different locations (Figure 3.5). In the recognition phase five pairs of
boxes are presented on the screen, one is the target and one is a distracter. The volunteer
is asked to indicate by touching the screen which box is in a location previously viewed
in the presentation phase. This test is repeated three times each with five new locations.
Figure 3.5: Spatial Recognition Memory Figure 3.6: Rapid Visual Processing
vi. Rapid Visual information Processing (RVP)
This task is an assessment of sustained attention with a small working memory
component. A white box appears in the centre of the screen, inside of which numbers
between 2 and 9 appear in a pseudo-random order at a rate of 100 digits per minute
(Figure 3.6). The first trial is a practice followed by a test trial. The volunteer is asked to
detect a series of consecutive odd numbers 3, 5, 7 and even numbers 2, 4, 6 by a button
press. Target sequences occur at a rate of 16 every 2minutes.
vii. Spatial Working Memory (SWM)
The task set is to find the blue token within each of the available boxes and use them to
fill up an empty column at the side of the screen (Figure 3.7). The number of boxes
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displayed on the screen increases to a total of eight. The colour and location of the
boxes changes with each trial to deter strategy formation. The volunteer must open each
box in turn until one reveals a blue token. The token is transferred to the column at the
side of the screen. The box that contained the token will no longer hold a future token
and opening this box again is recorded as an error. The volunteer continues to search for
the remaining tokens without re-visiting boxes that have already contained tokens.
Figure 3.7: Spatial Working Memory Figure 3.8: Stockings of Cambridge
viii. Stockings of Cambridge (Tower of London) (SOC)
This task is a spatial planning test that is based on the Tower of London task. The
subject is shown two displays containing three coloured balls (Figure 3.8). The
volunteer must use the balls in the lower display to copy the pattern in the upper
display. The balls can be moved one at a time by touching the required ball and then the
position to which it is to be moved. The time taken to complete the pattern and the
number of moves are recorded as an indicator of the volunteers planning ability (there is
no time limit). At first only one ball is to be moved, this increases gradually to five
moves. Two task insertions are made of a procedure to control motor performance. If
the volunteer makes more than double the number of moves for a trial, the trial is
terminated. If three trials in a row are terminated then the task is terminated.
3.5.3 National Adult Reading Test (NART, Nelson, 1982)
Chapter Six conformed to a between subjects design. This was adopted primarily due to
the potential for the TSST to evoke anticipatory responses in a within subjects design
which could create unnecessary noise in the data set. In order to control for differences
between volunteers in terms of cognitive ability, the National Adult Reading Test
(NART) was administered to provide an estimate of IQ of which could be used as a
covariate in the subsequent analysis of cognitive performance to control for prior
differences in cognitive ability.
69 Chapter Three: General Methodology
The NART is an estimation of premorbid intelligence. The test consists of 50 words of
increasing difficulty of which volunteers are asked to read and pronounce (See
Appendix 14). The words included on the scale deviate from the standard grapheme-
phoneme and stress rules of pronunciation. Therefore, in order for a volunteer to
correctly pronounce a word, they must first be familiar with it. The number of
mispronounced words is recorded to produce an error score. This is entered into an
equation (128-0.83 x NART error score) to calculate estimated WAIS (Wechsler Adult
Intelligence Scale) full scale IQ. The NART is successful in satisfying three criterions
for the viable estimation of IQ. Firstly, the test is reliable, second, it is capable of
predicting a substantial degree of variance in IQ and finally it is resistant to pre-existing
neurological or psychiatric disorder (Crawford, 1989; Crawford et al., 1990; O'Carroll
et al., 1992).
3.6 Conclusions
To examine the aims outlined in Chapter Two, it was necessary to identify suitable
methodologies and appropriate tests for the assessment of the three main areas of
interest; cortisol, central obesity and cognitive performance. Although these techniques
have not been employed in combination in the investigation of the effects of stress in
high and low waist-hip ratio individuals, the evidence for their sensitivity has been
demonstrated in the studies reviewed in Chapter One. The methods outlined in this
chapter, were chosen as they were considered to be the most reliable and valid of those
available for the studies outlined in this thesis.
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CHAPTER FOUR
The Practicalities of Assessing Basal Salivary Cortisol:
A Pilot Study
4.1 Introduction
Cortisol demonstrates a clear circadian profile of activity over the course of 24-hours
(Born et al., 1999). The natural circadian activity of cortisol can be displayed
graphically in the form of a diurnal profile. This profile is a plot of basal salivary
cortisol concentration against time post waking and includes the cortisol awakening
response (CAR). A dramatic change in cortisol activity is observed, during the first 30-
45minutes post waking (Born et al., 1999; Hucklebridge et al., 1998; PrUssner et al.,
1997). with an average increase of 9nmolll within a range of 4-15nmoVI (Clow et al.,
2004). Plotting a diurnal profile permits assessment of the cortisol awakening response
in the continuous measurement of cortisol activity during the afternoon and evening
(Stone et al., 2001). Cortisol diurnal profiles can be compared in terms of a number of
calculated cortisol indices (Edwards et al., 200 I; Schmidt-Reinwald et al., 1999; WUst
et al., 2000a) (see Chapter Three, Section 3.3.3). These are calculations based on the
shape of the cortisol profile obtained and indicate the overall level of cortisol activity
during a day. There are a number of practical issues to consider when sampling basal
salivary cortisol. Previous studies differ in the number of days sampled to observe
typical diurnal activity. For example, Steptoe et al. (2004) obtained saliva samples over
a single day. Other studies have assessed basal cortisol over two days (Federenko et al.,
2004; Edwards et al., 2001). The assumption that a single day of monitoring is sufficient
to reflect typical activity will be addressed. Further the suggestion that free-living
studies are commonly associated with non-compliance (Kudielka et al., 2003) despite
high ecological validity will be explored.
71 Chapter Four: Measuring Cortisol
4.2 Objectives
This study aimed to explore the cortisol diurnal profile in an older adult sample (35-65).
Profiles were explored for consistency over a period of three consecutive sampling days
to determine the reproducibility and reliability of the cortisol diurnal profile. Further,
the feasibility of implementing an averaging process on which the calculated cortisol
indices are based was assessed. These indices were used to compare the profiles
obtained over the three sample days. The practicalities of using saliva sampling as a
means of cortisol assessment were explored.
4.3 Method
4.3.1 Sample
Volunteers were recruited from the Institute of Psychological Sciences, University of
Leeds via an email recruitment flier to staff within the department. Eight volunteers
were recruited to complete a three consecutive day period of saliva sampling (5 females,
3 males). All were aged between 35 and 65 with an average age of 50.25 ± 6.1 years.
Smokers and individuals using any form of steroidal medication were excluded.
4.3.2 Design
The study conformed to a repeated measures design with each volunteer completing a
three consecutive day period of saliva sampling with 8 within day observations (cortisol
samples). A correlational assessment of each calculated index of cortisol activity across
the three sampling days was conducted.
4.3.3 Measures
4.3.3.1 Psychological Measures
Potential volunteers were asked to complete a screening booklet which was designed to
collect background/demographic information (height, weight, marital, occupational and
health status - See Appendix 1) and to administer the Perceived Stress Scale (PSS;
Cohen, 1994) to measure subjective stress (see Chapter Three, Section 3.4.2).
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4.3.3.2 Physiological Measures
Physiological measures of blood pressure, height and weight (to calculate BMI) and
waist-hip ratio (WHR) were obtained to assess body shape and current health status (see
Chapter Three, Section 3.2).
4.3.3.3 Biological Measures (Cortisol)
Salivary cortisol was measured eight times over each day for three consecutive days
using pre-labelled salivettes (Sarstedt) for each sample day and time. Twenty-four
salivettes per volunteer in total were collected.
4.3.4 Procedure
The procedure for the collection of cortisol and biochemical assay was described in
Chapter Three (see Section 3.3). Further to this, the following procedure was followed
on each day of saliva sampling.
Volunteers were asked to refrain from the consumption of alcohol the night prior to the
experiment commencement since alcohol can falsely elevate cortisol levels on the
subsequent sampling day. The following protocol was adhered to:
i. Immediately upon waking the volunteer was required to produce an initial cortisol
sample using the designated salivette provided. The volunteer was asked to remain in a
supine, relaxed position and to abstain from food and drink.
ii. The next sample was taken 15 minutes post waking and step (ii) repeated using the
designated salivette provided.
iii. The same procedure was repeated at 30 minutes and 45 minutes post waking. The
volunteer was asked to remain in a supine position until after the 30-minute sample.
Volunteers were asked to refrain from the consumption of food or drink other than
water until after the 45-minute sample. Similarly, the volunteer was asked to refrain
from brushing their teeth until this sample had been provided (to avoid vascular leakage
and micro-abrasion, which has been shown to alter the saliva in the sample).
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IV. Volunteers were asked to continue the saliva samples over the course of the
afternoon. Samples were collected at 3, 6, 9 and 12 hours post waking. It was
imperative that volunteers abstained from food and drink (other than water) for a
minimum of 30minutes prior to collecting the sample (to prevent food debris and
foreign liquids being absorbed by the cotton wool).
4.3.5 Data Treatment & Analysis
All data were analysed using SPSS for Windows Version 12 (SPSS, Inc.) Cortisol data
shows a general tendency for positive skewness (e.g. Edwards et aI., 2001). The cortisol
data was explored and normality assessed visually using histograms and statistically
using the Kolmogorov-Smirnov test of normality. The cortisol data was positively
skewed across all sample points and was normalised using a logarithmic transformation.
Diurnal profiles were constructed for each of the three days of sampling for each
individual to observe the inter- and intra-subject consistency of the basal salivary
cortisol profile. These profiles were used to calculate a number of indices of cortisol
activity (previously described in Section 3.3.3) which were used to compare profiles
using a correlational analysis The indices were tested for consistency using a Pearson's
Correlational analysis for each cortisol index across the three days for the 8 volunteers.
This assessed the consistency of cortisol activity over the 3 days and the feasibility of
the construction of an aggregate profile could be considered. This pilot study included
assessment of a small and fairly diverse sample in terms of age and gender, therefore the
analysis performed was an idiographic, graphical data analysis of the profiles with
reference to the demographical and psychological characteristics of each volunteer.
The subject characteristics of the sample were compared using corrected t-tests to
control for violations of homogeneity of variance concurrent with small sample sizes.
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4.4 Results
4.4.1 Sample Characteristics
The characteristics of the sample are shown in Table 4.1 below.
Total Male Female
Characteristic N = 8 N =3 N =5
Age (years) 50.25 ± 6.11 53 ± 4.58 48.60 ± 6.77
BMI (Kg/m2) 27.74 ± 4.42 27.50 ± 3.54 27.84 ± 5.11
WHR 0.85 ± 0.09 0.96 ± 0.04 0.81 ± 0.06
PSS Score 17.88 ± 5.84 19.67±7.l0 16.80 ± 5.54
Table 4.1: Sample Characteristics displaying age, BMI, WHR & Perceived Stress with
Means±SD
There were no differences between males and females in terms of age, BMI or PSS
score. Measured waist-hip ratio was significantly greater in males compared with
females (t (5) =-3.021; p=0.023).
4.4.2 Diurnal Profiles
Composite Diurnal Profile (N=8)
15 30 45 180 360 540 7Zl
Tlme Post Waking (Mlns)
Figure 4.1: Composite Diurnal Cortisol Profile for the sample (Means ± SEM)
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A composite profile based on the average of all the profiles for each volunteer in the
sample was constructed (Figure 4.1). A set of diurnal profiles for each of the 3 days
were constructed for each volunteer and are shown with their related psychological and
physiological characteristics (Figure 4.2 - 4.9 and Table 4.2 - 4.5).
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Figure 4.2: 3 day Basal Diurnal Cortisol Profile for Volunteer 001
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Figure 4.3: 3 day Basal Diurnal Cortisol Profile for Volunteer 002
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Figure 4.4: 3 day Basal Diurnal Cortisol Profile for Volunteer 003
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Figure 4.5: 3 day Basal Diurnal Cortisol Profile for Volunteer 004
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Volunteer 005
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Figure 4.6: 3 day Basal Diurnal Cortisol Profile for Volunteer 005 (missing data at times 0 &
l Srnins on Day I & 45mins on Day2)
Volunteer 006
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Figure 4.7: 3 day Basal Diurnal Cortisol Profile for Volunteer 006 (missing data at time 30mins
on Day 3)
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Figure 4.8: Volunteer 007 (Day 2 data missing)
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Figure 4.9: Volunteer 008 (Day 1 data missing)
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Volunteer Age Gender WHR BMI PSS
001 40 female 0.81 23 11
002 47 female 0.90 35 22
Table 4.2: Associated Psychological & Physiological Characteristics for 001 & 002 to
accompany the Basal Cortisol Profile
Volunteer Age Gender WHR BMI PSS
003 49 male 0.98 30 12
004 58 female 0.73 24 11
Table 4.3: Associated Psychological and Physiological Characteristics for 003 & 004 to
accompany the Basal Cortisol Profile
Volunteer Age Gender WHR BMI PSS
005 46 female 0.82 26 18
006 52 female 0.77 32 22
Table 4.4: Associated Psychological and Physiological Characteristics for 005 & 006 to
accompany the Basal Cortisol Profile
Volunteer Age Gender WHR BMI PSS
007 58 male • • 21
008 52 male 0.93 25 26
Table 4.5: Associated Psychological & Physiological Data for 007 & 008 (*data
missing)
Based on the descriptions of a classic diurnal cortisol profiles in the literature (Born et
al., 1999; Hucklebridge et al., 1998; PrUssner et aI., 1997), it is evident that volunteer's
003 (Figure 4.4) and 006 (Figure 4.7) show typical profiles on each of the 3 sampling
days. This suggests that it is possible to reproduce the basal diurnal cortisol profile
using the methods adopted in this pilot for some individuals. What is interesting is the
amount of variation even in this small sample. Volunteer 001 (Figure 4.2) demonstrates
a good cortisol awakening response but demonstrates disrupted activity over the
subsequent diurnal period. Volunteers 002 (Figure 4.3) and 004 (Figure 4.5)
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demonstrated a flattened awakening response (no increase after the initial sample) but
demonstrated a steady decrease in cortisol over the diurnal period. This was consistent
across the 3 sampling days for these volunteers.
The profiles obtained for volunteers 007 (Figure 4.8) and 008 (Figure 4.9) were
incomplete due to inadequate volumes of saliva collected. The profiles obtained were
flattened, showing great variability, lacking a cortisol awakening response and
remaining elevated over the remaining diurnal period. Volunteer 005 (Figure 4.6) also
showed flattened profiles on 2 of the 3 days sampled. Day 3 of sampling for volunteer
005 produced a classic basal profile which suggests that there is some variability in the
circadian rhythm of cortisol over the 3 days for this volunteer. This may indicate an
improvement in compliance as the volunteer became familiar with the sampling
protocol.
Minimal psychological assessment was made and as a result, it cannot be ascertained
what the variability may be attributable to. For example, a greater experience of daily
hassles or daily stressors may produce a more variable profile. In the current study,
minimal associations with subjective stress (using the PSS) were noted. Volunteer 002
reported high perceived stress, concurrent with a highly variable profile, however this
was not consistent for all volunteers. It is interesting to note high perceived stress in
volunteers 007 and 008 who also suffered the greatest loss in cortisol data.
All the indices of cortisol activity (as described in Chapter Three, Section 3.3.3) were
calculated (Day Mean, Diurnal Mean, AVC, AVRC, MnInc, Day Difference, Waking
Difference, Day Difference 3-12, Final Sample) for each profile.
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01-02 01-03 02-03
Cortisol Index N=6 N=7 N=6
Mean Increase r = 0.783* r = 0.751 r = 0.108
AVC r = -0.128 r = -0.444 r = 0.541
AURC r =0.829* r = 0.721 r = 0.138
Change 0-30 r =0.852* r = 0.098 r = 0.302
Day Mean r =0.361 r = 0.776* r = 0.344
Diurnal Mean r =0.673 r = 0.683* r = 0.279
Day Difference 0-12 r =0.668 r = 0.344 r = 0.639
Day Difference 3-12 r =0.460 r = 0.599 r=-0.014
Final Sample r =0.579 r=0.510 r = 0.469
Table 4.6: Correlations for consistency across 3 sampling days for each cortisol index
(*p<0.05; **p<O.OI)
The profiles correlated well over the initial 2 days of sampling (Table 4.6) for mean
increase, AVRC and the difference in cortisol between waking and 30minutes post
waking (Change 0-30). The mean of cortisol (both Day mean and Diurnal mean)
correlated well over a longer period of time (01-03). The consistency of the Final
Sample index, although not significant, did show moderate consistency across the three
days. There was no evidence of more consistency between days 1 and 2 than for days 1
and 3 or 2 and 3 to indicate consistency over a longer period of time. These
observations coincide with the degree of variability observed in the profiles both within
individuals for each of the three days and between individuals in terms of level and
pattern of activity (Figures 4.2-4.9).
4.5 Discussion
This study was designed to assess the feasibility and practicality of using 3 day diurnal
salivary cortisol profiles in a free living environment. Further, the feasibility of
producing an aggregate profile from three separate sampling days was explored. Due to
the small sample size and minimal psychological assessment in conjunction with basic
cortisol assessment, inferences made are by necessity, tentative. However, a number of
points for discussion can be raised.
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The profiles presented in this study demonstrated a degree of inter- and intra subject
variability in terms of the profile produced. It is clear that for some individuals, profiles
are reproducible over a 3 day period, but it is also clear that deviations from a classic
'textbook' profile are common for a number of volunteers. It is of importance to
highlight that although not all volunteers displayed a classic diurnal profile, the profiles
that were exhibited were consistent across the 3 days of sampling.
The study also highlighted a number of practical and methodological issues that must be
considered when using saliva samples for cortisol analysis.
4.5.1 Inter- & Intra- Subject Variability
The cortisol diurnal profile can demonstrate great both inter- and intra- variability in
both the cortisol awakening response and subsequent diurnal activity. This conflicts
with previous research which suggests moderate intra-individual stability using similar
correlational analyses (Edwards et al., 200 I; WUst et al., 2000). There is great variation
in the shape of the profile and in the consistency of the profile presented across the three
days. The indices of cortisol activity used to compare level of cortisol activity between
individual were based on an aggregated cortisol profile from 3 days of saliva sampling
in a procedure that is similar to previous studies (e.g. Edwards et al., 2001). It could be
misleading to compare individuals on their aggregate cortisol activity when it may be
that the underlying profiles themselves are highly inconsistent. Equally, if only one day
had been sampled, one would have been unaware of this and would have assumed that
the one day was typical of the basal cortisol profile for that individual. Previous
research has highlighted the importance of verifying the consistency of the profile prior
to forming the aggregate profile (Edwards et al., 200 I) and the current study reinforces
the importance of this.
The findings of this study highlight the need to consider potential variation in a cortisol
profile prior to its implementation in comparative research. Of the eight sets of profiles
obtained, only two individuals (003 and 006) exhibited a classic cortisol awakening
response (CAR). This evidences the potential to reproduce the cortisol diurnal profile,
and particularly the cortisol awakening response using this procedure. However, the
observation of a cortisol awakening response in only two out of eight data sets suggests
low prevalence of the response in the current sample. It is necessary to examine why the
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profiles exhibited were not classic for the remaining volunteers. There is an obvious
lack of psychological data, it is possible that some individuals experienced greater daily
stressors which were reflected in the profiles. Based on the available data, no
associations were found in terms of subjective stress using the Perceived Stress Scale
and no other differences in age, BMI or WHR were noted. This is will be considered in
Chapter Five.
4.5.2 Methodological Issues
Volunteer compliance is paramount when conducting free-living studies which rely
upon volunteer adherence to a demanding protocol. A number of issues relating to
compliance were raised in this study.
(i) Accurate Sample Timing
Sample times were individually synchronised to waking time in this pilot study. This is
heavily reliant on the volunteer noting the time of waking and calculating subsequent
sample times for the remainder of the sampling day. Cortisol responses to forced versus
natural waking have been explored by Hucklebridge et al. (1999). Hucklebridge et al.
(1999) concluded that the cortisol awakening response can be influenced by the time of
waking. For example, forced waking four hours earlier than normal disrupts the
awakening response compared with uninterrupted waking or natural nocturnal waking.
Bailey and Heitkemper (1991) found that the time of waking can affect the awakening
response. Edwards et al. (2001) also found that the time of waking can alter the pattern
of cortisol activity over the diurnal period. Therefore in the subsequent studies
conducted in this thesis, cortisol sampling was synchronised to natural waking time.
Further differences in the cortisol awakening response have been observed between
weekday and weekend cortisol measurement (Kunz-Ebrecht et aI., 2004; Thorn et aI.,
2006). As the sampling in the current study was conducted on week days, it is not
possible to explore this in the current data set. However, in the subsequent studies
conducted in this thesis, cortisol sampling will continue to be conducted on week days
to prevent the influence of a confounding factor.
Once the sample times have been determined, the next step is to ensure that volunteers
are compliant in producing the required samples at the required times. Volunteers were
briefed at the induction session prior to the pilot study to emphasise the need for
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accuracy when collecting saliva samples. It is difficult, however, to guarantee
adherence. Previous research has highlighted the importance of compliance in saliva
sampling using the methods outlined in the current study and has suggested the
implementation of a form of electronic monitoring device (Kudielka et al., 2003).
However, such devices are not infallible and could potentially produce forced waking.
In an attempt to preserve the integrity of the data, Edwards et al. (2001; 2000) have
suggested that individuals not displaying a cortisol awakening response should be
excluded from data analysis (Le. a profile that does not show an increase in cortisol
activity after the initial sample). This is based on the assumption that the awakening
response is an inherent response in individuals and a lack of response could signal the
non-compliance. In the current study, this would have meant that 8 out of the 24 profiles
obtained would have been excluded from the analysis or that 4 out of 8 volunteers
would have been removed. It is unlikely that 50% of the sample were non-compliant.
It is also of interest, not only from a methodological perspective, to examine the
proportion of profiles that show a non-classic profile since previous research has
suggested that abnormal profiles may be associated with poor health outcomes
(Bjomtorp and Rosmond, 2000). Thus in the subsequent studies presented in this thesis,
attention is paid to the prevalence of classic and non-classic profiles and the likelihood
that these are due to non-compliance as opposed to other psychological or physiological
factors.
(ii) Sample volume
The biochemical assay procedure applied to the saliva samples for cortisol
determination relies upon the collection of an adequate volume of saliva. Volunteers
007 and 008 failed to provide adequate volumes for the 8 samples collected on day three
and hence no profile could be obtained. Volunteers were asked at the induction session
to hold the cotton wool insert in the mouth for a minimum of thirty seconds (ideally it
should be retained in the mouth for one minute), to allow for complete saturation of the
cotton wool with saliva. This is again reliant on volunteer adherence and compliance.
The majority of missed samples occurred during the cortisol awakening response which
implies that these samples are the most difficult to obtain possibly due to a lack of
saliva. Many volunteers did report the tendency for a dry mouth upon waking and hence
perceived it to be difficult to produce an adequate volume of saliva.
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(iii) Movement during the Cortisol Awakening Response
Postural adjustment can stimulate the HPA axis due to a shift in blood volume. Hennig
et al. (2000) proposed that this can influence cortisol activity and consequently produce
an elevated cortisol awakening response. However, in a recent assessment,
Hucklebridge et al. (2002) found no influence of movement or body posture on the
cortisol awakening response. In the current study, it was decided that movement be
restricted as a precaution in light of conflicting literature. Movement was advised to be
kept at a minimum (remaining in a supine position) until the sample 30minutes post
waking has been provided. This protocol was adhered to in the subsequent studies
conducted in this thesis.
4.6 Conclusions
This pilot study has highlighted some important methodological issues and considered
the procedures adopted by previous research to decide upon the practicalities of saliva
sampling for cortisol determination. It has also been informative to assess the feasibility
of measuring cortisol diurnal profiles in a free living environment. The study has shown
that a great deal of variability exists both within and between subjects, which has
important implications for how cortisol profiles are interpreted and compared across a
number of variables and individuals. The data suggests that it is important to assess
profile consistency before any assertions about basal cortisol activity can be made. It is
also important to implement strict yet feasible procedures to maximise the accuracy of
the data obtained and to consider how best to relay these instructions to the volunteers
in subsequent studies. The pilot study presented in this chapter suggests that cortisol
profiles can be obtained, that 3 days of sampling is useful to ascertain intra-subject
variability and that demographic and psychological variables may be important in
examining inter-subject variability. This strategy was adopted for the studies
subsequently presented in this thesis.
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CHAPTER FIVE
Basal Cortisol variability in older adults: Exploring associated biopsychological
parameters
5.1 Introduction
Chapter One reviewed a wealth of literature which suggests that those individuals who
have a large amount of central fat or central obesity also exhibit altered levels of basal
cortisol activity. Some earlier studies, which did not consider the diurnal fluctuation in
cortisol, suggested that basal levels of plasma cortisol are elevated in obese individuals
(Simkin et al., 1961; Szenas and Pattee, 1959). Increased understanding of obesity and
its morphology indicates that the type of fat distribution is an important determinant of
basal cortisol activity. Basal cortisol activity is elevated in individuals who exhibit
peripheral obesity (Rivera and Svec, 1989). For those individuals who exhibit central
obesity the same does not hold true; basal cortisol activity is altered but detectable
levels of cortisol are lower (Ljung et al., 1996; Marin et al., 1992; Strain et al., 1980).
The fatty tissue type and distribution differs in the centrally obese compared to those
with peripheral obesity (see Chapter One, Section 1.5.1). Cortisol production in the
centrally obese is elevated but this elevation is not readily detectable in the basal
circadian profile. This is due to an enhanced cortisol clearance rate (Ljung et al., 1996;
Marin et al., 1992; Strain et al., 1980) evidenced by an increase in cortisol metabolites
in urine and an elevated cortisol activity over the nocturnal period. This cortisol
hypersecretion has been suggested to produce a blunted cortisol awakening response
(due to dysregulation of the hypothalamic-pituitary-adrenal axis, which lowers cortisol
peaks and raises troughs in activity). For example, Duclos et al. (1999) found that
salivary cortisol measurements taken over the diurnal period in centrally obese
individuals were lower in concentration compared to non-centrally obese volunteers.
Thus, individuals with central obesity and those with peripheral obesity display basal
cortisol profiles that differ from lean individuals. Central and peripheral obesity
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produces profiles distinctly different from each other. However, research has not
demonstrated this finding with great consistency (Andrew et al., 1998; Ljung et al.,
2000; Phillips et al., 1998; Phillips et al., 2000; Rask et al., 2002; Van Cauter et al.,
1996; Wallerius et al., 2004; Ward et al., 2003). Moreover, studies, which have
examined cortisol profiles over the diurnal period, have tended to sample only one day
and have varied in the timing and number of samples taken (Steptoe et al., 2004;
Edwards et al., 2001). Hence, the profile of inter and intra daily variation among lean,
central and peripheral obese individuals requires confirmation.
From the detailed discussion of the metabolic syndrome (MS) in Section 1.5, it was
evident that some of the biological parameters associated with metabolic syndrome
were also common in central obesity. For example, individuals with central obesity
often exhibit impaired glucose tolerance and/or insulin resistance (Rivera and Svec,
1989; Hartz et al., 1984), known components of the Metabolic Syndrome. Other
common characteristics include hypertension and elevated blood lipids. The observation
that central obesity and cortisol dysregulation co-occur, for example in patients with
Cushing's syndrome (Starkman et al., 1999; 2003), suggested a possible role for cortisol
in the expression of the metabolic syndrome. Bjorntorp and Rosmond (1999; 2000;
2001) labelled metabolic syndrome as a neuroendocrine disorder of cortisol
dysregulation based on stress released cortisol. Although studies have not examined
basal diurnal cortisol profiles in MS it has been suggested that cortisol is altered in this
condition. Key metabolic symptomology are associated with altered glucocorticoid
activity and hypothalamic-pituitary-adrenal axis regulation (Andrew et al., 2002;
Bjorntorp and Rosmond 1999; 2000; 2001; Rosmond et al., 2000). Since individuals
with central obesity may develop Metabolic Syndrome or may already be manifesting
undiagnosed symptoms, the identification of altered cortisol profile and the association
of this with other parameters of the metabolic syndrome may be of theoretical and
practical importance.
5.2 Objectives
This study is an examination of the consistency and replicability of basal salivary
cortisol activity in males and females aged between 35 and 65 years. The study
examines whether differences in basal glucocorticoid activity can be related to
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abdominal adiposity specifically waist-hip ratio. The study also examines the
relationship between salivary cortisol activity and biological parameters that are
associated with metabolic syndrome, for instance, glucose, insulin and blood lipids
(Bjorntorp 1997) and inflammatory markers, which reflect immune system activity.
5.3 Method
5.3.1 Sample
Volunteers were recruited through a variety of sources. Small adverts were inserted in
University Magazine 'The Reporter', which is distributed widely throughout the
University of Leeds campus. This document is also available as an 'online magazine'
readily accessible to university members at any time both on and off campus. Posters
were distributed about the university precinct, particularly in the students union and in
various departmental staff/canteen rooms at the discretion of departmental secretaries.
Posters were also displayed in public libraries, gymnasiums and community centres
around Leeds. Campus wide distribution lists were targeted using email fliers. A small
advert was also placed in the local government recruitment/news bulletin.
One hundred and ten volunteers were initially recruited using opportunity sampling on a
volunteer basis (58 females, 52 males). The exclusion criteria for the study are outlined
below.
Exclusion Criteria
• Any person not within the specified age boundary «35 or >65)
• Smokers or ex-smokers of less than one year.
• Night shift or abnormal shift workers
• Those who engage in excessive amounts of exercise regularly
• Any female on any form of Hormone Replacement Therapy currently or in the
last 12months.
• Any person on any type of steroidal/anti - inflammatory / hormonal
medication or any prescription or over the counter drugs in the past month,
including recreational drugs
• Any individual using medication for psychological problems e.g. depression,
anxiety etc. Similarly, anyone with a history of mental disorders /
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psychological problems
• Anyone with a history of cardiac, neurological, hepatic, digestive, thyroid,
renal or hormonal disorders etc, diabetes or asthma etc.
• Anyone with abnormal blood pressure and cardiac output (over 140/90mmHg
at rest (WHO, 2000)).
• Anyone who has donated blood in the past month
• Anyone with a high score on the Hospital Anxiety and Depression Scale
(HADS) indicating clinical caseness
• Anyone with a high score on the Dutch Eating Behaviour Questionnaire
(DEBQ)
The final sample size for analysis was 83; 41 male and 42 females (Figure 5.1). All
were aged between 35 and 65 with a mean age of 45.71 (± 7.21 SO) years. Volunteers
were not currently on any form of medication and were non-smokers. Ninety-three
percent of the volunteers in the sample were in current full or part time employment
(4% classed themselves as students, 2% as homemakers and 1%were retired).
5.3.2 Design
HWHR
N=38
LWHR
N=45
Male Female Male ~
~_N_=_2_0_ ~~ __N_=_18__ ~~ __N_=_2_1~~
Figure 5.1: FlowChart to illustratethe main study designwithWHR & gender as between
subjects factors
The study conformed to a 2x2 ANOVA design (See Figure 5.1), with 2 between
subjects' factors, waist-hip ratio and gender, each with 2 levels (high/low and
male/female). For cortisol sampling. time was included as a within subjects variable in
the ANOVA model with 8 levels.
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When the characteristics of the profile were considered, an additional IV was
introduced. The design thus conformed to a 2x2x2 ANOVA (Classic Versus Non-
Classic) with 3 between subjects factors, profile group, waist-hip ratio group and
gender, each with 2 levels (classic/non-classic, high/low and male/female) (See Figure
5.2).
Classic Profile
N =48
HWHR
N=22
LWHR
N=26
M
N=13
M
N=ll
Non-classic profile
N =35
HWHR
N = 16
LWHR
N = 19
M
N=IO
F
N=9
M
N=7
Figure 5.2: Flow Chart to illustrate the Classic versus Non-Classic study design with WHR,
gender & Profile Group as between subjects' factors
5.3.3 Measures
5.3.3.1 Psychological Measures
The following measures were administered during the study (See also Chapter 3:
General Methodology): (i) Perceived Stress Scale (PSS; Cohen, 1994). This was
administered at screening and used to measure of the perception of stress and the degree
to which situations in an individual's life are appraised as being stressful (see Appendix
10). (ii) Daily Hassles Scale (Kanner et al., 1981). This was used to assess the quality of
the day in terms of the frequency and intensity of potentially stressful eventslhassles
encountered. The scale includes one hundred and seventeen items, which measure the
frequency and severity of a person's transactions with the environment that are
considered by the person to be stressful. The scale was amended to include a self-report
section for the volunteer to detail any particular events occurring that were perceived as
being particularly stressful on each of the three sampling days (see Appendix 15). In
addition the following measures were administered:
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(i) Hospital Anxiety & Depression Scale (DADS; Snaith and Zigmond, 1994)
The HADS is a widely used screening tool, implemented as an indicator of mood
pathology, measuring subjective feelings of depression and anxiety (see Appendix 12).
Scores of 0-7 in each of the two subscales are considered normal, scores of 8-10 are
borderline and scores of 11+ are indicative of clinical 'caseness'. There is a possible
third cut-off of 14/15 for 'severe' cases. The HADS is easy to administer and is quick to
complete and to score. The HADS has demonstrated high acceptance ratings in both
patients and individuals devoid of psychopathology (Herrmann et al., 1991).
Assessment of the reliability of both subscales within the HADS yields satisfactory
internal consistency (Cronbach alpha's) of 0.80 to 0.93 for the anxiety subscale and
0.81 to 0.90 for depression (Herrmann, 1997; Herrmann et al., 1995). Retest reliability
correlates highly after up to two weeks demonstrating the stability of the scale over time
and in response to situational influences (Elliott, 1993; Prettyman et al., 1993;
Salkovskis et al., 1990). This measure was implemented as a screening tool and was not
subsequently analysed in the results.
(ii) Dutch Eating Behaviour Questionnaire (DEBQ; Van Strien et al., 1986)
The DEBQ measures three facets of eating behaviour; (i) restraint (ii) emotional eating
and (iii) external eating (see Appendix 13). Responses are formed on a scale of 1-5 with
an average score for each subscale. The DEBQ collectively measures these facets in one
easily administered questionnaire. Studies since its development the DEBQ has been
found to have high internal consistency (a. - .95) and good two week test re-test
reliability (r=.82) (Stice, 2001; Van Strien et al., 1986). This measure was implemented
as a screening tool and was not subsequently analysed in the results.
(iii) Leeds Sleep Evaluation Questionnaire (LSEQ, Parrott and Hindmarch, 1980)
The LSEQ assesses four aspects of sleep/sleeping behaviour: (i) getting to sleep (ii)
quality of sleep (iii) awakening from sleep and (iv) behaviour following waking. The
questions tap into subjective opinion of aspects of sleep and early morning activity (see
Appendix 11). Responses are made using a visual analogue scale (1-100). Compared
with other measures of sleep, one advantage of the LSEQ is that it contains more
questions (ten). Therefore, is able to provide a more detailed assessment of sleep
compared to scales applied by Bond and Lader (1974) and Nicholson et a1. (1976). The
use of visual analogue scales for subjective ratings is a widely used and validated
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approach (Aitken, 1969; Herbert et al., 1976). EEG studies demonstrate that visual
analogue measures of sleep correlate well with objective EEG recordings (Lewis, 1969).
The LSEQ has good retest reliability (0.63-0.78, Tarrasch et al., 2003) and stability
across a range of clinical settings (Zisapel and Laudon, 2003).
5.3.3.2 Biological Measures
The following physiological measures were obtained at screening to assess body shape
and current health status. These included; (i) blood pressure, (ii) body mass index
(BMI), (iii) body composition (fasted), (iv) waist-hip ratio (WHR) and (v) a range of
blood biomarkers including fasting insulin and glucose, total cholesterol, HDL, LDL
and triglycerides, IL-6, CRP and adiponectin (see Chapter Three Section 3.2.3.1)
Salivary cortisol was measured frequently over the course of the study using pre-
labelled salivettes (Sarstedt). Eight salivettes were provided for each volunteer per day
sampled labelled in accordance with the sample day and time. Three sampling days
were undertaken providing twenty-four salivettes per volunteer in total. The data
collected was used to construct a cortisol diurnal profile for each day.
Dehydroepiandrosterone (DHEA) was assessed on each of the three test days over the
course of the study. One passive drool sample using a small pre-labelled collection pot
was collected per day.
5.3.4 Procedure
Potential volunteers were screened via telephone interview (see Appendix 2). Suitable
volunteers were sent a Volunteer Screening Booklet (see Appendix 1). Selected
volunteers were asked to attend an induction session at the Institute of Psychological
Sciences. This session was designed to introduce the volunteer to the study, the
equipment and procedure. The study was approved by the Institute of Psychological
Sciences Ethics Committee prior to the study commencement.
5.3.4.1 Cortisol Monitoring Period
Volunteers were asked to refrain from the consumption of alcohol on the nights prior to
the experiment since alcohol can elevate cortisol levels on the subsequent sampling day.
The following protocol was thus adhered to (see Appendix 3):
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i. An initial sample for DHEA assessment was produced immediately upon waking
using the drool pot provided. This was conducted whilst the volunteer was still in bed,
in a supine position. No food or drink other than water (if necessary) was permitted at
this time.
ii. Immediately following this, the volunteer was asked to produce a saliva sample for
cortisol assessment using the designated salivette provided. The volunteer was asked to
remain in a supine, relaxed position and to abstain from food and drink.
iii. The next sample was taken 15 minutes post waking as in step (ii) using the
designated salivette provided.
iv. The same procedure was repeated at 30 minutes and 45 minutes post waking. The
volunteer was asked to remain in a supine position until after the 30-minute sample.
Volunteers were asked to refrain from consuming any food or drink other than water
until after the 45-minute sample. Additionally, volunteers were asked to refrain from
brushing teeth until this sample had been collected (to avoid vascular leakage and
micro-abrasion, which has been shown to alter the saliva in the sample - See Chapter
Three). Subsequently, volunteers were asked to complete the Leeds Sleep Evaluation
Questionnaire (LSEQ) to assess sleep quality during the previous night.
v. Volunteers were asked to continue collecting saliva samples over the course of the
afternoon. Samples were collected at 3, 6, 9 and 12 hours post waking. It was
imperative that volunteers abstained from food and drink (other than water) for a
minimum of 30minutes prior to collecting the sample (to prevent food debris and
foreign liquids being absorbed by the cotton wool).
vi. Before the volunteer retired to bed, volunteers were asked to complete the Daily
Hassles Scale to evaluate opinion of the day in terms of the frequency and number of
hassles/daily stressors encountered.
This procedure was repeated for three consecutive working/week days.
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5.3.5 Data Treatment & Analysis
5.3.5.1 Missing Data
Three independent observers (blind to waist-hip ratio or gender) considered each set of
profiles. The profiles were characterised as 'classic' or 'non-classic' in shape. A classic
profile was characterised by a clear response to waking followed by a steady decline to
stable concentrations in the later diurnal stages. A non-classic profile was flattened, and
lacked a cortisol awakening response with a less stable diurnal decline.
In the construction of the cortisol diurnal profile, data inclusion was based on each
volunteer presenting at least two sampling days of cortisol data for each time point in
order to aggregate the profile accurately. If this criterion was not satisfied then the
volunteer was excluded from analysis. Interpolation of data points was possible (if and
when necessary) during the diurnal period of the profile. However, no interpolations
were permitted for awakening response data as cortisol is subject to less stable changes
in concentration during the cortisol awakening response.
This research was dependent on volunteer compliance to produce the required samples
at the specified times and to produce adequate volumes of saliva for accurate assay. As
a result, the final analysis of cortisol did not include the full sample (n=110). The final
sample size comprised 83 individuals with some variation for specific analyses (sample
sizes are specified within the analysis of each hypothesis). The data for biomarker
assessment was almost complete with 7 exclusions due to unsuccessful venepuncture.
Figure 5.3 details the stages of volunteer exclusion and retention.
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Initial Sample Size
N = 110
"'II ,.
Cortisol assay results obtained. Seven volunteers
lost due to insufficient (or no) cortisol data.
N = 103
"'II ,.
Profiles constructed and a blind quality check performed
using three independent observers.20 volunteers
excluded due to insufficiently incomplete profiles
N =83
~
Classic Profile Non-classic profile
N=48 N =35
Figure 5.3: Flow chart to detail the stages of volunteer exclusion & retention
5.3.5.2 Data Screening
All data was screened for outliers using boxplots prior to analysis. The analysis was
subsequently conducted with outliers included unless they were extreme outliers which
had a major effect on the data, in which case the analysis was re-run with the outliers
excluded. The cortisol data was explored and normality assessed using histograms and
the Kolmogorov-Smirnov test of normality. The data was found to be positively skewed
across all sample points and was subsequently normalised using a logarithmic
transformation. All analyses were conducted using SPSS version 12.
As in Chapter 4, a correlational analysis for each cortisol index across the three days
was conducted. This assessed the consistency of cortisol activity across the 3 days and
the feasibility of the construction ofan aggregate profile was explored prior to analysis.
5.3.5.3 Statistical Analysis
(i) Basal Cortisol
A 2x2x8 repeated measures ANOVA with waist-hip ratio (high/low) and gender
(male/female) as between subjects factors and time as a within subjects factor was
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conducted to explore basal diurnal cortisol in relation to waist-hip ratio and gender. Age
was included as a covariate. Any significant interactions were explored further by post
hoc tests using Bonferroni corrected independent sample t-tests. The basal profile was
analysed in terms of the cortisol awakening response and subsequent diurnal activity
using the calculated indices of cortisol activity (outlined in Chapter Three, Section
3.3.3), i. area under the curve; ii. area under the curve with reference to the first sample;
iii. mean increase; iv. change 0-30; v. day difference 0-12; vi. day difference 3-12; vii.
day mean; and viii. diurnal mean. These were analysed using separate 2x2 ANOYA's
with each index included as the dependent variable. Age was included as a covariate in
each analysis. Any significant interactions were explored further by post hoc tests using
Bonferroni corrected independent sample t-tests. Linear regression was used to assess
strength of the covariates relationship with each dependent variable and beta values are
reported.
(ii) Classifying Diurnal Profiles
Following blind classification of the basal diurnal profiles by three independent
observers, a separate between subjects variable 'profile group' was formed. A 2x2x2
ANOYA with waist-hip ratio (high/low) and gender (male/female) as between subjects
factors and age as a covariate in each analysis, was conducted for each profile group
using the cortisol indices as dependent variables to explore differences between the
classic and non-classic profile classifications.
Each biomarker was assessed as a dependent variable separately in 2x2x2 ANOYAs
with waist-hip ratio (high/low), gender (male/female) as between subjects' factors for
each profile group (classic/non-classic). Age was included as a covariate in each
analysis. To assess the relationship between each biomarker and basal cortisol activity,
the calculated mean cortisol from the basal diurnal profile (Day Mean) was also
included as a covariate in addition to the area under the curve with reference to zero
(AUC). If covariates were significant, a linear regression was performed to examine the
nature of the relationship between the covariate and the dependent variable. Any
significant interactions were explored further by post hoc tests using Bonferroni
corrected independent sample t-tests.
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Each item on the Leeds Sleep Evaluation Questionnaire was analysed using a
multivariate analysis of variance (MANGYA) with each item included as dependent
variables and profile group, waist-hip ratio and gender as between subjects' factors.
Mean cortisol over the diurnal period (Day Mean) and two measures of the awakening
response (AVC and AURC) were included as covariates in the analysis of the LSEQ
items. Any significant interactions were explored further by post hoc tests using
Bonferroni corrected independent sample t-tests. Individuals were consistent in the time
of waking across the 3 sample days, therefore a median split on the mean waking time
data from the 3 days of sampling was performed. Based on this, the sample was split
into those who awoke earlier than the median (early risers) and those who rose later
than the median waking time (late risers). A chi-squared test of independence (2x2) was
conducted to explore the possible association between waking time group and profile
group. The data was subsequently analysed using the same approach as in the analysis
of basal cortisol.
Perceived stress score and scores for intensity and frequency of daily hassles were
assessed in relation to waist-hip ratio, gender and profile group using a 2x2x2 ANOYA.
Mean diurnal cortisol (Day Mean) was included as a covariate. Any significant
interactions were explored further by post hoc tests using Bonferroni corrected
independent sample t-tests.
5.4 Results
5.4.1 Sample Characteristics
The main characteristics of the sample are presented in Table 5.1. WHR and BMI
differed significantly between the high and low waist-hip ratio groups (F (1, 79) =
149.870; p<O.OI and F (1, 79) = 64.550; p<O.OI respectively). But the waist-hip ratio
and gender groups did not differ by age (F( 1,79)=0.761 ;p=0.386;NS and
F(I, 79)=0.281 ;p=0.598;NS). Perceived stress score significantly differed by gender (F
(1, 79) = 4.642; p<0.05). Females demonstrated a significantly greater perceived stress
score than males. Further, a trend for a waist-hip ratio group*gender interaction was
observed (F (1, 79) =3.247; p=0.075). High waist-hip ratio females scored significantly
higher than high waist-hip ratio males (p=0.016). High and low WHR females did not
significantly differ (p=O.106).
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Total Male LWHR Male HWHR Female LWHR Female HWHR
Characteristic N=83 N=21 N=20 N=24 N= 18
Age (years) 45.71±7.21 45.05±7.S6 45.30±7.01 47.54±7.31 44.50±6.62
BMI (Kg/ml) 27±5.57 24±2.63 30±5.60 24±2.70 32±5.31
WHR 0.S7±0.OS 0.S5±0.04 0.96±0.04 0.79±0.04 0.92±0.06
PSS Score 15±6.77 14.57±4.55 13.20±6.35 15.0S±7.3S lS.94±7.61
Table 5.1: Sample Characteristics displaying age, BMI, WHR & Perceived Stress with
Means± SD
5.4.2 Consistency of the Basal Diurnal Profile
The profiles demonstrated good consistency across the three days of sampling as
demonstrated in Table 5.2 below. In particular, area under the curve with reference to
zero (AVC), the change in cortisol between waking and 30minutes post waking
(Change 0-30), Day Mean, Diurnal Mean, Final Sample and the difference between
waking and the Final Sample (Day Difference 0-12) were highly consistent across all
three days of sampling. There was no evidence for a loss of consistency over a longer
period of sampling. Despite demonstrating that some variation in the profiles is evident,
this analysis largely supported the aggregation of the profiles for further analysis.
DI-D2 DI-D3 D2-D3
Cortisol Index N=63 N=71 N=74
Mean Increase r = 0.48 r = 0.228 r = 0.232
AVC r= -0.673" r = -0.673** r = 0.637**
AURC r =0.107 r = 0.224 r= 0.255*
Change 0-30 r =0.249* r = 0.182 r= 0.268*
Day Mean r=0.719** r = 0.512** r = 0.634*·
Diurnal Mean r =0.714** r= 0.492** r = 0.597**
Day Difference 0-12 r =0.381** r = 0.467** r = 0.550**
Day Difference 3-12 r=O.119 r = 0.125 r = 0.167
Final Sample r =0.199 r= 0.425** r = 0.379**
Table S.2: Correlations for consistency across 3 samphng days for each cortisol index
(*p<0.05; ** p<O.OI)
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5.4.3 Basal Cortisol in High/Low WHR Males & Females
The waist-hip ratio group*gender interaction illustrated in Figure 5.4, failed to reach
significance (F (1, 78) =0.002; p=0.967; NS).
Comparison of Diurnal Profiles By WHR and Gender
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Figure 5.4: Basal Diurnal Cortisol Profiles in high/low WHR males/females (Means ± SEM)
A trend for a main effect of waist-hip ratio group for mean cortisol secreted across the
profile was observed was observed (F (1, 78) =p=0.063). Figure 5.5 illustrates that high
waist-hip ratio individuals exhibited lower mean cortisol compared with low waist-hip
ratio individuals (1.084 ± 0.015 and 1.123 ± 0.014 LOGnM/L respectively).
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Comparison of High and Low Waist-Hip Ratio Diurnal Profiles
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Figure 5.5: Diurnal Cortisol Profiles in high/low WHR (Means ± SEM)
An overall main effect of time was observed (F (7,546) =8.312; p<0.01). Each of the
diurnal samples (5-8) significantly differed from each other (smallest p=O.OOl).During
the awakening response, sample 3 (30minutes post waking) significantly differed from
sample 1 (Ominutes) and sample 2 (15minutes post waking). Sample 4 (45minutes post
waking) differed from sample 1 (Ominutes) but did not differ from samples 2 and 3.
No main effect of gender was observed (F (1, 78) =2.583; p=0.112; NS) and age was
not found to be a significant covariate (F (1, 78) =0.502; p=0.S02; NS).
5.4.3.1 Indices of Cortisol Activity in HighILow WHR Males & Females
The waist-hip ratio group*gender interaction for Mean Increase failed to reach
significance (F (1, 78) =0.289; p=0.592; NS). No main effect of waist-hip ratio (F (1,
78) =1.612; p=0.208; NS) or gender (F (1,78) =0.100; p=0.7S3; NS) was observed. Age
was not found to be a significant covariate (F (1, 78) =0.046; p=0.831; NS).
The same pattern of results was observed for the area under the curve (with reference to
the first sample (AURC) and with reference to zero (AUC», change from waking to
30minutes post waking (Change 0-30), day difference from waking to final sample (Day
Difference), day difference from sample 5 to sample 8 (Day Difference 3-12) and Final
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sample (Sample H) were noted (for a table of the associated F values refer to Appendix
17).
The waist-hip ratio group*gender interaction for Day Mean failed to reach significance
(F (I, 78) =0.155; p=0.695; NS). However, a main effect of waist-hip ratio was
observed (F (1, 78) =4.223; p<0.05). High waist-hip ratio individuals exhibited lower
mean cortisol compared with low waist-hip ratio individuals (0.942 ± 0.015 and 0.982 ±
0.014 LOGnMiL respectively). No main effect of gender was observed (F (I, 78)
=1.584; p=0.212; NS). Age was not found to be a significant covariate (F (1, 78)
=0.113; p=0.738; NS).
The waist-hip ratio group*gender interaction for Diurnal Mean failed to reach
significance (F (1, 78) =0.541; p=0.464; NS). However, a trend for a main effect of
waist-hip ratio was observed (F (1, 78) =2.795; p=0.099). High waist-hip ratio
individuals exhibited lower mean cortisol compared with low waist-hip ratio individuals
(0.881 ± 0.017 and 0.920 ± 0.016 LOGnMIL respectively). No main effect of gender
was observed (F (1, 78) =0.760; p=0.386; NS). Age was not found to be a significant
covariate (F (1, 78) =0.004; p=0.951; NS).
Taking these findings together, the results suggest that high and low waist-hip ratio
groups differ in their expression of basal cortisol and that the cortisol level oscillated
over the day. However, no differences in the shape of the curve were noted. The
difference was based on the mean level of cortisol secreted over the diurnal period.
5.4.4 Classifying Basal Profiles
The composite classic and the non-classic profiles rated by 3 independent observers are
shown in Figure 5.6 below. The analysis above was re-run based on these profile
groups. This was conducted to determine differences between the profile groups and to
highlight which individual characteristics are associated with deviations from the classic
cortisol diurnal profile. A summary of the various characteristics is shown in Table 5.3.
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5.4.4.1 Basal Cortisol in, High fLow Waist-hip Ratio, Gender & ClassiclNon-
Classic Profile groups
Comparison of Classic and Non-Classlc Diurnal Profiles
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Figure 5.6: Cortisol Diurnal Profiles by the Classic/Non-Classic Profile Groups (Means ±
SEM)
The difference between the profiles is most evident during the cortisol awakening
response, with little difference observed for the subsequent diurnal activity. The
differences between a 'classic' and 'non-classic' profile were confirmed when the
indices of cortisol activity were reconsidered in each profile group. A significantly
greater mean increase (F(1,74)=10.002; p<O.OI), area under the curve with reference to
zero (AUC) (F(1, 74)= 11.191; p<O.Ol), area under the curve with reference to the first
sample (AURC) (F(1,74)= 11.565; p<O.Ol) and change from waking to 30minutes post
waking (Change 0-30) (F(1,74)=15.455; p<O.Ol) was observed in the 'classic' profile
compared with the 'non-classic' profile. The observation that a 'non-classic' profile was
flattened was supported by greater mean cortisol across the 12hours of sampling and
during the diurnal period post cortisol awakening response and greater concentration of
cortisol 12hours post waking. However, these mean differences were not significant.
103 Chapter Five: Cortisol & Central Obesity
CLASSIC NON-CLASSIC
Variable N=48 N=35
Waist-Hip Ratio 0.87 ± 0.09 0.88 ± 0.07
Age 45.46 ± 6.93 46.06 ± 7.67
BMI 26.72 ± 4.89 27.87 ± 6.40
Pulse 62.85 ± 8.31 66.14 ± 6.53
Blood Pressure (Systolic) 115 ± 12.91 117 ± 22.70
Blood Pressure (Diastolic) 73.83 ± 1010 76.51 ± 10.43
Perceived Stress 14.42 ± 6.43 16.60 ± 7.11
Daily Hassles - Intensity 1.09 ± 0.36 1.26 ± 0.29·
Daily Hassles - Frequency 14.13 ± 12.85 17.10± 16.14
Mean Waking Time 6:16am 6:25am
Sleep Quality - Ease of sleep 15.30 ± 13.05 29.73 ± 18.88·
Sleep Quality - Speed of sleep onset 15.73 ± 14.08 31.20±18.68··
Sleep Quality - Restfulness 25.52 ± 18.68 44.78 ± 17.60··
Sleep Quality - Wakefulness 27.73 ± 21.14 38.46 ± 16.65·
Sleep Quality - Ease of Waking 25.52 ± 16.07 39.33 ± 19.18··
Sleep Quality - Alertness on waking 43.30 ± 21.95 49.11 ± 21.24
Sleep Quality - Alertness Ihr after waking 29.55±21.11 32.60 ± 20.37
Sleep Quality - Time Taken to Awaken 24.04 ± 16.07 37.12 ± 18.45··
Plasma Glucose (mMIL) 5.09 ± 0.65 5.00 ± 0.62
Plasma insulin (mUlL) 5.97 ± 4.09 7.68 ± 6.02
Total Cholesterol (mMlL) 5.00 ± 0.94 5.27 ± 0.93
HDL(mMIL) 1.37 ± 0.31 1.34 ± 0.43
LDL(mMIL) 3.12 ± 0.83 3.23 ± 0.70
Triglycerides (mMIL) 1.15±0.73 1.55 ± 0.93·
IL-6 (pg/ml) 1.44 ± 1.24 1.70 ± 1.17
CRP(mglL) 2.41 ± 1.60 4.38 ± 4.82·
Adiponectin (ng/ml) 285.59 ± 187.12 272.88 ± 210.61
Insulin Resistance (HOMA) 1.42 ± 1.33 1.78 ± 1.70
Table 5.3: Summary of the Biological and Psychological Characteristics of a Classic & a Non-
Classic Diurnal Profile (·p<0.05 ··p<O.OI) NOTE: a higher score for ratings on the LSEQ
denotes poorer sleep
5.4.4.2 Sleep Quality
Because the literature suggests that sleep quality can influence cortisol, this may explain
the difference in the profile previously observed (Figure 5.6). The LSEQ measures
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aspects of sleep quality with a high score indicating poor sleep quality. The scores for
each item on the LSEQ were assessed collectively using a multivariate analysis of
variance (MANOVA). Scores for each item by profile group are shown in Figure 5.7.
lSeQ Scores for Each Questionnaire Item by Profile Group
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Figure 5.7: Scores on the LSEQ by the ClassiclNon-Classic Profile Groups (Means ± SEM)
There was a multivariate main effect of Profile group on LSEQ scores (Pillai's Trace F
(8, 51) =2.578; p<0.05). Profile group had a significant main effect on all items on the
LSEQ, except those measuring alertness (both upon waking and 1hour post waking).
Specifically, univariate analysis indicated there was an significant main effect of profile
group on the ease of getting to sleep (F(1,58)=10.999; p<O.OI), the quickness of getting
to sleep (F(l, 58)=11.464; p<O.OI), restfulness of sleep (F(1,58)=8.545; p<O.OI), the
number of periods of wakefulness reported (F(I,58)=3.890; p<0.05), the ease of waking
(F(1,58)=8.710; p<O.OI) and the time taken to wake (F(l,58)=5.957; p<0.05). This
pattern is clear in Figure 5.7 which shows that sleep quality was consistently reported to
be poorer in individuals who exhibited a non-classic diurnal cortisol profile.
Further, cortisol, as indexed by the area under the curve with reference to zero (AUC),
was a significant covariate (Pillai's Trace; F (8, 51) =2.121; p<0.05). Univariate
analysis indicated that the ease of getting to sleep (F(1,58)=10.724; p<O.Ol), quickness
of sleep (F(1 ,58)=9.689; p<O.OI), reported restfulness of sleep (F(1 ,58)=7.212; p<O.O1)
and reported number of periods of wakefulness (F(I,58)=8.402; p<O.OI) were
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associated with cortisol during the cortisol awakening response (marked by the Ave
index).
A linear regression was performed for each item with cortisol (AVC) to explore the
relationship between sleep quality and the cortisol awakening response. The linear
regression for Ave and the reported ease of getting to sleep, produced a beta value that
differed significantly from zero (t (79) =-5.330; p<O.O1). This indicated that subjective
rating for the ease of getting to sleep was associated with cortisol activity during the
cortisol awakening response on the subsequent day. Interpreting the beta value
indicates that an increase in the score for ease of getting to sleep (therefore more
difficult to fall asleep) is associated with a decrease in the amount of cortisol secreted
during the cortisol awakening response (AVC).
Similarly, the linear regression for AVe and the time taken to fall asleep revealed that
the given beta value differed significantly from zero (t (78) =-5.280; p<O.OI). This
again, indicated that subjective rating for the time taken to fall asleep was associated
with cortisol activity during the cortisol awakening response on the subsequent day. As
for ease of falling asleep, interpreting the beta value indicates that an increase in the
score for time taken to get to sleep (therefore taking a longer period of time) is
associated with a decrease in the amount of cortisol secreted during the cortisol
awakening response (AVC).
For Ave and the reported restfulness of sleep, the given beta value was found to differ
significantly from zero (t (78) =-4.458; p<0.05). This indicated that subjective rating for
restfulness of sleep was associated with cortisol activity during the cortisol awakening
response on the subsequent day. Interpreting the beta value indicates that an increase in
the score for restfulness sleep (therefore more restless sleep) is associated with a
decrease in the amount of cortisol secreted during the cortisol awakening response
(AVC).
For Ave and the number of periods of wakefulness, the given beta value was found to
differ significantly from zero (t (78) =-4.881; p<0.05). This indicated that subjective
rating of the number of periods of wakefulness was associated with cortisol activity
during the cortisol awakening response on the subsequent day. Interpreting the beta
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value indicates that an increase in the score for the number of periods of wakefulness
(therefore more periods of wakefulness) is associated with a decrease in the amount of
cortisol secreted during the cortisol awakening response (AUC).
5.4.4.3 Effect of Waking Time on the Basal Cortisol Profile
The waking times from each of the sampling three days were aggregated and assessed
for consistency using a series of Pearson Bivariate correlations. Waking times
demonstrated good consistency across the three days as illustrated in Table 5.2 below.
Day One Day Two Day Three
Day One 0.765** 0.692**
Day Two 0.765** 0.783**
Day Three 0.692** 0.783** I
Table 5.4: Correlations for consistency across 3 sampling days for Waking TIme (**p<O.OI)
To segregate the group into early and late risers, a median split performed. The median
time of waking was calculated as being 6:23am. Therefore, individuals waking earlier
than this time (or at this time) were classed as being early risers compared with
individuals waking later than this time (late risers). Each index of cortisol activity was
analysed individually. The composite diurnal profiles by waking time grouping are
shown in Figure 5.8 below.
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Diurnal Cortisol Profiles By Waking Group
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Figure 5.8: Basal Cortisol Diurnal Profile in early & later risers (Waking Group) (Means ±
SEM)
A chi-square test for independence was performed to determine whether waking times
differed between the classic and non-classic profiles. No association was observed
between waking time group (early/late) and profile group (classic/non-classic) (X}= O.
009; p=0.925; NS).
The effect of waking time on the basal cortisol profile (without profile group as a
between subjects factor) was explored using each index of cortisol activity.
i. Mean Increase (M!)
The waist-hip ratio group*waking time group interaction (F (1, 74) =1.659; p=0.202;
NS) and gender*waking time group interaction (F (1, 74) =0.416; p=0.521; NS) for
Mean Increase failed to reach significance. However, a main effect of waking time
group for the mean increase in cortisol was observed (F (1, 74) =7.749; p<O.OI). A
greater mean increase was observed in early risers compared with late risers (0.150 ±
0.02 and 0.089 ± 0.02 LOGnM/L respectively).
ii. Area under the curve with reference to zero (AVC)
A significant gender*waking group interaction was observed (F (1, 74) =4.264; p<0.05).
However, post hoc Bonferroni corrected t-tests failed to find any significant differences.
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Based on the means, males rising early demonstrated a greater AUC than female early
risers (4.06 ± 0.06 and 3.77 ± 0.07 LOGnMiL respectively). Further, female late risers
exhibited a greater AUC than female early risers (4.05 ± 0.08 and 3.77 ± 0.10
LOGnM/L respectively). The waist-hip ratio group*waking time group interaction (F
(1,74) =1.284; p=0.261; NS) for AUC failed to reach significance. No main effect of
waking time group (F (1, 74) =0.907; p=0.344; NS) was observed.
iii.Area under the curve with reference to the tirst sample (AURC)
The waist-hip ratio group*waking time group interaction (F (1, 74) =1.553; p=0.217;
NS) and gender*waking time group interaction (F (1, 74) =0.428; p=0.515; NS) for
AURC failed to reach significance. However, a main effect of waking time group for
the AURC (with reference to the first sample) in cortisol was observed (F (1, 74)
=7.910; p<O.O1). A greater AURC was observed in early risers compared with late
risers (0.315 ± 0.31 and 0.189 ± 0.32 LOGnM/L respectively).
iv. Change 0-30
The waist-hip ratio group*waking time group interaction (F (1,74) =1.194; p=0.278;
NS) and gender*waking time group interaction (F (1, 74) =0.432; p=0.513; NS) for the
change in cortisol secretion between zero (immediately on waking) and 30minutes post
waking (Change 0-30) failed to reach significance. However, a main effect of waking
time group was observed (F (1, 74) =7.808; p<O.OI). A greater change was observed in
the early risers compared to the later risers (0.180 ± 0.17 and 0.111 ± 0.18 LOGnMIL
respectively).
v. Mean Diurnal Cortisol
The waist-hip ratio group*waking time group interaction (F (1, 74) =422; p=0.518; NS)
and gender*waking time group interaction (F (I, 74) =0.654; p=0.42I; NS) for the
diurnal mean of cortisol failed to reach significance. However, a main effect of waking
time group for mean diurnal cortisol secretion was observed (F (1, 74) = 4.945; p<0.05).
A greater diurnal mean cortisol was observed in early risers compared with late risers
(0.926 ± 0.17 and 0.873 ± 0.17 LOGnMiL respectively).
No main effects for the Day Mean of cortisol were observed.
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vi. Day Difference 0-12hours Post Waking
A significant gender*waking time group interaction was observed (F (1, 74) =4.423;
p<0.05). Post hoc analyses revealed that a greater change in cortisol secretion between
waking and the final sample was observed in female later risers compared with female
early risers (p=O.OOI) (0.704 ± 0.04 and 0.427 ± 0.06 LOGnM/L respectively). The
waist-hip ratio group*waking time group interaction for the difference in cortisol
between waking and 12hours post waking, failed to reach significance (F (1, 74)
=0.081; p=0.776; NS).
A main effect of waking time group for mean diurnal cortisol secretion was observed (F
(1, 74) = 7.566; p<O.OI). A greater difference in cortisol was observed in late risers
compared to early risers (0.616 ± 0.41 and 0.456 ± 0.41 LOGnMIL respectively)
vii. Final Sample
A trend for a significant gender *waking group interaction was observed (F (1, 74)
=3.022; p=0.086). Post hoc analyses revealed that a reduced cortisol concentration at the
final sample was observed in female later risers compared with male later risers
(p=0.008) and compared with female early risers (p=0.012) (female late: 0.561 ±
0.03LOGnMIL versus male late: 0.721 ± 0.04LOGnMIL and female early: 0.716 ± 0.05
LOGnMIL respectively). The waist-hip ratio group*waking time group interaction (F
(I, 74) =0.363; p=0.549; NS) failed to reach significance.
A trend for a main effect of waking time group for the final sample (Sample H) in
cortisol was observed (F (1, 74) =3.548; p=0.064). A greater cortisol concentration was
observed in early risers compared to the later risers (0.724 ± 0.31 and 0.640 ± 0.32
LOGnMIL respectively).
5.4.4.4 Daily Hassles & Perceived Stress
Because the literature suggests that, like sleep quality, daily hassles and perceived stress
can influence cortisol, this may explain the difference in the profile previously observed
(Figure 5.6). Scores for daily hassles from the Daily Hassles Scale and perceived stress
from the Perceived Stress Scale, were analysed using a 2x2x2 ANOVA with waist-hip
ratio, gender and profile group as between subjects factors.
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(i) Influence of Daily Hassles on the Basal Cortisol Profile
Two scores are obtained from the daily hassles scale i. the intensity of the hassle
experienced and ii. frequency of the hassles encountered.
- Intensity
Day Mean of cortisol was a significant covariate in the analysis of the subjective
intensity of the daily hassles encountered (F (1, 73) =5.359; p<0.05). Using a linear
regression, the given beta value for the relationship between the subjective mean
intensity of daily hassles and mean cortisol was found to differ significantly from zero (t
(82) =-2.303; p<0.05). This indicated that subjective rating of the intensity of daily
hassles experienced was associated with mean cortisol activity over the diurnal period.
Interpreting the beta value indicates that an increase in the subjective intensity of daily
hassles is associated with a decrease in the mean of cortisol secreted (Day Mean).
The waist-hip ratio group*profile group interaction (F (1, 73) =0.859; p=0.357; NS) and
gender*profile group interaction (F (1, 73) =1.343; p=0.250; NS) for subjective
intensity of daily hassles failed to reach significance. However, a main effect of profile
group was observed (F (1, 73) = 6.200; p<0.05). A greater mean intensity of hassles was
noted in the non-classic profile group compared with the classic profile group (1.278 ±
0.06 and 1.093 ± 0.05 respectively).
- Frequency
No main effects or interactions for the frequency of daily hassles were observed.
(b) Perceived Stress
Scores from the Perceived Stress Scale were analysed using a 2x2x2 ANOVA with
waist-hip ratio, gender and profile group as between subjects factors.
Age was a significant covariate in the analysis of perceived stress score (F (1, 74)
=4.405; p<O.05). However, using a linear regression, the given beta value for the
relationship between the subjective perceived stress and age did not significantly differ
from zero (t (82) =-1.186; p=0.239; NS). This suggests that the relationship between age
and perceived stress score is non-significant.
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A significant waist-hip ratio*gender*profile group interaction was observed (F (I, 73) =
7.099; p<0.05). Post hoc analyses revealed a significant difference between classic and
non-classic profile groups in low waist-hip ratio females (p=0.005). Low waist-hip ratio
females displaying a non-classic profile exhibited a significantly greater perceived stress
score compared with low waist-hip ratio females displaying a classic profile (20.22 ±
2.51 and 12.00 ± 1.41 respectively). In addition, high waist-hip ratio females displaying
a classic profile also significantly differed from low waist-hip ratio females in the same
group (p=0.002). High waist-hip ratio females again exhibited significantly greater
perceived stress scores compared with low waist-hip ratio females (20.56 ± 2.22 and
12.00 ± 1.41 respectively). This is illustrated in Figure 5.9 below.
Perceived Stress Score by WHR. Gender and Profile Group
NONCLASSrC
Profile Group
IIlWHR Female • H'NHR MaleIILINHR Male • HlM-tR Female
Figure 5.9: Perceived Stress Score in High/Low WHR males/females & by Classic/Non-Classic
Profile Group (Means ± SEM)
A significant waist-hip ratio group*profile group interaction was observed (F (1, 74)
=4.077; p<0.05). Post hoc analysis revealed that low waist-hip ratio individuals
displaying a classic diurnal profile, differed from low waist-hip ratio individuals
displaying a non-classic diurnal profile, However, this was non-significant (p=0.045
Bonferroni corrected). Low waist-hip ratio individuals displaying a non-classic diurnal
profile reported greater perceived stress than low waist-hip ratio individuals displaying
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a classic diurnal profile (17.11 ± 1.59 and 13.19 ± 0.99 respectively). This is illustrated
in Figure 5.10 below.
Perceived Stress Score by Profile Group and WHR
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Figure 5.10: Perceived Stress Score in High/Low WHR Profile Group & by ClassicfNon-
Classic Profile Group (Means ± SEM)
The gender*profile group interaction (F (1, 74) =0.864; p=0.356; NS) and
gender*waist-hip ratio group interaction (F (I, 74) =1.243; p=0.269; NS) for perceived
stress failed to reach significance. However, a main effect of gender was observed (F (1,
73) =7.099; p<O.Ol). Females reported greater perceived stress compared with males
(17.66 ± 0.99 and 13.88 ± 1.01 respectively).
5.4.4.5 Blood Biomarkers & DHEA
As previous literature suggests that metabolic syndrome is a neuroendocrine disorder,
the measured concentration of each biomarker may explain the difference between the
classic and non-classic diurnal profiles. Each biomarker was analysed using a 2x2x2
ANOVA with waist-hip ratio, gender and profile group as a between subjects factors.
Due to missing data from unsuccessful venepuncture and removal of extreme outliers,
between 74 and 76 observations out of83 were included in the analysis.
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i. Fasting Plasma Insulin
Age (F (1, 64) = 0.043; p=0.836; NS) and cortisol (Day Mean) (F (1, 64) = 0.028;
p=0.867; NS) as covariates were non-significant.
The profile group*waist-hip ratio group*gender 3 way interaction was non-significant
(F (1, 65) = 0.005; p=0.941; NS). A trend for a profile group*waist-hip ratio group
interaction was noted (F (1, 64) =3.887; p=0.053) was observed. Post hoc analyses
revealed that high and low waist-hip ratio individuals significantly differed within the
non-classic profile group (p=0.005). High waist-hip ratio individuals displayed a greater
level of insulin compared with low waist-hip ratio individuals (10.76 ± 1.94 and 4.96 ±
0.48mU/L respectively). This is illustrated in Figure 5.11 below.
Fasting Plasma Insulin By Profile Group and WHR
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Figure 5.11: Fasting Plasma Insulin Score in High/Low WHR Profile Group & by ClassiclNon-
Classic Profile Group (Means ± SEM)
The gender*profile group interaction (F (1, 65) =2.036 p=0.158; NS) and waist-hip
ratio*gender interaction (F (1, 65) =1.347; p=0.250; NS) for fasting plasma insulin all
failed to reach significance.
A significant main effect of gender was observed (F (1, 69) =14.813; p<O.Ol). Males
exhibited a greater concentration of insulin compared with females (5.34 ± 0.96 and
4.81 ± 0.95mU/L respectively). Further, a main effect of waist-hip ratio was observed
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(F (I, 64) =12.831; p<O.O1). Higher insulin was observed in high waist-hip ratio
individuals compared with low waist-hip ratio individuals (9.08 ± 0.82 and 5.05 ±
O.73mUIL respectively). No main effect of profile group (F (1, 65) =0.508; p=0.478;
NS) was observed.
ii. Fasting Plasma Glucose
Age significantly co-varied with fasting plasma glucose (p=0.037). However, using a
linear regression, the given beta value for the relationship between the blood glucose
and age did not differ significantly from zero (t (76) = 1.631; p=0.107; NS). The
relationship between age and blood glucose was non-significant. Cortisol (Day Mean)
was not a significant covariate (F (1, 65) =0.000; p=O.994; NS)
The profile group*waist-hip ratio group*gender 3 way interaction was non-significant
(F (1,65) = 0.005; p=O.941; NS). The profile group*waist-hip ratio group interaction (F
(1, 65) =0.001; p=O.981; NS), gender*profile group interaction (F (1, 65) =0.125
p=O.724; NS) and waist-hip ratio*gender interaction (F (1, 65) =0.458; p=O.501; NS)
for fasting blood glucose all failed to reach significance.
A significant main effect of gender was observed (F (I, 69) =14.813; p<O.OI). Males
exhibited a greater concentration of blood glucose compared with females (5.34 ± 0.96
and 4.81 ± 0.95mMIL respectively). No main effects of waist-hip ratio (F (1, 65)
=1.139; p=0.290; NS) or profile group (F (1, 65) =0.508; p=0.478; NS) were observed.
iii. Total Cholesterol
Age was a significant covariate in the analysis of total cholesterol (F (1, 68) =6.814;
p<0.05). Using a linear regression, the given beta value for the relationship between
total cholesterol and age was found to differ significantly from zero (t (76) =2.729;
p<O.OI). This indicated that age was associated with changes in cholesterol. Interpreting
the beta value indicates that an increase in age is associated with an increase in total
cholesterol.
The profile group*waist-hip ratio group*gender 3 way interaction was non-significant
(F (1,64) = 0.006; p=0.937; NS). The profile group*waist-hip ratio group interaction (F
(I, 64) =1.268; p=0.264; NS), gender*profile group interaction (F (I, 64) =0.789;
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p=0.378; NS) and waist-hip ratio*gender interaction (F (I, 64) =1.230; p=0.272; NS)
for total cholesterol all failed to reach significance.
A trend for a main effect of profile group was observed (F (I, 64) =3.215; p=0.078).
Higher cholesterol was exhibited by individuals displaying a non-classic cortisol profile
compared with a classic profile (5.37 ± 0.18 and 4.91 ± 0.16mM/L respectively). No
main effect of waist-hip ratio group (F (I, 64) =0.035; p=0.852; NS) or gender (F (1,
64) =0.063; p=0.802; NS) was observed.
iv. Low Density Lipoproteins (LDL)
Age (F (1, 64) =1.109; p=0.296; NS) and cortisol (Day Mean) (F (I, 64) =1.143;
p=0.239; NS) were non-significant covariates.
The profile group*waist-hip ratio group*gender 3 way interaction was non-significant
(F (I, 64) = 0.397; p=0.531 ; NS). The profile group*waist-hip ratio group interaction (F
(I, 64) =0.833; p=0.365; NS), gender*profile group interaction (F (I, 64) =0.464;
p=0.498; NS) and waist-hip ratio*gender interaction (F (I, 64) =0.781; p=0.380; NS)
for LDL all failed to reach significance. No main effect of waist-hip ratio (F (1, 64)
=0.014; p=0.905; NS), gender (F (I, 64) =0.003; p=0.957; NS) or profile group (F (1,
64) =2.224; p=0.141; NS) was observed.
v. High Density Lipoproteins (HDL)
Age was found to significantly co-vary with HDL concentration (F (I, 68) =9.354;
p<O.OI). Using a linear regression, the given beta value for the relationship between
HDL and age was found to differ significantly from zero (t (76) =3.036; p<O.OI). This
indicated that age was associated with changes in HDL. Interpreting the beta value
indicates that an increase in age is associated with an increase in HDL.
The profile group*waist-hip ratio group*gender 3 way interaction was non-significant
(F (1,64) = 0.450; p=0.505; NS). The profile group*waist-hip ratio group interaction (F
(1, 64) =1.093; p=0.300; NS), gender*profile group interaction (F (1, 64) =1.891;
p=O.l74; NS) and waist-hip ratio*gender interaction (F (1, 64) =0.287; p=O.594; NS)
for HDL all failed to reach significance
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A main effect of gender on HDL was observed (F (1, 68) = 12.617; p<O.O1). Females
exhibited a significantly greater HDL concentration compared with males (1.478 ± 0.05
and 1.213 ± 0.05 mMiL respectively). A trend for a main effect of waist-hip ratio on
was also observed (F (1, 64) =3.261; p=0.076). No main effect of profile group was
observed (F (1,64) =1.040; p=0.312; NS).
vi. Triglycerides
Age (F (1, 64) =1.672; p=0.201; NS) and cortisol (Day Mean) (F (1, 64) =0.414;
p=0.512; NS) were not identified as significant covariates.
A trend was observed for a profile group*waist-hip ratio*gender three way interaction
(F (1, 64) =3.095; p=0.083). Post hoc analyses revealed a significant difference the
measures concentration of triglycerides between high waist-hip ratio males
demonstrating a classic profile and low waist-hip ratio males in the same profile group
(p=0.003) High waist-hip ratio males exhibited a greater level of triglycerides compare
with low waist-hip ratio males (1.87 ± 0.30 and 0.79 ± O.OSmMILrespectively). The
profile group*waist-hip ratio group interaction (F (I, 64) =0.181; p=0.672; NS),
gender*profile group interaction (F (1, 64) =0.991; p=0.323; NS) and waist-hip
ratio*gender interaction (F (1, 64) =1.457; p=0.232; NS) for triglycerides all failed to
reach significance.
A main effect of waist-hip ratio group was observed (F (1. 68) =5.996; p<0.05). High
waist-hip ratio individuals exhibited a greater concentration of triglycerides than low
waist-hip ratio individuals (1.56 ± 0.13 and 1.16 ± 0.12 mMIL respectively). A main
effect of profile group was also observed (F (1. 64) =4.839; p<0.05). A greater
concentration of triglycerides was noted in those displaying a non-classic cortisol
diurnal profile compared with those exhibiting a classic profile (1.591 ± 0.15 and 1.131
± O.13mMIL respectively). Finally, a main effect of gender was observed (F (1, 64)
=12.074; p<O.OI). A greater concentration oftriglycerides was noted in males compared
with females (1.674 ± 0.13 and 1.048 ± 0.12 mMIL respectively).
vii. Interleukin-6
Cortisol (AUC) was a significant covariate in the analysis of IL-6 (F (I. 63) =4.718;
p<0.05). Using a linear regression. the given beta value for the relationship between IL-
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6 and cortisol (AUC) was found to differ significantly from zero (t (69) =-0.253;
p<0.05). This indicated that cortisol is associated with changes in IL-6. Interpreting the
beta value indicates that an increase in IL-6 is associated with a decrease in cortisol
(AUC) secreted during the awakening response.
The profile group*waist-hip ratio group*gender 3 way interaction was non-significant
(F (1,61) = 0.842; p=0.363; NS). The profile group*waist-hip ratio group interaction (F
(1, 61) =0.180; p=0.673; NS), gender*profile group interaction (F (1, 61) =0.027;
p=0.87I; NS) and waist-hip ratio*gender interaction (F (1, 61) =0.656; p=0.421; NS)
for IL-6 all failed to reach significance. A main effect of waist-hip ratio was observed (F
(1, 66) =11.912; p<O.O1). High waist-hip ratio individuals exhibited a greater
concentration of IL-6 than low waist-hip ratio individuals (2.02 ± 0.21 and 1.09 ± 0.19
pg/ml respectively). No main effect of gender (F (1, 61) = 1.580; p=0.214; NS) or profile
group (F (1, 61) =0.045; p=0.832; NS) was observed.
viii. C-Reactive Protein
Cortisol (AUC) was a significant covariate in the analysis ofCRP (F (1, 69) =13.115;
p<0.05). Using a linear regression, the given beta value for the relationship between
CRP and AUC was found to differ significantly from zero (t (75) =-3.184; p<O.OI). This
indicated that cortisol is associated with changes in CRP. Interpreting the beta value
indicates that an increase in CRP was associated with a decrease in cortisol (AUC)
secreted during the awakening response.
The profile group*waist-hip ratio group*gender 3 way interaction was non-significant
(F (1, 64) = 0.05; p=0.816; NS). A significant profile group*waist-hip ratio group
interaction was observed (F (1, 64) =8.243; p<O.Ol). Post hoc analysis revealed a
significant difference between high and low waist-hip ratio individuals within the non-
classic profile group (p=0.002). High waist-hip ratio individuals demonstrated greater
CRP than low waist-hip ratio individuals (6.84 ± 1.01 and 2. 20 ± 0.94 mgIL
respectively) (Figure 5.12).
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C-Reactive Protein By Profile Group and WHR
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Figure 5.12: C-Reactive Protein Score in High/Low WHR Profile Group & by Classic/Non-
Classic Profile Group (Means ± SEM)
The gender*profile group interaction (F (1, 64) =0.046; p=0.830; NS) and waist-hip
ratio*gender interaction (F (1, 64) =0.884; p=0.351; NS) for CRP all failed to reach
significance.
A main effect of waist-hip ratio group was observed (F (I, 69) =13.115; p<O.Ol). High
waist-hip ratio individuals exhibited a greater mean concentration of CRP than low
waist-hip ratio individuals (4.86 ± 0.53 and 2.07 ± 0.47 mg/L respectively). Further, a
significant main effect of profile group was observed (F (1, 64) =4.109; p<0.05). Those
exhibiting a non-classic cortisol diurnal profile also exhibited elevated C-reactive
protein compared with those exhibiting a classic cortisol diurnal profile (4.31 ± 0.58 and
2. 62 ± 0.50 mg/L respectively). No main effect of gender was observed (F (1, 64)
=0.935; p=0.337; NS).
ix. Adiponectin
Age (F (1, 64) =1.855; p=O.178; NS) and cortisol (Day Mean) (F (1, 64) =0.338;
p=0.563; NS) were not identified as significant covariates.
The profile group*waist-hip ratio group*gender 3 way interaction was non-significant
(F (1, 64) = 0.021; p=O.885; NS). The profile group*waist-hip ratio group interaction (F
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(1, 64) =0.000; p=0.987; NS), gender*profile group interaction (F (I, 64) =0.196;
p=0.659; NS) and waist-hip ratio*gender interaction (F (1, 64) =0.034; p=0.853; NS)
for adiponectin all failed to reach significance.
A main effect of gender was observed (F (1, 64) =16.683; p<O.OI). Adiponectin was
higher in females compared with males (362.23 ± 28.69 and 187.74 ± 28.88ng/ml
respectively). No main effect of profile group (F (1,64) =2.420; p=0.125; NS) or waist-
hip ratio group (F (1,64) =0.388; p=0.536; NS) was observed.
x. Calculated Insulin Resistance
Age (F (1, 64) =0.213; p=0.646; NS) and cortisol (Day Mean) (F (1, 64) =0.160;
p=0.690; NS) were not identified as significant covariates.
A main effect of gender was observed (F (1, 64) =7.028; p<0.05). A greater
vulnerability to insulin resistance was demonstrated in males compared with females
(2.12 ± 0.24 and 1.22 ± 0.24 respectively). Further, a main effect of waist-hip ratio
group was observed (F (1, 64) =9.914; p<O.OI).A greater level of insulin resistance was
observed in high waist-hip ratio individuals compared with low waist-hip ratio
individuals (2.20 ± 0.25 and 1.14 ± 0.23 respectively). No main effect of profile group
was observed (F (1,64) =1.260; p=0.266; NS).
xi. Dehydroepiandrosterone (DHEA)
Age (F (1, 64) =0273; p=0.603; NS) and cortisol (Day Mean) (F (1, 64) =0.007;
p=0.933; NS) were not identified as significant covariates.
The profile group+waist-hip ratio group*gender 3 way interaction was non-significant
(F (1, 62) = 0.060; p=0.807; NS). The profile grouptwaist-hip ratio group interaction (F
(1, 62) =0.036; p=0.849; NS), gender*profile group interaction (F (1, 62) =0.020;
p=0.888; NS) and waist-hip ratio*gender interaction (F (1, 62) =0.000; p=0.983; NS)
for dehydroepiandrosterone failed to reach significance.
A main effect of waist-hip ratio group was observed (F (I, 62) =6.142; p<0.05). A
greater concentration of DHEA was observed in high waist-hip ratio individuals than in
low waist-hip ratio individuals (2.759 ± 0.47 and 1.147 ± 0.41nMIL respectively). No
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main effect of profile group (F (I, 62) =0.284; p=0.596; NS) or gender (F (1, 62)
=1.661; p=0.202; NS) was observed.
5.4.5 Summary of Results
• Basal Cortisol Diurnal Profile by Waist-hip Ratio & Gender
Basal cortisol profiles did not differ significantly in relation to waist-hip ratio or
gender, yet despite similar profiles, high waist-hip ratio individuals exhibited lower
mean cortisol over the diurnal profile than low waist-hip ratio individual's evidence
by a trend for a main effect of waist-hip ratio group. Age was not found to be related
to cortisol secretion and no gender differences were observed in the cortisol profiles.
• Waist-Hip ratio & Metabolic Factors
Greater insulin and calculated degree of insulin resistance, triglycerides, C-reactive
protein, IL-6 and DHEA were observed in high waist-hip ratio individuals compared
with low waist-hip ratio individuals.
• Classic & Non-Classic Diurnal Profiles
The non-classic profile differed significantly to the classic profile evidenced by
differences in a number of cortisol indices. A greater mean increase, AVRC, AVC
and change 0-30 were observed in the classic profile compared with the non-classic
profile. However, mean cortisol was greater in the non-classic profile group who
also showed a greater cortisol concentration at the final sample. The high incidence
of non-classic profiles was distributed in similar proportions across the waist-hip
ratio and gender groups. The non- classic profiles were associated with poor sleep
quality (LSEQ), subjective intensity of daily hassles experienced (Daily Hassles)
and elevated CRP and triglycerides. A trend for greater cholesterol concurrent with
a non-classic profile was also observed.
5.5 Discussion
5.5.1 General Aims
This study aimed to explore basal salivary cortisol activity in individuals with central
obesity (high waist-hip ratio) compared to peripherally obese (low waist-hip ratio) or
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lean individuals in the age range 35-65 years. Profiles were initially compared for
cortisol activity with respect to waist-hip ratio and gender. Assessment of the
prevalence of a classic diurnal profile as opposed to a non-classic profile and possible
factors associated with the profile were explored. Metabolic syndrome symptomology
(biomarkers associated with central obesity), sleep quality, waking time and perceived
stress (both daily hassles and perceived stress score were explored in terms of waist-hip
ratio, gender and cortisol profile group (classic/non-classic).
5.5.2 Basal Salivary Cortisol in HighlLow WHR MaleslFemales
5.5.2.1 Differences in Basal Cortisol
Analysis of the basal salivary cortisol data in relation to central obesity did not
demonstrate any differences in the shape of the diurnal profile between high waist-hip
ratio (centrally obese) individuals and low waist-hip ratio (lean and peripherally obese)
individuals. However, individuals with central obesity did demonstrate lower mean
cortisol across the diurnal profile.
The literature reviewed in Chapter One suggested that salivary cortisol levels are lower
in the centrally obese. This is supported by the findings ofthe current study. This can be
explained by the proposal that underlying HPA dysregulation permits over-secretion of
cortisol. However, over secretion is not detectable in plasma or saliva during the diurnal
period because cortisol clearance capability is enhanced (Lottenberg et al., 1998; Strain
et al., 1980; Ljung et al., 1996; Marin et al., 1992). The proposed cortisol hypersecretion
is primarily evidenced by elevated urinary cortisol excretory metabolites (Lottenberg et
al., 1998). Because of this, a large number of studies have reported no difference or
often lower basal cortisol secretion during the diurnal period in the centrally obese
compared to lean or peripherally obese individuals (high versus low waist-hip ratio).
The current study found that mean salivary cortisol was reduced in those with central
obesity compared with low waist-hip ratio individuals in support of previous findings.
However, as urinary cortisol was not sampled to examine the excretion of cortisol
metabolites, it cannot be ascertained if an enhanced clearance capability was exhibited
by individuals with central obesity in the study presented in this chapter.
An alternative explanation for the observed differences in basal cortisol secretion
derives from the idea that there exists a nocturnal circadian trough in cortisol activity
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(Andrew et al., 1998; Ljung et al., 2000; Phillips et al., 2000). An increase in cortisol
during this period of nocturnal low-level activity produces a compensatory reduction in
the peak level of cortisol (Le. the cortisol awakening response). This method of
response means that there is no detected change in the overall level of cortisol activity
or an observed lower than normal level of activity which is again due to a disrupted
HPA axis. The findings of the current study offer some support to for this proposal but
it is not possible to verify the existence of a circadian trough, responsible for this
compensatory response, as nocturnal cortisol was not assessed. Further, mean cortisol
secreted during the cortisol response to waking in the current study was lower in high
waist-hip ratio individuals (albeit not significantly). This would concur with a proposed
reduction in the peak level of cortisol during the circadian profile (Van Cauter et al.,
1996). Therefore, those exhibiting central obesity will exhibit a blunted cortisol
awakening response (Andrew et al., 1998; Ljung et al., 2000; Phillips et al., 2000) due
to elevated nocturnal cortisol. The findings of the current study partially support a
disrupted HPA regulation yet it is not possible to verify the existence of a circadian
trough nor can it be verified by an increase in the excretion of urinary cortisol
metabolites as these were not measured. Therefore, the claim that those with central
obesity exhibit lower cortisol due to HPA dysregulation in conjunction with an
enhanced clearance rate requires further evidence beyond the scope of this thesis. Based
on the current findings, basal cortisol secretion in those with central obesity is reduced
compared with low waist-hip ratio individuals. To determine what this reduction is
attributed to requires further research with measures of cortisol clearance.
5.5.2.2 Biomarkers of Obesity & the Metabolic Syndrome
The possibility that the metabolic syndrome is a neuroendocrine disorder is disputed
(Bjorntorp & Rosmond, 2000; Rosmond et al, 1998; Bahr et al., 2002). The current
study aimed to explore associations between cortisol activity, central obesity and the
various biomarkers that are implicated in the symptomology of the metabolic syndrome.
Hence, a number of biomarkers were also assessed in addition to the assessment of
salivary cortisol in relation to central obesity. These included insulin, glucose (including
the calculated degree of insulin resistance), cholesterol, low-density lipoprotein, high-
density lipoprotein, triglycerides, interleukin-6, C-reactive protein and adiponectin. In
the current study, measured insulin (and calculated degree of insulin resistance), IL-6,
C-RP, triglycerides, HDL differed between waist-hip ratio groups. For. all biomarkers
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(except HDL which was reduced) the measured level was elevated in high waist-hip
ratio individuals compared with low waist-hip ratio individuals. This is in accordance
with previous research findings and supports the postulation that the centrally obese are
of a poorer health status when compared to those exhibiting peripheral obesity
(Bjorntorp and Rosmond, 2000). Indeed individuals with peripheral obesity did not
demonstrate any of the associated health complications often associated with central
obesity. This supports of the view that the type and distribution of body fat is important
for the prognosis of long-term health consequences. Those exhibiting central obesity are
at increased risk of insulin resistance and diabetes, cardiovascular disease and stroke
(Hartz et al., 1984).
In terms of the role of cortisol in the expression of central obesity. minimal supporting
evidence was presented in the current study. Indices of cortisol were included as
covariates (AVC and Day Mean) to assess the potential for cortisol to interact with
other metabolic syndrome symptoms in the expression of the metabolic syndrome.
Cortisol only found to significantly correlate with C-reactive protein and IL-6
(inflammatory immune markers), with no observed co-variance with any of the
remaining biomarkers. The suggestion that the Metabolic Syndrome may indeed be a
neuroendocrine disorder (Bjorntorp and Rosmond, 2000; Gale et al., 2002; Rosmond
and Bjorntorp, 2001; Khani and Tayek, 2001) remains largely unsupported in the
current study. However, it may be that the relationship between cortisol and the
metabolic syndrome is far more complex than this assessment allowed. Gradual changes
in cortisol and metabolic parameters as a result of chronic stress and elevated basal
cortisol over a much longer period may be characteristic of the neuroendocrine
hypothesis (Bjorntorp and Rosmond, 2001). Confirmation of this would require a more
longitudinal assessment in a study much larger than this thesis permits.
DHEA was found to be elevated in high waist-hip ratio individuals. Previous research
has suggested that an inverse relationship exists between DHEA and BMI (De Pergola
et al., 1996) but is largely conflicting with some studies failing to find an association
(Kraemer et al., 2001). Evidence supporting the relationship between DHEA and waist-
hip ratio is sparse. The current findings appear to suggest that DHEA increases with
increases in waist-hip ratio. However, the sample for DHEA assessment was obtained
upon waking. DHEA has been shown to exhibit a diurnal profile that is similar to
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cortisol (Goodyer et al., 1996) with elevated DHEA in the AM phase relative to during
the afternoon or evening. With this in mind, it may be that the AM sample obtained is
insufficient to determine the relationship between DHEA and central obesity. Further
within day assessment is therefore required.
5.5.2.3 Cortisol & Perceived Stress/Daily Hassles
- Perceived Stress
Females reported greater subjective perceived stress using the Perceived Stress Scale
compared with males. This is consistent with previous research in that females
subjectively report more stress than males and report more physical and psychological
symptoms which could indicate greater vulnerability to stress (Bebbington, 1996;
Kessler et al., 1981; Kessler and McLeod, 1984; Kroenke and Spitzer, 1998; Miller and
Kirsch, 1987; Troisi, 2001).
Previous research has identified a positive association between perceived stress and
cortisol activity. Goldman et at. (2005), after adjusting for age and gender, found a
positive association between perceived stress and cortisol. These findings were stronger
in females than in males. However, Van Eck et al. (1996) failed to find an association
between perceived stress and cortisol responses. In conclusion, Van Eck et al. (1996)
suggested that perceived stress might not be a strong enough indicator of cortisol
activity. In the current study, no association between stress (cortisol) and perceived
stress using the perceived stress scale was observed.
- Daily Hassles
The subjective reporting of the intensity of the daily hassles encountered (using the
Daily Hassles Scale) across the three days of sampling was significantly associated with
mean cortisol. This indicated that an increase in the perceived intensity of daily hassles
resulted in a reduction in mean cortisol. The subjective frequency of the daily hassles
was not associated with cortisol. The association between daily hassles and cortisol is
supported by previous literature. Ockenfels et al. (1995) found that experiences of
stressful events (daily stressors recorded over a two consecutive day period) were
associated with increases in salivary cortisol. Van Eck et al. (1996) found similar
results. However, these findings did not differentiate between the number of stressor
experienced and subjective intensity. Further, in the current study, the findings
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suggested a reduction in cortisol activity with increasing intensity of daily hassles,
conflicting with previous findings. It is possible that exposure to chronic stress in the
form of daily hassles over time can cause a dysregulation of the HPA axis as in those
exhibiting central obesity. In order to fully explore this hypothesis, further measures of
cortisol, for example, nocturnal cortisol, are required.
The magnitude (intensity) of the stressful event is of importance, in terms of how
stressful such events are perceived to be. The influence of daily hassles on subsequent
cortisol responses is of greater importance when exploring the onset of depression. Sher
(2004) proposed that increased experience of daily hassles and elevations in cortisol can
be a characteristic of depressive behaviour and may be implicated in the pathogenesis of
depression. Ultimately, the response to a stressor depends on psychological appraisal of
the stressor. The reported severity of the stressful experience will reduce if the
individual implements effective coping strategies. Consequently, little or no
physiological stress response should be observed if coping is effective (Holroyd and
Lazarus, 1982; Vogel, 1985). Similarly, if no stress responses/cortisol elevations are
observed then it could be argued that the individual is demonstrating effective coping
(Levine, 1978). This may contribute to the observed relationship between cortisol and
subjective reporting of intensity daily hassles observed in the current study.
5.5.3 Classic & Non-Classic Cortisol Diurnal Profiles
Prior to the analysis, each set of profiles was assessed individually in terms of the
quality of the profile by three independent observers, who were blind to the individual
characteristics of the volunteer to whom the profile belonged. Profiles were segregated
into those clearly reflecting the 'classic' diurnal profile and those which did not, 'non-
classic' profiles. The aim was to explore the prevalence of the 'classic' diurnal profile
among a random healthy sample. A further aim was to examine the 'non-classic' profile
in terms of specific characteristics that might be associated with deviance from the
'classic' profile.
5.5.3.1 Metabolic Syndrome & the Basal Cortisol Profile
An initial hypothesis proposed that those who exhibit a non-classic diurnal profile were
also those individuals who exhibit central obesity; this was not found to be true. Waist-
hip ratio in the classic profile group did not significantly differ from waist-hip ratio in
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the non-classic profile group. Mean cortisol secreted during the monitoring period
differed significantly between groups, with a greater mean of cortisol secreted in the
non-classic profile (due to a blunted awakening response in conjunction with elevated
evening cortisol concentrations) but this was not associated with the presence of central
obesity. A second proposal, based on the theory of the metabolic syndrome as a
neuroendocrine disorder (Bjorntorp and Rosmond, 2000) suggested that those who
exhibit 'pathological' basal cortisol secretion are those who are most likely to also
exhibit central obesity and presence of the metabolic syndrome. Bjorntorp and
Rosmond (2000) assessed basal cortisol data and distinguished between two profile
types, i. high morning and low evening and ii. a flat profile with lower morning values
but little difference in evening values. Those who exhibited the latter profile also
exhibited metabolic symptomology, endocrine abnormalities and central obesity. In the
current study, insulin, cholesterol, LDL, triglycerides, IL-6, CRP and the calculated
degree of insulin resistance were higher in the non-classic profile group compared with
the classic profile group, but only measured level of triglycerides and CRP differed
significantly. The evidence to suggest that a more disrupted or flattened profile is
associated with the metabolic syndrome is therefore not strong but is suggestive as the
findings point in the same direction. In the current study, the profiles were segregated
purely on visual assessment to measure differences in endocrine and metabolic output.
Bjorntorp and Rosmond (2000) applied a statistical weighting procedure to subgroup
profiles, based on the level of variability within the profile (Rosmond et al., 1998). The
resultant profiles were visually similar to the profiles obtained in the current study but
the associated metabolic and endocrine characteristics were not so evident. With a
statistical segregation, those differences may become more distinct.
The minimal evidence in the current study, to suggest that the difference in profiles was
due to the metabolic and endocrine variation prompted the examination of other
variables that could be associated with a disrupted cortisol profile. Subsequent analysis
revealed that individuals who exhibited a non-classic diurnal profile also reported
greater sleep disturbance, generally poor quality sleep and greater intensity of daily
hassles. These are now discussed.
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5.5.3.2 Influence of Sleep OD the Basal Cortisol Profile
The findings of the current study suggested that non-classic profiles were associated
with poorer subjective sleep quality (based on subjective sleep reports from items on the
LSEQ). In the 'non-classic' profile, subjective reporting of sleep disturbance was
significantly greater than in the 'classic' diurnal profile. Individuals displaying a 'non-
classic' profile reported more difficulty falling asleep, more periods of wakefulness and
more difficulty awakening than those in the 'classic' profile group. Further, sleep
quality was significantly associated with cortisol secreted during the cortisol awakening
response, particularly for ease of getting to sleep, restfulness of sleep, time taken to fall
asleep and ease of waking. Thus, poorer sleep quality was associated with a reduced
awakening response. The non-classic profile in the current study was characterised by a
lack of, or flattened, cortisol awakening response and could be explained by the high
prevalence of sleep disturbance reported by individuals in this profile group. Sleep
quality has been linked to changes in the cortisol awakening response. Poor sleep
quality has been shown to result in a blunted awakening response (Backhaus et al.,
2004; Leproult et al., 1997; Williams et al., 2005).
5.5.3.3 Influence of Daily Hassles on the Basal Cortisol Profile
The findings of the current study suggested that non-classic profiles were associated
with greater subjective intensity of daily hassles experienced. However, the frequency
of occurrence of hassles experienced was not greater. The potential for daily hassles to
influence cortisol activity is supported by previous literature. Further, the potential for
daily stressors to alter HPA regulation has been raised, with observed flattened profiles
in those with repeated daily stress (Stone et al., 2001). Further, Ockenfels (1995) found
that altered diurnal profiles were associated with chronic stress (as marked by
unemployment stress) which although the nature of the stress was different (Le. the
current study was not a study of unemployed individuals) is consistent with the findings
in the current study.
5.5.3.4 Influence of Waking Time on the Basal Cortisol Profile
The differences between the classic and non-classic profile groups were not attributable
to differences in waking time (early/late risers). However, waking time was found to
have a substantial influence on the cortisol basal diurnal profile. Early risers exhibited a
significantly greater response to waking, (evidenced by a greater mean increase, AURC
128 Chapter Five: Cortisol & Central Obesity
and Change 0-30) and greater mean cortisol secretion during the diurnal period (Diurnal
Mean). These observations are consistent with previous findings. An earlier waking
time was associated with elevated cortisol across the diurnal period compared with
those waking later in the day, which is consistent with findings in previous literature
(Bailey and Heitkemper, 1991; Edwards et al., 200 I; Kudielka and Kirschbaum, 2003;
Federenko et al., 2004).
The relationship between waking time and cortisol is postulated to be in related to the
influence of the Suprachiasmatic nucleus (SCN) on sleep-wake cycles. Cortisol displays
a consistent circadian rhythm, in part, under the control of the SCN which is associated
with the control of sleep/waking cycles as previously discussed in Chapter One
(Dijkswa et al., 1996; Van Cauter and Turek, 1995). During slow wave nocturnal sleep,
cortisol activity is at its lowest and most stable as are levels of ACTH (Born and Fehm,
1998). Both cortisol and ACTH rise simultaneously during final stage REM sleep to
produce spontaneous waking (Born et al., 1999), closely followed by the cortisol
awakening response. As cortisol activity is closely linked to patterns of sleep, a wealth
of research exists in support of the effect of waking time and sleep quality on
subsequent cortisol responses (Bailey and Heitkemper, 1991; Edwards et al., 200 I;
Kudielka and Kirschbaum, 2003; Federenko et al., 2004).
Sleep duration has been shown to influence cortisol responses to waking. Shorter sleep
duration can result in an elevated cortisol response on the subsequent day (Kumari et
al., 2006; Leproult et al., 1997; Spath-Schwalbe et al., 1992; WUst et al., 2000b).
Unfortunately, sleep duration was not assessed in the current study. The time of waking
was noted, but the time of retiring to bed on the previous evening was not. It would be
easy to assume that early risers experience shorter sleep duration than late risers, hence
the elevated cortisol awakening response as previously observed (Leproult et aI., 1997;
Spath-Schwalbe et al., 1992; Wuest et aI., 2000b) but without the data this cannot be
ascertained. Similarly, it could be argued that disturbed sleep and poorer sleep quality
would result in shorter sleep duration with more periods of wakefulness.
It is clear that cortisol is closely associated with pattern of sleeping and sleep related
behaviour, most likely mediated by an interaction between the SCN and HPA axis (Van
Cauter and Turek, 1995). There have been clear effects of sleep quality and waking time
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on the cortisol profiles in the current study which were compatible with the literature.
The study highlights, however, the need to examine in detail the nature, timing and
duration of sleep in future studies.
5.5.4 Methodological Issues & Study Limitations
5.5.4.1 Compliance & the Basal Diurnal Profile
The issue of compliance is still very important in the discussion of the current study.
The inclusion of individuals who did not display a 'classic' diurnal profile (elevation
after waking and lower evening cortisol) may reflect the erroneous acceptance of non-
compliant volunteers. It is possible that the blunted awakening response observed in the
non-classic diurnal profile group is a result of failure to adhere to the strict sampling
protocol which could be manifested as disrupted cortisol activity. The cleaning and
screening of data in previous studies is likely to have excluded such subjects on this
basis, on the stance that it is not possible to determine whether the observed differences
are due to an underlying pathological condition or simply to non-compliance. However,
previous studies have also commented on the possibility that by excluding such
volunteers, relevant data on those who may well be exhibiting those characteristics the
research aims to examine being lost (Rivera and Svec, 1989). This will be discussed in
more detail in the following section.
In terms of data screening, previous studies have recommended that subjects be
excluded should no awakening response be observed in the profile (e.g. Clow et al.,
2004). This is as a caution against volunteer non-compliance. However, it has been
noted that approximately 10% of individuals fail to exhibit a cortisol awakening
response (PrUssner et al., 1997) and indeed, this may not necessarily reflect non-
compliant volunteers but leads to the exclusion of volunteers exhibiting a disrupted
HPA axis. Hence, this form of exclusion was not applied in the current study. Similarly.
the exclusion of individuals currently using any form of prescribed medication also
excludes a potentially large number of volunteers who may have insulin resistance.
diabetes or impaired glucose tolerance who would be of relevance to the aim of the
current study. Such groups are excluded on the basis of these possible confounds but
these individuals may be most likely to exhibit central obesity and therefore be
vulnerable to differences in cortisol. Indeed Rivera and Svec (1989) argue that this is
the subgroup of most interest to this hypothesis and argue further that exclusion of such
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individuals could skew the characteristics of the group towards those with lower body
proportions, or peripheral or whole body obesity rather than central obesity. Hence,
while individuals were not excluded on the basis of their cortisol profile, the possibility,
that certain medications can influence the activity of cortisol was acknowledged and
individuals on prescribed medication were excluded in the current study.
In the current study, if the strategy outlined previously was applied, then a significant
proportion of subjects would have been excluded from the analysis. Those exhibiting a
'non-classic' profile accounted for 48% of the whole sample, and just over half of
volunteers exhibited a classic profile (52%). Should the aforementioned rule of
exclusion have been applied in the current study, 48% of the sample would have been
excluded. The prevalence of this 'non-classic' profile and what it could or should be
attributed to require further investigation concurrent with stricter measures of
compliance. For example, Kudielka et al. (2003) successfully utilised electronic
monitoring devices to ensure that accurate sample timings were obtained to preserve the
accuracy of data. This results in some loss of data due to incorrect sampling but a
cleaner data set. However, the issue of compliance in free-living conditions is critical to
the trade-otT between data quality and accuracy and exclusion is difficult to resolve.
5.6 Conclusions
No difference in the basal cortisol profile was observed between those with central
obesity and those without. However, despite similar cortisol profiles, high waist-hip
ratio individuals (centrally obese) demonstrated less mean cortisol across the profile
compared with low waist-hip ratio individuals. Further, those with central obesity
exhibited elevated obesity related biomarkers as expected (greater insulin and calculated
degree of insulin resistance, elevated triglycerides, C-reactive protein and DHEA)
when compared with those without central obesity.
Classic and non-classic cortisol profiles differed on a number of psychological and
metabolic parameters. Non-classic diurnal profiles were associated with poorer sleep
quality and greater subjective intensity of daily hassles. Further, non-classic profiles
were associated with greater insulin resistance, elevated triglycerides and inflammatory
markers, possibly signalling a vulnerability to the metabolic syndrome. This evidence
seems to suggest that a culmination of contributing variables can account for ditTerences
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in the shape and magnitude of the basal cortisol profile. Poor sleeping patterns and
increased intensity of daily stressors are associated with disrupted profiles and may
present a vulnerability to associated metabolic symptoms which are minimal in the
present sample. These may elevate with time and more chronic exposure to stress.
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CHAPTER SIX
Exploring Stress Responsivity in the Centrally Obese Using the Trier Social Stress
Test (TSST): Impact on Cognitive Function using CANTAB.
6.1 Introduction
Chapter Five of this thesis explored the robustness of the basal cortisol profile in a
sample of older adults. The findings suggested that subtle changes occur in the absolute
level of cortisol secreted in those with central obesity compared with lean individuals
with no change to the profile shape. This is consistent with previous literature, which
suggests that cortisol is elevated in the centrally obese but that this elevation is not
reflected in the diurnal profile. Observed cortisol concentrations are lower than in lean
individuals or those with peripheral obesity, which may be attributed to an enhanced
clearance rate of cortisol (Ljung et al., 1996; Marin et al., 1992; Strain et al., 1980).
The identification of alterations in basal cortisol profiles in centrally obese individuals
led to the question of whether cortisol secretions in response to stress might also be
different to lean individuals. Research reviewed in Chapter One suggested that cortisol
responses to a psychological stressor are elevated in the centrally obese (Epel et al.,
2000; Marin et al., 1992; Moyer et al., 1994) compared with lean (Moyer et al., 1994;
Marin et al., 1992), peripherally obese and non-obese individuals (Epel et al., 2000).
Corticosteroid treatment has significant side effects in relation to mood and cognition
(Clark et al., 1952). Research has explored the relationship between glucocorticoid
activity and specific regions of the brain, which might have implications for mood and
cognition. The identification of distinctive MR (mineralcorticoid) and OR
(glucocorticoid) receptors (De Kloet and Reul, 1987; McEwen et al., 1986; Reul and De
Kloet, 1985) within the hippocampus lent support to the observation that stress related
decrements occurred in hippocampal related processing, particularly declarative
memory (Lupien et al., 1994; 1997; 1998; 2005). Elevated basal cortisol in elderly
adults is associated with cognitive impairments (Lupien et al., 1994; 1998). In adults,
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glucocorticoid administration endogenously (e.g, Domes et al., 2002; Lupien et al.,
2005) or exogenously (e.g. Wolf et al., 2001), has demonstrated that elevated cortisol
levels result in impairments in the conscious retrieval of recently acquired information
during both chronic and acute stress exposure (Lupien et al., 2005).
Basal cortisol activity is altered in the centrally obese and responses to stress may be
more pronounced compared to non-centrally obese individuals. Cognitive decrements
have been observed in the centrally obese who also show insulin resistance, high blood
pressure and other features of the metabolic syndrome (Convit, 2005; Elias et al., 2005;
Hashizume et al., 2006). The effect of psychological stress on cognitive function is the
aim of the study presented in this chapter.
6.2 Objectives
This study examined response to stress in a sample of male and female older adults aged
35-65 years during stress exposure using the Trier Social Stress Test compared with a
non-stress condition. The study aimed to explore differences in stress responsivity
between those exhibiting central obesity compared with lean or peripherally obese
individuals (high versus low waist-hip ratio) when exposed to stress. In particular, the
cortisol response to stress was examined. The influence of this on subsequent cognitive
performance was investigated. Research, which specifically links cognitive performance
in the centrally obese to cortisol responses, is sparse and at the time of writing
represents a novel avenue for investigation.
In an attempt to replicate findings from Chapter Five, basal cortisol activity in the
centrally obese was also assessed over the course of one day, prior to the test session.
Associated metabolic syndrome biomarkers were assessed concurrently.
6.3 Method
6.3.1 Sam pie
Volunteers were recruited using the same methods as outlined in Chapter Five (See
Section 5.3.1). Seventy volunteers were recruited to take part in this study (See Figure
6.1) All volunteers were aged between 35 and 60 years with an average age of 46 years
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± 7.36 (SD). The sample comprised 39 females (22 low waist-hip ratio and 17 high
waist-hip ratio) and 31 males (17 low waist-hip ratio and 14 high waist-hip ratio). 42
volunteers from the cortisol baseline study (Chapter Five) returned to take part in this
study. These were evenly distributed across the sample subgroups (Figure 6.1). The
volunteers were randomly assigned to either a stress condition (the Trier Social Stress
Test) or a no stress condition with 35 volunteers per condition (Figure 6.1). The same
exclusion criteria as in Chapter Five (See Section 5.3.1) were applied with an additional
exclusion of individuals with colour blindness (See Appendix 7).
6.3.2 Design
This study conformed to a 2x2x2 between subjects' analysis of variance design with 2
conditions (stress/no stress), 2 waist-hip ratio groups (high/low) and gender
(male/female). This design is illustrated in Figure 6.1 below.
STRESS
N=35
NO STRESS
N=35
HWHR
N=16
LWHR
N=19
HWHR
N=15
LWHR
N=20
Male
N=8
Female
N=8
Female
N=11
Male
N=8
Female
N=9
Male
N=6
Female
N=ll
Male
N=9
Figure 6.1: FlowChart to illustratethe main study designWHR& gender as betweensubjects
factors
6.3.3 Measures
6.3.3.1 Psychological Measures
The same psychological measures were implemented as in Chapter Five. These
included; i. The Hospital Anxiety and Depression Scale (HADS, Snaith and Zigmond,
1994); ii. The Dutch Eating Behaviour Questionnaire (DEBQ, Van Strien et al., 1986);
iii. Perceived Stress Scale (PSS, Cohen, 1994). The National Adult Reading Test
(NART; Nelson, 1982) was also administered to give a proxy measure of IQ. For a
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detailed discussion of these measures, see Chapter Three. In addition, the following
measures were administered:
(I) State Trait Anxiety Inventory (STAI; Spielberger 1979)
Since its inception, the STAI (Form X) (see Appendix 18) has been used more
frequently in psychological research than any other anxiety inventory (Buros, 1978).
The scale was originally developed in 1970 by Spielberger, Gorsuch and Lushene to
provide an operational measure of state and trait anxiety (Vagg et al., 1980). A revised
version of form X resulted in the development of the STAI Form Y which was
implemented in this research to discriminate more clearly between feelings of anxiety
and depression, to remove weaker psychometric properties and to improve the factor
structure (Spielberger, 1983). Responses are made on a four-point scale (not at all,
somewhat, moderately so and very much so). Test-retest reliability is moderate for an
overall score (r = 0.54; NHMHRDP, 1999), with good internal consistency (Cronbach
alpha a = 0.83-0.93; Hishinuma et al., 2000). The STAI was implemented to measure
changes in state anxiety during the experimental test session.
(ii) State Self Esteem Scale (SSES; Heatherton and Polivy, 1991)
The State Self-Esteem Scale (SSES) (see Appendix 19) was developed as a measure of
short-lived changes in self-esteem (Heatherton and Polivy 1991). The SSES consists of
20 items adapted from the Janis-Field Feelings of Inadequacy Scale (Janis and Field,
1959). There are three esteem factors in the scale (i) academic performance (ii) social
evaluation and (iii) appearance. The internal consistency of the scale is good (a = 0.92).
The SSES; was implemented to measure changes in state self-esteem during the
experimental test session.
6.3.3.2 Biological Measures
At screening, i. blood pressure, ii. body mass index, iii. body composition, iv. waist-hip
ratio and a range of blood biomarkers (glucose, insulin, calculated degree of insulin
resistance, total cholesterol, HDL, LDL, triglycerides, IL-6, CRP and adiponectin) were
obtained (See Chapter Three, Section 3.2.3.1).
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During the study period, measures of salivary cortisol, blood pressure and
dehydroepiandrosterone (DHEA) were obtained (See Chapter Three, Sections 3.3 and
3.4.3.1).
6.3.4 Procedure
Following telephone screening and completion of the Volunteer Screening Booklet (See
Appendix 1), screened volunteers were asked to attend an induction session at the
Institute of Psychological Sciences. This session introduced the volunteer to the study,
the equipment and procedure. Volunteers were told that they were to complete a number
of mentally challenging psychological tests to assess cognitive ability. Prior to study
commencement, ethical approval for the study was obtained from the Institute of
Psychological Sciences Ethics Committee. Reading ability as a proxy measure of IQ
using the NART and colour blindness were assessed.
6.3.4.1 Monitoring Day One
The monitoring day was the day immediately prior to the test day. Volunteers followed
the same procedure as detailed in Chapter Five (See Section 5.3.4.1) (see Appendices 3
and 4).
6.3.4.2 Test Day
On the test day morning, volunteers followed the same procedure as in Chapter Five for
the collection of saliva to determine the cortisol awakening response.
Following the final saliva sample. for determination of the cortisol awakening response
at 45minutes post waking, volunteers were permitted to consume breakfast, which they
were advised should be something that they would normally consume. Post breakfast,
volunteers were asked to refrain from snacks until their appointment at the Institute
when a lunch was provided. Lunch consisted of a white bread cheese sandwich with
salted crisps. This ad libitum meal ensured that all volunteers had eaten to a level of
comfortable fullness prior to the test session. Volunteers were asked to refrain from any
strenuous physical activity for at least one hour prior to the experiment Appointments
for the test session were consistently scheduled for 1.30pm on each test day.
A summary of the test session procedure is detailed in Figure 6.2 below.
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Time STRESS (S) r NO STRESS (NS)
1.30 Standard lunch
1.50 Baseline measures (BP, Cortisol, STAr, SSES)
2.00 Meet panel I Shown job advert
1Omins preparation
BP, Cortisol, STAr, SSES measured
2.10 TSST public speaking task I Friendly discussion of advert
BP and Cortisol measured
TSST mental arithmetic I Basic arithmetic worksheet
2.20 BP, Cortisol, STAI, SSES measured
2.30 Cognitive test battery
3.30 BP, Cortisol, STAI, SSES measured
3.40 Cortisol sample and BP measured. Study terminated (debrief
questionnaire and information sheet provided)
Figure 6.2: Test Session Schedule of Events
i. Upon arrival, the volunteer was provided with lunch and allowed to relax. Twenty
minutes post arrival, baseline measures of salivary cortisol and BP were collected. The
STAI and SSES questionnaires were com pleted (Figure 6.1).
ii. The volunteer was subsequently exposed to either the stress (TSST) or no-stressor
task depending on randomisation (see Figure 6.1). The tasks are explained in detail in
Chapter Three).
iii. Following the preparation phase of the task, a cortisol saliva sample was obtained
with measurement of blood pressure and completion of the STAI and SSES
questionnaires (Figure 6.1).
iv. Following the 'presentation'(S)/'chat' (NS) phase of the task, a cortisol saliva
sample was collected with measurement of blood pressure. The mental arithmetic phase
of the task was subsequently completed (Figure 6.1).
v. Following completion of the stress/no stressor task, the volunteer provided a cortisol
saliva sample, measurement of blood pressure was recorded and the STAI and SSES
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questionnaires were completed. The volunteer was asked to begin the cognitive test
battery (using CANTAB - Chapter Three Section 3.5). The order and timing of the
battery is shown below:
i. Auditory Verbal Learning Task (AVLT) Part One:
List A repeated five times followed by List B (distracter)
n. CANTAB: Motor Screening practice session (MOT)
iii. CANTAB: Delayed Matching to Sample (OMS)
IV. CANTAB: Paired Associates Learning Task (PAL)
v. Auditory Verbal Learning Task (AVLT) Part Two:
Delayed Recall of List A
vi. CANTAB: Pattern Recognition Memory (PRM)
VI. CANTAB: Rapid Visual Processing (RVP)
viii. CANTAB: Spatial Recognition Memory (SRM)
IX. CANTAB: Spatial Working Memory
x. CANTAB: Stockings of Cambridge (SOC)
5 minutes
2 minutes
5 minutes
8 minutes
3 minutes
5 minutes
5 minutes
5 minutes
10 minutes
8 minutes
Total Time: 56 minutes
viii. Upon completion of the cognitive test battery, the volunteer provided a cortisol
saliva sample with measurement of blood pressure and completion of the STAI and
SSES. The volunteer was asked to rest.
IX. Following 5-minutes of relaxation a final cortisol saliva was collected. The
experiment was terminated. A debrief questionnaire was administered to assess the
individual's perception of how stressful the Trier Social Stress Test or the no stressor
task was perceived to be and to rate their subjective performance on the cognitive test
battery (See Appendix 8 and 9).
6.3.4.3 Monitoring Day Two
Volunteers were required to provide saliva samples using salivettes for cortisol analysis
from waking on the day post-test session completion to assess the CAR and to examine
the influence of stress exposure on subsequent cortisol responses to waking. The same
procedure was used for monitoring day one (See Chapter Five, Section 5.3.4.1).
However, samples were only obtained on waking until 45minutes post waking.
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Collected saliva samples were refrigerated until returned to the Institute where they
were subsequently frozen at -20°C.
6.3.5 Data Treatment and Analysis
6.3.5.1 Missing Data
As in Chapter Five, this study relies upon the compliance of the volunteer to produce
the required samples at the specified times. In addition, adequate volumes of saliva were
required for assay. During the test session, the timing of the samples was determined by
the presence of the researcher. However, adequate volumes of saliva were not always
obtained. This was of particular relevance during the TSST when a dry mouth (due to
the public speaking task and a highly stressful situation) was common.
This analysis of cortisol (both basal and in response to stress) did not include the full
sample (n=70) because of missing data or lack of sufficient saliva. The data for the
blood biomarkers were almost complete with only one exclusion due to an unsuccessful
venepuncture. The sample size ranged from 65 to 69 within the analysis for each
hypothesis. For analysis of cognitive performance, subjective measures of mood, well-
being and performance and blood pressure complete data were obtained.
6.3.5.2 Data Screening
All data was screened for outliers using boxplots conducted in SPSS prior to analysis.
There were few outliers so the analysis was subsequently conducted with outliers
included unless they were extreme outliers, in which case the analysis was re-run with
the extreme outliers excluded. All data was explored using SPSS and normality assessed
using histograms and the Kolmogorov-Smirnov test of normality. The cortisol data was
found to be positively skewed across all sample points and was normalised using a
logarithmic transformation. All analyses were conducted using SPSS version 12.
6.3.5.3 Statistical Analysis
(i) Stress Responsivity, Central Obesity and Cognitive Performance
Cortisol responses obtained over the duration of the test session were analysed using a
2x2x2x6 repeated measures analysis of variance model with condition (stress/no stress),
waist-hip ratio (high/low) and gender (male/female) as between subjects factors and
time as a within subjects factor. As cortisol responses vary with age, age was included
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as a covariate. Significant interactions were explored post hoc using Bonferroni
corrected independent samples t-tests. Cortisol response to the stress/no stress task was
also assessed using change from baseline (sample 1 to the mean of time points 3 and 4).
This was calculated as percentage increase and analysed using a 2x2x2 between subjects
ANOVA. Significant interactions were explored post hoc using Bonferroni corrected
independent samples t-tests. The same analysis was conducted to assess recovery using
change from baseline to the final sample as the dependent variable. Blood pressure and
changes in mood/well-being using the STAI and SSES were analysed in the same way
as for salivary cortisol.
Scores generated from the CANTAB data handling facility were imported and analysed
in SPSS. Performance on each task was analysed individually using a 2x2x2 (waist-hip
ratio, gender, condition) between subjects ANOVA with age and predicted IQ (from the
NART) as covariates. Scores from the AVLT were entered manually for each of the five
trials and analysed using SPSS. Where multiple trials were performed, trial was
included as a within subjects factor. The number of words recalled in each trial relative
to baseline was analysed using the same procedure. The total number of words recalled
across the five trials, number of words recalled on list B and the delayed recall of list A
were assessed. Finally, pro-active interference was assessed using a calculation of the
difference between the number of words recalled in list A trial one and in List B. This
assessed the ability of previously learned material to influence acquisition of new
material. Cognitive performance on each task was analysed according to (i) condition
(stress/no stress), (ii) actual cortisol response (cortisol responders/non-responders) and
(iii) overall stress response based on both cortisol and blood pressure responses
(combined BP and cortisol responders/non-responders) using 2x2x2 between subjects
ANOVA's.
(ii) Associated Psychological and Biological Parameters
In an attempt to replicate findings from Chapter Five, a basic analysis of the basal
diurnal profile was conducted. A repeated measures ANOVA assessed cortisol profiles
according to waist-hip ratio and gender (between subjects' factors). Age was included
as a covariate. Significant interactions were explored post hoc using Bonferroni
corrected independent samples t-tests. The cortisol awakening response and subsequent
diurnal activity on monitoring day one using the calculated indices of cortisol activity
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(see Chapter Three Section 3.3.3) were analysed individually using univariate
ANOVA's. Further, a blind categorisation of the basal cortisol profiles was conducted
using the same procedure as outlined in Chapter Five (Section 5.2.5.1). The profiles
were subsequently compared in terms of associated psychological and metabolic
parameters using a 2x2x2 ANOVA including profile group as a between subjects factor.
Age was included as a covariate.
Subjective performance and blood biomarkers were analysed using analysis of variance
with condition, waist-hip ratio and gender as between subjects' factors. Analysis of
blood biomarkers included mean cortisol and AVC index of awakening response
activity on the monitoring day as covariates. DHEA was analysed using a repeated
measures ANOVA with waist-hip ratio and gender as between subjects' factors and day
(Monitoring Day One, Test Day, Monitoring Day Two) as a within subjects factor. Age
was included as a covariate. Covariates were assessed in terms of the strength of their
relationship with each dependent variable using separate linear regression analyses and
beta values were reported.
6.4 Results
6.4.1 Sample Characteristics
A summary of the main characteristics of the sample are shown in Table 6.1. A trend for
a waist-hip ratio group*gender interaction for age was observed (F (1, 62) =3.884;
p=0.053). Post hoc analysis revealed that low waist-hip ratio males were, on average,
the youngest members of the sample being significantly younger than low waist-hip
ratio females (p=0.040) and high waist-hip ratio males (p=0.023). A significant main
effect of waist-hip ratio on perceived stress score was observed (F (1, 62) =4.870;
p<0.05). Those with central obesity (HWHR) reported greater subjective stress than the
low waist-hip ratio subgroup. Measured waist-hip ratio was significantly higher in the
high waist-hip ratio groups than in the low waist-hip ratio groups as expected (F (1, 62)
=149.33; p<O.Ol). Further, a significant main effect of body mass index (BMI) was
observed (F (1. 62) =43.405; p<O.OI). BMI was significantly greater in the high waist-
hip ratio groups compared with the low waist-hip ratio group.
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Finally, a main effect of gender on estimated IQ (as determined by the NART) was
observed (F (1, 62) =141.583; p<O.OI). Estimated IQ was significantly higher in males
compared with females. No other differences were observed between the respective
groups.
6.4.2 Stress Responsivity, Central Obesity & Cognitive Performance
6.4.2.1 Salivary Cortisol in Response to the StresslNo Stress Tasks in HighILow
WHR
Salivary cortisol responses to stress were assessed in high and low WHR males and
females using a repeated measures ANOYA on the six samples taken during the
stress/no stress exposure. Due to missing data, 61 observations of 70 were included in
the analysis. The mean cortisol at each time point for each group is shown in Figure 6.3.
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Figure 6.3: Cortisol secreted across the test session in High/Low WHR Males/Females (Means
± SEM)
The potential four way time*condition*waist-hip ratio group*gender interaction also
failed to reach significance (F (1, 52) =9.336; p =0.079; NS).
A significant time*waist-hip ratio group*gender interaction was observed (F (5,260)
=2.397; p<0.05). However, Bonferroni corrected t-tests failed to reach significance for
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any post hoc comparisons. Based on means, high waist-hip ratio males appeared to
exhibit greater cortisol response at time points 3 and 4 than high waist-hip ratio females.
A significant time*condition interaction was observed (F (5,260) =13.973; p<O.OI).
Cortisol responses in the stress condition were significantly higher than cortisol
responses in the no stress condition at time point 2 (p=0.022), 3 (p=O.OO1), 4 (p=O.OO1),
5 (p=O.OOI)and 6 (p=O.OOI).Baseline cortisol at time 1 did not differ significantly
between conditions (p=0.20 1).
A main effect of condition for mean cortisol across the test session was observed (F (1,
52) =36.558; p<O.OI). Significantly, greater mean cortisol was observed in the stress
condition than in the no stress condition (1.44 ± 0.02 and 0.975 ± 0.02 LOGnM/L
respectively). Further, a main effect of gender was observed (F (1, 52) =7.946; p<O.OI).
Males exhibited greater mean concentrations than females (1.10 ± 0.21 and 1.02 ± 0.19
LOGnMIL respectively). No main effect of waist-hip ratio group was observed (F (1,
52) =0.138; p=0.712). Age was not found to be a significant covariate (F (1,52) =1.195;
p=0.279; NS).
A significant condition*waist-hip ratio group*gender interaction was observed (F (1,
52) =9.336; p<O.OI). This is illustrated in Figure 6.4. Post hoc analyses revealed that
high waist-hip ratio males under conditions of stress differed significantly from high
waist-hip ratio males in the no stress condition (p=0.004). High waist-hip ratio males
under stress exhibited greater mean cortisol than high waist-hip ratio males in the no
stress condition (1.26±0.06 and 0.97±0.05 LOGnMIL respectively). Further, high waist-
hip ratio females within the stress condition differed significantly from high waist-hip
ratio females in the no stress condition (p=0.003). High waist-hip ratio females
exhibited greater mean cortisol than high waist-hip ratio females in the no stress
condition (1.08 ±0.05 and 0.93 ± 0.02 LOGnMIL in females). Low waist-hip ratio
females in the stress condition also differed significantly from low waist-hip ratio
females in the no stress condition (p=O.OO1). Females in the stress condition exhibited a
greater mean of cortisol across the test session (1.15 ± 0.04 and 0.93 ± 0.03 LOGnMIL
respectively). There was an observed trend for high and low waist-hip ratio males in the
stress condition to differ (p=0.046). High waist-hip ratio males secreted greater cortisol
during the stress condition than low waist-hip ratio males in the same condition (1.26 ±
0.06 and 1.10 ± 0.04 LOGnMIL).
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Figure 6.4: Mean Cortisol secreted during the test session in High/Low WHR Males/Females
by StresslNo Stress Condition (Means ± SEM)
6.4.2.2 Calculated Cortisol Response to the StresslNo Stress Tasks (percentage
Rise)
The percentage increase (change from baseline) from baseline to mean cortisol at time
points 3 (during the task) and 4 (immediately post stress/no stress task) was calculated
and analysed using a 2x2x2 ANOV A with waist-hip ratio (high/low), gender
(male/female) and condition (stress/no stress) as between subjects factors. The mean
responses by gender and WHR for percentage rise are shown in Table 6.2.
Total (%) Male HWHR% Male LWHR% Fern HWHR% Fern LWHR%
Stress 26.17± 16.14 26.72±7.55 35.58±22.20 23.94± J 3.45 20.42± 14.49
No Stress 4.88± 13.42 14.33±lS.96 1.63±6.0S -1.86 ±7.03 8.22±17.73
Table 6.2: Mean Percentage RIse by WHR and gender (Mean ± SD)
It is evident that cortisol responses were greater under stress evidenced by a significant
main effect of condition (F (1, 52) =31.531; p<O.OI) was observed for the percentage
rise in cortisol from baseline to post stress/no stress task. A greater cortisol response
(26%) was observed in the stress condition compared with the no stress condition (5%).
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A significant condition*waist-hip ratio group*gender interaction was observed (F (I,
52) =4.528; p<0.05) and this is illustrated in Figure 6.5. Post hoc analyses revealed that
low waist-hip ratio males exhibited a greater cortisol response (percentage rise) during
the stress condition than low waist-hip ratio males in the no stress condition (p=O.OOI)
(35.58% versus 1.63% respectively). Further, high and low waist-hip ratio females
within the no stress condition differed significantly (p=O.OOI) for percentage cortisol
response. Low waist-hip ratio females demonstrated a greater cortisol response
(percentage rise) in the no stress condition compared to high waist-hip ratio females
(8.22 % versus -1.86 % respectively).
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Figure 6.5: % Rise in Cortisol In High/Low WHR Males/Females by Stress/No Stress
Condition (Means ± SEM)
The condition*waist-hip ratio group interaction (F (I, 52) =0.554; p=0.460; NS),
condition*gender interaction (F (1, 52) =0.383; p=0.539; NS) and waist-hip
ratio*gender interaction (F (I, 52) =0.163; p=0.688; NS) all failed to reach significance.
Further, a trend for a main effect of gender was observed ((F (I, 52) =3.859; p=0.055).
Males were more responsive than females (showing mean increases of 19% and 12%
respectively). No main effect of waist-hip ratio was observed (F (1, 52) =0.182;
p=0.671; NS). Age was not found to be a significant covariate (F (1, 52) =1.534;
p=0.221; NS).
147 Chapter Six: Stress, WHR & Cognition
6.4.2.3 Cortisol Change from Baseline (Recovery)
Recovery was calculated as a change from baseline to the final sample obtained
(Sample 6). Recovery was the dependent variable in a 2x2x2 between subjects ANOV A
with waist-hip ratio, gender and condition as between subjects' factors.
A trend for a condition*waist-hip ratio*gender interaction was observed (F (I, 52)
=3.440; p=0.069), however, Bonferroni corrected t-tests failed to reach significance.
Based on means, there was a tendency for high waist-hip ratio males to show poorer
recovery than low waist-hip ratio males within the stress condition (0.029 ± 0.06 and
0.183 ± 0.05 LOGnM/L respectively). Both high and low waist-hip ratio females
demonstrated poorer recovery than high and low waist-hip ratio males within the no
stress condition. This is illustrated in Figure 6.6 (an increase indicates better recovery).
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Figure 6.6: Recovery of Cortisol activity in High/Low WHR Males/Females by StresslNo
Stress Condition (Means ± SEM)
The condition*waist-hip ratio group interaction (F (1, 52) =0.247; p=0.621; NS),
condition*gender interaction (F (1, 52) =0.029; p=0.865; NS) and waist-hip
ratio*gender interaction (F (1,52) =1.478; p=0.230; NS) failed to reach significance.
A main effect of condition on recovery post cortisol response was observed (F (1, 52) =
4.405; p<O.05). Individuals in the stress condition demonstrated less recovery post
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stress/no stressor task compared to individuals in the no stress condition (0.070 ± 0.04
and -0.033 ± 0.03 LOGnMiL respectively). A trend for a main effect of gender was also
observed (F (1,52) =3.269; p=0.076). Males demonstrated poorer recovery than females
(0.063 ± 0.04 and -0.026 ± 0.03 LOGnMIL respectively). No main effect of waist-hip
ratio group was observed (F (1, 52) =0.136; p=0.714; NS). Age was not found to be a
significant covariate (F (1, 52) =3.616; p=0.063). However, the linear regression
indicated that recovery worsened with age.
6.4.2.4 Blood Pressure Response to the Stress/No Stress Tasks in HighlLow WHR
Males and Females
Blood pressure responses (systolic and diastolic) were analysed over the test session
using a 2x2x2x8 ANOYA with condition, waist-hip ratio and gender as between
subjects factors and time as a within subjects factor. All 70 observations were included
in the analysis.
i. Systolic Blood Pressure
Systolic blood pressure responses over the test session are illustrated in Figure 6.7. Age
was identified as a significant covariate in the analysis of systolic blood pressure over
the time (during the test session). A linear regression was conducted to assess the
strength of the relationship between the covariate and the dependent variable. Age was
found to exert significant adjustment to systolic blood pressure at two of the six
measurement time points. Specifically, the beta (p) value of 0.57 at time 4 (post
stress/no stress task) and 0.46 at time 6 differed significantly from zero (t (68) =2.160;
p<0.05 and t (68) =2.079; p<0.05 respectively). This indicated that systolic blood
pressure was associated with age. The beta values indicate that an increase in systolic
blood pressure is associated with increasing in age in this sample and the effect is
greatest immediately post stress, that is older individuals demonstrate the greatest
increase in systolic blood pressure.
The condition*waist-hip ratio*gender interaction was non-significant (F (1, 62) =0.238;
p=0.627; NS). A significant time*condition interaction was observed for blood pressure
measured across the session (F (5,305) =23.144; p<O.Ol). Systolic blood pressure was
significantly higher in the stress condition compared with the no stress condition at time
points 2 (p=O.OOl),3 (p=O.OOI)and 4 (p=O.OOI).This is illustrated in Figure 6.7.
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BP Responses (Systolic) by Condition
170
150
: 130
Es
D-
III
c 110
~
",
(/)
e~
~ 90
70
50
sys1
---t-
sys2 sys3 sys5 sys6sys4
Time Point
_NoStress -+-Stress
Figure 6.7: Systolic Blood Pressure Responses by StresslNo Stress Condition (Means ± SEM)
A significant waist-hip ratio group*gender interaction was observed (F (1, 61) =4.880;
p<0.05). Post hoc analyses revealed that low waist-hip ratio females exhibited
significantly lower mean systolic blood pressure (122.52 ± 2.48mmHg) compared with
high waist-hip ratio females (135.20 ± 2.92mmHg) (p=0.008) while there was no
difference in high and low waist-hip ratio males. This is illustrated in Figure 6.8 below.
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Figure 6.8: Systolic Blood Pressure Responses in High/Low WHR Males/Females (Means ±
SEM)
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The condition*waist-hip ratio group interaction (F (1, 52) =0.378; p=0.541; NS) and
condition*gender interaction (F (1, 52) =1.864; p=O.l77; NS) failed to reach
significance.
A main effect of condition (F (1,61) =18.543; p<O.OI) was observed for mean systolic
blood pressure. Mean blood pressure was greater in the stress condition (138.45 ±
1.98mmHg in the stress condition and 126.28 ± 2.01mmHg in the no stress condition).
A main effect of waist-hip ratio group (F (1, 61) =5.912; p<0.05) and gender (F (1, 61)
=4.872; p<0.05) were observed on mean systolic blood pressure. Higher systolic blood
pressure was recorded in males compared with females (135.49 ± 2.11 and 129.23 ±
1.88mmHg respectively). High waist-hip ratio individual's demonstrated higher systolic
blood pressure compared with low waist-hip ratio individuals (135.87 ± 2.13 and 128.86
± 1.90mmHg respectively).
ii. Diastolic Blood Pressure
The condition*waist-hip ratio*gender interaction was non-significant (F (1, 62) =0.022;
p=0.883; NS). Trends were evident for a condition*gender interaction (F (1,62) =3.842;
p=0.055) and the waist-hip ratio group*gender interaction (F (1, 62) =3.043; p=0.086).
For the condition*gender interaction, post hoc analyses revealed that males and females
in the stress condition differed significantly in terms of mean diastolic blood pressure
(p=0.003). Males exhibited greater mean diastolic pressure than females (89.93 ± 2.07
versus 81.34 ± 1.93mmHg). Further, males in the stress group exhibited significantly
greater mean diastolic blood pressure than males in the no stress group (89.93 ± 2.22
versus 79.72 ± 1.64mmHg respectively) (p=O.OOl).
For the waist-hip ratio group*gender interaction, diastolic blood pressure was
significantly lower in low waist-hip ratio females compared with low waist-hip ratio
males (p=O.005) (74.88 ± 1.76 and 83.11 ± 2.08mmHg respectively) and this was also
significantly lower than high waist-hip ratio females (p=O.OO1). This is illustrated in
Figure 6.9. The condition*waist-hip ratio group interaction was not significant (F (1,
62) =0.151; p=0.699; NS).
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Mean Diastolic Blood Pressure by WHR and Gender
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Figure 6.9: Diastolic Blood Pressure Responses in High/Low WHR Males/Females (Means ±
SEM)
A significant time*condition interaction was observed (F (5,300) =12.357; p<O.O1).
The pattern was similar to that of systolic blood pressure shown in Figure 6.7.Post hoc
analyses revealed that diastolic blood pressure was significantly higher in the stress
condition at time points 2 (post preparation), 3 (during the task) and 4 (post task)
compared with the no stress condition (smallest p=O.OO1). As expected, the stress and
no stress conditions differed significantly in terms of overall mean diastolic blood
pressure (p=0.003).
A main effect of waist-hip ratio (F (1, 60) =11.590; p<O.OI) and gender (F (I, 60)
=5.146; p<0.05) was observed for mean diastolic blood pressure. Higher mean diastolic
blood pressure was recorded in males compared to females (84.82 ± 1.50 and 80.21 ±
1.36mmHg respectively) and in high waist-hip ratio individuals compared with low
waist-hip ratio individuals (86.04 ± 1.54 and 79 ± 1.35mmHg respectively). A main
effect of condition was also observed (F (1, 62) =9.512; p<O.O1). Mean diastolic blood
pressure was higher in the stress condition than in the no stress condition (85.64 ± 1.41
and 79.40 ± 1.45 mmHg respectively).
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6.4.2.5 Calculated BP Response to the Stress/No Stress Tasks in HighlLow WHR
MalesIFemale (percentage Rise)
The percentage increase (change from baseline) from baseline to the mean of blood
pressure (systolic and diastolic) at time points 3 (during the task) and 4 (immediately
post stress/no stress task) was calculated. This was analysed using a 2x2x2 ANOYA
with waist-hip ratio (high/low), gender (male/female) and condition (stress/no stress) as
between subjects' factors separately for systolic and diastolic blood pressure. The mean
responses by gender and WHR for percentage rise are shown in Table's 6.3 and 6.4.
Total (%) Male HWHR Male LWHR FemHWHR FemLWHR
Stress 17.04 ±7.27 18.07 ± 9.03 15.35 ± 6.27 16.31±7.07 18.05 ± 7.45
No Stress 2.12 ± 5.68 3.89 ± 2.71 2.58 ± 5.64 0.07 ± 5.20 2.44 ± 7.28
Table 6.3: % Rise III Systolic Blood Pressure post stressor in HighILow WHR MaleslFemales
(Means ± SO)
Total (%) Male HWHR Male LWHR FemHWHR FemLWHR
Stress 15.09 ± 9.09 17.51 ± 9.37 15.04 ± 5.90 11.13 ± 9.98 16.24± 10.32
No Stress 3.07 ± 8.54 4.22 ± 9.83 2.93 ± 6.87 5.20 ± 5.50 0.81 ± 11.27
Table 6.4: % Rise in Diastolic Blood Pressure post stressor in High/Low WHR MaleslFemales
(Means ± SO)
Analysis of the percentage rise in systolic and diastolic blood pressure revealed a main
effect of condition for both systolic (F (I, 61) =80.056; p<O.OI) and diastolic blood
pressure (F (I, 61) =30.108; p<O.OI). A greater percentage rise was observed in the
stress condition for both systolic and diastolic blood pressure. No other significant
interactions or main effects for waist-hip ratio or gender were observed.
6.4.2.6 Change from Baseline Blood Pressure (Anticipation & Recovery)
As in the analysis of patterns of cortisol activity, patterns of blood pressure at various
time points were assessed in terms of anticipation and recovery.
i. Anticipation
Anticipation was calculated as the change from baseline to the blood pressure reading
obtained at time 2 (post preparation and pre-stress/no stress task). Anticipation was the
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dependent variable in a 2x2x2 between subjects ANOYA with waist-hip ratio, gender
and condition as between subjects' factors.
A main effect of condition on anticipation in both systolic and diastolic blood pressure
was observed (systolic: F (1, 61) =55.822; p<O.OI and diastolic: F (1, 61) =30.177;
p<O.O1). Greater anticipation was observed in the stress condition compared to the no
stress condition for both systolic (17.03 ± 1.32 and 3.01 ± 1.34 mmHg respectively) and
diastolic blood pressure (9.94 ± 1.14 and 1.03 ± 1.15 mmHg respectively). No other
significant interactions or main effects for waist-hip ratio or gender were observed.
ii.Recovery
Recovery was calculated as change from baseline to the final blood pressure reading
obtained (time 6). Recovery was the dependent variable in a 2x2x2 between subjects
ANOYA with waist-hip ratio, gender and condition as between subjects' factors.
A main effect of condition was observed for recovery (change from baseline from time
point 1 to time point 6) of systolic blood pressure (F (1, 61) =13.415; p<O.OI). Less
recovery was observed in the stress condition compared to the no stress condition (8.28
± 1.35 and 1.24 ± 1.37 mmHg respectively). Analysis of diastolic blood pressure
demonstrated only a trend for a difference (p=0.055) with less recovery observed in the
stress condition compared to the no stress condition (6.94 ± 1.18 and 3.62 ± 1.22 mmHg
respectively).
6.4.2.7 STAI and SSES Scores in High/Low WHR MaleslFemales by Stress/No
Stress Condition
Subjective anxiety and self-esteem (as measured by the State Trait Anxiety Inventory
and the State Self Esteem Scale) were assessed across the test session at baseline, post
preparation, post task and post session to monitor change in anxiety and self esteem in
each condition. All 70 observations were included in the analysis.
i. Anxiety (STAI)
Analysis of covariance revealed age was a significant covariate for subjective anxiety
score over the duration of the test session (F (1,61) =8.581; p<O.OI). A linear regression
was conducted to assess the strength of the relationship between and the dependent
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variable. Age was found to provide significant adjustment to STAI score at three of the
four assessment time points. Specifically, the beta (P) value of 0.51 at time I(t (68)
=3.356; p<O.OI), 0.59 at time 2 (t (68) =3.375; p<O.OI) and 0.37 at time 3 (t (68)
=2.047; p<O.OI) significantly differed from zero. This indicated that STAI was
associated with age, such that an increase in score for the STAI (less anxiety) was
associated with increased age in this sample.
A trend for a condition*waist-hip ratio group*gender interaction was observed (F (1,
61) =3.223; p=0.078). However, Bonferroni corrected t-tests fai led to reach
significance. Based on the means, there was a tendency for low waist-hip ratio males in
the no stress condition to report greater subjective anxiety (indicated by a lower score)
than high waist-hip ratio males in the same condition (72.50 ± 2.06 and 65.08 ± 2.25
respectively). Further, high waist-hip ratio males in the no stress condition reported
greater subjective anxiety than high waist-hip ratio males in the stress condition (72.50
± 2.06 and 63.44 ± 3.35 respectively). This is illustrated in Figure 6.10 below.
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Figure 6.10: STAr Scores in High/Low WHR Males/Females by StresslNo Stress Condition
(Means ± SEM)
A significant time*condition interaction was also observed (F3, 183) =18.662; p<O.OI).
Post hoc analyses revealed that subjective anxiety at time points 2 (p=O.OO1) and 3
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(p=O.OO1) differed significantly by condition. Subjective anxiety was consistently
greater in the stress condition than in the no stress condition.
The condition*waist-hip ratio group interaction (F (1, 61) =0.045; p=0.832; NS),
condition*gender interaction (F (1, 61) =0.000; p=0.990; NS) and waist-hip
ratio" gender interaction (F (1, 61) =0.292; p=0.591; NS) all failed to reach significance.
A main effect of condition was observed (F (1, 61) =5.908; p<0.05). Greater anxiety
was reported in the stress condition compared with the no stress condition (61.69 ± 1.46
and 66.76 ± 1.49 respectively). A main effect of gender was also observed (F (1, 61)
=4.477; p<0.05). Females reported greater subjective anxiety compared with males
(62.01 ± 1.39 and 66.44 ± 1.56 respectively). No main effect of waist-hip ratio was
observed (F (1,61) =0.025; p=0.875; NS).
A within subjects main effect of time was observed (F (3,183) = 7.913; p<O.OI)
indicating that subjective anxiety altered across the test period. Pairwise comparisons
revealed that subjective anxiety score was significantly lower (indicating greater
anxiety) at time points 2 and 3 (post preparation and post stress/no stress task; 60.68 ±
1.15 and 62.76 ± 1.25 respectively) compared with baseline (67.19 ± 1.12) and post
session (66.27 ± 1.23). Time point 2 and 3 did not significantly differ from each other.
This effect is qualified by the significant time*condition interaction described above.
ii. Subjective Self Esteem (SSES)
A trend for a condition*waist-hip ratio group*gender interaction was observed (F (1,
61) =3.040; p=0.083). Post hoc analysis revealed that high waist-hip ratio females in the
no stress condition reported lower subjective self esteem than high waist-hip ratio males
in the same condition (p=0.003) (66.17 ± 3.82 and 81.83 ± 1.61 respectively). Further, a
trend existed for high waist-hip ratio females in the no stress condition to report lower
subjective self esteem than low waist-hip ratio females in the same condition (p=0.032;
Bonferroni corrected) (66.17 ± 3.82 and 79.25 ± 4.01 respectively). This is illustrated in
Figure 6.11 below.
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Mean Subjective Self Esteem (SSES) By Condition, WHR and Gender
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Figure 6.11: SSES Scores in High/Low WHR Males/Females by StressINo Stress Condition
(Means ± SEM)
The condition*waist-hip ratio group interaction (F (1, 61) =0,006; p=0.941; NS),
condition*gender interaction (F (1, 61) =0.003; p=0,959; NS) and waist-hip
ratio*gender interaction (F (1, 61) =1.485; p=0.228; NS) all failed to reach significance.
A main effect of gender was observed (F (I, 61) =4.220; p<0.05), lower subjective self-
esteem was reported by females (71.32 ± 1.88) compared to males (77.13 ± 2.11). No
main effect of condition (F (1, 61) =1.176; p=0.282; NS) or waist-hip ratio (F (1, 61)
=1.389; p=0.243; NS) was observed. Age was not a significant covariate (F (1, 61)
=1.977; p=0.165; NS).
6.4.2.8 Cognitive Performance in High/Low WHR MaleslFemales by StresslNo
Stress Condition
Performance on each task was assessed separately using a 2x2x2 ANOYA with
condition, waist-hip ratio group and gender as between subjects factors. The score on
each cognitive task was the dependent variable in each analysis. Age and predicted IQ
were covariates. All 70 observations were included in each analysis. Performance on the
auditory verbal learning task is considered first followed by the tasks employed from
the Cambridge Automated Neuropsychological Test Battery (CANTAB). For a table of
the associated F-Yalues (for CANTAB) refer to Appendix 20.
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(a) Auditory Verbal Learning Task (AVLT)
Performance on the AVLT was assessed in terms of i. learning (acquisition) of words
across five trials (using a 2x2x2x5 ANOVA with condition and gender as between
subjects factors and trial as a within subjects factor) and using a change from baseline
analysis, ii. the total number of words recalled over the five trials (total recall) iii. recall
of list B (distracter list) iv. pro-active interference (the degree to which information
already learned can influence the acquisition of new material) and v. delayed recall
(following a 20 minute delay). Age was found to be a significant covariate providing
adjustment for AVLT score at each trial (1-5) (F (1, 60) =8.432; p<O.O1). Using a linear
regression analysis, the given beta values for trial one (p=-0.90; t(68)=-2.595; p<0.05),
trial two (p=-0.85; t(68)=-2.217; p<0.05), trial three (p=-0.95; t(68)=-3.242; p<0.05),
trial four (P=-0.104; t(68)=-3.567; p<0.05) and trial five (P=-0.78; t(68)=-2.967;
p<0.05) differed significantly from zero. This indicated that age was associated with
score on each of the trials, such that an increase in age was associated with a decrease in
recall on each trial. IQ was not a significant covariate (F (1, 60) =2.213; p=0.142; NS).
i. Learning
A main effect of trial on the number of words acquired across the five trials failed to
reach significance (F (4, 240) = 2.004; p=0.102; NS). However, mean word recall
across the five trials increases in from trial one to trial five, which demonstrates a clear
learning curve. This is illustrated in Figure 6.12 below.
A trend for a main effect of condition was observed (F (1,60) =3.899; p=0.053). More
words were acquired on average in the no stress condition compared with the stress
condition (11.37 ± 0.27 and 10.63 ± 0.26 respectively) (Figure 6.12).
No main effect of waist-hip ratio group (F (1, 60) = 2.410; p=0.126; NS) or gender (F
(1,60) = 1.348; p=0.250; NS) was observed.
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Figure 6.12: Mean number of words recalled on Trials 1-5 of the AVLT by StressfNo Stress
condition (Means ± SEM)
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Figure 6.13: Mean number of words recalled from Trials 1-5 of the AVLT in High/Low WHR
Males/Females (Means ± SEM)
The condition*waist-hip ratio*gender interaction was non-significant (F (1, 60) =0.864;
p=0.356; NS). The condition*waist-hip ratio group interaction (F (I, 61) =0.006;
p=0.941; NS) and condition*gender interaction (F (I, 61) =0.003; p=0.959; NS) failed
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to reach significance. A trend for a waist-hip ratio group*gender interaction was
observed (F (1, 60) =2.921; p=0.093). Post hoc analysis revealed high waist-hip ratio
males significantly differed from low waist-hip ratio males in the number of words
acquired (p=0.003) (9.93 ± 0.48 and 11.81 ± 1.48 respectively). This is illustrated in
Figure 6.13. The trial *condition interaction failed to reach significance (F (4,240)
=0.760; p=0.552; NS).
No significant interactions or main effects of condition, waist-hip ratio or gender were
observed when the change from baseline data for learning across the five trials was
analysed.
ii.Total words recalled from list A (Total A)
Age was a significant covariate in the analysis of the total number of words recalled
across trials 1-5 (F (1, 60) =8.432; p<O.OI). The beta value of -0.451 for age differed
significantly from zero (t (68) =-3.445; p<0.05). This indicated that age was associated
with verbal recall on the AVLT. Interpreting the beta value indicated that an increase in
age was associated with a decrease in the total number of words recalled in the current
sample. IQ was a non- significant covariate (F (1, 60) =2.213; p=0.142; NS).
The condition*waist-hip ratio*gender interaction was non-significant (F (1, 60) =0.864;
p=0.356; NS). The condition*waist-hip ratio group interaction (F (1, 61) =0.089;
p=0.766; NS) and condition*gender interaction (F (1, 61) =0.888; p=0.350; NS) failed
to reach significance. A trend for a waist-hip ratio group*gender interaction was
observed (F (1, 60) =2.921; p=O.093). Post hoc analysis revealed that high waist-hip
ratio males differed significantly from low waist-hip ratio males in the number of words
recalled (49.64 ± 2.41 and 59.06 ± 1.80 words respectively) (p=O.003). This is
illustrated in Figure 6.14 below.
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Total Number of Words Recalled by Gender and WHR
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Figure 6.14: Total number of words recalled from List A in High/Low WHR MaleslFemales
(Means ± SEM)
A trend for a main effect of condition was observed (F (I, 60) =3.899; p=0.053).
Individuals in the stress condition recalled fewer words in total than individuals in the
no stress condition (53.14 ± 1.31 and 5.84 ± 1.33 words respectively).
iii. Recall of list B
No significant interactions or main effects of condition, waist-hip ratio group or gender
were observed in the analysis of the number of words recalled from List B (distracter
list).
iv. Proactive Inhibition
Proactive Interference is the potential for information already learned to influence the
acquisition of new material. No significant interactions or main effects of condition,
waist-hip ratio group or gender were observed in the analysis of proactive inhibition.
v. Delayed Recall of List A
The number of words recalled after a 20minute delay assessed delayed recall
performance. Age was found to be a significant covariate (F (1, 60) =12.013' p<O.OI).
Using a linear regression analysis, the beta value of -0.137 differed significantly from
zero (t (68) =-3.964; p<0.05). This indicated that delayed verbal recall was associated
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with age. Interpreting the beta value suggested that as age increases, verbal recall
decreases. IQ was not found to be a significant covariate (F (I, 60) =1.598; p=0.211).
No significant interactions between condition, waist-hip ratio and gender were
observed.
A trend for a main effect of condition was observed (F (I, 60) =2.846; p=0.097).
Individuals in the stress condition demonstrated poorer delayed recall, (recalling fewer
words) than individuals in the no stress condition (11.04 ± 0.35 and 11.90 ± 0.36 words
respectively). A minor trend for a main effect of waist-hip ratio group was observed (F
(1, 60) =2.235; p=0.140). High waist-hip ratio individuals tended to recall fewer words
than low waist-hip ratio individuals (11.08 ± 0.38 and 11.90 ± 0.34 words respectively).
(b) Delayed Matching to Sample (DMS) (CANTAB)
Performance on the delayed matching to sample task was assessed using three scores; i.
the overall percentage correct regardless of the length of delay between viewing the
pattern and making a choice from four variations of the target pattern, ii. the percentage
correct when the pattern and variant choices appear at the same time and iii. the
probability of failure following an error on a preceding trial or a correct response on a
preceding trial.
i. Percentage correct all delays
IQ was a significant covariate (F (1, 60) =4.471; p<0.05). Using a linear regression
analysis, the beta value differed significantly from zero (t (68) =2.656; p<0.05). This
indicated that IQ was associated with performance on the delayed matching to sample
task. Interpretation of the beta value suggested that an increase in IQ was associated
with better performance on the task. Age was not found to be a significant covariate (F
(1, 60) = 0.620; p=0.434; NS). No significant interactions between condition, waist-hip
ratio and gender were observed.
A trend for a main effect of gender was observed (F (1, 60) =3.353; p=O.072). Males
demonstrated better performance in terms of correct responses, compared with females
(87.32% correct ± 1.75 and 82.89% correct ± 1.55 respectively). No main effect of
waist-hip ratio (F (1, 60) =0.708; p=0.403; NS) or condition (F (1, 60) =1.624; p=0.207;
NS) were observed.
162 Chapter Six: Stress, WHR & Cognition
ii.Percentage correct Simultaneous
In the analysis of percentage correct responses when target and variant choices were
presented simultaneously, no significant interactions or main effects of condition, waist-
hip ratio group or gender were observed. Age and IQ were not found to be significant
covariates.
iii. Error probability
Error probability was a score to indicate the likelihood of making an error based on
previous responses. A significant condition*waist-hip ratio group*gender interaction
was observed (F (1, 60) =4.581; p<0.05). However, Bonferroni corrected t-tests failed to
reach significance. Based on means, high waist-hip ratio females in the no stress
condition demonstrated a greater error probability than high waist-hip ratio females in
the stress condition (0.17 ± 0.05 and 0.06 ± 0.04 respectively). In contrast, high waist-
hip ratio males in the stress condition demonstrated greater error probability than high
waist-hip ratio males in the no stress condition (0.16 ± 0.07 and 0.03 ± 0.03
respectively). This is illustrated in Figure 6.15 below.
Error Probability In the Delayed Matching to Sample Task
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Figure 6.15: DMS Error Probability in High/Low WHR Males/Females by StressINo Stress
Condition (Means ± SEM)
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Figure 6.15 suggests that low waist-hip ratio females do not change across condition but
high waist-hip ratio females do, making fewer errors under stress (lower error
probability). The opposite is true for high waist-hip ratio males, while low waist-hip
ratio males show little change.
The condition*waist-hip ratio group interaction (F (I, 60) =0.036; p=0.850; NS),
condition*gender interaction (F (I, 60) =2.091; p=0.153· NS) and waist-hip
ratio*gender interaction (F (1,60) =0.373; p=0.543; NS) failed to reach significance.
No significant main effect of condition (F (1, 60) =0.063; p=0.803; NS), gender (F (1,
60) =0.856; p=0.359; NS) or waist-hip ratio group (F (1,60) =0.117; p=0.734; NS) were
observed. Age (F (1, 60) =0.285; p=0.595; NS) and IQ (F (1,60) =0.468; p=0.497; NS)
were not found to be significant covariates.
(c) Paired Associates Learning (PAL) (CANTAB)
Performance on the paired associates learning task was determined by the total number
of correct responses (number of completed trials).
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Figure 6.16: Total number of correct trials on the paired associates learning task (PAL) in
High/Low WHR by Stress/No Stress condition (Means ± SEM)
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The condition*waist-hip ratio*gender interaction was non-significant (F (1, 60) =0.708;
p=00403;NS). A significant condition*waist-hip ratio group interaction was observed (F
(1, 60) =6.194; p<0.05). Post hoc analyses revealed that poorer performance post stress
was found in high waist-hip individuals compared with high waist-hip ratio individuals
in the no stress condition (9044 ± 1.78 and 19.27 ± 4.62 words respectively). This is
illustrated in Figure 6.16.
The condition*gender interaction (F (1, 60) =0.894; p=0.348; NS) and waist-hip
ratio*gender interaction (F (1, 60) =0.108; p=0.744; NS) failed to reach significance.
No significant main effect of condition (F (1,60) =2.159; p=0.147; NS), gender (F (1,
60) =0.264; p=0.609; NS) or waist-hip ratio group (F (I, 60) =2.018; p=0.161; NS) were
observed. Age (F (1, 60) =2.310; p=0.134; NS) and IQ (F (1, 60) =0.045; p=0.834; NS)
were not found to be significant covariates.
(d) Pattern Recognition Memory (PRM) (CANTAB)
Performance on the Pattern Recognition Memory task was determined by the
percentage of correctly recognised patterns from a previously learned list. No significant
interactions between condition, waist-hip ratio and gender were observed.
A significant main effect of gender was observed (F (1, 60) =4.605; p<0.05). Males
performed significantly better than females, irrespective of condition or waist-hip ratio,
correctly recognising more patterns from the target and variant choices (94.53% ± 1.54
and 89.96% ± 1.37 correct respectively). No main effects of waist-hip ratio (F (1, 60)
=0.803; p=0.374; NS) or condition (F (1,60) =0.143; p=0.707; NS) were observed. Age
(F (1,60) =1.183; p=0.281; NS) and IQ (F (1, 60) =0.841; p=0.363) were not found to
be significant covariates.
(e) Rapid Visual Processing (RVP) (CANTAB)
Performance on the rapid visual processing task was measured by the sensitivity to the
target exhibited by the volunteer (signal detection). No significant interactions or main
effects of condition, waist-hip ratio group or gender were observed. Age and IQ were
not found to be significant covariates.
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(t) Spatial Recognition Memory (SRM) (CANT AB)
Performance on the spatial recognition task was assessed in terms of the percentage of
correctly recognised locations across all trials.
A trend for a condition*waist-hip ratio group*gender interaction was observed CF (1,
60) =3.556; p=0.064). However, Bonferroni corrected t-tests failed to reach
significance. Based on means, high waist-hip ratio males in the stress condition
correctly recognised fewer locations (expressed as percentage correct) than low waist-
hip ratio males in the same condition who performed better under stress (82.50% ± 2.83
and 90.63% ± 1.75 respectively). The low waist-hip ratio group appeared to perform
better than other groups both under stress and under no stress. This is illustrated in
Figure 6.17 below.
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Figure 6.17: % Correct on the spatial recognition task ( RM) in High/Low WHR
Males/Females by Stress/No Stress Condition (Means ± SEM)
The condition*waist-hip ratio group interaction CF (1, 60) =0.083 p=0.774; NS),
condition*gender interaction CF (1, 60) =0.001; p=0.978; NS) and waist-hip
ratio*gender interaction (F (1, 60) =0.494; p=0.485; NS) failed to reach significance.
A main effect of gender was observed CF Cl, 60) =5.761; p<0.05). Males performed
significantly better than females, remembering a higher percentage of previously
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learned locations (85.00 ± 1.58 and 79.65 ± 1.40 respectively). A trend for a main effect
of waist-hip ratio group was observed (F (1,60) =3.376; p=0.071). Low waist-hip ratio
individuals demonstrated better performance than high waist-hip ratio individuals
(84.20 ± 1.38 and 80.34 ± 1.54 respectively). No main effect of condition was observed
(F (I, 60) =1.563; p=0.216; NS). Age (F (I, 60) =1.294; p=0.260; NS) and IQ (F (I, 60)
=2.535; p=0.117; NS) were not found to be significant covariates.
(g) Spatial Working Memory (SWM) (CANTAB)
Performance on the spatial working memory task was assessed using two measures; i.
the number of errors made across trials in selecting an incorrect target location or re-
selecting a previously used target location and ii. an estimation of the probability that
the volunteer implemented some form of strategy to aid successful location of the target
blue tokens.
i. Number of Errors
Both IQ and age were significant covariates. Using a linear regression, the beta values
for IQ and age differed significantly from zero (t (68) =-2.749; p<0.05 and t (68)
=2.519; p<0.05 respectively). This indicated that both age and IQ were associated with
performance on this aspect of the spatial working memory task. Interpretation of the
beta value indicated that as age increased the number of errors made increased in this
sample, whilst IQ increased, the number of errors decreased.
No significant interactions or main effects of condition, waist-hip ratio group or gender
were observed.
ii. Strategy
Analysis of the probability that a strategy was implemented to aid successful location of
the blue tokens revealed no significant interactions or main effects of condition, waist-
hip ratio group or gender were observed. Age and IQ were not found to be significant
covariates.
(b) Stockings of Cambridge (SOC) (CANT AB)
The Stockings of Cambridge task similar to the Tower of London task. Performance is
assessed in terms of the minimum number of moves taken to solve a problem. It was
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also of interest in this task to explore; i. the mean initial thinking time for a 5-move
problem and ii. the mean subsequent thinking time after the first move in a 5-move
problem.
i. Minimum number of moves taken to solve a problem
No significant interactions of condition, waist-hip ratio group or gender were observed.
Age and IQ were not found to be significant covariates. A significant main effect of
gender was observed (F (1, 60) =15.421; p<O.OI). Males required significantly more
moves to solve a 5-move problem than females (10.10 ± 0.33 and 8.02 ± 0.29
respectively). No main effect of waist-hip ratio (F (I, 60) =1.079; p=0.303; NS) or
condition (F (1, 60) =1.278; p=0.263; NS) were observed.
ii. Mean initial thinking time (5 moves)
No significant interactions or main effects of condition, waist-hip ratio group or gender
were observed. Age and IQ were not found to be significant covariates.
iii. Mean subsequent thinking time (following the first move in a 5-move problem)
A significant condition*waist-hip ratio group*gender interaction was observed (F (1,
60) =3.993; p<0.05). However, Bonferroni corrected t-tests failed to reach significance
Based on means, high waist-hip ratio females in the no stress condition had longer
thinking time between the first and second moves than low waist-hip ratio females in
the same condition (2025.60 ± 470.18 and 891.02 ± 202.70 respectively). This is a large
mean difference but is more variable in the high waist-hip ratio females. No other
differences in terms of condition or waist-hip ratio were noted.
6.4.2.9 Cognitive Performance in ResponderslNon-Responders
The assessment of cognitive performance according to stress/no stress condition does
not reflect cortisol activity. It cannot be assumed that each individual in the stress
condition demonstrated a cortisol response to stress and no response occurred in the no
stress condition. Frequencies of responders by waist-hip ratio and gender are shown in
Table 6.5. Hence, cognitive performance was subsequently analysed using cortisol
response group (responders versus non-responders) irrespective of stress/no stress
condition. A median split was performed on the data for percentage rise in cortisol from
baseline to the mean of cortisol at time 3 and 4, to split the sample into responders and
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non-responders. The median cortisol response was an increase in cortisol of 13%.
Therefore, any individuals exhibiting a response greater than or equal to 13% was
classed as a responder and those whose response was less than 13%, a non-responder.
Because of low cell occupancy for some waist-hip ratio - gender combinations, it was
not possible to include stress/no stress condition in the analysis of cognitive
performance in responders and non-responders.
Stress No Stress
Responder Non Responder Responder Non Responder
HWHRMales 5 0 4 2
HWHR Females 4 1 0 9
LWHRMales 7 0 0 9
LWHR Females 7 3 4 6
Table 6.5: Frequency Table of Cortisol Responders & Non-Responders to stress induction
Table 6.5 indicates that the majority of individuals exposed to stress were cortisol
responders, further, the majority of individuals in the no stress condition did not show a
cortisol response with the exception of high waist-hip ratio males and low waist-hip
ratio females who demonstrated more of a response to the no stress condition compared
to the other subgroups.
The response to stress could also be identified by cortisol response combined with
systolic blood pressure response, rather than cortisol response alone. The same median
split procedure for cortisol was implemented, in conjunction with a median split for
systolic blood pressure. A volunteer was classed as a 'stress responder' if a greater than
median response was exhibited for both cortisol and blood pressure, (the median blood
pressure response was 7%). If both responses did not meet this criteria, then the
volunteer was classed as a non-responder. Cognitive performance was also assessed
accordingly based on this categorisation. A frequency table for responders vs. non-
responders in also shown in Table 6.6). A table for the associated F-values (for
CANTAB) for both the cortisol response and combined cortisol and blood pressure
response groups is shown in Appendix 21.
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Stress No Stress
Responder Non Responder Responder Non Responder
HWHRMales 5 0 0 6
HWHR Females 4 I 0 9
LWHRMales 6 I 0 9
LWHR Females 7 .. 1 9.)
Table 6.6: Frequency Table of Stress Responders (Cortisol & Blood Pressure) & Non-
Responders to stress induction
Table 6.6, as in Table 6.5, indicates that the majority of individuals exposed to stress
were cortisol responders, further, the majority of individuals in the no stress condition
did not show a cortisol response. However, the lack of response in the no stress
condition was more consistent than when cortisol responses were considered with a
high frequency of non-responders as would be expected. Due to missing data, 61 out of
70 observations were included in the analyses.
(a) AVLT
i. Learning
-Cortisol Response Group
There were no significant interactions for cortisol response group*waist-hip ratio
group*gender (F (1, 51) =0.294; p=0.590; NS), cortisol response group *gender (F (l,
51) =0.245; p=0.623; NS) and cortisol response group*waist-hip ratio (F (1, 51) =0.284;
p=0.596; NS).
A trend for a main effect of cortisol response group was observed (F (1, 51) =3.482;
p=0.068). Individuals who exhibited a cortisol response to the stress/no stress task
showed poorer verbal recall than individuals who did not show a cortisol response over
the five trials (10.66 ± 0.32 and 11.06 ± 0.38 respectively).
-Stress Response Group (Cortisol and BP)
There were no significant interactions for stress response group*waist-hip ratio
group*gender (F (1, 51) =0.147; p=0.703; NS), cortisol response group *gender (F (l,
51) =0.580; p=0.450; NS) and cortisol response group*waist-hip ratio (F (l, 51) =0.857;
p=0.359; NS).
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A trend for a main effect of stress response group was observed (F (1, 51) =3.322;
p=0.074). As in cortisol responders, individuals who exhibited a stress response
demonstrated poorer verbal recall (mean number of words recalled across trials 1-5)
compared to stress non-responders (10.54 ± 0.36 and 11.37 ± 0.28 respectively).
No significant interactions or main effects of response group (stress or cortisol), waist-
hip ratio or gender were observed when analysing the data in terms of change from
baseline.
ii.Total Recall of List A
-Cortisol Response Group
The cortisol response group*waist-hip ratio group*gender three way interaction (F (1,
51) =0.294; p=0.590; NS), cortisol response group *gender interaction (F (1, 51)
=0.245; p=0.623; NS) and cortisol response group*waist-hip ratio interaction (F (1, 51)
=0.284; p=0.596; NS) failed to reach significance.
A trend for a main effect of cortisol response group was observed (F (1, 51) =3.482;
p=0.068). Those individuals who exhibited a cortisol response to the stress/no stress
task demonstrated poorer verbal recall (total number of words recalled across trials 1-5)
than individuals who did not show a cortisol response (53.32 ± 1.61 and 58.02 ± 1.91
respectively).
-Stress Response Group (Cortisol and BP)
The stress response group*waist-hip ratio group" gender three way interaction (F (1, 51)
=0.147; p=0.703; NS), cortisol response group *gender interaction (F (1, 51) =0.580;
p=0.450; NS) and cortisol response group+waist-hlp ratio interaction (F (1, 51) =0.857;
p=0.359; NS) failed to reach significance.
A trend for a main effect of stress response group was observed (F (1, 51) =3.322;
p=0.074). Individuals who exhibited a stress response to the stress/no stress task
demonstrated poorer verbal recall than individuals who did not show a cortisol response
(52.72 ± 1.78 and 56.82 ± 1.38 respectively).
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iii. Recall of List B
-Cortisol Response Group
A significant main effect of cortisol response group was observed (F (1, 51) =4.281;
p<0.05). Those individuals who exhibited a cortisol response to the stress/no stress task
demonstrated poorer verbal recall of List B than individuals who did not show a
cortisol response over the five trials (5.34 ± 0.46 and 6.85 ± 0.55 respectively).
-Stress Response Group (Cortisol and BP)
No significant interactions of stress response group, waist-hip ratio and gender were
observed. No main effect of stress response group was observed.
iv. Proactive Inhibition
No significant interactions or main effects of response group (stress or cortisol), waist-
hip ratio or gender were observed.
iii. Delayed Recall
No significant interactions or main effects of response group (stress or cortisol), waist-
hip ratio or gender were observed.
(b) Delayed Matching to Sample (DMS)
No significant interactions or main effects of response group (stress or cortisol), waist-
hip ratio or gender were observed for the percentage of correct responses for all delays
and the percentage correct when target and variant choices were presented
simultaneously.
- Cortisol Response Group
A trend for a response group*waist-hip ratio group*gender interaction was observed (F
(I, 51) =3.098; p=0.084) for error probability. Post hoc analysis revealed a significant
difference between high waist-hip ratio female cortisol responders and non-responders
(p=0.008). High waist-hip ratio female responders demonstrated a greater probability of
making an error on the task than high waist-hip ratio female non-responders (0.15 ±
0.14 and 0.00 ± 0.00 respectively). The opposite was true for high waist-hip ratio males,
(0.12 ± 0.06 and 0.00 ± 0.00 respectively) however this failed to reach significance
(p=0.437). This is illustrated in Figure 6.18 below.
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Probability of Error (OMS) By Cortisol Response GrouP. WHR and Gender
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Figure 6.18: DMS Error Probability in High/Low WHR Males/Females Cortisol responders
(Means ± SEM)
The cortisol response group *gender interaction (F (1, 51) =2.343; p=0.132; NS) and
cortisol response group*waist-hip ratio interaction (F (1, 51) =0.004; p=0.948; NS)
failed to reach significance. No main effect of cortisol response group was observed (F
(1, 51) =0.279; p=0.600).
- Stress Response Group (Cortisol and BP)
A significant stress response group*waist-hip ratio group* gender interaction was
observed for the error probability (F (1, 51) =4.870; p<0.05). However, Bonferroni
corrected t-tests failed to reach significance. Based on the means, high waist-hip ratio
female stress responders demonstrated lower probability of error than high waist-hip
ratio female non-responders (0.00 ± 0.00 and 0.15 ± 0.04 respectively). Further high
waist-hip ratio female stress responders demonstrated a lower probability of error than
low waist-hip ratio female responders (0.00 ± 0.00 and 0.10 ± 0.05 respectively). Again,
the opposite was true for high waist-hip ratio males, (0.11 ± 0.07 and 0.06 ± 0.06
respectively) however this failed to reach significance (p=0.680).This is illustrated in
Figure 6.18 below.
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Figure 6.19: DMS Error Probability in High/Low WHR Males/Females Stress responders
(combined cortisol & BP) (Means ± SEM)
Further, a trend for a stress response group* gender interaction was observed (F (1, 51)
=2.987; p=0.090), Post hoc analyses revealed a trend for female non-responders to
demonstrate a greater probabi Iity of error than male non-responders (p=0,091) (0.13 ±
0.03 and 0.05 ± 0.03 respectively), However, it is evident from Figure 6,19 that this is
driven by the greater error probability in female high waist-hip ratio non-responders and
in male high waist-hip ratio responders. The stress response group*waist-hip ratio
interaction (F (1, 51) =0.002; p=0.963; NS) failed to reach significance. No main effect
of stress response group was observed (F (1, 51) =0.063; p=0.803).
(c) Paired Associates Learning (PAL)
- Cortisol Response Group
No significant interactions of cortisol response group, waist-hip ratio and gender were
observed. No main effect of cortisol response group was observed.
- Stress Response Group (Cortisol and BP)
The stress response group*waist-hip ratio group interaction was almost significant (F
(1, 51) =3.970; p=0.052). Post hoc analyses revealed that high waist-hip ratio stress
responders demonstrated significantly poorer performance than high waist-hip ratio
non-responders (7.33 ± 1.65 and 18,31 ± 4.43 words respectively) (p=0.036) but there
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was no difference in performance in the low waist-hip ratio group. This is illustrated in
Figure 6.20 below.
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Figure 6.20: Total number of correct trials on the paired associates learning task (PAL) in
High/Low WHR Males/Females Stress responders (combined cortisol & BP) (Means ± EM)
The stress response group *gender interaction*waist-hip ratio group interaction (F (1,
51) =0.510; p=0.479; NS) and stress response group *gender interaction (F (1, 51)
=0.053; p=0.819; NS) failed to reach significance.
A trend for a main effect of stress response group was observed (F (1 51) =3.243;
p=O.078). Stress responders demonstrated poorer performance (fewer correct trials) on
the PAL task compared with non-responders (8.35 ± 2.52 and 14.09 ± 1.96 words
respectively).
(d) Pattern Recognition Memory (PRM)
No significant interactions or main effects of response group (stress or cortisol), waist-
hip ratio or gender were observed.
(e) Rapid Visual Processing (RVP)
No significant interactions or main effects of response group (stress or cortisol), waist-
hip ratio or gender were observed.
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(f) Spatial Recognition Memory (SRM)
- Cortisol Response Group
A significant cortisol response group*waist-hip ratio group*gender interaction was
observed (F (1, 51) =6.403; p<0.05). Post hoc analyses revealed that male low waist-hip
ratio responders recognised significantly more spatial locations than male high waist-
hip ratio responders (p=0.003) (91.43% ± 1.80 and 81.11 % ± 2.17 respectively). Male
low waist-hip ratio responders also performed significantly better than female low
waist-hip ratio responders in the same task (91.43% ± 1.80 and 80% ± 2.78
respectively) (p=0.008). This is illustrated in Figure 6.21 below.
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Figure 6.21: %Correct on the spatial recognition task (SRM) in High/Low WHR
Males/Females cortisol responders (Means ± SEM)
The cortisol response group *gender interaction (F (1, 51) =0.294; p=0.590; NS) and
cortisol response group*waist-hip ratio interaction (F (1, 51) =0.179' p=0.674; NS)
failed to reach significance. No main effect of cortisol response group was observed (F
(1,51) =0.012; p=0.913).
- Stress Response Group (Cortisol and BP)
A significant combined cortisol and BP response group*waist-hip ratio group*gender
interaction was observed (F (1, 51) =4.841; p<0.05). However, Bonferroni corrected t-
tests failed to reach significance. Based on means low waist-hip ratio male stress
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responders recognised significantly more locations than high waist-hip ratio male stress
responders (90.83 ± 2.00 and 80 ± 3.87 respectively) (p=0.028). Further, high waist-hip
ratio female non-responders demonstrated poorer performance (recognising fewer
locations) than low waist-hip female non-responders (74.50 ± 2.63 and 82.08 ± 2.17
respectively) (p=0.036). This is illustrated in Figure 6.21 below.
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Figure 6.22: %Correct on the spatial recognition task (SRM) in High/Low WHR
Males/Females stress responders (combined cortisol & BP) (Mean ± EM)
(g) Spatial Working Memory (SWM)
i.Number of Errors
- Cortisol Response Group
A trend for a cortisol response group*gender interaction was observed (F (1, 51)
=3.055; p=0.087). Post hoc analyses revealed a significant difference between male and
female cortisol non-responders for the number of errors made across trials. Female
cortisol non-responders made significantly more errors compared with males of the
same group (26.84 ± 3.89 and 9.00 ± 3.40 respectively) (p=0.004).
The cortisol response group *gender interaction*waist-hip ratio group interaction (F (1
51) =0.098; p=0.756; NS) and cortisol response group *waist-hip ratio interaction (F (1
51) =0.321; p=0.573; NS) failed to reach significance. No main effect of cortisol
response group was observed (F (1, 51) =1.108; p=0.298; N ).
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-Stress Response Group
No significant interactions of stress response group, wai t-hip ratio and gender were
observed. No main effect of stress response group was observed.
ii. Strategy
No significant interactions or main effects of response group (stress or cortisol), waist-
hip ratio or gender were observed.
(b) Stockings of Cambridge (SOC)
i. Minimum number of moves taken to solve a problem
No significant interactions or main effects of response group (stress or cortisol), waist-
hip ratio or gender were observed.
ii. Mean initial thinking time (5 moves)
-Cortisol Response Group
No significant interactions of cortisol response group, waist-hip ratio and gender were
observed. No main effect of cortisol response group was observed.
-Stress Response Group
The stress response group*waist-hip ratio group*gender interaction just failed to reach
significance (F (1, 51) =3.929; p=0.053). However, post hoc analysis using Bonferroni
corrected t-tests did not reach significance. Based on means high waist-hip ratio
female non-responders had longer initial thinking time for a five-move problem than
low waist-hip ratio female non-responders (11316 ± 1196 and 8285 ± 1056
respectively). While the opposite pattern occurred in male non-responders. Low waist-
hip ratio male non-responders took longer than other non-responders and than low
waist-hip ratio male responders. Low waist-hip ratio female non-responders were faster
than male low waist-hip ratio non-responders and female low waist-hip ratio
responders. Further, high waist-hip ratio female non-responders took a longer initial
thinking time for a five-move problem than high waist-hip ratio female responders
(11316 ± 1196 and 7475 ± 1411 respectively). This is illustrated in Figure 6.23 below.
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Mean Initial Thinking Time (SOC) By Stres. Respons. Group, WHR .nd Gender
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Figure 6.23: Mean Initial Thinking time on the Stockings of Cambridge Task (SOC) in
High/Low WHR Males/Females stress responders (combined cortisol & BP) (Means ± SEM)
The stress response group "waist-hip ratio interaction (F (1, 51) =0,021; p=0.886; NS)
and the stress response group *gender interaction (F (1,51) =0,176; p=0.677; NS) failed
to reach significance. No main effect of cortisol response group was observed (F (1, 51)
=0.069; p=0.793 NS).
iii. Mean subsequent thinking time (following the first move in a 5-move problem)
No significant interactions or main effects of response group (stress or cortisol), waist-
hip ratio or gender were observed.
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6.4.3 Associated Psychological & Biological Parameters
6.4.3.1 Subjective Evaluation in High/Low WHR MaleslFemales by StresslNo
Stress Condition
Subjective evaluations of three aspects of the study were assessed. These were; i. Ease
and effectiveness of task preparation ii. Ease of cognitive testing and iii. How stressful
the stress/no stress task were perceived to be. Mean scores for preparation and
performance by condition, gender and waist-hip ratio are shown graphically in Figure
6.24. All 70 observations were included in the analysis.
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Figure 6.24: Subjective Task Evaluation of the stress & cognitive tasks in High/Low WHR
Males/Females by StressfNo Stress Condition (Means ± SEM).
i.Evaluation of Preparation
- Effectiveness of Preparation
No significant interactions of condition, waist-hip ratio group or gender were observed.
The main effect of condition on subjective perception of how well prepared the
individual was significant (F (1,61) =12.294; p<O.OI). Preparation was evaluated as
being poorer in the stress condition than in the no stress condition (55.16 ± 3.81 and
36.13 ± 3.86 respectively). No main effect of waist-hip ratio (F (1, 61) = 0.067·
p=O.796; NS) or gender (F (1, 61) = 0.799; p=O.37S; NS) was ob erved.
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- Ease of Preparation
No significant interactions or main effect of condition, waist-hip ratio or gender were
observed. The same pattern as for preparedness is evident in Figure 6.24.
- Stressfulness of Preparation
No significant interaction of condition, waist-hip ratio group or gender were observed.
A significant main effect of condition was observed for reported perceived stressfulness
of the preparation period (F (1, 61) =4.670; p<0.05). Preparation was evaluated as being
significantly more stressful in the stress condition compared with the no stress condition
(51.81 ± 4.74 and 66.43 ± 4.81 respectively). No main effect of waist-hip ratio (F (1,
61) = 1.174; p=0.283; NS) or gender (F (1, 61) = 2.613; p=0.ll1; NS) was observed.
ii. Evaluation of the Perceived Stressful ness of Stress/No Stre s Tasks
No significant condition, waist-hip ratio group or gender interactions were observed. A
significant main effect of condition was observed (F (1,61) =59.663; p<O.OI). As
expected, individuals exposed to the stress condition perceived it to be ignificantly
more stressful than those who experienced the no stress condition (23.02 ± 3.94 and
66.38 ± 4.00 respectively). This is illustrated in Figure 6.25 below.
Task Evaluation By Condition - Perceived Stress
10000
9000
8000
7000
j 6000
" 5000">:
:l 4000
3000
2000
1000
000
QUOltion
.NO STRESS .STRESS
Figure 6.25: Subjective Task Evaluation of the StresslNo tress & Cognitive tasks (Perceived
Stress) Females by StresslNo Stress Condition (Means ± EM)
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No main effect of waist-hip ratio (F (1,61) = 0.045; p=0.832; NS) or gender (F (I, 61) =
2.181; p=0.145; NS) was observed.
iii.Evaluation of Cognitive Testing and Perceived Performance
- Ease of Cognitive Tests
A significant condition*waist-hip ratio group also was observed (F (1, 61) = 8.335;
p<O.OI). Post hoc analyses revealed that high waist-hip ratio individuals in the stress
condition perceived the cognitive tests to be significantly easier than low waist-hip ratio
individuals in the same condition (p=0.009) (26.94 ± 5.09 and 47.26 ± 5.21
respectively). The condition*gender*waist-hip ratio group interaction (F (1,61) =0.733;
p=0.395; NS) and condition*gender interaction (F (1,61) =1.019; p=0.317; NS) failed
to reach significance.
A main effect of waist-hip ratio was observed (F (I, 61) = 3.811; p<0.05). High waist-
hip ratio individuals reported greater subjective ease in completing the cognitive tests
than low waist-hip ratio individuals (33.82 ± 3.75 and 43.72 ± 3.34 respectively). No
main effect of condition (F (1, 61) = 0.661; p=0.419; NS) or gender (F (l, 61) = 0.071;
p=0.790; NS) was observed.
- Perceived Performance on the Cognitive Tests
A significant waist-hip ratio group*condition interaction was observed for subjective
performance on the cognitive tests (F (1, 61) = 5.783; p<0.05). Post hoc analyses
revealed a significant difference between high waist-hip ratio individuals in the stress
group and high waist-hip ratio individuals in the no stress condition (p=O.O18).
Performance was perceived to be better in the stress condition than in the no stress
condition (35.78 ± 3.04 and 43.71 ± 3.08 respectively) than in the no stress condition.
This is illustrated in Figure 6.26 below.
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Figure 6.26: Subjective Task Evaluation of the StressINo Stress & Cognitive tasks
(Performance) in High/Low WHR (Means ± SEM)
The condition*gender*waist-hip ratio group interaction (F (1 61) =0.891; p=0.349 NS)
and condition*gender interaction (F Cl, 61) =0.108; p=0.744; N ) failed to reach
significance.
A trend for a main effect of condition on perceived performance on the cognitive tasks
was observed (p=O.072).lndividuals in the stress condition perceived their p rformance
on the cognitive tests to be better than those in the no stress condition (35.78 ± 3.04 and
43.71 ± 3.08 respectively). This effect is possibly due to the waist-hip ratio*condition
interaction described earlier. No main effect of waist-hip ratio (F (1 61) = 1.424;
p=0.237; NS) or gender (F (I, 61) = 2.373; p=0.129; NS) was observed.
- Perceived Stressfulness of the Cognitive Testing
No significant interactions of condition, waist-hip ratio group or gender were observed.
A significant main effect of condition was found (F (I, 61) =13.274; p<O.OI).
Individuals completing the cognitive test battery following exposure to the Trier Social
Stress Test (stress condition), perceived the tests to be significantly less tressful than
those in the no stress condition (75.56 ± 3.53 and 57.22 ± 3.58 respectively). No main
effect of waist-hip ratio CF (1, 61) = 1.492; p=0.227; NS) or gender (F (1,61) = 0.012;
p=0.915; NS) was observed.
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6.4.3.2 Basal Cortisol in High/Low WHR Males/Females
(a) Basal Cortisol (Monitoring Day One) in High/Low WHR MalesIFemales
Basal cortisol was analysed using a 2x2x8 ANOV A with waist-hip ratio and gender as
between subjects factors and time as a within subjects factor. Age was included as a
covariate. Due to missing data, 66 observations were included in the analysis. In
addition, the calculated indices of cortisol activity were used to explore differences in
the shape of the profile according to waist-hip ratio group and gender.
The waist-hip ratio group*gender interaction was not significant (F (I, 61) =0.003;
p=0.958; NS). The main effect of waist-hip ratio group on mean diurnal cortisol was
almost significant (F (1, 61) =3.888; p=0.053). Low waist-hip ratio individuals
demonstrated greater cortisol levels over the whole session (mean cortisol) than high
waist-hip ratio individuals (1.144 ± 0.02 and 1.090 ± 0.02 LOGnM/L respectively). This
is illustrated in Figure 6.27 below.
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Figure 6.27 Basal Diurnal Cortisol Profiles in High/Low WHR (Means ± EM)
A significant main effect of time on cortisol concentration was observed (F (1 427)
=4.873; p<O.Ol). Pairwise comparisons revealed that the cortisol sample obtained
immediately upon waking (time = 0) significantly differed in concentration to all other
samples obtained during that monitoring day. Samples at time points 2, 3 and 4 (15min,
30min and 45minutes) differed significantly from all other sample points but not from
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each other. Samples 5-8 (3-12 hours at 3h intervals) differed significantly from all
remaining samples and from each other (smallest p=0.047). As is evident from Figure
6.27. The profile for the high and low waist-hip ratio groups was similar.
No main effect of gender was observed (F (I, 61) =2.289; p=0.135; NS). Age was not
found to be a significant covariate (F (I, 61) =0.437; p=0.55I ; NS).
(b) Analysis of the Diurnal Profile using Calculated Indices of Activity
Each index was analysed using a 2x2 ANOVA with waist-hip ratio group and gender as
between subjects' factors. Age was included as a covariate.
For the following indices; i. Area under the curve (AVC), ii. Area under the curve with
reference to the first sample (AURC), iii. Mean Increase (MI), iv. Change 0-30, v. Day
Mean, vi. Diurnal Mean, vii. Day Difference 3-12, no significant interactions or main
effects of waist-hip ratio or gender were observed.
i. Day Difference 0-12
A trend for a waist-hip ratio group*gender interaction was observed (F (I, 61) =3.282;
p=0.075) for the change in cortisol concentration from waking to the final sample
obtained at 12 hours post waking. However, Bonferroni corrected post hoc t-tests failed
to reach significance. Based on means, high waist-hip ratio males demonstrated a
greater change in cortisol activity from waking to 12-hours post waking compared to
low waist-hip ratio males (0.60 ± 0.09 and 0.39 ± 0.08 LOGnMIL respectively). No
main effects of waist-hip ratio (F (1,61) =1.302; p=O.258) or gender (F (1,61) =0.421;
p=0.519) were observed. Age was not found to be a significant covariate (F (1, 61)
=1.384; p=0.244; NS).
ii. Final Sample
Analysis of the final sample in the profile (12 hours post waking) revealed a trend for a
main effect of waist-hip ratio group (F (l, 61) =3.017; p=0.087). Low waist-hip ratio
individuals tended to exhibit a greater mean cortisol at 12 hours post waking than high
waist-hip ratio individuals (0.786 ± 0.05 and 0.656 ± 0.06 LOGnMIL respectively). No
main effect of gender was observed (F (1, 61) =0.692; p=0.409; NS). Age was not found
to be a significant covariate (F (1, 61) =1.099; p=0.299; NS).
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6.4.3.3 Classic & Non-Classic Diurnal Cortisol Profiles
(a) Forming the profiles
Following classification by three independent observers as described in Chapter Five,
the composite classic and non-classic cortisol diurnal profiles were constructed and are
displayed in Figure 6.28 below.
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Figure 6.28: Basal Diurnal Cortisol Profiles in the Classic/Non-Classic Profile Groups (Means
±SEM)
As in Chapter Five, the differences between the profile group were confirmed
statistically by assessment of the cortisol indices. A ignificantly greater mean increase
(p=O.021), area under the curve with reference to zero (AVC) (p=O.OOl), area under the
curve with reference to the first sample (AVRC) (p=O.O16) and change in corti 01 from
waking to 30minutes post waking (Change 0-30) (p=O.Ol 0) were observed in the classic
profile compared with the non-classic profile. No differences in the mean level of
cortisol were observed.
A summary of the characteristics explored to compare the 'classic' and 'non-classic'
diurnal cortisol profiles is shown in Table 6.7.
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CLASSIC NON-CLASSIC
Variable N=37 N =28
Waist-Hip Ratio 0.84 ± 0.01 0.87 ± 0.02
Age 47.32 ± 1.21 44.29 ± 1.29
BMI 26.37 ± 0.74 29.78 ± 1.49
Perceived Stress 15.51 ± 1.11 19.18± 1.42
Plasma Glucose (mMIL) 4.70 ± 0.06 5.02 ± 0.09
Plasma insulin (mUlL) 5.18 ± 0.47 7.33 ± 0.65
Total Cholesterol (mMIL) 4.72±0.14 4.81 ± 0.19
HDL(mMIL) 1.46 ± 0.04 1.35 ± 0.06
LDL(mMIL) 3.19 ± 0.13 3.32 ± 0.16
Triglycerides (mMIL) 1.06 ± 0.08 1.26 ± 0.18
IL-6 (pg/ml) 1.43 ± 0.13 2.21 ± 0.26
CRP(mglL) 1.08 ± 0.31 2.67 ± 0.80
Adiponectin (ng/ml) 237 ± 20.09 187 ± 20.04
Insulin Resistance (HOMA) 1.09 ± 0.11 1.66 ± 0.15
Table 6.7: Summary of the Biological and Psychological Characteristics ofa Classic & a Non-
Classic Diurnal Profile
No significant differences were noted for age or waist-hip ratio. However, BMI was
significantly higher in the non-classic profile group than the classic (t (63) =-2.047;
p=0.05). Further, there was a significantly greater reporting of perceived stress in the
non-classic group (t (63) =-2.064; p<0.05).
In a repeat of the analysis conducted in Chapter Five, the associated metabolic
syndrome and obesity related biomarkers are discussed in the following section.
(b) Analysis of relevant Biomarkers in Metabolic Syndrome Symptomology
Each of the biomarkers; i. insulin, ii. glucose, iii. cholesterol, iv. triglycerides, v. HDL,
vi. LDL, vii. IL-6, viii. CRP, ix. adiponectin was analysed individually using a 2x2x2
ANOYA with waist-hip ratio, gender and profile group as between subjects factors.
Mean values for each biomarker by WHR and gender are shown in Table 6.8 below.
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Biomarker Total LWHR HWHR LWHR HWHR
Male Male Female Female
Insulin (mmoIlL) 6.46±4.2l 4.42±2.7l 9.83±6.66 4.76±1.8l 8.01±2.71
Glucose (mmoI/L) 4.83±O.46 4.80±O.41 4.98±O.30 4.56±O.31 5.12±O.59
Cholesterol (mmoIlL) 4.76±O.92 4.24±O.89 4.86±O.92 4.99±O.79 4.90±I.OO
HDL (mmol/L) 1.41±O.O4 1.31±O.20 1.28±O.26 I.S8±O.26 1.40±O.35
LDL (mmoIlL) 3.2S±O.81 2.83±O.82 3.S9±O.93 3.33±O.66 3.26±O.79
Triglycerides (mmoIlL) 1.14±O.70 O.91±O.SI I. I 8±O.39 O.90±O.33 1.68±1. I0
CRP (mg/L) 1.78±3.14 O.42±O.S7 2.S 1±3.2S O.72±O.73 4.06±4.95
IL-6 (pg/ml) l.80±1.53 O.9S±O.45 2.48±2.IS 1.3S±O.60 2.74±1.84
Adiponectin (ng/ml) 220±119 l81±21 IS5±84 298±147 2l4±77
Insulin Resistance 1.34±O.77 O.99±O.69 1.84±O.98 O.94±O.38 1.82±O.61
Table 6.8: Summary of Blood Biomarkers In High/Low WHR MaleslFemales (Means ± SD)
i. Insulin
A significant waist-hip ratio group*profile group interaction was observed (F (I, 56)
=6.849; p<O.05). This is illustrated in Figure 6.29.
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Figure 6.29: Fasting Plasma Insulin in High/Low WHR males/females& by Classic/Non-
Classic Profile Group (Means ± SEM)
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Post hoc analyses revealed that high waist-hip ratio individuals who displayed a non-
classic diurnal profile exhibited higher fasting plasma insulin than high waist-hip ratio
individuals with a classic diurnal profile (p=0.008) and than low waist-hip ratio
individuals with a non-classic diurnal profile (p=O.OOI).
The profile group*waist-hip ratio*gender interaction (F (I, 56) = 1.721; p=0.195; NS),
profile group*gender interaction (F (I, 56) =0.582; p=0.499; NS) and waist-hip
ratio*gender interaction (F (1, 56) =0.895; p=0.348) failed to reach significance.
A main effect of profile group was observed (F (1, 56) =5.919; p<O.OI). Higher
measured fasting plasma insulin was observed in individuals who exhibited a non-
classic diurnal cortisol profile than in those who did not (7.25 ± 0.53 and 5.51 ±
0.46mUIL respectively). Further, a main effect of waist-hip ratio group on insulin was
observed (F (1, 59) = 23.357; p<O.Ol). High waist-hip ratio individuals demonstrated
higher insulin compared with low waist-hip ratio individuals. No main effect of gender
was observed (F (1, 56) =0.192; p=0.663; NS).
ii. Glucose
A significant waist-hip ratio group*profile group interaction was observed (F (1, 56)
=4.848; p<0.05). Post hoc analysis revealed that high waist-hip ratio individuals who
displayed a non-classic diurnal profile exhibited higher fasting glucose than high waist-
hip ratio individuals with classic diurnal profiles (p=0.002) and low waist-hip ratio
individuals with non-classic diurnal profiles (p=O.OOI).This is illustrated in Figure 6.30
below.
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Figure 6.30: Fasting Glucose in High/Low WHR males/females & by Classic on-Classic
Profile Group (Means ± SEM)
The profile group*waist-hip ratio*gender interaction (F (I, 56) =0.081; p=0.777; NS),
profile group*gender interaction (F (I, 56) =0.727; p=0.398; NS) and wai t-hip
ratio*gender interaction (F (1, 56) =2.360; p=0.130) failed to reach significance.
A main effect of waist-hip ratio group on fasting gluco e wa ob erved (F (1, 59) =
13.268; p<O.OI). High waist-hip ratio individuals demonstrated higher observed level of
fasted glucose compared with low waist-hip ratio individuals (5.02 ± 0.08 and 4.71 ±
0.07mM/L respectively). Further, a significant main effect of profile group was
observed (F (1, 56) =7.434; p<O.Ol). Higher fasted glucose was evident in individuals
who exhibited a non-classic diurnal cortisol profile than in those with classic profiles
(5.01 ± 0.08 and 4.72 ± 0.07 mM/L respectively). No main effect of gender was
observed (F (1, 56) = 1.508; p=0.225; NS).
iii. Calculated Insulin Resistance
A significant waist-hip ratio group*profile group interaction was ob erved (F (I, 56)
=8.581; p<0.05). Post hoc analyses revealed that high waist-hip ratio individuals with
non-classic diurnal profiles exhibited greater insulin resi tance than high waist-hip ratio
individuals who displayed classic diurnal profiles (p=O.OOl) and low waist-hip ratio
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individuals who displayed non-clas ic diurnal profiles (p=O.OOI). This is illustrated in
Figure 6.31 below.
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Figure 6.31: Insulin Resistance in High/Low WHR males/females & by Cia le/Non-Classic
Profile Group (Means ± SEM)
The profile group*waist-hip ratio*gender interaction (F (1,56) =1.572; p=0.215; N ),
profile group*gender interaction (F (I, 56) =0.446; p=0.507; N ) and waist-hip
ratio* gender interaction (F (I, 56) =0.528; p=O.471) fai led to reach significance.
A significant main effect of waist-hip ratio was ob erved (F (I, 58) = 24.687; p<O.OI).
Individuals with a high waist-hip ratio demonstrated greater in ulin re i tance compared
to Iow waist-hip ratio individuals (1.85 ± 0.12 and 0.95 ± 0.11 re pectively). Further, a
main effect of profile group was observed (F (1,56) =7.434; p<O.Ol). Insulin re istance
was greater in individuals who exhibited non-cia ic diurnal corti 01 profile than in
individuals who exhibited classic diurnal profile (1.64 ± 0.12 and 1.17 ± 0.10
respectively). No main effect of gender was observed (F (1, 56) =0.431; p=0.514· N ).
iv. Cholesterol
No significant interactions or main effect of waist-hip ratio group, profile group or
gender were observed.
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v. Triglycerides
No significant interactions for waist-hip ratio group, profile group or gender were
observed. A main effect of waist-hip ratio was observed (F (1, 59) = 9.816; p<O.OI).
Individuals who exhibited a high waist-hip ratio also showed higher levels of
triglycerides compared with low waist-hip ratio individuals (1.42 ± 0.13 and 0.88 ± 0.12
mMlL respectively). No main effect of profile group (F (1, 56) =0.023; p=0.881; NS) or
gender was observed (F (1, 56) =1.223; p=0.272; NS).
vi. HDL
No significant interactions for waist-hip ratio group, profile group or gender were
observed. A main effect of gender for level of high-density lipoproteins was observed
(F (1,56) = 6.853; p<0.05). Females exhibited higher levels ofHDL than males (1.28 ±
0.05 and 1.49 ± 0.05 mM/L respectively). There was also a trend for a main effect of
waist-hip ratio group (F (1, 56) =3.058; p=0.086). High waist-hip ratio individuals
demonstrated lower levels of high-density lipoprotein than low waist-hip ratio
individuals (1.32 ± 0.05 and 1.45 ± 0.05 mMIL respectively). No main effect of profile
group was observed (F (1,56) =2.633; p=2.633; p=0.110; NS).
vii. LDL
No significant interactions or main effects of waist-hip ratio group, profile group or
gender were observed.
viii.IL-6
A significant waist-hip ratio group*profile group interaction was observed (F (1, 56)
=4.753; p<0.05). Post hoc analysis revealed that high waist-hip ratio individuals who
displayed non-classic diurnal profiles exhibited significantly higher IL-6 than low
waist-hip ratio individuals who displayed non-classic diurnal profiles (p=0.004). The
profile group*waist-hip ratio*gender interaction (F (1, 56) =1.207; p=0.277; NS),
profile group*gender interaction (F (1, 56) =0.790 p=0.378; NS) and waist-hip
ratio*gender interaction (F (1, 56) =0.124; p=0.726) failed to reach significance.
A significant main effect of waist-hip ratio group was observed (F (1, 59) = 16.011;
p<O.OI). Individuals who exhibited a high waist-hip ratio demonstrated higher levels of
interleukin-6 than low waist-hip ratio individuals (2.54 ± 0.25 and 1.13 ± 0.23pglml
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respectively). Further, a trend for a main effect of profile group was observed
(p=0.086). Higher IL-6 was observed in individuals who exhibited non-classic diurnal
cortisol profiles compared to those who did not (2.13 ± 0.25 and 1.54 ± 0.22pg/ml
respectively). No main effect of gender was observed (F (1, 56) =1.298; p=0.260; NS).
ix. CRP
No significant interactions for waist-hip ratio group, profile group or gender were
observed. A main effect of waist-hip ratio was observed (F (1, 59) = 13.048; p<O.OI).
Individuals with a high waist-hip ratio demonstrated higher levels of CRP than low
waist-hip ratio individuals (3.24 ± 0.57 and 0.50 ± 0.52 mg/ml respectively).
x. Adiponectin
No significant interactions for waist-hip ratio group, profile group or gender were
observed. A main effect of waist-hip ratio group for level of adiponectin was observed
(F (1, 59) =6.297; p<0.05). High waist-hip ratio individuals exhibited lower levels of
adiponectin than low waist-hip ratio individuals (172 ± 20.48 and 227 ± 18.63 ng/ml
respectively). A main effect of gender was also observed (F (1, 59) =11.967; p<0.05).
Males exhibited significantly lower levels of adiponectin compared with females (150 ±
20.69 and 249 ± 17.75 ng/ml respectively).
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6.4.4 Summary of Results
• Stress Responsivity in HighlLow Waist-Hip Ratio Males and Females
High waist-hip ratio males secreted most cortisol in response to the stressor task and
exhibited greater cortisol at baseline. When considering change from baseline
response to the stressor, low waist-hip ratio males demonstrated the greatest cortisol
response (evidenced by a greater percentage rise). Less recovery was observed in
the high waist-hip ratio males than in low waist-hip ratio males who demonstrated
good HPA regulation (evidenced by cortisol changes post task). High waist-hip ratio
females demonstrated the smallest change in cortisol in response to the stressor task.
Changes in systolic and diastolic blood pressure generally mirrored changes in
cortisol in response to the stress/ no stress interventions. Mean blood pressure
responses were highest in high waist-hip ratio males and lowest in low waist-hip
ratio females.
• Cognitive Performance by Stress/No Stress Condition and Stress Responses
Exposure to the TSST and stress responses (cortisol and blood pressure) impaired
performance on the AVLT compared with no stress exposure. Performance on the
paired associates learning task was impaired in high waist-hip ratio males who
demonstrated a cortisol and/or cortisol and BP response to the stressor/no stressor
task. Performance on the spatial recognition memory task was impaired in high
waist-hip ratio individuals generally. Further, impairment was evident in high waist-
hip ratio males who demonstrated a cortisol and/or cortisol and BP response to the
stressor task.
• Basal Cortisol Profiles in High/Low Waist-Hip Ratio Males and Females
Basal cortisol differed in terms of the overall mean cortisol secreted across the
diurnal profile according to waist-hip ratio group. High waist-hip ratio individuals
secreted less cortisol. No changes in the shape of the profile between high and low
waist-hip ratio groups were evident. Further, significantly higher insulin, glucose
and insulin resistance were associated with a non-classic diurnal profile. A trend for
a higher concentration of IL-6 in non-classic profiles was observed.
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6.5 Discussion
6.5.1 General Aims
This study was based on previous research findings, which proposed that cortisol
responses in high waist-hip ratio individuals are elevated compared to low waist-hip
ratio individuals. Further, the study explored the possibility of enhanced vulnerability to
display cognitive impairment on hippocampal related tasks in those with central obesity.
It has already been established that those with central obesity can show cognitive
impairment due to metabolic factors such as hypertension, insulin resistance and risk of
diabetes (Bent et al., 2000; Elias et al., 2005; Hiltunen et al., 2001). However, this study
specifically explored cognitive impairment related to stress exposure, which produced
an elevation in salivary cortisol.
6.5.2 Stress Responsivity in HighlLow WHR MalesIFemales
6.5.2.1 Physiological & Psychological Responses to Stress
Analysis of cortisol responses to the stress condition suggested that high waist-hip ratio
males secreted the most cortisol in response to the stressor. However, high waist-hip
ratio males exhibited greater cortisol at baseline prior to stress exposure although this
was not significant. Therefore, when the change in cortisol from baseline was
considered, high waist-hip ratio males did not demonstrate the greatest response. The
change from baseline analysis indicated that low waist-hip ratio males exhibited the
largest cortisol response to the stressor. Further, blood pressure responses were more
elevated in males and tended to be higher in individuals with a high waist-hip ratio.
Subjective anxiety as measured by the State Trait Anxiety Inventory was elevated by
the stress condition compared with the no stress condition. Self-esteem also reduced
because of stress exposure although this did not reach significance. Females, in general
and high waist-hip ratio females in particular reported greater anxiety compared to
males.
The literature reviewed in Chapter One largely suggested that individuals with central
obesity should exhibit a more pronounced cortisol response to a psychosocial stressor.
The current findings generally support this. However, the study found heightened stress
responsivity occurred in males, whereas previous studies have demonstrated elevated
stress responses only in high waist-hip ratio females often only considering females and
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not males (Epel et al., 2000; Marin et al., 1992; Moyer et al., 1994). Research exploring
stress responsivity in high waist-hip ratio males is sparse and so it cannot be ascertained
if the current findings are consistent with previous research. Further, whether high
waist-hip ratio males are most responsive to stress must be viewed tentatively due to the
observation that these high waist-hip ratio males also demonstrated greater cortisol at
baseline and the sample size of this subgroup was low. Mean cortisol over the test
session was elevated in high waist-hip ratio males, while low waist-hip ratio males
demonstrated a larger response. However, it is important to note that the greater
observed concentration of cortisol at baseline conflicts with previous findings in
Chapter Five of this thesis, which suggested that basal cortisol, is reduced in high waist-
hip ratio individuals. With this in mind, a separate analysis of the cortisol response to
the stressor was conducted as a change from a comparable sample time point on
Monitoring Day One prior to the test session. This supported the suggestion that the
high waist-hip ratio males were indeed the most responsive in the sample. A graphical
representation of this can be found in the appendix (Appendix 22).
The observation that males are more responsive to a stressor than females is consistent
with previous research (Kirschbaum et al., 1995; Wolf et al., 2001). Perhaps the most
feasible explanation for this finding is that the observed effect is a gender difference.
not related to waist-hip ratio group (or only minimally associated with waist-hip ratio).
This could explain the consistency of findings that suggest that males particularly those
with high waist-hip ratios are more responsive. It also would account for the apparent
elevated response of the low waist-hip ratio males.
Wolf et al. (2001) reported more pronounced stress responses in males than in females
when exploring the effect of stress induced glucocorticoids on cognitive function. No
heightened responsivity was observed in females, which is consistent with the current
study. To explain the lack of responsivity in females, Wolf et al. (2001) proposed that
females are in someway protected from over-responding and hence. males appear more
responsive. It has been suggested that oestrogen is protective against the negative
effects of stress (Galea et al., 1997). Further. Kudielka et al. (1999) found that estradiol
treatment for 2 weeks resulted in a blunted response to stress. However. in animal
studies, a potential oestrogenic enhancement of the HPA axis was supported by elevated
responses to stress in oestrogen supplemented animals (Burgess and Handa, 1992; Viau
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and Meaney, 1991). In humans, the same has been observed. Kirschbaum et al. (1996)
exposed a sample of males to short-term estradiol treatment and found enhanced stress
responsivity. This contradicts the proposal that oestrogen is protective rather than
stimulatory. The idea that sex hormones could be protective against chronic stress may
explain the current findings However, since oestrogen was not assessed in females in
this sample this remains suggestive. Therefore, further research is required.
Further, in relation to the role of oestrogen, the level of corticosteroid binding globulin
(CBG) can also potentially influence stress responsivity. CBG is bound to the majority
of circulating cortisol and has been shown to be higher in pre-menopausal females than
in males of the same age (Fernandez-Real et al., 2003) and is higher during oral
contraceptive use (Fujimoto et al., 1986; Weigratz et al., 2003). Higher CBG would
signal reduced bioavailability of free cortisol and result in dampened responses.
Females currently using oral contraceptives were not excluded from participating in the
current study since research conflicts over the interaction between oral contraceptive
use and cortisol activity. For example, Kirschbaum et al. (1995) failed to find any
association between oral contraceptive use and stress responsivity. However, some
other studies have found that oral contraceptive use can attenuate the response to stress
(Kirschbaum et al., 1999). In the current study, only a small number of females reported
oral contraceptive use and none were outliers. It is therefore unlikely to have influenced
the pattern of results. It is clear that a number of additional factors, outside the scope of
this thesis, need to be assessed in order to determine the true existence of a gender
difference. Oestrogen is fat-soluble and can disrupt the feedback of the HPA axis in
obesity. Oestrogen levels may be elevated by obesity and central adiposity and hence,
could influence hormone levels. It therefore, remains to be explored what the effect of
oestrogen and central obesity has on stress responsivity.
Measurement of the response to stress was not limited to changes in cortisol activity.
Measures of blood pressure confirmed prior patterns of cortisol activity with greater
elevation of blood pressure (both systolic and diastolic) in the stress condition than in
the no stress condition. This supports the observation that the Trier Social Stress Test
was successful in inducing a stress response marked by both cortisol and blood pressure
responses consistent with previous research (Kirschbaum et al., 1993). It was also
interesting to note that age significantly co-varied with systolic (but not diastolic) blood
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pressure yet did not co-vary with cortisol measurement. It is generally assumed that
cortisol in response to challenge varies as a function of age (Otte et al., 2005). However,
this study confirms previous findings by Lupien et al. (1996) that an age related change
is not always observed. It is possible, however, that this sample of middle-aged
volunteers will not reflect age related changes, since they do not include the 'elderly'
and the age range of the sample was not wide enough to demonstrate a correlation.
In addition to physiological correlates of stress, various measures were administered to
determine perceived psychological response to stress. These largely confirmed previous
findings with respect to physiological and biological measures. This is consistent with
the observation that females subjectively experience more stress than males, reporting
more physical and psychological symptoms and reflecting a greater vulnerability
(Bebbington, 1996; Kessler et aI., 1981; Kessler and McLeod, 1984; Kroenke and
Spitzer, 1998; Miller and Kirsch, 1987; Troisi, 2001). If this observation is combined
with previous findings relating to cortisol responsivity, it could be argued that females
respond psychologically to the stressor but not physiologically. This could lend further
support to the view that females may be protected against the physiological effects of
stress (Galea et al., 1997; Wolf et al., 2001).
6.5.2.2 Efficacy of the TSST
Assessing changes in salivary cortisol concentration across the session confirmed that
greater responses occurred during the stress condition compared with the no stress
condition. Baseline cortisol did not differ between the groups indicating that cortisol
level was comparable prior to the experimental manipulation and did not differ between
conditions. The TSST was successful in eliciting a greater cortisol response post task
(evidenced by a percentage rise) with less recovery than in the no stress condition.
These findings verify the use of the TSST and its ability to successfully induce stress
and elevate salivary cortisol.
In the current study, the mean increase in cortisol was 26% in the stress condition.
Schommer et al. (2003) found the TSST capable of eliciting a 2- to 4- fold increase in
cortisol above baseline in just under 80% of subjects. Compared with Schommer, the
elevation in cortisol observed, although significant by difference between conditions,
was moderate as demonstrated in previous applications of this procedure. Kirschbaum
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et al. (1993) reported that most volunteers displayed a minimum of a 2.5mmol/l increase
as a result of exposure, which is consistent with the current study. Each volunteer
exposed to the TSST displayed an elevation in cortisol and hence demonstrated a stress
response. Concurrent with an observed physiological response, the stress condition was
perceived to be significantly more stressful compared with the no stress condition as
reported on the post session debrief questionnaire. Although no differences were
observed in the ease of preparing for the tasks, preparation in the stress condition was
perceived to be less successful than in the no stress task. Taken together, the findings
confirm that the stress induction was successful in inducing a stress response that was
both physiological and psychological prior to the cognitive testing period. This confirms
that feasible comparisons in terms of responsivity were made and an accurate
assessment of the influence of stress on cognitive performance.
6.5.3 Cognitive Performance by Condition & Stress Responses
One of the main aims of this thesis was to explore the impact of stress-induced cortisol
on cognitive performance in the centrally obese, who were hypothesised to demonstrate
a greater response to the TSST and be vulnerable to stress induced cognitive
impairment. Cortisol responses to stress were hypothesised to specifically impact on
cognitive tasks that required hippocampal processing, for example, declarative memory
tasks such as delayed recall on the Auditory Verbal Learning Task and paired associates
leaning task (PAL) in CANTAB. Of additional interest was the impact of cortisol on
spatial tasks (SRM and SWM in CANTAB), which have been linked to hippocampal
functioning. It was also of interest to explore subsequent cognitive performance in
relation to gender and the possible interaction of gender and waist-hip ratio, since these
have been shown to differ in response to stress responsivity and the cortisol profile.
i. Auditory Verbal Learning Task
Performance on the AVLT in both conditions demonstrated a similar learning curve Le.
a gradual increase in the number of words acquired from List A over trials one to five.
Fewer words were acquired at each trial following exposure to the stress task compared
with the no stress task. Similarly, the total number of words recalled (immediate verbal
recall) was also less in the stress condition compared with the no stress condition.
Finally, stress induction reduced the number of words recalled after a twenty-minute
delay post learning (delayed verbal recall). These findings are consistent with previous
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research confirming that stress induction has a detrimental effect on new learning and
recall (Lupien et al., 1997). When performance was assessed in terms of actual cortisol
and/or cortisol and blood pressure response (responders versus non-responders), stress
was observed to reduce the number of words learned across the five trials. However, the
effect of stress (cortisol and/or cortisol and blood pressure) on delayed recall was
removed. This suggests that the cortisol response was insufficient or is not directly
linked to delayed recall performance. It is possible that the acute response elicited by
the TSST was insufficient to induce impairment. Wolkowitz et al. (1990; 1993) found
that only high doses of exogenously administrated glucocorticoids were sufficient to
produce impairment, with no deficit observed at lower concentrations. Further, acute
exposure may fail to induce impairment compared with longer-term exposure, even with
lower concentrations of exogenous glucocorticoids (Newcomer et al. 1994). The
greatest impairment is observed in elderly individuals who have experienced high basal
levels of glucocorticoids over a considerable period of time, in addition, to heightened
stress responses (Lupien at al. (1994; 1995). It was hypothesised that high waist-hip
ratio individuals would exhibit altered basal cortisol (as in elderly individuals) with
heightened stress responses that impact on cognitive performance compared with low
waist-hip ratio individuals (whose cortisol profile both basally and in response to stress
should be normal). However, the findings did not conclusively fit this hypothesis. High
waist-hip ratio males in the stress condition recalled fewer words (total A) during trials
one to five. This is consistent with a potentially elevated response to the stressor task
but this response was not significantly greater than low waist-hip ratio males. It can be
tentatively suggested that basal cortisol is disrupted in high waist-hip ratio males and so
it is possible that the stress responses observed during the test session were insufficient
to produce significant impairment. Hence, any impairment observed might be more
related to disruptions in basal cortisol. This is difficult to ascertain, as this possibility
has not been explored in previous literature. Furthermore, the observation that delayed
recall was worse in high waist-hip ratio individuals irrespective of condition or cortisol
response this suggests that impairments may be due to associated metabolic factors, for
example, high blood pressure (Singh-Manoux and Marmot, 2005) and is consistent with
elevated blood pressure responses to the stressor task. Waldstein and Katzel, (2005)
specifically explored stress-induced blood pressure responses and observed diminished
performance on immediate and delayed verbal memory. Messier et al. (2003) found that
poor glucoregulation has been shown to impair performance on declarative memory
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tasks and this was more evident in high waist-hip ratio individuals in the current study.
Cortisol is also involved in the regulation of glucose, however, it is difficult to
distinguish in the current study between precipitating factors.
ii. Paired Associates Learning (PAL)
Like the AVLT, the paired associates learning task is an additional test of declarative
memory. Stress exposure appeared to reduce performance in high waist-hip ratio
individuals compared with low waist-hip ratio individuals but did not do so
significantly. This is consistent with observed performance on the AVLT. However,
unlike previous findings, performance in the no stress condition was significantly better
in the high waist-hip ratio group, compared with low waist-hip ratio individuals.
Moreover, stress appeared to improve performance in the low waist-hip ratio group.
Stress has been shown to impair performance on this type of task (Young et al., 1999)
while further facilitation of performance on various hippocampal tasks has also been
previously reported in younger adults (Domes et al., 2002). A possible explanation for
this observed difference in performance relates to the inverted 'U' hypothesis of cortisol
receptor activity (Luine et al., 1993). Low waist-hip ratio individuals exhibit a lower
mean basal cortisol secretion and minimal receptor occupancy, which neither impairs
performance nor greatly improves it. Inducing a stress response and hence, elevating
cortisol activity increases receptor occupancy to a point where performance is facilitated
and could explain why performance might be improved in the stress condition. In the
high waist-hip ratio condition, due to a potentially a higher basal cortisol activity
(observed salivary cortisol levels were lower in females indicating a higher overall
cortisol functioning) performance is already at or near optimum level. Inducing stress
effectively tips the balance and pushes toward receptor over-occupancy, which could
result in a decline in performance. However, impairment was observed in the analysis
based on combined cortisol and blood pressure response to the stressor. This means that
it is difficult to infer that performance is directly related to cortisol activity and not to
changes in blood pressure. Blood pressure has been documented in previous research as
a potential mediator of cognitive decline coinciding with central obesity (as the two co-
occur). For example, Singh-Manoux and Marmot (2005) found that cognitive
impairment was related to elevations in blood pressure in a sample of middle-aged men
and women as part of the Whitehall II study and further confirmed by findings of
Waldstein and Katzel (2005) who found diminished performance on immediate and
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delayed verbal memory in relation to stress-induced blood pressure responses. Similar
findings in older adults have also been reported by the Framingham study (e.g. Elias et
al., 1993; 1995; 1997). Other factors such as insulin resistance and the incidence of
diabetes have also been found to be inversely related to cognitive function (Convit,
2005; Elias et al., 2005; Hashizume et al., 2006). Indeed, insulin and glucose levels
were found to be higher in those exhibiting a high waist-hip ratio in the current study
and blood pressure responses mirrored the response pattern of cortisol, being
significantly different by stress/no stress condition and in those with a high waist-hip
ratio. To be able to attribute cognitive impairment in the centrally obese directly to
cortisol requires further research in a larger sample with a wider range of waist-hip
ratio.
iii. Spatial Recognition Memory
Performance on the spatial recognition task was not directly related to stress/ no stress
condition or to response group but to a combination of response group with waist-hip
ratio and gender. A strong gender difference was observed with males performing
significantly better than females on the task. In general, high waist-hip ratio males
demonstrated poorer performance than low waist-hip ratio males in the stress condition.
Impairment on this task was also evident when the combined cortisol and blood
pressure response was used to indicate stress responsivity.
These findings are consistent with previous research that supports hippocampal
involvement in visual spatial tasks (Lupien et al., 1999b; Reilly, 2000; Young et al.,
1999). Further, it has been frequently documented that males out perform females on
spatial tasks and that this is mediated by testosterone (Kimura, 2000; Voyer et al.,
1995). Females perform better on tasks of verbal memory mediated by oestrogen, which
has been demonstrated to preserve synapses (Le Blanc et al., 2001; Sherwin, 1997). In
this research, this is supported by performance on the AVLT. However, the observation
that performance in high waist-hip ratio males is poorer contradicts this idea and
suggests that stress or central obesity may have modulated the influence of testosterone.
The observation that deficits are further identified when actual cortisol responses are
considered. This contributes to a more convincing argument for the adverse effect of
stress-induced cortisol on performance for the spatial recognition task and further still in
the centrally obese. Particularly, in males who previously showed better performance.
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To conclude that the differences in performance are purely due to a gender difference
requires further assessment.
In summary, small effects of stress per se were identified on a small range of cognitive
tasks. Waist-hip ratio appeared to induce subtle alterations in performance but only on
the AVLT and spatial recognition tasks. All other tests from the CANTAB battery
failed to demonstrate any significant detriment in terms of stress, central obesity or
gender. It is clear that cortisol alone does not mediate cognitive performance in this
sample. Other metabolic factors need to be explored further in conjunction with stress
responsivity. However, these findings suggest that subtle associations may exist.
6.5.4 Basal Cortisol Profiles in HigblLow WHR MaleslFemales
6.5.4.1 Basal Cortisol
In an attempt to replicate the findings from Chapter Five, measures of salivary cortisol
were obtained over the course of one day prior to the test session.
There was an observed differentiation between cortisol concentrations at waking and
cortisol during the diurnal period. This indicated that the awakening response was
distinct from the cortisol secreted during the remainder of the profile. It has been
suggested that cortisol secreted in response to waking is under separate control to that
secreted outside of this response and does not exclusively involve action of the
hypothalamic pituitary adrenal axis (Born et al., 1999; Fehm et al., 1984; Spath-
Schwalbe et al., 1991; Thorn et al., 2004).
Mean cortisol secretion across the profile, (incorporating both the awakening response
and diurnal cortisol) was lower in the high waist-hip ratio group than the low waist-hip
ratio group. However, no differences were identified using the various cortisol indices.
The observation that cortisol secretion was reduced overall in the centrally obese is
consistent with previous research findings (Ljung et al., 1996; Marin et al., 1992; Strain
et al., 1980). Subjective perceived stress (measured prior to the study) was also
significantly greater in high waist-hip ratio females, probably reflecting an underlying
vulnerability or presence of HPA dysregulation. Mean cortisol concentrations across the
awakening response and the diurnal period should be treated with caution and may not
necessarily reflect a potential underlying difference. It is possible that the dynamic
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change in activity during the awakening response altered the mean cortisol of the
profile. Further, these observations were based on a single day of salivary cortisol
assessment and hence may not be truly representative of each individual's usual profile.
However, the differences observed in the current study replicated the findings from
Chapter Five demonstrating some consistency in the findings.
6.5.4.2 Metabolic Parameters & the Basal Diurnal Profile
In order to further assess the relationship between cortisol and the collective
symptomology of the metabolic syndrome (including central obesity) a range of blood
biomarkers were assessed. Of these markers, glucose, insulin, triglycerides, IL-6, CRP
and the degree of insulin resistance (using HOMA) were higher in those with central
obesity who also showed lower levels of HDL. This confirms previous research findings
(Bjorntorp and Rosmond, 2000; Hartz et al., 1984) and is compatible with the
suggestion that those exhibiting a high waist-hip ratio also have a higher prevalence of
diabetes and hypertension compared to those who exhibit a low waist-hip ratio.
To assess the hypothesis that cortisol is linked to the incidence of the metabolic
syndrome, the correlation of cortisol with metabolic syndrome symptomology was
explored. Basal cortisol co-varied with glucose of the biomarkers assessed. However,
cortisol regulates glucose activity as part of gluconeogenesis (Miller and Tyrell 1995)
which supports this finding but provides little support for the view of metabolic
syndrome as a neuroendocrine disorder. However, further analysis provided more
substantial support for the hypothesis that the metabolic syndrome is a neuroendocrine
disorder, characterised by an underlying HPA dysregulation with overt cortisol
disruption (Bjorntorp and Rosmond, 2000; Rosmond et al., 1998; 1999b). A greater
incidence of metabolic symptomology (namely elevated glucose, insulin, level of
insulin resistance, and the inflammatory marker IL-6) co-occurred with non-classic
diurnal cortisol profiles. A non-classic profile may signal vulnerability to HPA
dysregulation and hence 'pathological' cortisol secretion. These findings replicate those
described in Chapter Five and suggest that disrupted basal cortisol secretion may
contribute to the development of the metabolic syndrome by increasing vulnerability
(Bjorntorp and Rosmond, 2000). Replicating the findings from Chapter Five, lends
weight to this hypothesis. However, further research is necessary to fully ascertain the
role of cortisol in metabolic syndrome, since volunteers in the current study did not
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have the syndrome nor was the research design adequate to determine the likelihood
that many might develop it. As pathological cortisol secretion can occur over many
years of chronic stress exposure, it may be that the occurrence of the metabolic
syndrome is a gradual process. Therefore, assessment of cortisol activity alongside
metabolic syndrome symptomology in a longitudinal study may be more appropriate.
6.5.5 Methodological Issues & Study Limitations
There are, as with any piece of research, methodological issues and study limitations
that should be acknowledged when interpreting the research findings. These will be
discussed in the following section.
As in Chapter Five, the issue of compliance and the exclusion of individuals based on
poor profiles should be considered. The findings in the current study replicated Chapter
Five in that 'non-classic' diurnal profiles, that might otherwise have been removed from
the dataset were shown to be associated with an increased incidence of subjective stress
reporting and metabolic syndrome symptomology. The prevalence of a classic profile in
the current sample was only 53%, which is very similar to the 52% reported in Chapter
Five. This underlies the need to consider the exclusion process in studies of this nature
to prevent key populations of interest being excluded from analyses, which might have
had the effect of reducing the likelihood of finding effects.
High waist-hip ratio females were found to be the least cortisol responsive subgroup in
the study. This contradicts previous research findings, which suggest that females with
central obesity are more responsive to stress. Primarily, findings from Epel et al. (2000)
demonstrated a pronounced cortisol response to stress in high waist-hip ratio females.
This has been confirmed by previous studies (Uhart et al., 2006) and attributed to a
decrease in HPA feedback sensitivity (Born et al., 1995; Heuser et aI., 1994; Gallucci et
al., 1993). This was not observed in the current study. It is possible that the
discrepancies highlighted in terms of the lack of responsivity in females and high waist-
hip ratio females in particular may be due to methodological issues. Epel et al. (2000)
implemented a series of stressors to measure cortisol responsivity and habituation. In
the current study, a single episode of stress exposure was employed, which may have
been insufficient to induce the level of responsivity observed by Epel in high waist-hip
ratio females. Furthermore, comparisons were made amongst a small number of
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volunteers when comparing within condition, gender and waist-hip ratio groups. The
sample size in the high waist-hip ratio male group is, in particular, small in comparison
to other groups. The groups relied on volunteers and may not be truly representative. It
is also possible that this small sample size could have inflated effects or lead to a failure
to detect effects (type II error).
An important issue to consider in a study of this nature is volunteer compliance, an
issue that is often reported in this type of research (Kudielka et aI., 2003) as previously
discussed. This relates specifically to saliva collections for cortisol assessment. The
majority of the samples for basal cortisol assessment are collected by volunteers at
home or at work away from the research unit. This issue is identical to that encountered
in Chapter 5 (See Section 5.5.4) and concerns the accuracy of the timing of each sample
and the volume of saliva obtained. The issue of compliance was in part removed during
the experimental session, as the researcher was present to prompt each sample and to try
to ensure adequate volumes. During a procedure such as the Trier Social Stress Test this
is particularly difficult as inducing a stress response by public speaking frequently
induces a dry mouth, which makes saliva collection difficult. This is a consequence of
the stress induction procedure that is ultimately unavoidable. If individuals are
responsive to the procedure, they are more likely to experience a dry mouth. This could
mean that those individuals who show the greatest responsivity might be those who are
most likely to be excluded for failing to provide a saliva sample of adequate volume.
Hence, this is something that must be taken into consideration when designing studies
of this nature. It is of paramount importance that the TSST is conducted in a
professional manner in order for it to have the most impact. Greater adherence to the
protocol results in a greater stress response. It is commonly observed that responses are
not as elevated as in a truly stressful situation due to the essentially unrealistic nature of
the procedure. As with all experimental procedures, care must be taken when
generalising the findings. It is also of interest to consider the range of volunteers within
the sample, with consideration for each individual's background. For example, those in
the profession where public speaking is a regular task may respond differently to the
TSST than those who rarely if ever undertake such a task, Le. prior experience of the
various aspects of the task may lead some individuals to develop 'immunity' to it.
In the current study, it would have perhaps been more efficacious to employ a repeated
measure design in order to assess individual performance on the tasks under both
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condition of stress and condition of no stress and to reduce between group variation.
However, the nature of the TSST, this means that there is a great potential effect or
interference of anticipation on subsequent exposure to the task. The lack of baseline
cognitive data is a major weakness in the current study and limits the reliability of the
findings. An alternative approach, would have included assessment of cognitive
performance prior to the onset of the stress/no stress tasks. However, there are three
issues with this approach. The first concerns the length of the experimental session. In
the current study, the session duration lasted two hours with approximately one hour of
cognitive testing. Any increase on this is certain to induce fatigue effects and would
reduce the accuracy of the results and add to volunteer discomfort. Second, pre and post
cognitive testing would increase the likelihood of practice effects on the cognitive
testing even if counterbalancing of the tasks was employed. Finally, the stressfulness of
the cognitive battery itself must be ascertained, as there is the potential for the cognitive
testing to induce a stress response. Bohnen et al. (1990) specifically employed a
cognitive test battery as an effective stress induction tool; similarly, Lupien et al. (1997)
found a crossover of response when basal measures of cognitive performance were
obtained prior to the stress induction demonstrated by an early cortisol response that
could have been attributed to the test battery. This demonstrates the potential for the
procedure to create substantial noise in the data. To try to address the lack of baseline
cognitive performance data in the current study, IQ was estimated from the National
Adult Reading Test and used as a covariate to provide adjustment for IQ if necessary.
Further, due to the characteristics of the sample assessed (waist-hip ratio, gender,
condition etc) only a small number of volunteers were included per cell in some of the
analyses with a consequent reduction in the power to detect effects. Therefore, any
generalisations from the current data set must be treated with caution. It is of necessity
that these findings are to be replicated in a much larger sample to increase the reliability
of the findings. When these issues are considered, there is scope for improvement in the
reliability and validity of the findings obtained.
6.6 Conclusions
The main findings of this study suggest that males are more responsive to stress than
females, and specifically high waist-hip ratio males may secrete more cortisol during
stress exposure. Performance in high waist-hip ratio males was poorer on some tasks of
declarative memory indicating that the hypothesis for increased vulnerability to
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impairment in this subgroup may be supported. However, impairments on some tasks
were only maintained when blood pressure responses were considered indicating that
other physiological and metabolic parameters should be considered in this relationship.
In a replication of findings in Chapter Five, classic and non-classic diurnal profiles
differed in relation to the expression of metabolic syndrome symptomology and
psychological characteristics such as perceived stress. This provides further support for
the role of altered cortisol secretion in the development of metabolic syndrome. The
study also raised important issues relating to data screening and exclusion procedures.
In conclusion, the findings of the study presented in this chapter suggest that a subtle
association between cortisol and central obesity may exist. Other metabolic factors are
involved in the determination of stress responsivity and in the manipulation of cognitive
performance. Exploring the direct influence of central obesity through action of cortisol
is novel and these findings are encouraging for future research to further explore the
mechanisms involved.
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CHAPTER SEVEN
General Discussion
This final chapter is a general discussion of the main research findings of this thesis in
relation to the original aims discussed in Chapter Two. The chapter will explore the
implications of these findings for current research and what future research is suggested
as a result of this thesis. The methodological limitations of the thesis will be discussed.
7.1 General Aims
This thesis represents a detailed exploration of stress responsivity in individuals with
central obesity marked by the activity of the glucocorticoid, cortisol. Salivary cortisol
activity, both basal and stimulated in response to stress was explored in those who
exhibit central obesity (high waist-hip ratio) and those who do not (low waist-hip ratio).
Further, the potential for altered cortisol response to stress to influence cognitive
performance was assessed.
7.2 Basal Cortisol in High and Low Waist-Hip Ratio Individuals
7.2.1 Reproducibility and Consistency of the Cortisol Diurnal Profile
A pilot study of the use of saliva samples for basal salivary cortisol measurement in a
sample of older adults formed the first study in this thesis. This was conducted to
explore the natural circadian activity of cortisol in the form of a diurnal profile. As the
literature review in Chapter One suggested, the diurnal profile of cortisol is a plot of
basal salivary cortisol concentration against time post waking and incorporates the
cortisol awakening response, a dramatic change in cortisol activity during the first 30-
45minutes post waking (PrUssner et al., 1997). The profiles, once constructed, were
compared using a number of cortisol indices (Edwards et al., 2001; WUst et al., 2000a;
Schmidt-Reinwald et al., 1999) described in Chapter Three (Section 3.3.3). These are
computational calculations based on the shape of the cortisol profile obtained and the
mean level of cortisol activity during a sampled day. The practicalities and
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methodological issues of assessing cortisol in this way were explored by this pilot
study.
The findings suggested that a substantial degree of inter-and intra-subject variability
exists in the basal cortisol diurnal profile which needs consideration when exploring an
individual's 'typical' basal cortisol activity. The consistency of the profile should be
determined prior to aggregation to preserve the accuracy of the final aggregate profile
that is analysed in relation to other outcome variables. The findings also suggested that
more than one day of sampling is necessary to accurately reflect underlying basal
activity and that sampling over 3days in the current study provided an more informative
insight into variations in basal cortisol activity. It was observed that the prevalence of a
significant cortisol awakening response and 'textbook' profile were low, even in a small
sample. It was apparent that variations were due to more than just an issue of
compliance and this was the subject of further investigation in the subsequent studies
presented in this thesis.
The observation that substantial variation in the basal profile was obtained conflicts
with previous research findings which suggested that moderate consistency is usually
observed when measuring cortisol in this way (WUst et al., 2000). However, it was
observed that, there was a tendency for some consistency in the nature of the profile.
For example, if an individual exhibited a poor profile on one of the sampling days, then
the likelihood that a poor profile would be exhibited on all three of the sample days was
high. Similarly, those exhibiting a profile with an identifiable diurnal profile shape,
tended to exhibit a similar profile across the three days with some variation within that
profile.
Above all, this study was important in exploring some of the methods used in basal
saliva cortisol measurement that were to be used in the subsequent studies of this thesis.
In terms of the data obtained, it was of great importance is to realise that only tentative
claims can be made from a small sample size and that the points raised required further
assessment. This was explored in more detail in Chapter Five.
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7.2.2 Patterns of Basal Diurnal Cortisol in High and Low Waist-Hip Ratio
Individuals in Relation to Psychological and Metabolic Parameters.
After exploring the feasibility and practicality of the use of saliva samples for cortisol
measurement, the basal activity of cortisol in the centrally obese was examined.
Previous research suggests that cortisol production in the centrally obese is elevated,
however, this elevation is not readily detectable in the basal circadian profile. This is
due to an enhanced cortisol clearance rate (Ljung et al., 1996; Marin et al., 1992; Strain
et al., 1980). Salivary cortisol measurements taken over the diurnal period in centrally
obese individuals are suggested to be lower in concentration than in non-centrally obese
volunteers (Duclos et al., 1999). As a result of cortisol hypersecretion, diurnal profiles
have demonstrated a blunted cortisol awakening response with comparable diurnal
cortisol concentrations (Akana, et al., 1992; Dallman et al., 1993).
The prevalence of a classic diurnal profile within the sample, examined in Chapter Five,
was assessed, with a view to identifying non-classic diurnal profiles in those with
central obesity. This was based on the observation that the diurnal profile of cortisol
differs with the incidence of central obesity (Andrew et al., 1998; Ljung et al., 2000;
Phillips et al., 1998; Phillips et al., 2000; Rask et al., 2002; Van Cauter et al., 1996;
Wallerius et al., 2004; Ward et al., 2003). However, the accuracy and reliability of the
profiles obtained is often confounded by the issue of volunteer compliance (Kudielka et
al., 2003). Deviations from a textbook or 'classic' profile are presumed to be due to
non-compliance but may be more related to actual metabolic and psychological
variables of interest (Rivera and Svec, 1989). The psychological and biological
characteristics of 'non-classic' profiles were assessed to explore what factors were
associated with 'non-classic' profile expression. Furthermore, the observation that
central obesity and cortisol dysregulation co-occur, for example in patients with
Cushing's syndrome (Starkman et al., 1999; 2003), suggested that cortisol is implicated
in the expression of the metabolic syndrome. Rosmond et al. (1998; 1999b) assessed
salivary cortisol in relation to central obesity and demonstrated pathological cortisol
secretion in males with metabolic syndrome symptoms. The metabolic syndrome has
been labelled a neuroendocrine disorder of cortisol dysregulation (Bjorntorp and
Rosmond 1999; 2000; 2001). Therefore the relationship between cortisol activity and
metabolic symptoms was assessed. Further, the incidence of metabolic symptomology
in those who exhibit a non-classic profile was explored.
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The findings suggested that profiles in high waist-hip ratio individuals were almost
identical to those exhibited by low waist-hip ratio individuals with no difference in
shape. However, the mean level of cortisol secreted across the diurnal profile did differ
between high and low waist-hip ratio individuals. High waist-hip ratio individuals
exhibited significantly lower cortisol across the diurnal profile compared with low
waist-hip ratio individuals. No differences in the cortisol awakening response were
observed with exception that high waist-hip ratio individuals secreted less mean cortisol
in response to waking than low waist-hip ratio individuals. Further, high waist-hip ratio
females exhibited the smallest cortisol awakening response out of the four groups.
These findings were replicated in Chapter Six. A high prevalence of non-classic profiles
was observed in the current study relative to the classic 'textbook' profiles. Profiles that
deviated from a 'classic' profile ('non-classic') were associated with a significantly
greater vulnerability to insulin resistance, higher levels of triglycerides and a
significantly greater concentration of inflammatory markers, specifically c-reactive
protein. Although not significant, non-classic profiles were associated with higher
cholesterol, IL-6, LDL and lower HDL levels. Non-classic diurnal profiles were also
associated with an increased incidence of subjective reporting of the intensity of daily
hassles and poorer subjective sleep quality.
(i) The Basal Cortisol Profile and Central Obesity
The observed difference in the mean level of cortisol between high and low waist-hip
ratio individuals is consistent with previous research findings. Individuals with central
obesity exhibit elevated cortisol levels in a state reminiscent of Cushing's disease
(Bjorntorp and Rosmond, 2000). However, measured basal cortisol concentrations in
saliva are observed as being lower in the centrally obese than in lean or peripherally
obese individuals as demonstrated in the current findings. This has been observed in
both morning salivary cortisol (Ljung et al., 1996; Marin et al., 1992) and diurnal
cortisol concentrations (Duclos et al., 1999). It has been proposed that individuals with
central obesity are capable of enhanced breakdown of excess cortisol evidenced by an
increased urinary output of cortisol metabolites (Lottenberg et al., 1998). In light of this
observation. the current findings offer only partial support for altered cortisol secretion
in the centrally obese. As no measure of urinary output was made. it cannot be clearly
determined whether cortisol hypersecretion is occurring as the current study provides no
evidence of an enhanced clearance capability since urinary metabolites were not
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measured. Despite the consistency of the current findings with previous research,
further research is required to explore the possibility that HPA dysregulation underlies
potential cortisol hypersecretion in those with central obesity.
(ii) The Basal Cortisol Profile and Sleep Quality
The observation that non-classic profiles were associated with significantly greater
reporting of daily hassles (intensity of) and poorer sleep quality is also consistent with
previous findings (Ockenfels, 1995; Stone et al., 2001; Backhaus et al., 2004). More
specifically, the relationship between sleep quality and cortisol secreted during the
cortisol awakening response may offer support to the role of the HPA axis in the control
of the cortisol awakening response, or at the very least, suggests that the HPA axis is
capable of substantial influence. The debate as to whether the cortisol awakening
response is under the control of the HPA axis or the Suprachiasmatic nucleus (SCN) in
the hypothalamus (Chapter One, section 1.3.2, part ii) is longstanding. The cortisol
awakening response is affected by changes in sleep patterns that collectively produce
spontaneous waking (Born et al., 1999; Spath-Schwalbe et al., 1992). The findings of
the current study suggest that it cannot solely be the SCN which is in control of the
cortisol awakening response. The finding that altered cortisol profiles (non-classic) are
associated with poorer sleep quality and a greater intensity of daily hassles suggests that
stress (and the HPA axis) is still very much in control. To full determine the weighting
of this influence requires further research.
(iii) The Basal Cortisol Profile and Metabolic Syndrome
The collective increase in metabolic symptomology in those who exhibited a 'non-
classic' diurnal profile observed in this study provides some evidence that cortisol may
be linked in some way to the metabolic syndrome and is consistent with previous
research. The proposed relationship between cortisol and the metabolic syndrome was
initially based on the observation that insulin resistance, the main symptom of the
metabolic syndrome, is linked to cortisol activity. Cortisol has a primary role in the
process of gluconeogenesis (Miller and Tyrell 1995) and therefore may contribute to the
expression of impaired glucose tolerance and insulin resistance, particularly in the
centrally obese. This linkage led to the suggestion that cortisol could directly underlie
the expression of the syndrome and the proposal that metabolic syndrome is, in essence,
a neuroendocrine disorder (Bjorntorp and Rosmond, 2000). Bjorntorp and Rosmond,
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(2000) suggested that flattened profiles with lower morning cortisol or 'pathological'
cortisol secretion were associated with metabolic symptomology, endocrine
abnormalities and central obesity. Further, Rosmond et al. (1998; I999b) observed
pathological basal cortisol secretion in males who exhibited symptoms of the metabolic
syndrome, from assessment of basal cortisol profiles. The findings of this thesis provide
some support for the proposed relationship between cortisol and each individual
biomarker of the metabolic syndrome. The findings of Rosmond et al. (1998; 1999b)
were based on a statistical weighting procedure applied to cortisol data within the basal
profile of which was not applied to the current data set. Consequently, using this
statistical approach may provide further support for the role of cortisol in the metabolic
syndrome. To fully examine this relationship may be beyond the scope of this thesis and
not possible with the modest sample in each study. However, in light of the observation
that cortisol dysregulation should precede the metabolic syndrome, the finding do
suggest a relationship. Further, research to explore this in more detail is essential.
(iv) Cortisol, Central Obesity and Inflammation
An alternative hypothesis for the relationship between cortisol activity and central
obesity is based on the observation that chronic stress exposure produces a state of
chronic inflammation, which is associated with central obesity and metabolic syndrome
symptomology (Black, 2006). This process is more mediated by the stress hormones
epinephrine, norepinephrine and cortisol, which collectively promote fat accumulation
and promote an inflammatory state marked in the visceral tissue of central obesity. This
contributes to the development of insulin resistance and the metabolic syndrome and
presents as a risk for cardiovascular disease and type II diabetes. Black (2006) argues
that the linkage of fat accumulation and an inflammatory state is further supported by
the observation that weight loss reduces the concentration of inflammatory markers
present. Further, the neural pathways linking the brain to fat deposition are the same as
those mediating stress responses. The hypothesis that central obesity and associated
metabolic syndrome symptomology are an inflammatory response resulting from
chromic stress exposure is supported by the current findings since the inflammatory
markers IL-6 and CRP were elevated in those with central obesity. CRP also
demonstrated significant covariance with mean measures of cortisol sampled during the
same period. To ascertain fully, the feasibility of this theory, further research is required
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including assessment of a much wider range of inflammatory markers and change in
these in relation to weight loss.
Building on the idea that the relationship between stress and obesity is mediated through
inflammation, the relationship between stress and immune status must be considered.
Psychological stress is known to affect immune status leading to a vulnerability to
infectious disease (Herbert and Cohen, 1993). As discussed in Chapter One (section
1.3.2, part iii), elevations in cortisol from chronic stress could mediate the change of
night time Type 1 activity to daytime Type 2 activity (Edwards et al., 2003; Petrovsky
and Harrison, 1995; 1997). Previous research has observed that abnormal cortisol
profiles have been associated with certain pathologies including cancer and AIDS
(Sapse, 1997). Further, flattened profiles have been found to be predictive of earlier
mortality particularly in breast cancer patients (Sephton et al., 2000). There is some
evidence to suggest that stress reactivity is associated with a suppression of the immune
system (Marsland et al., 1995). It is possible that difference in endocrine and
cardiovascular activity (reactivity) may regulate immune responses, increasing
vulnerability to infection and disease, and that this might be greater in those exhibiting
central obesity. Indeed, advanced disease states such as Type II diabetes have been
suggested to be an immune system disorder (Pickup and Crook (1998). This is because
in type II diabetes, there is a cytokine associated acute phase response, consistent with
the observation that stress can induce an acute phase response and which is associated
with the onset of metabolic diseases (Black, 2003). This suggests that collectively
chronic stress (in the form of elevated cortisol) via interactions with metabolic factors
and the immune system promotes a vulnerability to a poorer prognosis for health.
7.3 Cortisol Responses to Stress in High and Low Waist-Hip Ratio Individuals
Once basal cortisol activity in those with central obesity had been established, an
assessment of stress responsivity was made. Despite the absence of pathological basal
salivary cortisol secretion in those with central obesity, it was postulated that further
evidence for a dysregulated HPA axis would manifest in the form of an exaggerated
response to stress. Cortisol responses to a psychological stressor are elevated in the
centrally obese (Epel et al., 2000; Marin et al., 1992; Moyer et al., 1994) compared with
lean (Moyer et al., 1994; Marin et al., 1992), peripherally obese and non-obese
individuals (Epel et al., 2000).
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Analysis of the cortisol response to the stressor suggested that high waist-hip ratio
males secreted the largest cortisol response to the stressor. However, because high
waist-hip ratio males exhibited greater cortisol at baseline, prior to stress exposure, high
waist-hip ratio males did not demonstrated a greater response. As a result, low waist-hip
ratio males appeared to exhibit the largest response. The observed elevation in cortisol
at baseline conflicted with previous findings, which suggested that basal cortisol is
reduced in those with central obesity. This led to the possibility that high waist-hip ratio
males were demonstrating an anticipatory response. In a separate analysis using a
comparable sample time point from the prior Monitoring Day One as an alternative
baseline in the response calculation, high waist-hip ratio males were found to be the
most responsive in comparison to the remaining members of the sample (Appendix 22).
Blood pressure response to stress was greater in males and further in high waist-hip
ratio males compared with low waist-hip ratio males. Less recovery was observed in the
high waist-hip ratio males compared with low waist-hip ratio males who demonstrated
good HPA regulation (evidenced by cortisol changes post task). High waist-hip ratio
females demonstrated the smallest change in cortisol in response to the stressor task.
The observation that those with central obesity secrete more in response to a stressor
than lean or peripherally obese individuals is consistent with previous research (Epel et
al., 2000; Marin et al., 1992; Moyer et al., 1994). However, such studies reported that
increased stress responsivity was apparent in females with central obesity but not males.
The literature examining increased responsivity in centrally obese males is sparse.
Further, the observation that in the current thesis, females were least responsive
contradicts previous findings. Epel et al. (2000) observed that greater cortisol responses
to a stressor were evident in females with central obesity compared with lean and
peripherally obese females. It has been suggested that hyper-responsivity occurs as a
consequence of impaired HPA regulation (Born et al., 1995; Heuser et al., 1994;
Gallucci et aI., 1993). The lack of stress responsiveness in females may be linked to sex
hormones and their protective influence. Wolf et al. (2001) proposed that females are
protected from over-responding to stress by the specific action of oestrogen (Galea et
al., 1997). Previous studies have demonstrated a blunted response to stress after a period
of oestrogen supplementation (Kudielka et aI., 1999). This lack of response in females
may concurrently cause males to appear more responsive when faced with a stressor
(Wolf et al., 2002). In addition to the influence of oestrogen, oral contraceptive use can
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influence stress responsivity. Kirschbaum et al. (1999) observed that salivary cortisol
responses to the TSST were significantly lower in females taking oral contraceptives
which contributed to an observed gender difference in the salivary cortisol response to
stress. However, no differences were observed for total plasma cortisol or ACTH
responses. Although, females currently using oral contraceptives were not excluded
from participating in the research contained in this thesis, only 3 of 70 were taking oral
contraceptives. This is unlikely to account for the lack of stress response in females.
Previous studies have demonstrated increased stress responsivity in males (Kirschbaum
et al., 1995; Wolf et al., 2001) in both younger (Kirschbaum et al., 1992; 1995a, b) and
older adults (Kudielka et al., 1998). The possibility that centrally obese males could
demonstrate an enhanced response to stress due to sex hormones is IittIe researched.
Centrally obese males often show lower levels of testosterone (Derby et al., 2006).
Further, testosterone has been shown to inhibit HPA activity, particularly the in release
of ACTH (reviewed by Williamson et al., 2005). Lower levels of testosterone in
centrally obese males could signal increased responsiveness to stress, which would
concur with the current findings. This postulation however, has not been assessed and
so requires further research in studies which measure circulating (unbound)
testosterone.
In summary, a gender difference in the response to stress between males and females
was observed. The likelihood that this difference was due to central obesity is small and
is more likely due to the influence of sex hormones in a gender mediated response. Sex
hormones should measured in a study of this nature, to fully ascertain this hypothesis.
7.4 The Effect of Psychological Stress on Cognitive Performance in High and Low
Waist-Hip Ratio Individuals
It has been established previously that stress induced elevations in cortisol result in
cognitive impairment on hippocampal tasks, particularly declarative memory (Lupien et
al., 2005). Cognitive decrements have been observed in the centrally obese who also
show insulin resistance, high blood pressure and other features of the metabolic
syndrome (Convit, 2005; Elias et al., 2005; Hashizume et al., 2006). However, little
research has specifically explored the impact of stress induced cortisol in the centrally
obese on cognitive performance. Heightened stress responses in the centrally obese
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imply greater cortisol and hence a greater vulnerability to cognitive impairment. This
thesis is novel in the examination of this hypothesis.
The potential for stress induced cortisol to impair subsequent cognitive performance
was explored. It was of particular interest to assess cognitive performance in those with
central obesity who, it has been argued, may be more vulnerable to cognitive
impairment. The results demonstrated significant impairment on tasks that are most
clearly associated with hippocampal processing. Specifically, stress induction (TSST)
impaired performance on the immediate verbal recall component (total number of words
recalled) of the auditory verbal learning task (AVLT). Delayed recall was also reduced
in those in the stress condition. The total number of words recalled across the initial five
trials was lower in high waist-hip ratio males. This impairment was maintained when
actual cortisol responses and combined cortisol and BP responses were considered.
However, performance on the delayed recall component of the AVLT when cortisol and
blood pressure responses were considered was not impaired. Performance on the paired
associates learning task was also poorer in the stress condition; further so in high waist-
hip ratio males within the stress condition. However, in the no stress condition, high
waist-hip ratio males performed better than low waist-hip ratio males. Further, poorer
performance was observed in high waist-hip ratio individuals who demonstrated both a
cortisol and blood pressure response to the stressor task. Performance on the spatial
recognition task was poorer in high waist-hip ratio individuals, in addition to an overall
gender difference with males performing better than females. When actual cortisol
responses were considered, high waist-hip ratio responders showed poorer performance.
Further, when combined cortisol and blood pressure responses were considered,
performance was again poorer in high waist-hip ratio male responders. High waist-hip
ratio female responders also demonstrated poor performance. Unfortunately due to cell
frequencies it was not possible to include condition and response in the same analysis.
The study therefore requires replication with a large sample size across all cells.
The finding that performance was poorer for tasks that involved hippocampal
processing after stress exposure is consistent with previous research findings (De Kloet
et al., 1998; McEwen et al., 1995; 1997). This was true for comparisons between the
stress and no stress conditions and further, in terms of actual cortisol responses
(responders versus non-responders). It was also observed that high waist-hip ratio
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individuals demonstrated poorer performance on certain tasks (AVLT, PAL, and SRM)
as hypothesised. This provided some support for the idea that chronically elevated
cortisol levels in those with central obesity may present a vulnerability to cognitive
impairment after stress exposure. These findings however are not conclusive and require
further investigation. At the time of writing, no previous assessment of cortisol induced
cognitive impairment in those with central obesity has been made in the literature, hence
there is no comparative research. Previous studies exploring cognitive deficits in those
with central obesity have identified impairments in tasks of declarative memory as a
result of poor glucoregulation (Messier et aI., 2003). Other studies have identified
impairment related to the incidence of impaired glucose tolerance (for a review, see
Messier et al., 2005) and type II diabetes (Bent et al., 2000; Goldstein et al., 200 I;
Strachan et al., 1997). The absence of impairment on the delayed recall task when only
cortisol responses are considered, suggests that it cannot be cortisol alone which is
mediating the effect. This is further confirmed since the impairment is evident when a
combined cortisol and blood pressure response is included as a between subjects factor.
Previous research has demonstrated that high blood pressure and hypertension can cause
impairment on certain cognitive tasks (Singh-Manoux and Marmot, 2005). It may be
that additional metabolic factors are collectively involved in mediating impairment.
Performance on the paired associates learning task was also poorer in response to the
stressor, which is again, consistent with previous research (Young et al., 1999). This
was maintained when actual cortisol responses to the stressor were considered. Poorer
performance was observed in high waist-hip ratio individuals in the stress condition as
hypothesised and consistent with findings on the AVLT. However, interestingly in the
no stress condition, performance was better in high waist-hip ratio individuals than in
low waist-hip ratio individuals whose performance was worse. It is hypothesised that
this pattern of impairment can be linked to the inverted 'U' hypothesis of glucocorticoid
and mineralcorticoid receptor activation. In high waist-hip ratio individuals, basal levels
of cortisol are postulated to be high and so receptor occupancy is at an optimal rate.
Therefore under conditions of no stress performance is good. Elevating cortisol further
via stress exposure pushes receptor occupancy to the limit and impairment occurs. At
the other end of the scale, in low waist-hip ratio individuals, receptor occupancy is low
due to low/normal basal cortisol and so performance is below optimal. In conditions of
stress, receptor occupancy increases toward optimal levels and so performance
219 Chapter Seven: General Discussion
improves. That is not to say that everyday cognition is poor in low waist-hip ratio
individuals, it would simply appear poorer in comparison to better performance in high
waist-hip ratio individuals. At this stage, it is impossible to ascertain if this theory is
feasible due to the lack of comparable research in this area. Yet it does coincide with the
observation that hippocampal volumes in those with central obesity are often reduced
(Jagust et aI., 2006). This would be an anticipated consequence of chronic
glucocorticoid exposure (Sapolsky et al., 1986).
Consistent with the AVLT and paired associates learning task, performance on the
spatial recognition task was poorer as a result of stress exposure. Spatial memory is also
mediated by the hippocampus and so these findings are consistent with previous
research (Lupien et al., 1999b; Reilly, 2000; Young et al., 1999). The observation that
high waist-hip ratio individuals demonstrate poorer performance is perhaps the most
convincing evidence for the influence of cortisol on cognition in the centrally obese. It
has been frequently documented that males perform better on tasks of spatial memory
than females (Kimura, 2000; Voyer et al., 1995) and this was reflected in the findings.
Yet high waist-hip ratio males demonstrated poor performance on this task. This
suggests the possibility of a strong combined influence of cortisol and central obesity on
cognition, especially as this impairment was maintained when actual cortisol responses
were considered. As previously discussed, it has been observed that those with central
obesity exhibit lower testosterone (Derby et al., 2006). Lower testosterone has been
associated with poorer memory performance (Barrett-Connor et al., 1999; Moffat et al.,
2002). Testosterone is also linked to HPA activity (Williamson et al., 2005). It may be
that these factors collectively mediate subsequent impairment. Teasing out the relative
contribution of these predictors of impairment requires further research, which is
beyond the scope of this thesis.
In summary, the current findings offer some clear insight into the potential for
psychological and metabolic factors to collectively mediate cognitive performance. The
evidence for cortisol as a key factor is promising.
220 Chapter Seven: General Discussion
7.5 Methodological Issues and Limitations
The studies contained in this thesis possess certain methodological weaknesses that
limit the conclusions of which can be drawn from the research. These will be discussed
in the following sub-sections.
7.5.1 The Assessment of Basal Cortisol in the Centrally Obese
An assessment of basal cortisol in those with central obesity suggested that basal
cortisol differs between high and low waist-hip ratio individuals. The findings
demonstrated that basal salivary cortisol was lower in high waist-hip ratio individuals.
This was consistent with the hypothesis that centrally obese individuals suffer elevated
basal cortisol but demonstrate normal or less than normal concentrations in saliva due to
an enhanced clearance capability. However, despite the consistency in findings, it
cannot be fully ascertained using the current data set that an enhanced clearance
capability exists. To explore fully this hypothesis, would require an assessment of
urinary metabolites. An elevation in excreted cortisol metabolites in those with central
obesity would offer support for an excess cortisol breakdown (Lottenberg et al., 1998)
and would provide evidence for cortisol hypersecretion in those with central obesity.
Further, an assessment of nocturnal cortisol responses to waking should be made.
Previous research suggests that cortisol responses to nocturnal waking would result in a
compensatory lowering of peak morning cortisol levels (Akana et al., 1992) so that the
net mean cortisol during the 24-hour circadian rhythm does not change. This would
further assess the ability of the HPA axis to regulate itself and would be a more
comprehensive assessment of cortisol activity in those with central obesity.
7.5.2 Efficacy of the TSST
Observed cortisol responses to the Trier Social Stress Test (TSST) suggested that the
procedure was efficacious in stimulating a HPA response. Previous research has shown
the found the TSST capable of eliciting a 2- to 4- fold increase in cortisol above
baseline in 80% of subjects (Schommer et al., 2003). Further, Kirschbaum et al. (1993)
reported that most volunteers displayed a minimum of a 2.Smmolll increase as a result
of exposure. Although each volunteer who was exposed to the stressor task
demonstrated a cortisol response, not every increase was quite so profound. There was
great variation in cortisol response, suggesting that although the TSST was essentially
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effective as a stress induction tool, it may not have reached full potential in terms of
stimulated cortisol response. The characteristics of the testing environment are
important in inducing a stress response, for example, Kuhlman and Wolf (2005)
demonstrated greater responsivity in a formal testing environment compared to a
relaxed environment and further, that this lead to greater impairment in post stress
cognitive assessment.
In terms of an observed gender difference in the response to the stressor, it may be
possible that the qualities of the stress tool induced differing responses. The TSST
comprises elements of social-evaluative threat and uncontrollability. It is possible that
these elements may be appraised differently in males than females and hence results in
differing cortisol responses manifesting as a gender difference. This may link with the
observation that greater perceived stress can produce a greater cortisol response to the
TSST (Fries et al., 2006). Should a different tool for stress induction be used, the same
responses mayor may not be observed. However, no gender differences have been
noted in terms of the efficacy of the TSST (Dickerson and Kemeny, 2004) and it has
been shown to be the most effective stress induction technique.
In the assessment of stress responsivity in those with central obesity, Epel et al. (2000)
implemented a series of stressors to measure cortisol responsivity and habituation. In
the current study, only a single episode of stress exposure was employed. This may
offer a partial explanation for the lack of stimulated cortisol response in high waist-hip
ratio females. A single exposure may have been insufficient to induce the level of
responsiveness observed previously. However, this does not explain the opposing
cortisol responses exhibited in high waist-hip ratio males. To assess this further,
response to repeated stress should be assessed to more comprehensively assess
stimulated cortisol responses in this sub-group.
7.5.3 Assessing Cognitive Performance
Perhaps the most significant weakness in the assessment of cognitive performance is the
lack of baseline cognitive data prior to exposure to the stressor task. This places the
reliability of the cognitive assessment into question. Due to time constraints and the
nature of the test session as it stands, additional assessment of baseline performance was
deemed impractical. To compensate for this, an estimate of IQ (using the National Adult
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Reading Test) was made and included as a covariate to control for IQ related differences
in performance. This eliminated the possibility of practice effects often observed with
the repeated use of cognitive test batteries and further the possibility of the battery
inducing a significant anticipatory response prior to stress exposure or acting as a
stressor per se, as observed in previous research (Lupien et al., 1997).
Neuropsychological test batteries have been implemented as stressors in their own right
(Bohnen et al., 1990). However, it cannot be fully ascertained whether poor
performance post stressor was also poor prior to testing. Cognitive ability can differ by
cognitive task, despite variance in IQ. An example of this is the difference in
performance between males and females for spatial memory. Males generally perform
better on spatial tasks than females. The method of encoding information can also affect
retrieval. Therefore, to provide a more comprehensive assessment of declarative
memory, it would be of interest to assess visual verbal memory, both recall and
recognition. Further, in addition to proactive interference, retroactive interference
should be assessed. This is the potential for newly learned material to affect material
already acquired. This would collectively provide a more comprehensive and reliable
assessment of cognitive performance which is influenced by the hippocampus.
7.5.4 Compliance and Basal Cortisol Profiling
The use of saliva samples for cortisol measurement is a practical and feasible method of
exploring basal diurnal cortisol profiles in a free-living paradigm. However, the
accuracy and reliability of the profiles obtained is often confounded by the issue of
volunteer compliance (Kudielka et al., 2003). Safeguards were employed to preserve the
accuracy of the saliva samples collected as previously discussed in the respective
Chapters. These included verbal and written instructions for the production of saliva
samples for research used in Chapter's Four, Five and Six.
One of the most interesting findings of this thesis was the high prevalence of a non-
classic diurnal profile observed throughout the thesis and the psychological and
metabolic factors that the incidence of this type of profile appeared to be associated
with. This non-classic profile was characterised by a lack of a cortisol awakening
response and normal or elevated diurnal cortisol secretion. In the past, researchers have
sought to remove individuals not displaying a clear cortisol awakening response from
the data set as a means to protect against volunteer non-compliance. However,
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approximately 10% of individuals fail to exhibit a cortisol awakening response
(Prussner et al., 1997). Therefore, this may result in exclusion of volunteers with a
disrupted HPA axis. If a lack of a cortisol awakening response is a sign of compliance
then in the current study, then 48% of the sample in Chapter Five and 47% of the
sample in Chapter Six would have been excluded. The findings of this thesis support the
argument that a flattened profile is more than just a signal of volunteer non-compliance
(Bjorntorp and Rosmond, 2000; Rosmond et al., 1998). Further, the observation that in
both Figure 5.6 in Chapter Five and Figure 6.28 in Chapter Six, mean cortisol at waking
did not differ significantly between the classic and non-classic groups, effectively
eliminates the possibility of non-compliance. Non-classic profiles were associated with
a significantly greater incidence of metabolic syndrome symptomology, perceived stress
and poor sleep quality. Rivera and Svec (1989) have argued against the exclusion of
subgroups in volunteer samples for example, individuals bordering on diabetic in an
assessment of cortisol, central obesity and the metabolic syndrome may be an exclusion
of the subgroup of most interest. The exclusion of such individuals based on flattened
profiles or metabolic conditions may cause a skewness of the characteristics of the
group towards those with lower body proportions (peripheral obesity).
7.6 Future Research
The potential for further research to arise as a result of this thesis is great. Initial
suggestions are based on suggested improvements to the current studies. For example,
of key interest would be an assessment of urinary cortisol output in those with central
obesity to elucidate the HPA dysregulation hypothesis. HPA responsivity to stress
should be further assessed in those with central obesity in a much larger sample and
with pre-test baseline measures of cognitive function across a wide set of cognitive
domains to comprehensively assess cognition. Further, gender differences in the
response to stress could be explored further concurrent with the assessment of male and
female sex hormones, specifically, testosterone and oestrogen. Recent animal research
suggests that activation of oestrogen receptors using a selective oestrogen receptor beta
agonist improves learning and memory (Day et al., 2006). As discussed previously,
centrally obese males have been found to show lower levels of testosterone (Derby et
aI., 2006) and that testosterone can inhibit HPA activity, particularly the release of
ACTH (Williamson et aI., 2005). A lower level of testosterone in centrally obese males
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could signal increased responsiveness to stress, which would concur with the current
findings. Further research to explore the collective effects of sex hormones on stress
responsivity and cognition could therefore, be conducted.
Poor diet and physical inactivity are often associated with being chronically stressed,
leading to weight gain (Wardle and Gibson, 2002). This may be an alternative route to
the expression of the metabolic syndrome (Epel et al., 2004). Building on these
observations it would be of interest to explore the potential for diet and exercise to
modulate both basal and stimulated cortisol activity in conjunction with the expression
of central obesity and the metabolic syndrome. Dimitrov and Koeva (2006) observed a
reduction in obesity co-morbidities (triglycerides, LDL) following 3 months of dietary
supplementation with omega-3 fatty acid, magnesium and soybean isoflavones. Further,
despite no change in body weight or cortisol, better mood and stress coping were
observed.
Improvements in blood pressure responses to stress have been observed following a
period of aerobic exercise (Brownley et al., 2003; Hamer et al., 2006; Probst et al.,
1997). Further, Traustad6ttir et al. (2005) observed that greater HPA reactivity marked
by increases in cortisol were more common in unfit women. Higher aerobic fitness was
associated with a blunted cortisol response to stress. It would be of interest to explore
the impact of exercise on stress responsivity particularly in those with central obesity.
Further, the impact this could have on the development of metabolic syndrome could be
explored. Green et al. (2004) assessed the impact of exercise on metabolic syndrome
status in a sample of postmenopausal women with and without oestrogen replacement
therapy (ERT) but failed to find an effect. Therefore, there is scope for further research.
Exploring the impact of exercise on stress responsivity could also contribute to a test of
the hypothesis that the relationship between cortisol and central obesity is mediated
through inflammation, based on the observation that weight loss reduces the
concentration of inflammatory markers present (Black 2006).
Interestingly, exercise has also been found to influence cognition, particularly in the
elderly (Fratiglioni et al., 2004; Van Gelder et al., 2004). In a meta-analysis, Colcombe
and Kramer (2003) found evidence to suggest that aerobic training in older persons
improves cognitive functioning, particularly executive control. A review by Eggermont
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et al. (2006) observed that these improvements were observed even in the presence of
cardiovascular risk factors. This implies, that improvements in cognitive function could
be observed in individual's borderline for the diagnosis of metabolic syndrome. The
main aim of future research might be intervention and prevention, once clear differences
have been established in a replication of the studies presented in Chapters Five and Six
of this thesis with larger sample sizes.
More interestingly, more recent research has identified a potential relationship between
vascular endothelial growth factor (VEGF) and obesity status (Hubold et aI., 2006).
VEGF has been shown to allocate glucose to the brain (across the blood brain barrier).
Based on this Hubold et al. (2006) demonstrated that lower VEGF was linked with the
presence of obesity and postulated that this may be linked to the glucose feedback
mechanism of food intake and body mass. The relationship between VEGF and cortisol
is yet to be determined. However, in terms of the current thesis, it would be interesting
to explore the impact lowered VEGF has on cognition, based on the hypothesis that low
VEGF reduces brain glucose transportation with consequences for cognitive
performance. This may be an alternative mechanism of action to explain poorer
cognitive performance in those with central obesity.
7.7 Concluding Remarks
In conclusion, the research presented in this thesis suggests that individuals with central
obesity exhibit altered basal cortisol levels compared with lean or peripherally obese
individuals. Observed variability in the profiles (and possible pathological cortisol
secretion) was associated with a vulnerability to the metabolic syndrome with a
flattened profile associated with biological markers of the metabolic syndrome,
including elevated inflammatory markers and insulin resistance. The identification of
psychological and metabolic parameters associated with the expression of non-classic
basal cortisol profiles has important implications for the issue of volunteer compliance.
The collective presence of elevated cortisol responses to stress in individuals with
central obesity and associated metabolic symptomology appeared to influence cognitive
performance leading to impairments on some hippocampal related memory tasks. With
further research, these findings could contribute to a more detailed exploration of the
impact of chronic stress on psychological and metabolic functioning.
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Appendix 1: Volunteer Screening Booklet
~
~ "E PARTICIPANT SCREENING PACK
Thank you for your decision to participate in this study. The following information
pack is designed to collect some data about yourself, your health and well being, in order to
assess your suitability for this study and to determine what benefits participating may hold for
you.
You are under no obligation to answer any question that you may not wish to
answer for any reason, but are reminded that your responses will help us to help you and will
aid the understanding of you as a person. Your confidentiality will be respected at ALL times.
Thank you
Section One: About You
1. Name: .....................................................
Date of Birth: DJ /DJ /I I I I I
Age: DJ
2. Gender: MALE \ FEMALE (Please circle)
3. Are you currently: (please tick)
Single
Married
Living with partner
Divorced and single
Divorced and remarried
Widowed and remarried
Widowed and single
If you are in a relationship, how long? D years
Do you have any children? (Please tick)
No
Yes
o
0(...number of children)
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Section Two: Your Employment
1. Are you? (Please tick)
Retired
o
o
o
o
o
o
Employed - full time
Employed -part time
Unemployed
Student
Housewife
2. What is / was your most recent employment?
3. Did / does this position require that you work any abnormal shifts e.g. night shifts?
YES /NO (Please circle)
If 'YES' please specify:
Section 3: Your Diet
1. Are you currently dieting to lose weight?
YES/NO
2. Do you avoid any specific foods?
YES/NO
If 'YES', which foods do you avoid?
Why do you avoid this / these food(s)? Slimming o
Allergic 0
Health 0
Religion 0
Dislike the food 0
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Vegetarian o
3. How would you rate your diet? (Please indicate with a vertical line)
Not at all
Healthy
Extremely----------------------------------------- Healthy
Section 4: Your Health
1. How would you rate your general health? (Please indicate with a vertical line)
Not at all
healthy
Extremely__________________________________ Healthy
2. Do you smoke?
No, have never smoked o
No, have given up o (How Long? years)
Yes, regularly
o
o
Yes, occasionally
3. Are you currently on any form of medication? If so please detail below:
Medication What is it for?
If you are MALE, please skip to question S
4. Please tick the statement which best applies to you;
I still have regular periods
I have not had a period for 2 years
I have not had a period for 1 year
I still have some periods but they are irregular and erratic
Have you experienced hot flushes? (Please tick)
Rarely
Yes, frequently
Sometimes
Never
If you still have regular periods;
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What method of contraception do you use? (Please tick)
Spermicidal cream (cream, foam, sponge)
o
o
o
o
None
Condom I Femidom
Diaphragm I Cap
Rhythm method (taking temperature, counting)
Implants (e.g. Norplant)
Which? _
Coil I IUD: 0
Which? _
Contraceptive injections 0
Which? --------------- o
o
o
o
o
o
o
o
o
Withdrawal (coitus interruptus)
Combined pill
Progesterone only pill (or mini pill)
Hysterectomy
Sterilised
Partner is sterilised
Past menopause ('- years ago)
If you use another form of contraception, please specify below:
Are you currently takinglhave taken any form of Hormone Replacement Therapy?
No 0
Yes, Years ago 0
Yes, take it at present 0
If 'YES', what is I was it called?
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What was the date of your last period?
How many days do you usually bleed for? e.g. 5
Appendices
/ /
_Days
How long is your average cycle? Le. how many days from the start of one period
to the start of the next e.g. 29 days
5. Have you ever suffered from any of the following in the past or at present
(currently)? (Please tick if applicable)
Asthma
Diabetes
High blood pressure
Low blood pressure
Any cardiac (heart) problems
Hormonal problems
Digestive disorders/problems
Liver problems
Neurological problems (nervous system disorders)
Mental problems E.g. depression, anxiety etc
Any type of eating disorder
Section 5: Exercise
1. What forms of exercise do you do? (Please tick all that apply)
Running
Walking
Cycling
Swimming
Aerobics ..............................................
Gym Use
Other (please specify below)
.............................................
..............................................
_Days
Past Currently
B
2.Do you play sport? ..... YESINO. Ifyes ..........
- Which sport do you play most frequently?
- How many hours a week? ..... (Circle ).... <1 1-2 2-3 3-4 >4
- How many months a year? ..... (Circle) .... <1 1-3 4 7-9 >9
- If you playa second sport, what is it?
- How many hours a week? ..... (Circle) .... <1 1-2 2-3 3-4 >4
- How many months a year? ..... (Circle) .... <1 1-3 4-6 7-9 >9
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3. In comparison with others of my own age I think my physical activity during leisure
time is: (please circle)
Much less less the same more much more
THANK YOU FOR YOUR TIME
If you have any comments or queries about this questionnaire or your participation in this study then
please do not hesitate to contact me:
Nicola Lasikiewicz
Tel: 0113 343 6697
Email: pscnjlril)leeds.ac.uk
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Appendix 2: Telepbone Screening Questionnaire
Date:
Telephone Interview.
Time:
Ppt name:
Age/DOB: M / F (circle)
Contact Details:
Tel num:
Email:
Address (optional):
Where did you hear about this study?
A few preliminary Questions:
Do you smoke? Y / N
Are you currently on any form of medication e.g. steroidal, anti-inflammatory, hormonal
medication etc? Y / N
If yes, please indicate what this medication is for (optional):
IF FEMALE Are you currently taking any form of contraception, implants or HRT treatment
at the moment? Y / N
What is your occupation?
Does this job require that you work any night or abnormal shifts? Y / N
Have you given blood in the past few months? Y / N
Thank the caller and inform the candidate that the researcher will be in touch shortly with
further details.
Office Use Only
Selected for participation:
Participant informed?
Screening pack provided:
YIN
YIN
YIN
Date:
Date:
Participant assigned code:
Authorisation: -------------------------------
EXINL- _
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Appendix 3: Saliva Sampling Guide 1
Date: / Participant Identification: EX2NL - _
Sample Day: Monitoring Day One Test day Monitoring Day Two (please circle)
SAMPLE GUIDE
PLEASE ENTER YOUR WAKING TIME FOR THIS MORNING IN THE SPACE BELOW:
Time: __ : __ am/pm (delete as appropriate)
PLEASE COMPLETE THE TIME SLOTS BELOW BASED ON YOUR WAKING TIME.
IT IS IMPORTANT THAT YOU TAKE EACH SAMPLE ON TIME AND MAKE SURE THAT THE
COTTON WOOL IS SATURATED WITH SALlY A BEFORE RETURNING TO THE TUBE.
TIME SAMPLE TO COMMENTS
BE TAKEN
D1 - FIRST Remain in bed and keep movements to a minimum.
What time did you Cl Use Drool pot first - generate as much saliva as possible
wake up? and drool into pot
-- -- Use the salivette IMMEDIA TELY following this.
Nil by Mouth except water if necessary and refrain from
brushing teeth.
C2 Remain in bed and keep movements to a minimum.
15 minutes post Nil by mouth except water if necessary. Refrain from
waking: brushing teeth.
-- --
C3 Remain in bed and keep movements to a minimum.
30 minutes post Nil by mouth except water if necessary. Refrain from
waking: brushing teeth.
-- --
C4 Nil by mouth except water if necessary and refrain from
45 minutes post brushing teeth until after sample has been taken.
waking: Resume normal activities after this sample.
-- --
C5 Nil by mouth 30minutes before the sample is due to be
3 hours post waking: taken.
-- --
C6 Nil by mouth 30minutes before the sample is due to be
6 hours post waking: taken.
-- --
C7 Nil by mouth 30minutes before the sample is due to be
9 hours post waking: taken.
-- --
C8 Nil by mouth 30minutes before the sample is due to be
12 hours post waking: taken.
-- :--
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Appendix 4: Saliva Sample Guide 2
Date: Participant Identification: EX2NL - _
Sample Day: Monitoring Day One Test day Monitoring Day Two (please circle)
SAMPLE GUIDE
PLEASE ENTER YOUR WAKING TIME FOR THIS MORNING IN THE SPACE BELOW:
Time: __ : __ am/pm (delete as appropriate)
PLEASE COMPLETE THE TIME SLOTS BELOW BASED ON YOUR WAKING TIME.
IT IS IMPORTANT THAT YOU TAKE EACH SAMPLE ON TIME AND MAKE SURE THAT THE
COTTON WOOL IS SATURATED WITH SALIVA BEFORE RETURNING TO THE TUBE.
TIME SAMPLE TO COMMENTS
BETAKEN
01 - FIRST Remain in bed and keep movements to a minimum.
What time did you Cl Use Drool pot first - generate as much saliva as possible
wake up? and drool into pot
Use the salivette IMMEDIATELY following this.
-- -- Nil by Mouth except water if necessary and refrain from
brushing teeth.
C2 Remain in bed and keep movements to a minimum.
15 minutes post Nil by mouth except water if necessary. Refrain from
waking: brushing teeth.
-- :--
C3 Remain in bed and keep movements to a minimum.
30 minutes post Nil by mouth except water if necessary. Refrain from
waking: brushing teeth.
-- :--
C4 Nil by mouth except water if necessary and refrain from
45 minutes post brushing teeth until after sample has been taken.
waking: Resume normal activities after this sample.
-- :--
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Appendix 5: Salivette Instruction Sheet
Instructions for Saliva Sampling using Salivettes.
1. Collect saliva at the times specified on your Daily Sampling Schedule. Saliva should be
collected no earlier than 30 minutes after eating or drinking.
2. Hold the salivette at the rim of the suspended insert and remove the stopper. Removal of
the stopper is easier if you slightly push it to the side when opening the suspended
insert.
3. Now remove the cotton wool swab from the salivette.
4. Collect the saliva by chewing the cotton wool. Keep the cotton in your mouth until you
feel that you can no longer prevent yourself from swallowing the saliva produced. This
normally takes about 30-45 seconds.
5. Now return the saturated cotton wool swab to the suspended insert and close the
salivette firmly with the stopper.
6. Until you have collected all samples, keep the salivettes refrigerated until they can be
returned to the researcher.
If you have any problems or queries, please contact Nicola on 01133436697 or
pscnjl@leeds.ac.uk.
Ppt ID: EXINL _
Blood sample Obtained?
Difficult venepuncture?
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Appendix 6: Physiological Data Record Sheet
Date: / /
Participant Physiological Data
YES INO
YE INO
Comments: --------------------------------------------------------
Height (cm)
Weight (kg)
BMI
Waist (cm)
Hip (cm)
Waist Hip Ratio
Pulse
Blood Pressure I.
Body Composition performed?
% Fat:Body Comp Fat Mass:
Thank the Participant
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Appendix 7: Colour Blindness Test
VOLUNTEER ID: EX2NL: DATE: / /
COLOUR BLINDNESS
Please indicate the colour ink each word is printed in using the spaces below.
Thank you.
COLOUR COLOUR COLOUR
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Appendix 8: Visual Analogue Scales (Subjective EvaluationlDebrief
Questionnaire)
Version for Stress Condition
PARTICIPANT ID: EX2NL- DATE: /
DEBRIEF OUESTIONNAIRE
Please answer the following questions about the experiment you have just taken part in. Thank you.
1. Please indicate using a vertical line on the scale below how well you feel you did in the interview task
for each of the following aspects:
(a) preparation
Very well ----------------------- not very well
(b) in the interview itself
Very well ------------------------ not very well
(c) in the mental arithmetic task
Very well not very well
2. Please indicate using a vertical line on the scale below how easy/difficult you felt it was to complete
each of the following aspects:
(a) preparation
Easy Difficult
(b) in the interview itself
Easy -------------------------- Difficult
(c) in the mental arithmetic task
Easy Difficult
3. (a) How easy/difficult did you find the cognitive tests?
Very well not very well
(b) How well do you think you have done in the cognitive tests?
Very well not very well
4. Please indicate using a vertical line on the scale below how stressful you felt each of the following
aspects was for you:
(a) preparation
Very --------------------------------------------
stressful
not at all
stressful
(b) the interview (including the mental arithmetic task)
Very
stressful
not at all
stressful
(c) the cognitive tests
Very
stressful
not at all
stressful
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Version for No Stress Condition:
PARTICIPANT ID: EX2NL- DATE:
DEBRIEF QUESTIONNAIRE
Please answer the following questions about the experiment you have just taken part in. Thank you.
1. Please indicate using a vertical line on the scale below how well you feel you did in the preparing your
application letter?
Very well ------------------------- not very well
2. Please indicate using a vertical line on the scale below how easy/difficult you felt it was to prepare
your application letter?
Easy Difficult
3. (a) How easy/difficult did you find the cognitive tests?
Easy Difficult
(b) How well do you think you have done in the cognitive tests?
Very well not very well
4. Please indicate using a vertical line on the scale below how stressful you felt each of the following
aspects was for you:
(a) preparing the application letter:
Very
stressful
not at all
stressful
(b) talking about the application letter:
Very
stressful
not at all
stressful
(c) the cognitive tests
Very
stressful
not at all
stressful
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Appendix 9: Post Stress Study Debrief Sheet
Version for Stress Condition
PARTICIPANT INFORMATION SHEET - DEBRIEF
Thank you for taking part in this research. Now that the experiment is complete, I would like to
provide with some information the study and the types of task you have completed and what
they were for.
This study was an examination of the impact of stress induced cortisol activity on cognition, i.e.
your memory, attention and concentration. It also aimed to examine differences in stress
responsivity (how you responded to the stressor in terms of cortisol, blood pressure and mood)
in terms of body shape (apples vs. pears).
You were placed in the 'stress' condition. The interview scenario of which you took part is a
version of what is known as the Trier Social Stress Test (TSST). This is a widely used
standardised laboratory stress induction tool pioneered by researchers at the University of Trier
in Germany. This served as a stressor in the form of a public speaking task in an attempt to
increase your cortisol levels and effectively to induce a stress 'response'. Once a response was
initiated it was then possible to examine whether an increase in stress would affect your ability
to remember information, to pay attention to certain stimuli, maintain concentration, plan moves
in a sequence and solve problems in basic computer tasks. The tests that you completed form
part of the widely used and reliable Cambridge Automated Neuropsychological Test Battery or
CANTAB. This is comprises a number of tests administered to assess various aspects of
memory and mental performance.
By conducting this research it is hopeful that an insight will be gained into how we cope
mentally during stressful situations, are we able to remember information and pay attention
when under stress. Of particular interest is the action of the stress hormone cortisol, often found
to influence cognitive performance. Cortisol is also linked to body shape, and often we see that
levels of circulating cortisol are altered in those with a high waist hip ratio (apple shaped). By
exploring the impact body shape has on our responses to stress we can hopefully see if anyone
individual is more vulnerable to the effects of stress both on health and on cognition. With this
knowledge it may be possible to aid further research into combating the more negative aspects
of stress and improving quality of life. Once all data has been collected and the results
processed a special feedback evening will be arranged for all who took part. Details will be
available nearer the time. Should you have any questions or comments then please contact me
using the details below.
THANK YOU
Email: pscnil@leeds.ac.uk Telephone: 01133436697
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Version for No Stress Condition:
PARTICIPANT INFORMATION SHEET - DEBRIEF
Thank you for taking part in this research. Now that the experiment is complete, I would like to
provide with some information the study and the types of task you have completed and what
they were for.
This study was an examination of the impact of stress induced cortisol activity on cognition, i.e.
your memory, attention and concentration. It also aimed to examine differences in stress
responsivity (how you responded to the stressor in terms of cortisol, blood pressure and mood)
in terms of body shape (apples vs. pears).
You were placed in the 'no stress' condition. Preparing an application letter served as a control
condition to the Trier Social Stress Test (TSST) a procedure used to initiate a stress response so
that the impact of elevated stress levels on cognitive performance can be examined. In the no
stress condition your ability to complete various cognitive tasks such as remembering
information, paying attention to certain stimuli, maintaining concentration, planning moves in a
sequence and solving problems in basic computer tasks was examined under 'normal' or
'control' conditions. The tests that you completed form part of the widely used and reliable
Cambridge Automated Neuropsychological Test Battery or CANTAB. This is comprises a
number of tests administered to assess various aspects of memory and mental performance.
By conducting this research it is hopeful that an insight will be gained into how we cope
mentally during stressful situations, are we able to remember information and pay attention
when under stress. Of particular interest is the action of the stress hormone cortisol, often found
to interact with cognitive performance. Cortisol is also linked to body shape, and often we see
that levels of circulating cortisol are altered in those with a high waist hip ratio (apple shaped).
By exploring the impact body shape has on our responses to stress we can hopefully see if any
one individual is more vulnerable to the effects of stress both on health and on cognition. With
this knowledge it may be possible to aid further research into combating the more negative
aspects of stress and improving quality of life. Once all data has been collected and the results
processed a special feedback evening will be arranged for all who took part. Details will be
available nearer the time. Should you have any questions or comments then please contact me
using the details below.
THANK YOU
Email: pscnjl@leeds.ac.uk Telephone: 01133436697
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Appendix 10: Perceived Stress Scale (PSS)
Perceived Stress Scale
The questions in this scale ask you about your feelings and thoughts during the last
month. In each case, you will be asked to indicate by circling how often you felt or
thought a certain way.
O=Never L=Almest Never 2=Sometimes 3=Fairlyoften 4=Very often
1. In the last month, how often have you been upset about 0 1 2 3 4
something that has hapI'_ened unexpectedly?
2. In the last month, how often have you felt that you were 0 1 2 3 4
unable to control the important things in your life?
3. In the last month, how often have you felt nervous and 0 1 2 3 4
'stressed'?
4. In the last month, how often have you felt confident about 0 1 2 3 4
your ability to handle your personal problems?
5. In the last month, how often have you felt that things were 0 1 2 3 4
going your way?
6. In the last month, how often have you found that you 0 1 2 3 4
could not cope with all the things that you had to do?
7. In the last month, how often have you been able to control 0 1 2 3 4
the irritations in your life?
8. In the last month, how often have you felt that you were 0 1 2 3 4
on top of things?
9. In the last month, how often have you been angered 0 1 2 3 4
because of things that were outside your control?
10. In the last month, how often have you felt difficulties 0 1 2 3 4
were piling up so high that you could not overcome them?
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Appendix 11: Leeds Sleep Evaluation Questionnaire (LSEQ)
Ppt ID: EX2NL - _
DAY: 1 2 3 (circle)
Time: ____ AM/PM
Sleep
Each of the following questions are about a TYPICAL night's sleep. Answer the questions by placing a
vertical mark through the line in the place that best indicates your answer.
1. In a typical night how EASY is it to get to sleep?
very
easy
2. How QUICKLY do you get to sleep?
very
quickly
3. What is the QUALITY of your sleep in a typical night?
very
restful
no periods
of
wakefulness
4. What is your pattern of AWAKENING like in a typical morning?
very
easy
takes a
short time
5. How do you usually FEEL ON AWAKENING?
alert
6. How do you usually feel 1 HOUR AFTER awakening?
alert
very
difficult
very
slowly
not at all
restful
many
periods
of
wakefulness
very
difficult
takes a
long time
tired
tired
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Each of the following questions are about LAST night's sleep. Answer the questions by placing a vertical
mark through the line in the place that best indicates your answer.
1. How EASY was it to get to sleep last night?
very
easy
2. How QUICKLY did you get to sleep last night?
very
quickly
3. What was the QUALITY of your sleep last night?
very
restful
no periods of
wakefulness
4. What was your pattern of AWAKENING like this morning?
very
easy
took a
short time
5. How did you FEEL ON AWAKENING this morning?
alert
6. How did you feel 1 HOUR AFTER awakening this morning?
alert
very
difficult
very
slowly
not at all
restful
many periods
of wakefulness
very
difficult
took a
long time
tired
tired
.-
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Appendix 12: Hospital Anxiety and Depression Scale (HADS)
Hospital Anxiety and Depression Scale (HADS)
Please read each item and place a tick opposite the reply which comes closest to how you have been
feeling in the past few weeks. Remember that your immediate reaction to each item may be more accurate
than a long thought-out response.
1. I feel tense or 'wound up'
Most of the time
A lot ofthe time
Time to time, occasionally
Not at all
3. I still enjoy the things I used to enjoy:
Definitely as much
Not quite so much
Only a little
Hardly at all
5. I get a sort of frightened feeling as if
something awful is about to happen:
Very definitely and quite badly
Yes but not too badly
A little but it doesn't worry me
Not at all
7. I can laugh and see the funny side of
things:
As much as Ialways could
Not quite so much now
Definitely not so much now
Not at all
9. Worrying thoughts go through my
mind:
A great deal of the time
A lot of the time
From time to time but not too often
Only occasionally
11. I feel cheerful:
Not at all
Not often
Sometimes
Most of the time
13. I can sit at ease and feel relaxed:
Definitely
Usually
Not often
Not at all
2. I feel as if I am slowed down:
Nearly all the time
Very often
Sometimes
Not at all
4. I get a sort of frightened feeling like
'butterflies' in the stomach:
Not at all
Occasionally
Quite often
Very often
6. I have lost interest in my appearance
Definitely I
Idon't take so much care as Ishould
Imay not take quite as much care
Itake just as much care as ever
8. I feel restless as if I have to be on the move:
I Very much indeed ~Quite a lotNot very muchNot at all
10. I look forward with enjoyment to things:
As much as Iever did
Rather less than Iused to
Definitely less than Iused to
Hardly at all
12. I get sudden feelings of panic:
I Very often indeedQuite oftenNot very oftenNot at all
14. I can enjoy a good book or radio or TV
~
6~~me:
Sometimes
Not often
Very seldom
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Appendix 13: Dutch Eating & Behaviour Scale (DEBQ)
Dutch Eating and Behaviour Scale (DEBQ)
Please answer the following questions as carefully and honestly as possible. Read each
question and simply circle the number which best applies to you.
O=Never 1= Seldom 2=Sometimes 3=Often 4=very often
1. If you have put on weight, do you eat less than you normally do? 0 1 2 3 4
2. Do you have a desire to eat when you are irritated? 0 1 2 3 4
3. If food tastes good to you, do you eat more than you usually do? 0 1 2 3 4
4. Do you try to eat less at meal times than you would like to eat? 0 1 2 3 4
5. Do you have a desire to eat when you have nothing to do? 0 1 2 3 4
6. Do you have a desire to eat when you are 'fed-up'? 0 1 2 3 4
7. If food smells good and looks good, do you eat more than you usually 0 1 2 3 4
do?
8. How often do you refuse food and drink offered because you are 0 1 2 3 4
concerned about your weight?
9. Do you have a desire to eat when you are feeling lonely? 0 1 2 3 4
10. If you see or smell something delicious do you have a desire to eat it? 0 1 2 3 4
11. Do you watch exactly what you eat? 0 1 2 3
4
12. Do you have a desire to eat when someone disappoints you? 0 1 2 3 4
13. If you have something delicious to eat, do you eat it straight away? 0 1 2 3 4
14. Do you deliberately eat foods that are slimming? 0 I 2 3 4
15. Do you have a desire to eat when you are cross? 0 1 2 3 4
16. Do you have a desire to eat when you are expecting something to 0 1 2 3 4
happen?
17. If you walk past the baker, do you have the desire to buy something 0 1 2 3 4
delicious?
18. When you have eaten too much do you eat less than usual on the 0 1 2 3 4
following days?
19. Do you get a desire to eat when you are anxious, worried or tense? 0 1 2 3 4
20. If you walk past a snack bar or cafe do you have a desire to buy 0 1 2 3 4
something delicious?
21. Do you deliberately eat less in order not to become heavier? 0 1 2 3 4
22. Do you have a desire to eat when things go against you or when things 0 1 2 3 4
have gone wrong?
23. If you see others eating, do you also have a desire to eat? 0 1 2 3 4
24. How often do you try not to eat between meals because you are 0 1 2 3 4
watching your weight?
25. Do you have a desire to eat when you are frightened? 0 1 2 3 4
26. Can you resist eating delicious foods? 0 1 2 3 4
27. How often in the evening do you try not to eat because you are watching 0 1 2 3 4
your weight?
28. Do you have a desire to eat when you are disappointed? 0 1 2 3 4
29. Do you eat more than usual when you see others eating? 0 1 2 3 4
30. Do you think about you weigh before deciding how much to eat? 0 1 2 3 4
31. Do you have a desire to eat when you are upset? 0 1 2 3 4
32. When you see someone preparing a meal, does it make you want to eat 0 1 2 3 4
something?
33. Do you have a desire to eat when you are bored or restless? 0 I 2 3 4
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Appendix 14: National Adult Reading Test (List of words)
CHORD SUPERFLUOUS
ACHE SIMILE
DEPOT BANAL
AISLE QUADRUPED
BOUQUET CELLIST
PSALM FAC;ADE
CAPON ZEALOT
DENY DRACHM
NAUSEA AEON
DEBT PLACEBO
COURTEOUS ABSTEMIOUS
RAREFY DETENTE
EQUIVOCAL IDYLL
NAIVE PUERPERAL
CATACOMB AVER
GAOLED GAUCHE
THYME TOPIARY
HEIR LEVIATHAN
RADIX BEATIFY
ASSIGNATE PRELATE
HIATUS SIDEREAL
SUBTLE DEMENSE
PROCREATE SYNCOPE
GIST LABILE
GOUGE CAMPANILE
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Appendix 15: Daily Hassles Scale with Self-Report Section
Ppt ID: EXI NL: ___ Date: _- _- --
Daily Hassles Questionnaire
Please read each item and circle the appropriate number in terms of how much the item was a
hassle to you TODAY.
o = none or did not occur 1= somewhat severe 2= moderately severe 3 = extremelysevere
1.Misplacing or losing things 0 1 2
3
2. Troublesome neighbours 0 1
2 3
3. Social obligations 0 1 2
3
4. Inconsiderate smokers 0 1 2
3
5. Troubling thoughts about your future 0 1 2
3
6. Thoughts about death 0 1
2 3
7. Health of a family member 0 1
2 3
8. Not enough money for clothing 0 1 2
3
9. Not enough money for housing 0 1 2
3
10. Concerns about owing money 0 1 2
3
11. Concerns about getting credit 0 1
2 3
12. Concerns about money for emergencies 0 1 2
3
13. Someone owes you money 0 1
2 3
14. Financial responsibility for someone who does not live with you 0 1 2 3
15. Cutting down on electricity, water etc 0 1 2 3
16. Smoking too much 0
1 2 3
17. Use of alcohol 0
1 2 3
18. Personal use of drugs 0
1 2 3
19. Too many responsibilities 0 1
2 3
20. Decisions about having children 0 1 2
3
21. Non-family members living in your house 0 1 2
3
22. Care for pet 0
1 2 3
23. Planning meals 0
1 2 3
24. Concerned about the meaning of life 0 1 2 3
25. Trouble relaxing 0
1 2 3
26. Trouble making decisions 0 1
2 3
27. Problems getting along with fellow workers 0 1 2
3
28. Customers or clients giving you a hard time 0 1 2
3
29. Home maintenance (inside) 0 1
2 3
30. Concerns about job security 0 1
2 3
31. Concerns about retirement 0 1
2 3
32. Laid off or out of work 0 1
2 3
33. Don't like current work duties 0 1
2 3
34. Don't like fellow workers 0 1
2 3
35. Not enough money for basic necessities 0 1 2 3
36. Not enough money for food 0 1
2 3
37. Too many interruptions 0 1
2 3
38. Unexpected company 0
1 2 3
39. Too much time on hands 0
1 2 3
40. Having to wait 0 1
2 3
41. Concerns about accidents 0 1
2 3
42. Being lonely 0
1 2 3
43. Not enough money for healthcare 0 1
2 3
44. Fear of confrontation 0 1
2 3
45. Financial security 0 1
2 3
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46. Silly practical mistakes 0
1 1 3
47. Inability to express yourself 0 1
2 3
48. Physical illness 0
1 2 3
49. Side effects of medication 0
1 2 3
50. Concerns about medical treatment 0
1 2 3
51. Physical appearance
0 1 2 3
52. Fear of rejection
0 1 2 3
53. Difficulties with getting pregnant 0
1 2 3
54. Sexual problems that results from physical problems 0 1
2 3
55. Sexual problems other than those resulting from physical problems 0 1 2
3
56. Concerns about health in general 0
1 2 3
57. Not seeing enough people 0
1 2 3
58. Friends or relatives too far away 0
1 2 3
59. Preparing meals
0 1 2 3
60. Wasting time
0 1 2 3
61. Car maintenance
0 1 2 3
62. Filling out forms
0 1 1 3
63. Neighbourhood deterioration 0
1 2 3
64. Financing children's education 0
1 2 3
65. Problems with employees
0 1 2 3
66. Problems on job due to being a man or a woman 0
1 2 3
67. Declining physical abilities
0 1 2 3
68. Being exploited
0 1 2 3
69. Concerns about bodily functions 0
1 2 3
70. Rising prices of common goods 0
1 2 3
71. Not getting enough rest
0 1 2 3
72. Not getting enough sleep
0 1 2 3
73. Problems with ageing parents
0 1 2 3
74. Problems with your children
0 1 2 3
75. Problems with persons younger than yourself 0
1 2 3
76. Problems with your lover
0 1 2 3
77. Difficulties seeing or hearing
0 1 2 3
78. Overloaded with family responsibilities 0
1 2 3
79. Too many things to do
0 1 2 3
80. Unchallenging work
0 1 2 3
81. Concerns about meeting high standards 0
1 2 3
82. Financial dealings with friends or acquaintances 0
1 2 3
83. Job dissatisfaction
0 1 2 3
84. Worries about decisions to change jobs 0
1 2 3
85. Trouble with reading, writing, or spelling abilities 0 1
2 3
86. Too many meetings
0 1 2 3
87. Problems with divorce
0 1 2 3
88. Trouble with arithmetic
0 1 2 3
89. Gossip
0 1 2 3
90. Legal problems
0 1 2 3
91. Concerns about weight
0 1 2 3
92. Not enough time to do the things you need to do 0
1 2 3
93. Television
0 1 1 3
94. Not enough personal energy
0 1 2 3
95. Concerns about inner conflicts
0 1 2 3
96. Feel conflicted over what to do
0 1 2 3
97. Regrets over past decisions
0 1 2 3
98. Menstrual (period) problems
0 1 2 3
99. The weather
0 1 2 3
100. Nightmares
0 1 2 3
101. Concerns about getting ahead 0
1 2 3
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102. Hassles from boss or supervisor 0 1 2 3
103. Difficulties with friends 0 1 2 3
104. Not enough time for family 0 1 2 3
105. Transportation problems 0 1 2 3
106. Not enough money for transportation 0 1 2 3
107. Not enough money for entertainment and recreation 0 1 2 3
108. Shopping 0 1 2 3
109. Prejudice and discrimination from others 0 1 2 3
110. Property, investments or taxes 0 1 2 3
Ill. Not enough time for entertainment and recreation 0 1 1 3
112. Yard work or outside home maintenance 0 I 1 3
113. Concerns about news 0 1 1 3
114. Noise 0 1 2 3
115. Crime 0 1 2 3
116. Traffic 0 1 2 3
117. Pollution 0 1 1 3
How was your day today? If anything particularly unusual or stressful occurred today or if today
differed from any normal day then we would like you to tell us about it!
Please detail in the space below:
Thank you
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Appendix 16: Auditory Verbal Learning Task (List of words)
List A ListB
Drum Desk
Curtain Ranger
Bell Bird
Coffee Shoe
School Stove
Parent Mountain
Moon Glasses
Garden Towel
Hat Cloud
Farmer Boat
Nose Lamb
Turkey Gun
Colour Pencil
House Church
River Fish
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Appendix 18: State Trait Anxiety Inventory (STAI)
Questionnaire 2 Ppt ID: EX2NL: _ Time: ---- Date:
A number of statements which people have used to describe themselves are given below. Read each
statement and then circle the appropriate number to the right of the statement to indicate how you feel right
now, that is, at this moment. There are no right or wrong answers. Do not spend too much time on anyone
statement but give the answer which seems to describe your present feelings best.
Not at all Somewhat Moderately So Very Much So
1. I feel calm 1 2 3 4
2. I feel secure 2 3 4
3. I am tense 2 3 4
4. I feel strained 2 3 4
5. I feel at ease 2 3 4
6. I feel upset 2 3 4
7. I am presently worried over
possible misfortunes 2 3 4
8. I feel satisfied 2 3 4
9. I feel frightened 2 3 4
10. I feel comfortable 2 3 4
11. I feel self-confident 2 3 4
12. I feel nervous 2 3 4
13. I am jittery 2 3 4
14. I feel indecisive 2 3 4
15. I am relaxed 2 3 4
16. I feel content 2 3 4
17. I am worried 2 3 4
18. I feel confused 2 3 4
19. I feel steady 2 3 4
20. I feel pleasant 2 3 4
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Appendix 19: State Self Esteem Scale (SSES)
Questionnaire 1 Ppt ID: EX2NL: _ Time: -- -- Date:
This is a questionnaire designed to measure what you are thinking at this moment. There is, of course, no
right or wrong answer for any statement. Read each statement and then circle the appropriate number to the
right of the statement. The best answer is what you feel is true of yourself at this moment. Be sure to
answer all of the items, even if you are not certain of the best answer. Again, answer these questions as they
are true for you RIGHT NOW.
Not at A Some- Very Extremely
all little What Much
bit
1. I feel confident about my abilities. 2 3 4 5
2. I am worried about whether I am
regarded as a success or failure. 2 3 4 5
3. I feel satisfied with the way my body looks right now. 2 3 4 5
4. I feel frustrated or rattled about my performance. 2 3 4 5
5. I feel that I am having trouble understanding
things that I read. 2 3 4 5
6. I feel that others respect and admire me. 2 3 4 5
7. I am dissatisfied with my weight. 2 3 4 5
8. I feel self-conscious. 2 3 4 5
9. I feel as smart as others. 2 3 4 5
10. I feel displeased with myself. 2 3 4 5
11. I feel good about myself. 2 3 4 5
12. I am pleased with my appearance right now. 2 3 4 5
13. I am worried about what other people think of me. 2 3 4 5
14. I feel confident that I understand things. 2 3 4 5
15. I feel inferior to others at this moment. 2 3 4 5
16. I feel unattractive. 2 3 4 5
17. I feel concerned about the impression I am making. 2 3 4 5
18. I feel that I have less scholastic ability
right now than others. 2 3 4 5
19. I feel like I'm not doing well. 2 3 4 5
20. I am worried about looking foolish. 2 3 4 5
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Appendix 22: Cortisol secreted across the test session from alternative baseline in
HighlLow WHR MaleslFemales (Means ± SEM)
Cortisol Responses from Alternative Baseline By Condition, WHR and Gender N=61
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